dipyridamole has been researched along with aspirin in 1607 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 900 (56.00) | 18.7374 |
| 1990's | 273 (16.99) | 18.2507 |
| 2000's | 292 (18.17) | 29.6817 |
| 2010's | 125 (7.78) | 24.3611 |
| 2020's | 17 (1.06) | 2.80 |
| Authors | Studies |
|---|---|
| Cillero, FJ; Fau de Casa-Juana, M; Ortega, MP; Priego, JG; Sunkel, CE | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Jobin, F | 2 |
| Borasi, G; Pallestrini, EA; Sperati, G | 1 |
| Glusa, E | 1 |
| Fabris, F; Pernigotti, L | 1 |
| Haft, JI | 1 |
| Belli, R; Biasci, R; Bruna, C; Caruzzo, C; Gaschino, G | 1 |
| Bream, ML; Ferguson, GG; Philp, RB | 1 |
| Serradimigni, A | 1 |
| Loo, J | 1 |
| Björk, VO; Henze, A | 1 |
| Faergeman, O; Gormsen, J; Meinertz, H | 1 |
| Dougherty, JH; Levy, DE; Weksler, BB | 1 |
| Hou-Jensen, K; Stahl, D; Thomsen, K | 2 |
| Chalmers, TC; Douglas, AS; Klimt, CR; Stamler, J | 1 |
| Korbut, R; Moncada, S | 1 |
| Olsson, JE | 1 |
| Glusa, E; Hoffmann, A | 1 |
| Bessler, H; Djaldetti, M; Fishman, P | 1 |
| Hanson, SR; Harker, LA | 2 |
| Abrahamsen, AF | 2 |
| Heller, H; Hilgard, P; Schmidt, CG | 1 |
| Buckley, FO; DeWeese, JA; Green, RM; Oblath, RW; Schwartz, SI | 1 |
| Allain, P; Leblondel, G | 1 |
| Dechavanne, M; Lagarde, M; Thouverez, JP; Verry, M | 1 |
| Rosenberg, JC; Sell, TL | 1 |
| Rosenberg, JC; Sell, T | 1 |
| Bonta, IL; Vincent, JE; Zijlstra, FJ | 1 |
| Couturier, JY; Duhamel, G; Feldman, A; Fraitag, B; Gorin, NC; Najman, A; Vallot, T | 1 |
| Bryon, PA; Dechavanne, M; Lagarde, M | 1 |
| Moncada, S; Vane, JR | 2 |
| Shannon, R; Sirridge, MS; Willoughby, TL | 1 |
| Colombo, M; Hollander, W; Kirkpatrick, B; Nagraj, S; Paddock, J; Prusty, S | 1 |
| Fujitani, B; Shimizu, M; Tsuboi, T; Yoshida, K | 1 |
| Ferber, RH; Parrish, SL; Vigdahl, RL | 1 |
| Mazal, S | 2 |
| Deykin, D; Gurewich, V; Harker, L; Hirsch, J | 1 |
| Fuster, V; Josa, M; Kaye, MP; Lie, JT; Metke, MP | 1 |
| Coeugniet, E | 5 |
| Chesebro, JH; Dewanjee, MK; Fuster, V; Josa, M; Kaye, MP; Metke, MP | 1 |
| Birenbaum, E; Brish, M; Sagy, M | 1 |
| Mustard, JF; Packham, MA | 1 |
| Loeliger, EA | 8 |
| Didisheim, P; Fuster, V | 2 |
| Verstraete, M | 8 |
| Bokarev, IN; Komarov, FI; Liusov, VA | 1 |
| Hirsh, J; Turpie, AG | 1 |
| Krol, WF | 1 |
| Kinlough-Rathbone, RL; Mustard, JF; Packham, MA | 4 |
| Furlan, AJ; Sandok, BA; Sundt, TM; Whisnant, JP | 1 |
| Breddin, K | 3 |
| Zicot, M | 1 |
| Frick, G; Frick, U | 1 |
| Bhargava, RK; Jhawar, BK; Misra, NP; Trivedi, HH | 1 |
| Aosaki, M; Kitamura, N | 1 |
| Yasunaga, K | 1 |
| Weissbach, G | 1 |
| Gryglik, J | 1 |
| Byrnes, JJ; Lian, EC | 1 |
| Salvadori, G; Zannino, L | 1 |
| Hirsh, J | 5 |
| Huguier, M; Uhl, JF | 1 |
| Calvin, L; DeMots, H; Goodnight, SH; Harlan, BJ; Pantely, GA; Rahimtoola, SH; Rösch, J | 1 |
| Caen, JP; Wautier, JL | 1 |
| de Gaetano, G; Villa, S | 1 |
| Ahnfelt-Rønne, I; Arrigoni-Martelli, E | 1 |
| Cazenave, JP; Dejana, E; Kinlough-Rathbone, R; Mustard, JF; Packham, MA | 1 |
| Albizzati, MG; Bassi, S; Fassio, G; Frattola, L | 1 |
| Dettori, AG; Pini, M; Quintavalla, R | 1 |
| Latour, JG | 1 |
| Dmoszyńska-Giannopoulou, A; Pluta, A | 1 |
| Mitchell, JR | 2 |
| Novo, S; Strano, A | 1 |
| Ostendorf, P | 1 |
| McGiff, JC | 1 |
| Gantmacher, ML | 1 |
| Harker, LA; Sauvage, LR; Slichter, SJ | 1 |
| al-Mefty, O; Marano, G; Nugent, GR; Raiaraman, S; Rodman, N | 1 |
| Oelz, O | 1 |
| Jones, RL; Peterson, CM | 1 |
| Shannon, R; Sirridge, MS; Steele, P; Willoughby, TL | 1 |
| DeWeese, JA; Feins, RH; Green, RM; Roedersheimer, R | 1 |
| Carone, FA; Green, D; Rossi, EC; Thorsen, CA | 1 |
| Mehta, J; Mehta, P | 2 |
| Chojnowski, K; Eichelkraut, A; Kuźmicka, J; Mazurowa, A; Olszańska-Skorek, T; Połczyńska, I | 1 |
| Grover, RF; Hyers, TM; Reeves, JT; Scoggin, CH; Will, DH | 1 |
| Bergamaschi, M; Ceserani, R; Pierucci, L; Pogliani, E; Spelta, A | 1 |
| Hladovec, J | 6 |
| Zabel Langhennig, R | 1 |
| Fields, WS | 1 |
| Buchanan, MR; Gent, M; Hirsh, J; Lawrence, W; Rosenfeld, J | 1 |
| Hecker, JF; Spanos, HG | 1 |
| Christensen, BE; Hansen, MS; Jønsson, V | 1 |
| Adams, JH; Mitchell, JR | 1 |
| Crow, MJ; Penny, AF; Pepper, MD; Rajah, SM; Watson, DA | 1 |
| Baumgartner, HR | 1 |
| Himawan, T; Kho, LK; Wulur, H | 1 |
| Fuster, V; Owen, CA; Tyce, GM | 1 |
| Dechavanne, M; Follea, G; Trzeciak, MC | 1 |
| Rossi, EC | 2 |
| Burén, A; Ygge, J | 1 |
| Schulman, JD | 1 |
| Andersen, JC; Bennett, PB; Briner, W; Fields, GN; Francey, I; McIntyre, BA; Philp, RB | 1 |
| Davies-Jones, GA; Martin, JF; Preston, FE; Stewart, RM | 1 |
| Mori, H | 1 |
| Adams, MB; Ekbom, GA; Hussey, CV; Kauffman, HM | 1 |
| Bruhn, HD | 1 |
| Gundlach, WJ; Tarnasky, R | 1 |
| Amorosi, EL; Karpatkin, S | 1 |
| Bozdech, MJ; Crowell, EB; Eckel, RH; Waterhouse, BE | 1 |
| Burkhardt, JH; Fitzgibbons, JF; Goodnight, SH; Kirk, PE | 1 |
| Birgens, H; Ernst, P; Hansen, MS | 1 |
| Beck, R; Cornell, CJ; Smith, RE; Stern, R | 1 |
| Watson, RT | 1 |
| de Gaetano, G; Donati, MB; Farina, ML; Langer, M | 1 |
| Kato, T; Umetsu, T | 1 |
| Sanai, K; Umetsu, T | 1 |
| Burns, TS; Saunders, RN; Stelzer, MR; Waskawic, ER | 1 |
| Zekert, F | 2 |
| Callis, M | 1 |
| Buchanan, M; Hirsh, J | 2 |
| Heslop, PA; Morris, CD | 1 |
| Fabris, VE; Lastória, S; Maffei, FH; Pinto, AM; Rollo, HD | 1 |
| Beasci, R; Belli, R; Caruzzo, C | 1 |
| George, JN; Lewis, PC | 1 |
| Glenn, WW; Hammond, GL; Moggio, RA; Stansel, HC | 1 |
| Diaz, EG; Eldor, A; Naparstek, E | 1 |
| El-Sabban, F; Rosenblum, WI | 2 |
| Weiss, HJ | 6 |
| Agarwal, B; Mudd, SH; Schulman, JD; Shulman, NR | 1 |
| Balavoine, JF; Bouvier, CA; Diez, C; Martin, D; Wyss, M | 1 |
| Aleksandrova, NP; Kovalenko, VI; Pokrovskii, AV | 1 |
| Sowier, J | 1 |
| Hess, H; Ingrisch, H; Mietaschk, A; Müller-Fassbender, H | 1 |
| Buchanan, MR; Hirsh, J | 1 |
| Colombo Pirola, L; Rognoni, F; Viganò, V | 1 |
| Loew, D | 2 |
| Deykin, D | 1 |
| Bucher, HJ | 1 |
| Gent, M; Genton, E; Harker, LA; Hirsh, J | 4 |
| Burke, PF; O'Sullivan, EF; Renney, JT | 1 |
| Gavrilov, OK; Kaveshnikova, BF; Rachinskaia, NA | 1 |
| Doub, NH; Doub, PH; Klimt, CR | 1 |
| Gallus, AS; Hirsh, J | 1 |
| Grether, U; Huth, F; Jacobi, E; Maar, K; Wagner, W | 1 |
| Aledort, LM | 1 |
| Biermé, R; David, J; Géraud, G; Guiraud, B; Rascol, A | 1 |
| Köhler, H | 1 |
| Mitchell, JR; Morris, GK | 1 |
| Bendixen, G; Bendtzen, K; Coeugniet, E; Soeberg, B | 1 |
| Harker, LA; Ritchie, JL | 1 |
| Lagergren, H; Olsson, P; Schalin, L; Swedenborg, J | 1 |
| Hockaday, TD; Honour, AJ; Mann, JI | 1 |
| Bick, RL; Dukes, ML; Fekete, LF; Wilson, WL | 1 |
| Aragon, PJ; Gottberg, C | 1 |
| Corn, M | 1 |
| Gotshall, RA; Harker, LA | 1 |
| Kinlough-Rathbone, RL; Moore, S; Mustard, JF; Packham, MA | 1 |
| Berciano, JI; Gaztañaga, R; Pastor, A; Prats, JM; Sanjurjo, P; Vallo, A | 1 |
| Weber, E | 1 |
| Glick, JL; Lusted, D; Zacharski, LR | 1 |
| Reuter, H | 2 |
| Alkjaersig, N; Chaplin, H; Fletcher, A; Joist, H | 1 |
| Dalessio, DJ | 1 |
| Gurewich, V; Lipinski, B | 1 |
| Baxter, DJ; Haygood, CC; Kraikitpanitch, S; Lindeman, RD; Yunice, AA | 1 |
| Brine, JA; Jackson, JM; Reynolds, PM; Vivian, AB | 1 |
| Lorenz, H; Schmidt, B; Sutor, H | 1 |
| Hoak, JC; Wu, KK | 1 |
| Dumke, HO; Encke, A; Stock, C | 1 |
| Bleyl, U; Brückner, UB; Klöss, T; Leinberger, H; Metzker, M; Saggau, W; Schmier, J | 1 |
| Fujitani, B; Shimizu, M; Takeno, K; Tsuboi, T; Yoshida, K | 1 |
| de Gaetano, G; Donati, MB; Garattini, S | 1 |
| Coeugniet, E; Dirksen, A | 1 |
| Kakkar, VV | 5 |
| Arfors, KE; Bergqvist, D; Tangen, O | 1 |
| Gent, M; Genton, E; Hirsh, J | 1 |
| Dennis, MB; George, CR; Harker, LA; Kenny, GM; Quadracci, LJ; Slichter, SJ; Striker, GE | 1 |
| Hilz, C; Kraus, V; McBride, JA; Turpie, AG | 1 |
| Browder, A; Browder, J | 1 |
| Berberich, FR | 1 |
| Davies, H; Genton, E; Ppppas, G; Steele, P; Weily, H | 1 |
| Dale, J; Myhre, E; Rootwelt, K | 1 |
| Kendall, MJ | 1 |
| Castaldi, PA | 2 |
| Arenson, EB; August, CS | 1 |
| Ben Ismail, M; Ghariani, M; Jais, JM | 1 |
| Bandinelli, C; Bellini, PG; De Mauro, G; Provvedi, D; Rubegni, M | 2 |
| David, JL; Herion, FP | 1 |
| Lavelle, SM; MacIomhair, M | 1 |
| Hellinger, J; Seidel, M | 1 |
| Dechavanne, M; Dejour, H; Faivre, J; Kher, A; Pousset, MB; Viala, JJ; Ville, D | 1 |
| Gottlob, R; Polterauer, P; Zekert, F | 1 |
| de Gaetano, G | 1 |
| Vermylen, J | 1 |
| Dumke, HO | 1 |
| van Cauwenberge, H | 1 |
| Bendixen, G; Bendtzen, K; Coeugniet, E | 1 |
| Barnes, RW; Hoak, JC; Wu, KK | 1 |
| de Gaetano, G; Lambelin, G; Lansen, J; Miragliotta, G; Roncucci, R | 1 |
| Belia, M; Bouronikou, H; Dervenoulas, J; Economopoulos, T; Karakassis, D; Papageorgiou, E; Pappa, V; Raptis, S; Stavrou, A; Stylogiannis, S | 1 |
| Bunyaratvej, A; Chantaraksri, U; Fucharoen, S; Piankijagum, A; Siritanaratkul, N; Sonakul, D; Wasi, P; Winichagoon, P | 1 |
| Lydtin, H; Trenkwalder, P | 1 |
| Beaufils, M; Bréart, G; Paris, J; Uzan, M; Uzan, S | 1 |
| Revell, P; Slater, NG | 1 |
| Dalen, JE; Fuster, V; Harker, LB; Hirsh, J; Salzman, EW | 1 |
| Airaksinen, KE; Huikuri, HV; Ikäheimo, MJ; Korhonen, UR; Linnaluoto, MK; Takkunen, JT; Yli-Mäyry, S | 1 |
| Cámara, S; De La Cruz, JP; Frutos, MA; Sánchez De La Cuesta, F | 1 |
| Balelli, LA; Faxon, DP; Haudenschild, C; Ryan, TJ; Sandborn, T; Valeri, R | 1 |
| Cabusao, EA; Garfield, JD; Greisler, HP; Henderson, SC; Kim, DU; Tattersall, CW | 1 |
| Hach-Wunderle, V | 1 |
| Chong, BH | 1 |
| Agnew, TM; Brandt, PW; French, JK; Kerr, AR; Neutze, JM; Rutherford, JD; Webber, BJ; Whitlock, RM | 1 |
| Eldor, A; Laufer, N; Reubinoff, BE; Sadovsky, E | 1 |
| Avruscio, GP; Cordiano, I; Fabris, F; Girolami, A; Randi, ML; Steffan, A | 1 |
| Gordge, MP; Neild, GH; Rylance, PB | 1 |
| Brosens, J; Elder, MG; Fusi, L; Sullivan, MH | 1 |
| Naruse, T | 1 |
| Bernstein, EF; Dilley, RB; Gent, M; Harker, LA; Hye, RJ; Otis, SM; Roberts, RS; Scala, TE; Sise, MJ | 1 |
| Akopov, SE; Gabrielian, ES | 1 |
| Laakso, M; Lowenthal, A; Riekkinen, P; Sivenius, J; Smets, P | 1 |
| Bastida, E; Cardona, M; Escolar, G; Ordinas, A; Roig, E; Sanz, G | 1 |
| Bär, FW; de Swart, JB; van der Veen, FH; van Ommen, V; van Oppen, J; Wellens, HJ | 1 |
| Hattori, A | 1 |
| Fudo, T; Kambara, H; Ono, S | 1 |
| Heimpel, H; Hertenstein, B; Kurrle, E; Rozdzinski, E; Schmeiser, T; Seifried, E | 1 |
| Cruess, DF; Dieffenbach, CW; Du, W; Gould, KE; Sharefkin, JB; Yamaguchi, M | 1 |
| Fogelholm, R; Kaste, M | 1 |
| Riekkinen, P; Sivenius, J | 1 |
| Aspry, K; Eatherton, J; Hsieh, T; O'Donnell, R; Welborn, JL | 1 |
| Bazin, B; Beaufils, M; Breart, G; Capitant, C; Paris, J; Uzan, S | 1 |
| Belch, JJ; Henderson, IS; Stewart, WK; Taylor, JE | 1 |
| Akhaladze, GG; Aref'ev, AE; Gal'perin, EI; Nasirov, FN; Sakevarashvili, GR; Tatishvili, GG | 1 |
| Darnige, L; Delahousse, B; Gruel, Y; Guilmot, JL; Lang, M; Lermusiaux, P; Leroy, J; Rupin, A | 1 |
| Easton, JD | 2 |
| Sureau, C | 1 |
| Bakhoviddinova, GSh | 1 |
| Kilpeläinen, H; Laakso, M; Penttilä, I; Riekkinen, PJ; Sivenius, J | 1 |
| North, EA | 1 |
| Hirche, H; Ranft, J; Rudofsky, G | 1 |
| Boudreaux, MK; Dillon, AR; Ravis, WR; Sartin, EA; Spano, JS | 1 |
| Lowenthal, A | 2 |
| Ferlito, S | 1 |
| Jafri, SM | 1 |
| Coutinho, MA; de Albuquerque, PF; Houly, RS; Houly, SR; Lira Neto, FS; Lira, N; Oliveira, CC; Santos, RJ | 1 |
| Bertuch, H; Decrinis, M; Krejs, GJ; Lammer, J; Pfeiffer, KP; Pilger, E; Stark, G | 1 |
| Delahaye, JP; Sagnol, P | 1 |
| Battista, RN; Boucher, J; Bravo, G; Côté, R; Stachenko, SJ | 1 |
| Badimon, L; Chesebro, JH; Fuster, V; Heras, M; Lam, JY; Steele, PM; Webster, MW | 1 |
| Bourassa, MG; Côté, G; Eastwood, C; Hudon, G; Kazim, F; Lespérance, J; Schwartz, L | 1 |
| Ciuffetti, G; Innocente, S; Mannarino, E; Pasqualini, L; Rignanese, A; Scricciolo, V | 1 |
| Laakso, M; Lowenthal, A; Penttilä, IM; Riekkinen, PJ; Sivenius, J; Smets, P | 1 |
| Laakso, M; Lowenthal, A; Riekkinen, PJ; Sivenius, J; Smets, P | 3 |
| Bertrand, JC; Comtet, C; Decousus, H; Page, Y; Tardy, B; Tardy-Poncet, B; Zeni, F | 1 |
| Dillon, MJ; Levin, M; Suzuki, A; Tizard, EJ | 1 |
| Aylward, PE; Federman, J; Giles, RW; Harris, PJ; Hodge, RL; Nelson, GI; Thompson, PL; Thomson, A; Tonkin, AM; Walsh, WF | 1 |
| Alexander, C; Franks, PJ; Greenhalgh, RM; Kenchington, G; McCollum, C | 1 |
| Dalen, JE | 1 |
| Kutner, M; Nixon, G; Silverstone, F | 1 |
| Huang, ZS; Lee, TK | 1 |
| Cataldo, G; Marubini, E; Mezzanotte, G; Montoro, C; Petroccione, A; Rovelli, F | 1 |
| Baim, DS; Cabin, HS; Cleman, MW; Ellis, SG; Goldberg, S; Hirshfeld, JW; Leon, M; Schatz, RA; Stagg, J; Walker, C | 1 |
| Alexander, C; Franks, PJ; Greenhalgh, R; Kenchington, G; McCollum, C | 1 |
| Giorgi, LV; Good, TH; Hartzler, GO; Ligon, RW; McCallister, BD; O'Keefe, JH; Webb, DL | 1 |
| Altman, R; D'Ortencio, O; de La Fuente, L; Favaloro, RG; Gurfinkel, E; Manzanel, R; Rouvier, J | 1 |
| Dodobaeva, MS; Khamidov, NKh | 1 |
| Burns, DA; Graham-Brown, RA; Healsmith, MF | 1 |
| Belch, JF; Fisher, TC; Forbes, CD; McLaren, M; Saniabadi, AR | 1 |
| Dichgans, J; Diener, HC; Loherstorfer, E; Seboldt, H | 1 |
| De la Cruz, JP; Sanchez de la Cuesta, F | 1 |
| Blanchette, VS; Buskard, NA; Kelton, JG; Nair, RC; Rock, GA; Shumak, KH; Spasoff, RA | 1 |
| Bell, WR; Braine, HG; Kickler, TS; Ness, PM | 1 |
| Ollivier, JP | 1 |
| Rudofsky, G | 1 |
| Akedo, Y; Nagakawa, Y; Orimo, H; Yano, H | 1 |
| Burckhardt, D; Burkart, F; Jockers, G; Meyer, B; Müller-Brand, J; Pfisterer, M; Regenass, S; Schmitt, HE; Skarvan, K; Stulz, P | 2 |
| Sanz, G | 1 |
| Prentice, CR | 2 |
| Chesebro, JH | 1 |
| Bourassa, MG; Eastwood, C; Kazim, F; Lespérance, J; Schwartz, L | 1 |
| de la Cruz, JP; García Campos, J; Moreno, A; Sanchez de la Cuesta, F | 1 |
| Baldev, TS; Kraev, Z | 1 |
| Duff, HJ; Flintoft, VF; Hansen, JL; Knudtson, ML; Roth, DL | 1 |
| Bisacci, R; Boschetti, E; Cipolloni, S; Costantini, V; Nenci, GG; Talpacci, A; Tristaino, B | 1 |
| Deichsel, G; Heiss, HW; Just, H; Middleton, D | 1 |
| Bech, FR; Cronenwett, JL; Freeman, DH; McDaniel, MD; Ogletree, ML | 1 |
| Anzalone, N; Baldereschi, M; Bonatti, ML; Candelise, L; Fratiglioni, L; Gandolfo, C; Inzitari, D; Mamoli, A; Prencipe, M; Rasura, M | 1 |
| Lane, IF; Lumley, P; McCollum, CN; Michael, MF; Peters, AM | 1 |
| Drucker, CR | 1 |
| Folts, JD; Rowe, GG | 1 |
| Alegría, E; Cardona, M; Coello, I; Fournier, JA; Gómez-Recio, M; Hidalgo, R; Medina, A; Pajarón, A; Ruano, J; Sanz, G | 1 |
| Brickl, R; Eisert, WG; Müller, TH; Nehmiz, G; Su, CA; Weisenberger, H | 1 |
| Peregrin, J; Pirk, J; Rohn, V | 1 |
| Charvát, J; Fiserová, J | 1 |
| Ablett, MB; Ilsley, CD; Nye, ER; Robertson, MC; Sutherland, WH | 1 |
| Copeland, J; Goldman, S; Henderson, W; Kern, KB; Khuri, S; Moritz, T; Ovitt, T; Sethi, G; Sharma, GV; Zadina, K | 1 |
| Frauchiger, B | 1 |
| Davis, JW | 1 |
| Sternon, J | 2 |
| Brodin, UB; Ekeström, SA; Gunnes, S | 1 |
| Boerboom, LE; Ferrans, VJ; Kissebah, AH; Liu, TZ; Olinger, GN; Rodriguez, ER | 2 |
| Bottaro, T; Cordì, GC; Gaggero, E; Motta, A; Venzano, C | 1 |
| Górski, A; Lao, M; Małdyk, M; Morzycka-Michalik, M; Orłowski, T; Rancewicz, Z; Smogorzewski, M; Szczesny-Nowicka, B | 1 |
| Bouquet, J; Hofhuis, WJ; Oranje, AP; Sinaasappel, M | 1 |
| Jáchymová, M; Knotková, V; Nĕmecek, K; Petrů, I | 1 |
| Mathur, AK; Mittal, SR; Tandon, R | 1 |
| Buring, JE; Hennekens, CH | 1 |
| Copeland, JG; Goldman, S; Henderson, WG; Moritz, T; Sethi, GK; Zadina, K | 1 |
| Arafah, M; Bourassa, MG; Eastwood, C; Ganassin, L; Kazim, F; Lesperance, J; Schwartz, L | 1 |
| Black, AJ; Douglas, JS; King, SB; Lembo, NJ; Mufson, LH; Roubin, GS; Wilentz, JR | 1 |
| Casonato, A; Dal Bo Zanon, R; De Zanche, L; Fabris, F; Girolami, A; Manzoni, S; Randi, ML; Tonin, P | 1 |
| Edwards, WH; Jenkins, JM; Mulherin, JL | 1 |
| Calandre, L; Molina, JA | 1 |
| Fabris, F; Girolami, A; Luzzatto, G; Mazzucato, M | 1 |
| Kienast, J; Verstraete, M | 1 |
| Bagi, P; Birgens, HS; Ernst, P | 1 |
| del Zoppo, GJ | 1 |
| Fuster, V; Stein, B | 1 |
| Davies, JA; Hopper, AH; Tindall, H | 1 |
| Chung, GK; Giordano, GF; Mammana, RB; Marco, JD; Raczkowski, AR; Rivers, SL; Sabbagh, A; Sanderson, RG; Strug, BS | 1 |
| Cieslar, P; Jáchymová, M; Knotková, V; Nĕmecek, K; Pelèska, J; Petrů, I; Pick, P; Tomasy, M | 1 |
| Aza, MJ; Castellarnau, C; Collado, PS; Gonzalez, J; Lasierra, J; Melon, J; Rutllant, M; Vazquez, E | 1 |
| Acciai, N; Bosco, G; Calafiore, AM; Cappelletti, L; Di Vincenzo, V; Piccone, M; Scipioni, G; Zecchini, F | 1 |
| Ammous, A; Damak, J; Ghorbel, A; Hachicha, J; Hammami, M; Jarraya, A; Rekik, S | 1 |
| Davis, JW; Hartman, CR; Ruttinger, HA; Shelton, L | 1 |
| Völkl, KP | 1 |
| Eldor, A; Ezra, Y; Mordel, N; Sadovsky, E; Schenker, JG | 1 |
| Haehl, M | 1 |
| Okafor, JP; Oyekan, AO | 1 |
| Al-Mondhiry, H; Pennock, JL; Pierce, WS | 1 |
| DeWeese, JA; Hicks, GL; Jensen, LA; Norsen, LH; Quinn, JR; Stewart, SS | 1 |
| Donadio, JV; Offord, KP | 1 |
| Chrobocek, J | 1 |
| Alvarez, L; Castillo-Olivares, JL; de Haro, J; Escudero, MC; Millán, I; Rodríguez, V | 1 |
| Carp, HJ; Frenkel, Y; Many, A; Mashiach, S; Menashe, Y; Nebel, L; Serr, DM; Toder, V | 1 |
| Benjamin, V; Dominguez, R; Famulari, A; Fraiman, H; Gonzalez, AM; Herskovits, E; Matera, V; Tamaroff, L; Vila, J; Vzquez, A | 1 |
| Johannessen, KA; Osterud, B; Stratton, JR; Taulow, E; von der Lippe, G | 1 |
| Cairns, JA; Collins, R; Dalen, JE; Fuster, V; Harker, L; Hirsh, J; Salzman, EW | 1 |
| Altimiras, J; Arís, A; Augé, JM; Bassons, T; Bonal, J; Caralps, JM; Castellarnau, C; Crexells, C; Guiteras, P; Masotti, M | 1 |
| McCormick, KC | 1 |
| Bazin, B; Beaufils, M; Danays, T; Uzan, S | 1 |
| David, M; Griesmacher, A; Müller, MM | 1 |
| Billingham, ME; Cahill, PD; Glasson, JR; Miller, DC; Mitchell, RS; Sarris, GE | 1 |
| Charvat, J; Kuruvilla, T | 1 |
| Chesler, E; Copeland, J; Doherty, J; Goldman, S; Henderson, W; Moritz, T; Ovitt, T; Read, R; Sako, Y; Zadina, K | 1 |
| Shalaev, SV | 1 |
| Burkart, F; Grädel, E; Jockers, G; Pfisterer, M; Regenass, S; Schmitt, HE | 1 |
| Anda, L; Császár, A; Daróczy, J; Hosszúfalusi, N; Kalabay, L; Karádi, I; Romics, L; Szénási, P; Tóth, L | 1 |
| Fuster, V; Kazmier, FJ; Muller, SA; Quimby, SR; Schroeter, AL | 1 |
| Heng, MC; Heng, MK; Song, MK | 1 |
| D'Andrea, G; Joseph, R; Welch, KM | 1 |
| Aliavi, AL; Kinoshenko, EI; Vlasenko, MA | 1 |
| Alvarez, L; Castillo-Olivares, JL; del Moral, JH; Escudero-Vela, MC; Millán, I; Rodríguez, V | 1 |
| Belcaro, G; Cesarone, MR; De Cenzo, A; Errichi, BM; Laurora, G; Marinucci, R | 1 |
| Dewanjee, MK; Mashburn, JP; McCarthy, PM; Schaff, HV | 1 |
| Ingerman-Wojenski, CM; Silver, MJ | 1 |
| Collen, D; Coller, BS; Fallon, JT; Gold, HK; Guerrero, JL; Kanke, M; Leinbach, RC; Ross, MJ; Scudder, LE; Shealy, D; Yasuda, T | 1 |
| Campbell, WB; Dehmer, GJ; Eichhorn, EJ; Jennings, L; Popma, JJ; Prewitt, JB; Schmitz, JM; van den Berg, EK; Willerson, JT | 1 |
| Deichsel, G; Hess, H; Mietaschk, A | 1 |
| Beaufils, M; Colau, JC; Donsimoni, R; Uzan, S | 3 |
| Armout, J; Deckmyn, H; Gresele, P; Vermylen, J | 1 |
| Borhani, NO | 2 |
| Bélanger, GL; Lavallée, JP; Lenis, J; Ouellet, CA | 1 |
| Bonaventi, C; Caneschi, S; Finzi, F | 1 |
| Klimt, CR; Knatterud, GL; Meier, P; Stamler, J | 1 |
| Tomov, I | 1 |
| Gelman, JS; Mehta, J | 1 |
| Cannizzaro, S; Davì, G; Giubilato, A; Strano, A | 1 |
| Khimenko, PL | 1 |
| Baeten, E; Casteels-Van Daele, M; Corbeel, L; Eggermont, E; Gewillig, M | 1 |
| Rotmans, N; Wallenburg, HC | 2 |
| Bergh, PA; Breen, JL; Gregori, CA; Hollander, D | 1 |
| D'Andrea, G; Joseph, R; Oster, SB; Welch, KM | 1 |
| Evancho, MM; Falkow, LJ; Hunter, TJ; Schmidt, SP; Sharp, WV | 1 |
| Zeitler, E | 1 |
| Irwin, JT; Lane, IF; McCollum, CN; Peters, AM; Sinclair, M | 1 |
| Ritchie, JL; Stratton, JR | 2 |
| Frishman, WH; Miller, KP | 1 |
| Hayashida, N | 1 |
| Niikura, H | 1 |
| Chesebro, JH; Fuster, V | 8 |
| Hrcková, Y; Indrák, K; Jezdinský, J; Kapustová, M; Kubis, M; Scudla, V | 1 |
| Lorenz, RL; Schramm, W; Theisen, K; Weber, MA | 1 |
| Baudoin, C; Bousser, MG; Eschwege, E; Haguenau, M; Lefauconnier, JM | 1 |
| Barnathan, ES; Hirshfeld, JW; Kleaveland, JP; Kussmaul, WG; Laskey, WK; Schwartz, JS; Taylor, L | 1 |
| Kent, KM | 1 |
| Harker, LA | 3 |
| Cronenwett, JL; Huntsman, WT; McDaniel, MD; Miett, TO | 1 |
| Black, AJ; Brown, JE; Douglas, JS; Gianturco, C; King, SB; Robinson, KA; Roubin, GS; Siegel, RJ | 1 |
| Bollinger, A | 1 |
| Brewer, ML; Kinnison, ML; Perler, BA; White, RI | 1 |
| Aldridge, HE; Bonan, R; Bourassa, MG; David, PR; Henderson, M; Kazim, F; Lespérance, J; Salvatori, VA; Schwartz, L | 1 |
| Fujita, Y; Kono, T; Kurihara, M; Miyake, H; Mori, K; Shingu, T; Tsujimura, M | 1 |
| Masotti, G | 1 |
| Aviram, M; Brook, JG; Winterstein, G | 1 |
| Maurer, HJ | 1 |
| Matsuda, T | 1 |
| Forn, J; García-Rafanell, J; Gomez, L; Ramis, J | 1 |
| Balcon, R; Gershlick, AH; Layton, CA; Lyons, JP; Sturridge, MF; Wright, JE | 1 |
| Gau, GT; Lavie, CJ; Squires, RW | 1 |
| Hainaut, P; Lavenne, E; Lebacq, EG; Magy, JM | 1 |
| Band, V; Farooq, A; Kharbanda, SM; Murugesan, K | 1 |
| Greenhalgh, RM; McCollum, CN; Meek, AC | 1 |
| Lane, I; McCollum, C; Meek, A; Poskitt, K | 1 |
| Kassirer, JP; Kopelman, RI | 1 |
| Albers, JW; Langer, SL; Levine, SR; Welch, KM | 1 |
| Barrall, DT; Dennison, A; Grossman, JA; Lally, EV | 1 |
| Alijotas Reig, J | 1 |
| Davì, G; Gallo, V; Mazza, A; Palumbo, MG; Pinto, A; Strano, A | 1 |
| Goldman, M; McCollum, CN | 1 |
| Boerboom, LE; Bonchek, LI; Kissebah, AH; Olinger, GN | 1 |
| Chesebro, JH; Fuster, V; Steele, PM | 1 |
| Abe, M; Hayashi, T; Ida, T; Ito, Y; Matsuda, M; Obunai, Y; Sakakibara, T; Shimizu, Y; Takayama, Y; Tanaka, T | 1 |
| Chidlow, A; Greenhalgh, RM; Lane, IF; McCollum, CN; Meek, AC | 1 |
| Braun, B; Grande, P; Hess, F; Jerusalem, C; Skotnicki, S; Steeghs, S; van Det, R | 1 |
| DeCampli, WM; Handen, CE; Kosek, JC; Miller, DC; Mitchell, RS | 1 |
| Liusov, VA; Savenkov, MP | 1 |
| Braun, B; Grande, P; Hess, F; Jerusalem, C; Steeghs, S | 1 |
| Hausdorf, G; Nienaber, CA; Spielmann, RP | 1 |
| Nath, KA | 1 |
| Botindari, G; Catalano, I; Davì, G; Strano, A | 1 |
| Chalmers, TC; Pincus, MM; Reitman, D; Sacks, HS; Sze, PC | 1 |
| Fella, M; Ferrari, M; Frisoni, R; Pellicci, R; Piri, C; Quaratino, S; Valbonesi, M; Valente, U; Zia, S | 1 |
| Kallenberg, CG; van der Meer, J; Wesseling, H; Wouda, AA | 1 |
| Cairns, JA | 1 |
| Burton, NA; Eichwald, EJ; Hendrickson, M; Muskett, A; Shelby, J; Sullivan, JJ | 1 |
| Colwell, JA | 1 |
| Codina, A; Dávalos, A; Matías-Guiu, J; Monasterio, J; Picó, M; Vilaseca, J | 1 |
| Nordestgaard, AG; Wilson, SE | 1 |
| Donadio, JV; Holley, KE; Ilstrup, DM; Romero, JC | 1 |
| Beller, GA; Burwell, LR; Craddock, GB; Gascho, JA; Hays, LJ; Moore, CA; Nygaard, TW; Smucker, ML; Tedesco, C | 1 |
| Fujitani, RM; Marcus, CS; Nordestgaard, AG; Wilson, SE | 1 |
| Sams, WM | 1 |
| Christakis, GT; Ivanov, J; Levitt, DS; Madonik, MM; Mee, AV; Reilly, PA; Rosenfeld, JM; Teoh, KH; Weisel, RD; Wong, PY | 1 |
| Argiolu, F; Marongiu, L; Pinna, AD; Pinna, DC | 1 |
| Bjornsson, TD; Hanson, SR; Harker, LA | 2 |
| da Rocha Filho, JM; da Rocha Neto, JM; da Rocha, AM | 1 |
| Bloor, CM; Longhurst, J; O'Konski, MS; Roth, D; White, FC | 1 |
| Fabián, J; Firt, P; Kovác, J; Pirk, J; Vojácek, J | 1 |
| Burkart, F; Grädel, E; Hasse, J; Jockers, G; Meier, B; Pfisterer, M; Schmitt, HE; Stulz, P | 1 |
| Austin, EH; Greenberg, CS; Lowe, JE; Makhoul, RG; McCann, RL | 1 |
| Limet, R | 1 |
| Burkart, F; Grädel, E; Hasse, J; Jockers, G; Pfisterer, M; Schmitt, HE; Skarvan, K; Stulz, P; Wolff, G | 1 |
| Dale, J; Frøysaker, T; Thaulow, E; Vatne, K | 1 |
| Fuster, V; Hirsh, J; Salzman, E | 1 |
| Chediak, J; Hirsh, J; Lewis, D; Resnekov, L | 1 |
| Clowes, AW | 1 |
| Brown, BG; Chesebro, JH; Ekeström, S; Harker, LA; Henderson, AH; Jewitt, DE; Oliver, MF; Sleight, P; Verstraete, M | 1 |
| Catalano, M; Libretti, A | 2 |
| Barlattani, A; De Martiis, A; De Martiis, M; Parenzi, A | 1 |
| West, CD | 1 |
| Głab-Kordecka, E | 1 |
| Sierakowski, S | 1 |
| Böhm, R | 1 |
| Patrono, C | 1 |
| Freeman, JW | 1 |
| Kovác, J; Pirk, J; Vojácek, J | 1 |
| Fujimoto, T; Yamazaki, H | 1 |
| Aiken, JW; Humphrey, WR; Weselcouch, EO | 1 |
| Lecompte, T; Samama, M | 1 |
| Gay, WA; Karwande, SV; Subramanian, VA; Weksler, BB | 1 |
| Eisert, WG; Eldor, A; Fuks, Z; Muller, TH; Vlodavsky, I | 1 |
| Chan, KW; Chan, MK; Kwan, SY; Yeung, CK | 1 |
| Archer, TJ; Atuhaire, LK; Chant, AD; Clyne, CA; Webster, JH | 1 |
| Bingham, SF; Colwell, JA | 1 |
| Douville, C; Kempczinski, RF; Ramalanjaona, GR; Silberstein, EB | 1 |
| Blitzer, JB; Goldberg, J; Gottlieb, AJ; Granfortuna, JM; Lamberson, H; Landaw, SA; Scalzo, AJ; Smith, JR; Theodorakis, ME; Zamkoff, KW | 1 |
| Clark, MD; Ellison, RG; Lamis, PA; Rosenthal, D; Stanton, PE | 1 |
| Davies, JA; Hopper, AH; Tindall, H; Urquhart, S | 1 |
| Donovan, DL; Evancho, MM; Hirko, MK; Hunter, TJ; Schmidt, SP; Sharp, WV | 1 |
| Balbarini, A; Evangelisti, L; Gherarducci, G; Giordani, R; Mariani, M; Petronio, AS; Preti, R | 1 |
| Blahey, W; Bowen, T; Docksteader, B; Falconer, J; Jadusingh, I; Pineo, G | 1 |
| David, JL | 1 |
| González Utor, AL; López Campos, JL | 1 |
| Gausí, C; Kian, C; Martínez-Brotons, F; Pérez-Ayuso, MJ; Portis, T; Reynaldo, C; Simón, R | 1 |
| Estes, JW; Jones, DH; Lamis, PA; Mittenthal, MJ; Rosenthal, D; Ruben, DM; Stanton, PE | 1 |
| Lemberg, L; Valladares, BK | 1 |
| Holm, K; Kasuya, A | 1 |
| Deans, KW; Hartshorn, JC | 1 |
| Crawford, J; Fox, S; Hawkins, M; Heptinstall, S | 1 |
| Connor, FO; Gil Aguado, M; Larrea, JL; Nuñez, L; Pinto, AG | 1 |
| Dale, J; Nitter-Hauge, S | 1 |
| Irwin, JT; Jennings, SA; Lane, IF; McCollum, CN; Meek, AC; Poskitt, KR | 1 |
| Edgerton, TA; Faust, KB; Geisinger, KR; Hansen, KJ; Howe, HR; Kon, ND; Meredith, JH | 1 |
| Aguilar Muñoz, A; de la Cruz Cortés, JP; de Pablo Molina, J; García Arnés, J; Martos Crespo, F; Sánchez de la Cuesta, F | 1 |
| Barker, MJ; Davies, JA; Hooper, AH; Spencer, AA; Stainton, C; Tindall, H | 1 |
| Cole, CW; Hagen, PO; Makhoul, RG; McCann, RL; Mikat, EM; O'Malley, MK; Radic, ZS | 1 |
| Berk, PD; Goldberg, JD; Tartaglia, AP; Wasserman, LR | 1 |
| Brownson, RJ; Fell, D; Madeira, T; Zollinger, WK | 1 |
| DeBoer, A; Hartz, RS; Kucich, V; LoCicero, J; Meyers, SN; Michaelis, LL; O'Mara, S | 1 |
| Burns, JC; Glodé, MP; Leung, DY; Newburger, JW; Toews, WH; Wiggins, JW; Wilson, H | 1 |
| Castaldi, PA; Chong, BH | 1 |
| Ebert, PA; Soifer, SJ; Tranbaugh, RF; Turley, K; Verrier, ED; Yee, ES | 1 |
| de Gaetano, G; Dejana, E; Lauri, D; Zanetti, A | 1 |
| Al Saigh, AH; Geeraert, AJ | 1 |
| Buckels, JA; Nordestgaard, AG; Wilson, SE | 1 |
| Baca, M; Boschello, M; Dalla Volta, S; Marzari, A; Pengo, V; Schivazappa, L | 1 |
| Augsburger, JJ; Magargal, LE; Perkins, SA; Sanborn, GE | 1 |
| Di Perri, T | 1 |
| Annis, D; de Cossart, L; Fisher, AC; How, TV | 1 |
| Pilger, E | 1 |
| Wasserman, LR | 1 |
| Breyer, RH; Engelman, RM; Lemeshow, S; Rousou, JA | 1 |
| Brown, BG; Carey, JS; Cukingnan, RA; DeRouen, T; Fee, HJ; Goede, LV; Roth, JA; Wong, M | 1 |
| Gallus, AS | 1 |
| Balcon, R; Brooks, N; Honey, M; Layton, C; Magee, P; Pepper, J; Sturridge, M; Walesby, R; Wright, J | 1 |
| Dominguez, R; Famulari, A; Fraiman, H; Gonzalez, AM; Herskovits, E; Tamaroff, L; Vázquez, A; Vila, J | 1 |
| Kulkarni, GA; Nathanson, L; Pellegrini, JR | 1 |
| Sherry, S | 4 |
| Delahaye, JP; Ffrench, P; Malquarti, V; Milon, H; Philippe-Bert, J; Saradarian, W | 1 |
| Dewanjee, MK; Hollier, LH; Plate, G; Stanson, AW | 1 |
| Boyle, RM; Donaldson, DR; Partridge, JB; Rajah, SM; Salter, MC; Subba Rao, R; Watson, DA | 1 |
| Boey, J; Chan, TK; Cheung, KL; Chow, J; Lee, PK; Mok, CK; Ng, RP; Tse, TF; Wang, R | 1 |
| Rühle, H | 1 |
| Findlay, JM; Gentili, F; Glynn, MF; Houle, S; Lougheed, WM; Walker, PM | 1 |
| FitzGerald, GA; Pedersen, AK | 1 |
| Chesebro, JJ; Fuster, V | 1 |
| Bourassa, MG; Campeau, L; Fisher, LD; Gillespie, MJ; Lespérance, J; McConney, M | 1 |
| Davies, JA | 1 |
| Abraira, C; Anderson, JW; Bingham, SF; Colwell, JA; Kwaan, HC | 2 |
| Gershlick, AH; Lewis, CT; Mills, PG; Murday, AJ; Syndercombe Court, YD | 1 |
| Jouve, R; Larrue, J | 1 |
| Al Fagih, M; Al Kasab, S; Al Zaibag, M; Davies, G; Idris, M; Mashat, E; Ribeiro, PA; Wareham, E | 1 |
| Chesebro, JH; Holmes, DR; Orszulak, TA; Schaff, HV | 1 |
| Cameron, C; Landymore, RW; MacAulay, M; Sheridan, B | 1 |
| de Bono, DP; Mackay, A | 1 |
| Chandy, T; Sharma, CP | 1 |
| Snethlage, W; Ten Cate, JW | 1 |
| Bown, E; Carter, RD; Haitas, B; Jones, DB; Mann, JI | 1 |
| Boerboom, LE; Bonchek, LI; Gunay, II; Kissebah, AH; Olinger, GN | 1 |
| Hashimoto, N; Kholoussy, AM; Kumashiro, R; Matsumoto, T; Piotrowski, JJ | 1 |
| Melander, A; Nitelius, E; Wåhlin-Boll, E | 1 |
| Capel, P | 1 |
| Case, RB; Choy, DS; Fajadet, J; Fournial, G; Marco, J; Silvernail, PJ | 1 |
| Eriksson, SE | 1 |
| Bradley, LM; Getson, PR; Midgley, FM; Scott, LP; Watson, DC | 1 |
| Ambrose, A; Cefalo, RC; Welham, RT | 1 |
| Borer, J; Braunwald, E; Chesebro, JH; Cohen, LS; Dalen, J; Dodge, HT; Francis, CK; Hillis, LD; Knatterud, G; Ludbrook, P | 1 |
| Bollinger, A; Brunner, U | 1 |
| Grunwald, J; Haudenschild, CC | 1 |
| Aiba, T; Seki, Y; Shiozawa, R; Tsukada, T; Yoshii, K | 1 |
| Bastida, E; Castillo, R; Escolar, G; Ordinas, A | 1 |
| Barton, BA; Forbes, CD; Krol, WF; Lowe, GD; Machado, SG | 1 |
| Aznar, J; Pérez-Requejo, JL; Santos, MT; Vallés, J | 1 |
| Harrison, MJ; Pollock, SS; Steiner, M; Weisblatt, E | 1 |
| Aguilar Muñoz, A; de la Cruz Cortés, JP; de Pablo Molina, J; Martos Crespo, F; Sánchez de la Cuesta, F | 1 |
| Harrison, MJ; Marshall, J; Meadows, JC; Russell, RW | 1 |
| Krusch, G; Vogel, G | 1 |
| Baxter, TJ; Hayhurst, JW; Ishida, H; O'Brien, BM | 1 |
| Scheidler, K; Weser, C | 1 |
| Lahiri, K; Lyons, M; Moschos, CB; Oldewurtel, HA; Regan, TJ; Weisse, AB | 1 |
| Berger, KE; Mansfield, PB; Overton, JB; Sauvage, LR; Smith, JC; Wood, SJ | 1 |
| Douglas, AS | 1 |
| Hampton, J | 1 |
| Jenkins, CS; Kinlough-Rathbone, RL; Mustard, JF; Packham, MA | 1 |
| Borges, WH; Redondo, D; Rossi, EC | 1 |
| Berger, S; Bloom, S; Salzman, E; Wonders, T; Zapol, W | 1 |
| Lekas, N; Lysz, K; Morrell, R; Rosenberg, JC; Sell, T; Villalalva, A | 1 |
| Adelson, E; Segal, A | 1 |
| O'Sullivan, EF; Vellar, ID | 1 |
| Corterier, H; Dragojevic, D; Hetzer, R | 1 |
| Smith, GM | 1 |
| Sherman, LA; Wessler, S | 1 |
| Johnson, G; Mandel, SR | 1 |
| Hayhurst, JW; MacLeod, AM; Miller, GD; Morrison, WA; Newing, RK; O'Brien, BM | 1 |
| George, CR; Harker, LA; Quadracci, LJ; Slichter, SJ; Striker, GE | 1 |
| Bove, LG | 1 |
| Bouvier, CA | 1 |
| Abrahamsen, AF; Eika, C; Godal, HC; Lorentsen, E | 1 |
| Didisheim, P; Fuster, V; Kazmier, FJ | 1 |
| Forbes, CD; Prentice, CR | 1 |
| Gershengorn, K; Haft, JI; Kranz, PD; Oestreicher, R | 1 |
| Bierme, R; Boneu, B; David, J; Fernet, P; Géraud, G; Géraud, J; Guiraud, B; Rascol, A | 1 |
| Bologna, E | 1 |
| Cortellaro, M; Pogliani, E; Polli, EE; Praga, C | 1 |
| Cepelák, V; Cepeláková, H; Nĕmecek, O; Roubal, Z | 1 |
| Ulutin, ON; Ulutin, SB; Yaramanci, TE | 1 |
| Penner, JA; Schnetzer, GW | 1 |
| Kummer, H | 1 |
| Attar, S; Masaitis, C; McLaughlin, JS | 1 |
| Pogliani, EM; Praga, CA | 1 |
| Shreeve, DR; Utting, JA | 1 |
| Hammond, GL; Mayer, JE | 1 |
| Amir, J; Krauss, S | 1 |
| Dacie, JV | 1 |
| Lereboullet, J; Olivier-Martin, R; Rosa, A | 1 |
| de Leval, M; Gerbode, F; Hill, JD; Macur, MF; Mielke, CH | 1 |
| Bart, JB | 1 |
| Bounameaux, Y | 2 |
| Millikan, CH | 1 |
| McGrouther, DA; McNicol, GP; Prentice, CR; Sinclair, J; Wood, EH | 1 |
| Banks, DC; Mitchell, JR | 1 |
| Freuler, F; Smith, GM | 1 |
| Jaffe, EA; Merskey, C; Nachman, RL | 1 |
| Borrelli, F; Caprino, L; Falchetti, R | 1 |
| Hofmann, HP; Kreiskott, H | 1 |
| O'Sullivan, EF; Renney, JT | 1 |
| Clagett, GP; Fry, WJ; Lindenauer, SM; Stanley, JC; Zelenock, GB | 1 |
| Skillman, JJ | 1 |
| Althaus, U; Hunziker, HR; Kummer, H | 1 |
| Ekert, H; Powell, HR | 1 |
| Edwards, WS; Justice, C; Papavangelou, E | 1 |
| Künzer, W; Schindera, F; Sutor, HA; Wehinger, H | 1 |
| Dziewolska, M; Krug, H | 1 |
| Harker, LA; Slichter, SJ | 2 |
| Berberich, FR; Chard, RL; Cuene, SA; Hartmann, JR | 1 |
| Bauer, H; Hogan, GP; Lewers, DT; Maher, JF; Mathew, TH; Schreiner, GE | 1 |
| Ames, M; Murphy, S; Oski, F; Schut, L; Stockman, J; Stuart, M; Urmson, J | 1 |
| Bouvier, CA; Dami, R; Denizot, M; Giromini, M; Jeannet, M | 1 |
| McIntyre, OR; Walworth, C; Zacharski, LR | 1 |
| Danese, CA; Haimov, M | 1 |
| Breddin, K; Scharrer, I; Schepping, M | 1 |
| Peterson, J; Zucker, MB | 1 |
| Stormorken, H | 1 |
| Beekley, W; Byrne, JJ; Guardione, VA; Migliore, JJ; Williams, LF | 1 |
| DeSanctis, RW; Harris, WH; Salzman, EW | 1 |
| Didisheim, P | 1 |
| Sowier, J; Zawilska, K | 1 |
| McNicol, GP | 1 |
| Budd, GT; Bukowski, RM; Cato, AE; Cocchetto, DM; Lucas, FV | 1 |
| Genton, E | 1 |
| Schröder, R | 1 |
| Famulari, A; Fraiman, H; Gonzalez, AM; Herskovits, E; Matera, V; Smud, R; Tamaroff, L; Vazquez, A; Vila, J | 1 |
| Marshall, AJ | 1 |
| de Bono, DP | 1 |
| Breddin, K; Loew, D; Uberla, K | 1 |
| Gross, F | 1 |
| Bertelè, V; Cerletti, C; de Gaetano, G | 1 |
| Adachi, K; Toshima, H | 1 |
| Spann, JF | 1 |
| Kelton, JG | 1 |
| Breddin, HK; Pauliks, V; Weichert, W | 1 |
| Offerhaus, L | 2 |
| Dalen, JE; Goldberg, RJ; Gore, JM; Struckus, J | 1 |
| Cuttner, J | 1 |
| Hirsh, J; Kelton, JG | 1 |
| Clagett, GP; Hufnagel, H; Russo, M | 1 |
| Calloni, MV; Landi, G; Scarlato, G | 1 |
| Bolte, HD | 1 |
| Mellmann, J; Pretschner, P; Trentz, O; Westermann, K | 1 |
| Bukowski, RM; Groppe, CW; Hewlett, JS; Livingston, RB; Reimer, RR; Weick, JK | 1 |
| Heidrich, H | 1 |
| Hinton, RC | 1 |
| Finlay, AY; Marks, R; Statham, B | 1 |
| Tullio, D | 1 |
| Boccaccio, P; Casciaro, S; Ghio, R; Rattenni, S; Ratti, M; Sergnese, G | 1 |
| Kahaleh, MB; Leroy, EC; Osborn, I | 1 |
| Ebert, PA; Mavroudis, C; Weinstein, GS | 1 |
| Catron, PW; Flynn, ET | 1 |
| Bettmann, MA; Garnic, JD; Murray, PD | 1 |
| Dettori, AG; Pini, M; Potí, R | 1 |
| Buckler, P; Douglas, AS | 1 |
| Webster, J | 1 |
| Douglas, JT; Forbes, CD; Lowe, GD; Prentice, CR; Stewart, ME | 1 |
| Bergqvist, D | 1 |
| Thiele, R | 1 |
| Bove, AA; Bresnahan, JF; Holmes, DR; Reeder, GS; Smith, HC; Swanson, KT; Vlietstra, RE | 1 |
| Aushri, Z; Berginer, V; Dvilansky, A; Nathan, I | 1 |
| Branson, HE; Endo, Y; Fagin, AR; Schlutz, M | 1 |
| Cobo, R; Lasierra, J; López-Campos, JL; Moreno, J; Navas, P; Piñero, J | 1 |
| Burkel, WE; Ford, JW; Graham, LM; Kahn, RH; Stanley, JC; Vinter, DW; Whitehouse, WM | 1 |
| FitzGerald, GA; Sherry, S | 1 |
| Butt, R; de Boer, AC; Gent, M; Genton, E; Han, P; Turpie, AG | 1 |
| Chesebro, JH; Dewanjee, MK; Fuster, V; Hollier, LH; Pairolero, PC; Pumphrey, CW; Wahner, HW | 1 |
| Cella, G; Colby, SI; McCracken, L; Parisi, AF; Sasahara, AA; Taylor, AD | 1 |
| Faxon, DP; Kellett, MA; Ryan, TJ; Sanborn, TA | 1 |
| Goldman, MD; Hawker, RJ; McCollum, CN; Norcott, HC; Simpson, D | 1 |
| Po, HG; Wang, ZG | 1 |
| Guiraud-Chaumeil, B | 1 |
| Bousser, MG; Eschwège, E; Haguenau, M; Lefauconnier, JM; Thibult, N; Touboul, D; Touboul, PJ | 3 |
| Biland, L; Bollinger, A; Brunner, U; Kappert, A; Krähenbühl, B; Mahler, F; Monti, M; Nachbur, B; Schneider, E; Widmer, LK | 1 |
| Faxon, DP; Haudenschild, CC; Ryan, TJ; Sanborn, TA | 1 |
| Carter, WJ; Liem, PH; Wilkerson, RJ | 1 |
| Kester, RC | 1 |
| Hillis, LD | 1 |
| Bazzan, M; Della Dora, N; Pannocchia, A; Schinco, PC; Tamponi, G | 1 |
| Birgens, HS; Hansen, MS | 2 |
| Dyerberg, J; Jørgensen, KA; Stoffersen, E | 1 |
| Markiewicz, A | 1 |
| Agarwal, K; Kane, RL; Richardson, PD | 1 |
| Kitamura, Y; Ohnishi, H; Shimada, S; Suzuki, Y; Yamaguchi, K | 1 |
| Gaillard, JL; Kher, A; Lecompte, T; Samama, M | 1 |
| Toda, N; Yamamoto, M | 1 |
| Harada, Y; Hayashi, H; Kamikawa, T; Kaneko, M; Kisamori, K; Kobayashi, A; Masumura, Y; Suzuki, Y; Yamaguchi, T; Yamazaki, N | 1 |
| Cauchie, C | 2 |
| Bousser, MG | 2 |
| Mehta, J | 1 |
| Brymer, JF; Colfer, HT; Goldberg, AD; Goldstein, S; Khaja, F; Kurian, T; Lee, T; Lo, E; O'Neill, WW; Osterberger, L; Pitt, B; Walton, JA; Weiss, R | 1 |
| Stamler, J | 1 |
| Chesebro, JH; Danielson, GK; Elveback, LR; Fuster, V; McGoon, DC; Orszulak, TA; Piehler, JM; Pluth, JR; Puga, FJ; Schaff, HV; Wallace, RB | 1 |
| Bulla, M; Bussmann, K; Gillor, A; Gladtke, E; Roth, B; Schrör, K; Tekook, A | 1 |
| Folland, ED; Josa, M; Khuri, SF; Parisi, AF; Sharma, GV | 1 |
| Bertha, G; Lechner, H; Ott, E | 1 |
| Gurewich, V; Louie, S | 1 |
| Cheatham, JP; Hofschire, PJ; Kugler, JD; Pinsky, WW | 1 |
| Bardsley, WT; Chesebro, JH; Clements, IP; Elveback, LR; Fuster, V; Holmes, DR; Pluth, JR; Puga, FJ; Smith, HC; Wallace, RB | 1 |
| Inoue, T | 1 |
| Fitzpatrick, JW; Freed, N; Giudice, JC; Papa, L | 1 |
| Ramirez-Lassepas, M | 1 |
| Anderson, CF; Chesebro, JH; Donadio, JV; Fuster, V; Holley, KE; Ilstrup, DM; Mitchell, JC | 1 |
| Heros, RC; Kistler, JP; Ropper, AH | 1 |
| Florkiewicz, H; Markiewicz, M; Rymar, B; Wysokiński, A | 1 |
| Eichner, ER | 1 |
| Clark, DD; Crowley, JP; O'Shea, PA; Zaroulis, CG | 1 |
| Barnett, HJ | 1 |
| Beckett, VL; Chao, EY; Chesebro, JH; Conn, DL; Fuster, V; O'Fallon, WM; Osmundson, PJ; Strong, CG | 1 |
| Biller, J; Martin, GJ | 1 |
| Alexander, MR; Rivey, MP; Taylor, JW | 1 |
| Ordinas, A | 1 |
| Beris, P; Miescher, PA; Parmeggiani, L; Trono, D | 1 |
| Dworski, R; Musiał, J; Szczeklik, A | 1 |
| Dahl, ML; Matintalo, M; Puustinen, T; Uotila, P | 1 |
| Gitler, B; Gitler, ES | 1 |
| Dykes, J; Goldman, M; Hall, C; Hawker, RJ; McCollum, CN | 1 |
| Hagen, PO; McCann, RL; Wang, ZG | 1 |
| Block, LH; Rhyner, K; Stenger, M | 1 |
| Lewis, GP; Smith, JR | 1 |
| Kaliman, J; Sinzinger, H; Strobl-Jäger, E | 1 |
| Crow, MJ; Kester, RC; McCollum, CN; Rajah, SM | 1 |
| Butler, KD; White, AM | 1 |
| Burke, W; DePace, NL; Glazier, EE; Kotler, MN | 1 |
| Naruse, T; Ogawa, S | 1 |
| Liguori, J; Rothfeld, D; Werres, R | 1 |
| Agarwal, KC; Chesebro, JH; Danielson, GK; Dewanjee, MK; Feldt, RH; Fuster, V; Puga, FJ; Wahner, HW | 1 |
| Gershlick, AH; Lewis, CT; Mills, PG; Murday, AJ; Syndercombe-Court, YD | 2 |
| Bahn, RC; Gloviczki, P; Hollier, LH; Kaye, MP; Plate, G; Rainwater, LM | 1 |
| Lucas, MA | 1 |
| Ingerman-Wojenski, CM; Sedar, AW; Silver, MJ; Smith, M | 1 |
| Clowes, A; Couch, NP; Donaldson, MC; Kacoyanis, G; Kaufman, JL; Kelly, E; Kohler, TR; Mannick, JA; Skillman, J; Whittemore, AD | 1 |
| Wang, ZG | 1 |
| Heinrich, F | 1 |
| Kukora, JS; Rushton, FW | 1 |
| Bastida, E | 1 |
| Saldan, IR | 1 |
| Bertoli, L; Colli, S; Lo Cicero, S; Maderna, P; Mantero, O; Tremoli, E | 1 |
| Colardyn, F; Delbarge, W; Noens, L; Thiery, M; Vandekerckhove, F | 1 |
| Banthien, FC; Clemm, C; Gurland, HJ; Habersetzer, R; Samtleben, W; Stoffner, D; Unterburger, P; Zähringer, J | 1 |
| Aul, C; Grabensee, B; Königshausen, T; Küppers, H; Scharf, RE | 1 |
| Salokannel, J; Viinikka, L; Ylikorkala, O | 1 |
| Buchanan, MR; Reilly, PA; Rosenfeld, J; Turpie, AG | 1 |
| Donaldson, IM | 1 |
| Bouchier-Hayes, D | 1 |
| Nair, CK; Pagano, T; Sketch, MH | 1 |
| Dewanjee, MK; Fuster, V; Josa, M; Kaye, MP; Tago, M | 1 |
| von Schacky, C | 1 |
| Copeland, JG; Goldman, S | 1 |
| Firt, P; Horák, K; Peregrin, J; Pirk, J; Vojácek, J | 1 |
| Friedman, EW; Hamilton, AJ | 1 |
| Kholoussy, AM; Kumashiro, R; Matsumoto, T; Pavlides, CA | 1 |
| Gendeleka, GF; Gruzina, EA | 2 |
| de Croizet, V; Lazcano, F; Passalacqua, W; Plaza de los Reyes, M; Plaza de los Reyes, X; Saffie, A | 1 |
| Mannucci, PM | 1 |
| Asano, H; Kurasawa, T; Matumoto, K; Shimada, E; Yamane, Y | 1 |
| Fernández Basave, E; Filgueira Rubio, JS; Jiménez Fernández, J; Ortiz Monzó, F; Sancho García, RA | 1 |
| de Vaan, G; Flapper, B; Van Oostrom, C | 1 |
| Hutchins, GM; Imbembo, AL; McManama, GP; Ricotta, JJ; Sitzmann, JV | 1 |
| Crow, MJ; Davison, AM; Donaldson, DR; Rajah, SM; Roberts, TG; Salter, MC | 1 |
| Hayslett, JP | 1 |
| Furlan, AJ | 2 |
| García Muñoz, S; Gutstein Feldman, D; López Pastor, A; Martínez Ramos, C; Vara Thorbeck, C | 1 |
| Karczewiczowa, D; Krzystolikowa, Z | 1 |
| Boneu, B; Fournie, A | 1 |
| Chiba, J; Fukushima, K; Ishigatsubo, Y; Itoh, A; Kodama, F; Matsunaga, K | 1 |
| de Gaetano, G; Dejana, E; Villa, S | 1 |
| DeWeese, JA; Green, RM; Roedersheimer, LR | 1 |
| Greaves, M; Jackson, CA; Preston, FE | 1 |
| Van Aken, WG | 1 |
| Drolc, Z; Goldman, M; Hawker, RJ; McCollum, CN; Norcott, HC; Rafiqi, EI | 1 |
| Verdecchia, P | 2 |
| Famulari, A; Fraiman, H; Gonzáles, AM; Herskovits, E; Matera, V; Smud, R; Tamaroff, L; Vazquez, A; Vila, J | 1 |
| Fuchs, JC; Hagen, PO; McCann, RL | 1 |
| Damasio, E; Marmont, AM; Rossi, E; Spriano, M | 1 |
| Barajas, L; Chen, AF; Morin, RJ; Moss, RA; Narayanan, AS; Raye, C; Srikantaiah, MV | 1 |
| Adams, MB; Hebert, LA; Kauffman, HM; Walczak, PM | 1 |
| Akman, N | 1 |
| Cortellaro, M; Polli, EE | 1 |
| Morris-Jones, W; Preston, FE | 1 |
| Chelapurath, A; Essers, U; Häussinger, G; Pfennigs, H; Reul, H | 1 |
| Berliner, S; Pinkhas, J; Shaklai, M; Shoenfeld, Y | 1 |
| Hirono, S; Ito, S | 1 |
| Flinn, WR; Green, D; Rossi, EC; Spies, SM; Yao, JS | 1 |
| Bierme, R; Boneu, B; Clanet, M; David, J; Guiraud-Chaumeil, B; Rascol, A | 1 |
| Addiego, JE; deLorimier, AA; Koerper, MA; Lipow, H; Lubin, BH; Price, D | 1 |
| Burg, J; Gaudiani, VA; Jamieson, SW; Kosek, JC; Miller, DC | 1 |
| Kazmier, FJ | 1 |
| Dudley, FJ; Firkin, BG; Merrett, A; Perkin, J; Salem, HH | 1 |
| Deck, JH; Kelton, JG; Littlejohn, GO; Reynolds, WJ | 1 |
| Dewanjee, MK; Forshaw, PL; Fuster, V; Kaye, MP; Rao, SA | 1 |
| Brass, LF; Shattil, SJ | 1 |
| Chojnowski, K; Drzewoski, J; Hołub, A; Mazurowa, A; Olszańska-Skorek, T; Pełczyńska, I | 1 |
| Held, K | 1 |
| Yeung Laiwah, AC | 1 |
| Norlin, M; Oxelius, VA; Thysell, H | 1 |
| Firt, P; König, J; Krajícek, M; Pavel, P; Pirk, J; Ruzbarský, V | 1 |
| Thiers, B | 1 |
| Chen, WY; Chou, JH; Hsieh, BS; Lee, FN; Yen, TS | 1 |
| Lazzari, MA; Meschengieser, SS; Schattner, MA; Woods, AI | 1 |
| Poliwoda, H | 1 |
| Beshany, SE; Kongtahworn, C; Phillips, SJ; Zeff, RH | 1 |
| Forshaw, PL; Hancock, JB; Kaye, MP | 1 |
| Bianco, RL; Josa, M; Kaye, MP; Lie, JT | 1 |
| Fuzisawa, S; Kakinuma, H; Usami, Y | 1 |
| Crow, MJ; Donaldson, DR; Rajah, SM; Sreeharan, N | 1 |
| Boerboom, LE; Bonchek, LI; Hutchinson, L; Kissebah, AH; Munns, J; Olinger, GN; Pepper, JR | 1 |
| De Vita, C | 1 |
| Alperin, JB; Chesson, AL; Levin, HS; Masel, BE; Peters, BH | 1 |
| Jones, RJ | 1 |
| Cattell, V; Mehotra, A | 1 |
| Willoughby, ML | 1 |
| Finlay, AY; Marks, R; Statham, BN | 1 |
| Passamani, ER | 1 |
| Bunting, S; Moncada, S; O'Grady, J | 1 |
| Alkjaersig, N; Chaplin, H; Fletcher, AP; Joist, JH; Michael, JM | 1 |
| Bäcklund, H; Brechter, C; Krook, H; Müller, R; Nitelius, E; Olsson, JE; Olsson, O; Thornberg, A | 1 |
| Castaneda, W; Lindsay, WG; Mayer, JE; Nicoloff, DM | 1 |
| Viinikka, L; Ylikorkala, O | 1 |
| Kanazawa, T; Matsuoka, H | 1 |
| Moncada, S | 1 |
| Harjola, PT; Meurala, H | 1 |
| Loogen, F; Misera, R; Reimers, HJ; Schneider, W | 1 |
| Sloan, RW | 1 |
| Cristol, R | 1 |
| Bousser, MG; Eschwege, E; Haguenau, M; Lefauconnier, JM; Touboul, D; Touboul, PJ | 1 |
| Lubsen, J | 1 |
| Goldfinger, D; Ho, WG; Rosove, MH | 1 |
| Turpie, AG | 3 |
| Cazenave, JP; Dejana, E; Groves, HM; Kinlough-Rathbone, RL; Mustard, JF; Richardson, M | 1 |
| Boissel, JP; Destors, JM; Gillet, J; Leizorovicz, A; Schbath, J | 1 |
| Mehta, JL | 1 |
| McNicol, GP; Paton, RC; Tindall, H | 1 |
| Bardsley, WT; Chesebro, JH; Clements, IP; Danielson, GK; Elveback, LR; Frye, RL; Fuster, V; Holmes, DR; Orszulak, TA; Piehler, JM; Pluth, JR; Puga, FJ; Schaff, HV; Smith, HC; Vlietstra, RE; Wallace, RB | 1 |
| Schöndorf, TH | 1 |
| Meloche, JP | 1 |
| Ryan, RE | 2 |
| Hackel, DB; Hagen, PO; Mikat, EM; Wang, ZG | 1 |
| Hansen, JH; Hansen, PE; Stenbjerg, S | 1 |
| Salzman, EW | 1 |
| Friedman, C; Romem, M; Singer, L | 1 |
| Marshall, M | 1 |
| Kern, AB | 1 |
| Schmidt, B | 1 |
| Brantmark, B; Melander, A; Wåhlin-Boll, E | 1 |
| Boeynaems, JM | 1 |
| Bambach, D; Fontana, ME; Hermiller, JB; Huss, P; Leier, CV; Magorien, RD; Thompson, MJ; Unverferth, DV | 1 |
| Drucker, CR; Duncan, WC | 1 |
| Punt, J; Wind, J | 1 |
| Broomé, A; Davidsson, T; Eklöf, B; Hansson, L | 1 |
| Ambrose, TA; Bomberger, RA; DePalma, RG; Manalo, P | 1 |
| Newton, R; Tomlin, P | 1 |
| Marquardsen, J; Sørensen, PS | 1 |
| Bengtsson, U; Brun, C; Bygren, P; Jonsson, M; Jørgensen, F; Larsen, S; Laurell, AB; Lindholm, T; Norlin, M; Sjöholm, A; Thysell, H | 1 |
| Biale, Y; Cantor, A; Gueron, M; Lewenthal, H | 1 |
| Clark, WF; Moriarity, TA; Reid, BD; Tevaarwerk, GJ | 1 |
| Ball, ED; Myers, TJ; Tremont, SJ; Wakem, CJ | 1 |
| Pisciotta, AV | 1 |
| Deuel, T; Gardner, F; Peck, WA | 1 |
| Cornu, P; Gratwohl, A; Richner, J; Speck, B | 1 |
| Myers, TJ | 1 |
| Frankel, AE; Rubenstein, MD; Wall, RT | 1 |
| Boswell, EB; Sims, PJ | 1 |
| Kosaka, H; Nagata, S; Sadamoto, H | 1 |
| Aubert, D; Ferrand, C; Loubrie, JC; Tuong, A; Tuong, CC | 1 |
| Bowen, TE; Brott, WH; Davia, J; Green, DC; Zajtchuk, R | 1 |
| Dujovny, M; Kossovsky, N; Loubeau, JM; McManus, G; Nelson, D | 1 |
| Hamilton, GW; Harker, LA; Huang, TW; Ritchie, JL; Stratton, JR; Thiele, B; Warrick, LN | 1 |
| Chatterjee, DK; Greaney, M; Morris-Jones, W; Preston, FE | 1 |
| Lorenz, R; Siess, W; Weber, PC | 1 |
| Donner, L | 1 |
| Malinow, MR | 1 |
| Bersini, M; Gliori, A; Lavagnino, G; Ponzio, E; Raso, SM | 1 |
| Fucharoen, S; Wasi, P; Youngchaiyud, P | 1 |
| Baumgartner, HR; Turitto, VT; Vicic, WJ; Weiss, HJ | 1 |
| Mobarok, AT; Morley, J | 1 |
| Cavanagh, D; Gaston, LW; Rao, PS | 1 |
| Rainwater, J; Steele, P; Vogel, R | 1 |
| Chong, BH; Grace, CS; Rozenberg, MC | 1 |
| Boeri, L; Brida Di Priò, S; Buono, S; Cottafava, F; Della Casa, C; Dodero, P; Nardelli, E | 1 |
| Collins, JJ; H'Doubler, P; Koster, JK; Tryka, AF | 1 |
| De Marinis, M; Falchetti, R; Fieschi, C; Paolucci, S; Prencipe, M | 1 |
| Futrakul, P | 1 |
| Yatsu, FM | 1 |
| Rainwater, J; Steele, P | 1 |
| Giudice, JC; Kaufman, J; Komansky, HJ | 1 |
| Kahn, SB | 1 |
| Abiko, Y; Ashida, S; Sakuma, K | 1 |
| Dudka, PF | 1 |
| Castrucci, G; Ciabattoni, G; De Salvo, A; Parachini, M; Patrono, C; Pinca, E; Pugliese, F; Satta, MA | 1 |
| Culliton, BJ; Waterfall, WK | 1 |
| Diamond, S; Medina, JL | 1 |
| Crutchley, DJ; Ryan, JW; Ryan, US | 1 |
| Gomperts, ED; Lieberman, E | 1 |
| Chesney, RW; Mongeau, JG; O'Regan, S; Robitaille, P | 1 |
| Schott, G | 1 |
| Paredero Del Bosque Martin, V | 1 |
| Chesebro, JH; Elveback, LR; Frye, RL; Fuster, V | 1 |
| Croveri, G | 1 |
| Bossi, MC; Cipolli, PL; Taccola, A | 1 |
| Cooley, BC; Li, X | 1 |
| Fitzgerald, GA; Meagher, EA | 1 |
| Bergentz, SE; Bergqvist, D; Greenfield, LJ; Lindblad, B; Nichol, BJ; Stanley, JC; Stanley, TJ; Wakefield, TW | 1 |
| Bayazit, K; Gol, K; Kiziltepes, U; Mavitas, B; Sener, E; Tarcan, O; Tasdemir, O; Yamak, B | 1 |
| Hirahatake, K; Sato, C; Yamaguchi, M; Yamamoto, R | 1 |
| Heijstraten, FM; Thien, T; van den Berkmortel, FW; Wollersheim, H | 1 |
| Fiane, AE; Geiran, O; Lindberg, HL; Seem, E | 1 |
| Brown, MA; Cross, DB; French, JK; Hamer, AW; Ormiston, JA; White, HD; Williams, BF | 1 |
| Laakso, M; Riekkinen, PJ; Sivenius, J | 1 |
| Beythien, C; Hamm, CW; Terres, W | 1 |
| Bell, PR; London, NJ; Sayers, RD; Thompson, M; Varty, K | 1 |
| Bailey, KR; Chesebro, JH; Danielson, GK; Fuster, V; Grill, DE; Heras, M; Orszulak, TA; Penny, WJ; Pluth, JR; Puga, FJ | 1 |
| Bullough, DA; Montag, A; Mullane, KM; Young, MA; Zhang, C | 1 |
| Brutel de la Rivière, A; Dunselman, PH; Hillege, HL; Kootstra, GJ; Lie, KI; Mulder, BJ; Pfisterer, M; van der Meer, J; van Gilst, WH | 1 |
| Cohen, AT; Das, SK; Edmondson, RA; Kakkar, VV; Wagner, MB | 1 |
| Böhler, J; Braun, N; Grupp, C; Heering, P; Schollmeyer, P; Zäuner, I | 1 |
| Do, DD; Mahler, F | 1 |
| Dunning, AJ; Mulder, BJ; Piek, JJ; Tijssen, JG; van der Doef, RM; van der Meer, J; van der Wall, EE | 1 |
| Hakim, RM; Himmelfarb, J; Lazarus, JM; Sreedhara, R | 1 |
| Ascoop, CA; Hillege, HL; Kootstra, GJ; Lie, KI; Mulder, BJ; Pfisterer, M; van der Meer, J; van Gilst, WH | 1 |
| Houben, JJ; Nicolai, G | 2 |
| Anconina, J; Buffet, P; Cherrier, F; Cuillière, M; Danchin, N; Juillière, Y; Kettani, C | 1 |
| Alvarez, L; Castillo-Olivares, JL; de Haro, J; Escudero, MC; Jorge, E; Millán, I | 1 |
| Visser, J | 1 |
| Buyse, M; Lowenthal, A | 1 |
| Dietz, R; Frees, U; Hoberg, E; Katus, HA; Niebauer, J; Rauch, B; Schömig, A; Schuler, G; Schwarz, F; Tillmanns, H | 1 |
| Beton, D; Campbell, C; Critchley, A; Lawson, RA; Nair, U; Rajah, SM; Rees, M; Saunders, N; Walker, D; Williams, G | 1 |
| Ben-Hur, T | 1 |
| Bearn, PE; Bull, H; Marston, A; McCollum, CN; Seddon, AM | 1 |
| Braga, M; Cataldo, G; Lavezzari, M; Marubini, E; Pirotta, N; Rovelli, F | 1 |
| Paller, AS; Suarez, SM | 1 |
| Bastida, E; Bozzo, J; Escolar, G; Hernández, MR; Ordinas, A | 1 |
| Duclos, J | 1 |
| Alam, S; Gharzeddine, W; Malouf, JF; Stefadouros, MA | 1 |
| Durham, SK; Heran, CL; Megill, JR; Schumacher, WA; Steinbacher, TE | 1 |
| Braun, B; Grande, P; Hess, F; Jerusalem, C; Jerusalem, R; Reijnders, O; Steeghs, S | 1 |
| Bayazit, K; Eralp, A; Karagöz, HY; Tasdemir, O; Yamak, B; Zorlutuna, Y | 1 |
| Verheugt, FW | 1 |
| Gotch-Martin, KF; Hockings, BE; Ireland, MA; Taylor, RR | 1 |
| Androsova, SO; Katamadze, KT; Nikiforova, OV; Rogov, VA; Sidorova, IS; Tareeva, IE | 1 |
| Mach, T; Pirk, J; Rohn, V | 1 |
| Ben-Baruch, G; Carp, HJ; Greenspoon, JS; Many, A; Mashiach, S; Menashe, Y; Rosen, DJ | 1 |
| Green, D; Miller, V | 1 |
| Cleophas, TJ; Niemeyer, MG; Tavenier, P | 1 |
| Bearn, P; Cheatle, TR; Coleridge Smith, PD; Sarin, S; Scurr, JH; Shami, SK | 1 |
| Bearn, PE; Bull, H; Fox, B; Marston, A; McCollum, CN; Moffat, C; Seddon, AM | 1 |
| Chen, E; Christakis, GT; Fremes, SE; Goldman, BS; Levinton, C; Naylor, CD | 1 |
| LeBlanc, JG; Sett, SS; Vince, DJ | 1 |
| Debruyne, FM; Doesburg, W; vd Meijden, AP; Witjes, JA | 1 |
| Alonso, JJ; de la Fuente, L; Durán, JM; Fernández-Avilés, F; Gimeno, F; Muñoz, JC; San Román, JA | 1 |
| Duran, CM; Gometza, B | 1 |
| Franck, G | 1 |
| Arrobas, M; Caravaca, F; Cid, MC; Cubero, J; López-Minguez, JR; Miranda, MP; Pizarro, JL; Sanchez-Casado, E | 1 |
| Ferguson, JJ | 1 |
| Eldor, A; Ezra, Y; Rose, M | 1 |
| Altman, R; Gurfinkel, E; Rouvier, J | 1 |
| Copeland, J; Goldman, S; Henderson, WG; Moritz, T; Sethi, G | 1 |
| Bozzo, J; Hernández, MR; Ordinas, A | 2 |
| Ferrazzi, P; Fiocchi, R; Gamba, A; Glauber, M; Mamprin, F; Senni, M; Somaschini, M; Szefner, J | 1 |
| Iwamoto, Y; Naritomi, H; Nishimura, H; Sugita, M; Tachibana, H | 1 |
| Zuckerman, GR | 1 |
| Calpe Climent, AV; Horrach Pérez, M; Llobera C-anaves, J; Peña Díaz, JJ; Rodríguez Moreno, C; Thomàs Mulet, V; Tomàs Arbona, FJ | 1 |
| Beris, P; Mach-Pascual, S; Samii, K | 1 |
| Díaz-Marín, C; Matías-Guiu, J | 1 |
| Fairley, KF; Ferrier, C; Gamble, G; Kincaid-Smith, P; North, RA | 1 |
| Schafer, AI | 2 |
| Kozlovskaia, NL; Miroshnichenko, NG; Nikiforova, OV; Rogov, VA; Zozulia, OV | 1 |
| Iomhair, MM; Lavelle, SM | 1 |
| Heinz, M; Söhngen, M; Theiss, W; van de Flierdt, E | 1 |
| Diener, HC; Sivenius, J | 1 |
| Angueira, CE; Kadakia, SC; Moore, M; Ward, JA | 1 |
| Bozzo, J; Del Giorgio, A; Hernández, MR; Ordinas, A | 1 |
| Heidland, UE; Heintzen, MP; Schwartzkopff, B; Strauer, BE | 1 |
| Griesshammer, M; Heimpel, H; Pearson, TC | 1 |
| Cunha, L; Diener, HC; Forbes, C; Lowenthal, A; Sivenius, J; Smets, P | 1 |
| Enserink, M | 1 |
| De la Cruz, JP; García Campos, JM; Moreno, A; Muñoz, M; Sánchez de la Cuesta, F | 1 |
| Gensini, GF; Inzitari, D; Pantoni, L; Simone, I | 1 |
| Barer, D | 1 |
| Regan, JD | 1 |
| Barner, A | 1 |
| Zelger, B | 1 |
| Hama, J; Ishikawa, K; Kanamasa, K; Katori, R; Kimura, A; Naito, T; Nakai, S; Ogawa, I; Oyaizu, M; Takenaka, T; Yamamoto, K; Yamamoto, T | 1 |
| de Maistre, E; Lecompte, T | 1 |
| Canaple, S; Rosa, A | 1 |
| Eliyahu, S; Shalev, E | 1 |
| Cooley, BC; Hupkens, P | 1 |
| Vickerson, F | 1 |
| Bradley, SM; Crawford, FA; Sade, RM; Stroud, MR | 1 |
| Agarwal, V; Parimoo, P; Thomas, SK; Umapathi, P | 1 |
| Algra, A; Rosendaal, FR | 1 |
| Forbes, CD | 4 |
| Chandy, T; Sharma, CP; Vasudev, SC | 1 |
| Hillis, GS; Jennings, KP | 1 |
| Hacke, W; Orberk, E; Schellinger, PD | 1 |
| Azaceta, G; Civeira, E; Cornudella, R; Iturbe, T; Moreno, JA; Olave, T; Peleato, J; Sánchez, C; Varo, MJ | 1 |
| Divon, MY; Pollack, RN; Yaffe, H | 1 |
| Assanta, N; Baracchini, A; Buti, G; Ceccarelli, M; Chiaravalloti, G; Matteucci, L; Rossomando, V | 1 |
| Heidland, UE; Heintzen, MP; Kelm, M; Klimek, WJ; Leschke, M; Michel, CJ; Schwartzkopff, B; Strauer, BE; Vester, EG | 2 |
| Ben Amor, F; Bibi, M; Chaieb, A; Chebil, S; Khairi, H; Kortas, M; Maaroufi, R; Mahjoub, T; Mokni, M; Monastiri, K; Nouira, M; Saidi, H; Skouri, H; Slama, A; Snoussi, N; Zanina, R | 1 |
| Abbracchio, MP; Picano, E | 1 |
| Gibbs, CR; Li-Saw-Hee, FL; Lip, GY | 1 |
| Dresler, C; Haverich, A; Wahlers, T; Wittwer, T | 1 |
| Laakso, M; Puranen, J; Riekkinen, P; Sivenius, J | 1 |
| Algra, A; Koudstaal, PJ; van Gijn, J | 1 |
| Algra, A; De Schryver, EL; Gorter, JW | 2 |
| Diener, HC | 10 |
| Cataldo, G; Heiman, F; Lavezzari, M; Marubini, E | 1 |
| Oshima, T | 1 |
| Annemans, L; Dresse, A; Kurz, X | 1 |
| Laakso, M; Puranen, J; Riekkinen, PJ; Sivenius, J | 1 |
| Chandy, T; Rao, GH; Vasudev, SC | 1 |
| Tijssen, JG | 1 |
| Bentsen, N | 1 |
| Caidahl, K; Haglid, M; Hartford, M; Herlitz, J; Karlson, BW; Karlsson, T; Lindelöw, B | 1 |
| Tisdale, JE | 1 |
| Harbison, JW | 1 |
| Coller, B; Dalen, JE; Fuster, V; Gent, M; Harker, LA; Hirsh, J; Patrono, C; Roth, G | 1 |
| Dalen, JE; Goldman, S; Stein, PD; Théroux, P | 1 |
| Deng, MC; Hammel, D; Nabavi, D; Scheld, HH; Schmid, C; Weyand, M | 1 |
| Hoffmann, MW; Rauhöft, C; Terres, W | 1 |
| Otsuka, K; Sakurai, I; Satoh, T | 1 |
| Cunha, L; Diener, HC; Forbes, C; Laakso, M; Lowenthal, A; Riekkinen, P; Sivenius, J; Smets, P | 1 |
| Dyken, ML | 1 |
| French, L; Zielinski, R | 1 |
| Horbatiuk, OM | 1 |
| Scott, G; Scott, HM | 1 |
| Crisp, CB; Garrard, EA | 1 |
| Baker, RI; Hankey, GJ | 1 |
| Algra, A; De Schryver, EL; Gorter, JW; van Gijn, J | 1 |
| Algra, A; van Gijn, J | 2 |
| Higasa, S; Kakishita, E; Suehiro, A; Yoshimoto, H | 1 |
| Easton, JD; Wilterdink, JL | 1 |
| Goa, KL; Hervey, PS | 1 |
| Almdal, TP; Eldrup, E; Godtfredsen, J; Kofoed-Enevoldsen, A | 1 |
| Morikawa, A; Shinohara, M; Sone, K; Tomomasa, T | 1 |
| Himmelfarb, J | 1 |
| Deichsel, G; Marshall, S; Theis, JG | 1 |
| Abe, F; Abe, K; Ito, S; Omata, K; Yamada, M | 1 |
| Bayazit, K; Iscan, Z; Katircioglu, SF; Mavitas, B; Tasdemir, O; Ulus, AT; Yamak, B | 1 |
| Henney, JE | 1 |
| SoRelle, R | 1 |
| Chambers, M; Gladman, J; Hutton, J | 1 |
| Ranhosky, A | 1 |
| Amakawa, R; Fujimoto, M; Fukuhara, S; Hanada, M; Katsura, K; Kawamura, M; Kishimoto, Y; Nakai, K; Tajima, K; Yamamoto, Y; Zen, K | 1 |
| Mohammad, SF; Solen, KA; Sukavaneshvar, S | 1 |
| Bousser, MG; Crassard, I; Niclot, P | 1 |
| Baumgartner, RW; Mosso, M | 1 |
| Fastenau, DR; Matsubayashi, H; McIntyre, JA | 1 |
| Hughes, RL | 1 |
| Blanco, E; De La Cruz, JP; Sánchez de la Cuesta, F | 1 |
| Elkind, MS; Sacco, RL | 1 |
| Bo, A; Bruni, R; Damasio, E; De Luigi, MC; Florio, G; Giannini, G; Gobbi, A; Lercari, G; Marmont, A; Valbonesi, M | 1 |
| Algra, A; Eikelboom, BC; Kappelle, LJ; Klijn, CJ; Tulleken, CA; van Buren, PA; van Gijn, J | 1 |
| Cohen, SN | 1 |
| Glogar, D; Gottsauner-Wolf, M; Hornykewycz, S; Huber, K; Maurer, G; Nikfardjam, M; Probst, P; Stepan, E; Wexberg, P; Zasmeta, G; Zorn, G | 1 |
| Gondek, K; Shah, H | 1 |
| Reverter, JC | 1 |
| Bounameaux, H; Gaspoz, JM; Sarasin, FP | 1 |
| Bergmann, SR | 2 |
| Dippel, DW; Limburg, M; Niessen, LW | 1 |
| Gallai, V; Paciaroni, M | 1 |
| Brown, MM; McCabe, DJ | 1 |
| Bogousslavsky, J; Devuyst, G | 1 |
| Bhatt, DL; Kapadia, SR; Topol, EJ; Yadav, JS | 1 |
| Weksler, BB | 1 |
| Hilleman, DE; Lenz, TL | 1 |
| Berdié, J; Galindo, G; Morató, J; Navarro, MA; Peiró, R; Plana, A | 1 |
| Baumgartner, RW; Kollias, SS; Sandor, P; Siegel, AM | 1 |
| Coller, B; Dalen, JE; FitzGerald, GA; Fuster, V; Gent, M; Hirsh, J; Patrono, C; Roth, G | 1 |
| Alpert, JS; Bussey, HI; Dalen, JE; Stein, PD; Turpie, AG | 1 |
| Horibe, K; Iwase, K; Kojima, S; Kondo, M; Kudo, K | 1 |
| Little, SH; Massel, D | 1 |
| Scheen, AJ | 1 |
| Davis, SM; Donnan, GA | 2 |
| Butenas, S; Cawthern, KM; DiLorenzo, ME; Lock, JB; Mann, KG; van't Veer, C | 1 |
| Pettigrew, LC | 1 |
| Lee, SS; Yoon, TY | 1 |
| Kipp, A | 1 |
| Heidebrink, JL | 1 |
| Bertrand-Hardy, JM; Darius, H; Diener, HC; Humphreys, M | 2 |
| Lapane, KL; Quilliam, BJ | 1 |
| Barone, P; Betta, P; Distefano, G; Falsaperla, R; Marletta, M; Mattia, C; Sciacca, P; Tornambene, G | 1 |
| Davis, CJ; Lowry, DR; McKenzie, ME; Nair, GV; Serebruany, VL | 1 |
| Hara, T; Matsushima, T; Ohga, S; Suita, S; Tokunaga, Y | 1 |
| Ito, H; Kimura, Y; Ozeki, Y; Sudo, T | 1 |
| Steinhubl, SR; Van De Graaff, E | 1 |
| Müller, TH | 1 |
| Bath, P; Heptinstall, S; Zhao, L | 1 |
| Redman, AR; Ryan, GJ | 2 |
| Delanty, N; Kantor, J; Majid, A | 1 |
| Hansen, DB | 1 |
| Brass, LM | 2 |
| Lalouschek, W; Lang, W; Müllner, M | 1 |
| Dalton, B; Evans, MF; Papoushek, C | 1 |
| Crawford, KM; Talbert, RL | 1 |
| Baron, BW; Baron, JM; Jeon, H; Martin, MS; Sucharetza, BS | 1 |
| Geroulakos, G; Matsagas, MI; Mikhailidis, DP | 1 |
| Candelas, D; Mediero, IG; Sevilla, J; Torrelo, A; Zambrano, A | 1 |
| Khajehdehi, P; Mostafavi, H; Roozbeh, J | 1 |
| Pettigrew, LC; Williams, SC | 1 |
| Anderson, JD; Littmann, L; Monroe, MH | 1 |
| Warlow, C | 1 |
| Baştürk, T; Harmankaya, O; Karabiber, N; Obek, A; Oztürk, Y | 1 |
| Mehta, P | 1 |
| MacWalter, RS; Shirley, CP | 1 |
| Iwata, M; Nakamura, T; Uchiyama, S; Yamazaki, M | 1 |
| Ishikawa, K; Nakai, S | 1 |
| Algra, A; De Schryver, EL; van Gijn, J | 3 |
| Feloney, CD; Malacaria, B | 1 |
| Arnold, M; Mattle, HP; Nedeltchev, K | 1 |
| Dörffler-Melly, J; Mahler, F; Schmidli, J | 1 |
| Ojeda Cuchillero, RM; Sánchez Regaña, M; Umbert Millet, P | 1 |
| Connolly, SJ | 1 |
| Malinin, AI; Sane, DC; Serebruany, VL | 1 |
| Lecompte, T | 1 |
| Ishikawa, K | 1 |
| Kaste, M; Sivenius, J | 1 |
| Eikelboom, JW; Hankey, GJ | 1 |
| Bath, PM; Fox, S; Heptinstall, S; Judge, H; Lösche, W; May, J; Zhao, L | 1 |
| Curtin, R; Fitzgerald, DJ | 1 |
| Lenz, T; Wilson, A | 1 |
| Christ, G; Huber, K; Kopp, CW; Maurer, G; Minar, E; Priglinger, U; Probst, P; Steiner, S | 1 |
| De Schryver, EL | 1 |
| Grieco, G; Jonas, S | 2 |
| Christian, JB; Lapane, KL; Toppa, RS | 1 |
| Haberl, R | 1 |
| Little, SH; Massel, DR | 2 |
| Rao, U; Weston, C | 1 |
| Behan, MW; Storey, RF | 1 |
| Fisher, M; Moonis, M | 1 |
| Belch, J; Betteridge, DJ; Brown, MM; Gent, M; Julian, D; Long, S; Morris, S; Pittard, J; Pye, M | 1 |
| Atar, D; Ferguson, JJ; Hanley, DF; Serebruany, VL | 1 |
| Jüttler, E; Meyding-Lamadé, UK; Schellinger, PD; Schwark, C | 1 |
| Uchiyama, S | 1 |
| Besta, F; Gawaz, M; Müller, I | 1 |
| Bédard, PJ; Goldstein, WG; Hendry, PJ; Masters, RG; Mesana, TG; Pipe, AL; Rubens, FD; Ruel, M | 1 |
| Marissal, JP; Selke, B | 1 |
| Lindberg, M | 1 |
| Husted, S; Lindgren, A; Staaf, G; Ziegler, B | 1 |
| Aronow, WS | 1 |
| Atar, D; Hennekens, CH; Jilma, B; Malinin, AI; Sane, DC; Serebruany, VL; Takserman, A | 1 |
| Bigal, ME; Davidai, G; Gorelick, PB; Kolodner, KB; Lipton, RB; Schoebelock, M; Wilks, K | 1 |
| Griffin, S; Hawkins, N; Henderson, R; Jones, L; Main, C; Orton, V; Palmer, S; Riemsma, R; Sculpher, M; Sudlow, C | 1 |
| Anand, SS; Tran, H | 1 |
| Nicholls, C; Sani, M | 1 |
| Li, J; Mo, S; Shen, W; Wu, X | 1 |
| Bath, PM; Bousser, MG; Davalos, A; Dewey, ME; Diener, HC; Guiraud-Chaumeil, B; Leonardi-Bee, J; Sivenius, J; Yatsu, F | 1 |
| Denis, MM; Dixon, DA; Kuhlmann-Eyre, JR; Marathe, GK; McIntyre, TM; Prescott, SM; Spencer, ED; Weyrich, AS; Zimmerman, GA | 1 |
| Büller, HR; Dörffler-Melly, J; Koopman, MM; Prins, MH | 1 |
| Moussouttas, M; Papamitsakis, N | 1 |
| Caplain, H | 1 |
| Albers, GW; Bernstein, RA | 1 |
| Artem'eva, VB; Gordovskaia, NB; Kozlovskaia, NL; Krylova, MIu; Rogov, VA; Shilov, EM; Sidorova, IS | 1 |
| Weinberger, J | 2 |
| Bath, P; Fletcher, S; Fox, S; Heptinstal, S; Leonardi-Bee, J; May, J; Weaver, C; Willmot, M; Zhao, L | 1 |
| Goudswaard, AN; van Bentum, ST; van Binsbergen, JJ; Verhoeven, S; Wiersma, TJ | 1 |
| Hosoya, M; Isome, M; Kawasaki, Y; Suzuki, H; Takahashi, A; Tanji, M | 1 |
| Diener, HC; Sacco, RL; Sivenius, J | 1 |
| Ringleb, PA; Schellinger, PD; Schwaninger, M; Schwark, C | 1 |
| Gray, CS; Morton, JA; Newton, J | 1 |
| Hughes, DA; Mehta, AB | 1 |
| Houben, J | 1 |
| Brickl, RS; Derendorf, H; Eisert, W; MacGregor, TR; VanderMaelen, CP | 1 |
| Boneu, B; Cadroy, Y; Sakariassen, K; Thalamas, C | 1 |
| Bernstein, RA | 1 |
| Nowak, DA; Topka, HR | 1 |
| Gebel, JM | 2 |
| Abraham, R; Biaggioni, I; Diedrich, A; Farley, G; Gamboa, A; Paranjape, SY; Shibao, C | 1 |
| Ezekowitz, MD; Jamieson, DG; Parekh, A | 1 |
| Sudlow, C | 2 |
| Dorofeikov, VV; Ivasenko, IN; Shlyakhto, EV | 1 |
| Fieschi, C; Volante, F | 1 |
| Szapáry, L | 1 |
| Algra, A; Ariesen, MJ; Kappelle, LJ | 1 |
| Beck, GJ; Dember, LM; Depner, TA; Dixon, BS; Feldman, HI; Gassman, JJ; Greene, T; Himmelfarb, J; Hunsicker, LG; Kaufman, JS; Lawson, JH; Meyers, CM; Middleton, JP; Radeva, M; Schwab, SJ; Whiting, JF | 1 |
| Atar, D; Hanley, D; Jilma, B; Malinin, A; Pokov, A; Serebruany, V; Ziai, W | 1 |
| Born, G; Patrono, C | 1 |
| Andersen, G; Boysen, G; Husted, SE; Johnsen, SP; Petersen, P | 1 |
| Bath, PM; Gray, L; Heptinstall, S; Leonardi-Bee, J; Weaver, CS; Zhao, L | 1 |
| Angerson, WJ; Blatchford, O; Knill-Jones, RP; Taha, AS | 1 |
| Caplan, LR | 1 |
| Schuler, G | 1 |
| Hara, T; Kira, R; Ohga, S; Sanefuji, M; Torisu, H; Yoshiura, T | 1 |
| Norrving, B | 1 |
| Algra, A; Halkes, PH; Kappelle, LJ; Koudstaal, PJ; van Gijn, J | 2 |
| Horton, HL | 1 |
| Chang, YJ; Lee, TH; Ryu, SJ | 1 |
| Byrne, MF; Conroy, R; Cox, D; Dooley, M; Fitzgerald, DJ; Maree, AO | 1 |
| Habib, GB | 1 |
| Chairangsarit, P; Nidhinandana, S; Niyasom, S; Sithinamsuwan, P; Suwantamee, J; Udommongkol, C | 1 |
| Durall, AL; Mullett, CJ; Phillips, JR; Weisse, ME | 1 |
| Filippi, A | 1 |
| Eikelboom, JW; O'Donnell, M | 1 |
| Broderick, JP; Flaherty, ML; Kissela, B | 1 |
| Buell, U; Koch, KC; Noth, J; Nowak, B; Schaefer, WM; Weiss, PH | 1 |
| De Keyser, JH; Luijckx, GJ | 1 |
| Cordonnier, C; Leys, D | 1 |
| Busse, O; Diener, HC; Grond, M | 1 |
| Derendorf, H | 1 |
| Abraham, J; Jones, PA; Kramer, J; Teven, CM | 1 |
| Schindler, B | 1 |
| Bochenek, A; Wilczyński, M | 1 |
| Hill, MD | 1 |
| Brouwer, MA; Dieker, HJ; Elliott, J; French, JK; Joziasse, IC; Verheugt, FW; Webber, BJ; West, TM; White, HD | 1 |
| Eusman, JP; Schrama, E | 1 |
| Einhäupl, K | 1 |
| Moussouttas, M | 1 |
| Al-Bahrani, A; Bakhiet, M; Shaath, H; Taha, S | 1 |
| Diener, HC; Sacco, R; Yusuf, S | 2 |
| Fontana, P | 1 |
| Liao, JK | 1 |
| Jamieson, DG | 1 |
| Anavekar, NS; Baddour, LM; Chandrasekaran, K; Haddad, C; Khandaker, MH; Mirzoyev, Z; Steckelberg, JM; Tleyjeh, IM; Wilson, WR | 1 |
| Han, ZX; Ma, CM; Ma, GY | 1 |
| Aldandashi, S; Noor, R; Shuaib, A; Uddin, G; Wang, CX | 1 |
| Laroche, ML; Macian-Montoro, F; Merle, L; Vallat, JM | 1 |
| Bhatt, DL; Meadows, TA | 1 |
| Gogol, M | 1 |
| Ackerstaff, RG; de Borst, GJ; de Vries, JP; Hilgevoord, AA; Moll, FL; van de Pavoordt, HD; van der Mee, M | 1 |
| Kakuliia, MSh | 1 |
| Macdonald, S | 1 |
| Diener, HC; Grond, M; Weber, R | 1 |
| Fintel, DJ | 1 |
| Kirshner, HS | 1 |
| Sedrakyan, A; Shih, C | 1 |
| Husted, SE; Overgaard, K; Poulsen, TS | 1 |
| Eldrup, N; Laustsen, J; Lorenzen, ND | 1 |
| Algra, A; Halkes, PH | 1 |
| Boutary, M; Dorr, LD; Gendelman, V; Long, WT; Maheshwari, AV; Wan, Z | 1 |
| Hankey, GJ | 1 |
| Delate, T; Johnson, SG; Rogers, K; Witt, DM | 1 |
| Hanley, DF; Malinin, AI; Serebruany, VL | 1 |
| Bates, V; Forrest, A; Gengo, FM; Gengo, MF; Hourihane, M; Rainka, M; Robson, M | 1 |
| Benzimra, JD; Chung, AK; Eke, T; Galloway, PH; Jaycock, P; Johnston, RL; Lambert, G; Sparrow, JM | 1 |
| Iba, T | 1 |
| Di Gennaro, L; Landolfi, R | 1 |
| Adams, RJ; Albers, G; Alberts, MJ; Benavente, O; Furie, K; Goldstein, LB; Gorelick, P; Halperin, J; Harbaugh, R; Johnston, SC; Katzan, I; Kelly-Hayes, M; Kenton, EJ; Marks, M; Sacco, RL; Schwamm, LH | 1 |
| Hills, NK; Johnston, SC | 1 |
| Gorelick, PB; Nguyen, D; Verro, P | 1 |
| Hanley, DF; Malinin, AI; Pokov, AN; Serebruany, VL | 1 |
| Fieuws, S; Lemmens, R; Thijs, V | 1 |
| Albers, GW; Schwartz, NE | 1 |
| Brandslund, I; Buck, TC; Christensen, C; Jørgensen, LG; Nielsen, AA; Veien, KT | 1 |
| Jamieson, DG; Skliut, M | 1 |
| Algra, A; Bath, PM; Diener, HC; Gray, LJ; Guiraud-Chaumeil, B; Halkes, PH; Yatsu, FM | 1 |
| Algra, A; De Schryver, EL; Halkes, PH | 1 |
| Sztriha, LK; Vécsei, L | 1 |
| Albers, GW; Amarenco, P; Easton, JD; Sacco, RL; Teal, P | 1 |
| Einecke, D | 1 |
| Diener, C | 1 |
| Hoover, PL; Mold, JW | 1 |
| Bath, PM; England, T; Gray, LJ; Sare, GM; Sprigg, N; Willmot, MR; Zhao, L | 1 |
| Kesteven, P; McCaslin, J; Smout, J; Stansby, G | 1 |
| Chaturvedi, S | 1 |
| Anderson, CS | 1 |
| Albers, GW; Bath, P; Bornstein, N; Chan, BP; Chen, ST; Cotton, D; Cunha, L; Dahlöf, B; De Keyser, J; Diener, HC; Donnan, GA; Estol, C; Gorelick, P; Gu, V; Hermansson, K; Hilbrich, L; Kaste, M; Lawton, WA; Lu, C; Machnig, T; Martin, RH; Ounpuu, S; Pais, P; Palesch, Y; Roberts, R; Sacco, RL; Skvortsova, V; Teal, P; Toni, D; Vandermaelen, C; Voigt, T; Weber, M; Yoon, BW; Yusuf, S | 2 |
| Kent, DM; Thaler, DE | 1 |
| Panagos, PD | 1 |
| Rosenson, RS | 1 |
| Lam, SK; Owen, A | 1 |
| Kappelle, LJ | 1 |
| Saseen, JJ; Vande Griend, JP | 1 |
| Rajek, A; Sandner, SE; Schima, H; Steinlechner, B; Wieselthaler, GM; Wolner, E; Zimpfer, D; Zrunek, P | 1 |
| Lodder, J; Rouhl, RP | 1 |
| Selim, M | 1 |
| Barabás, JB; Horváth, C; Joób-Fancsaly, A; Kalmár, G; Koppány, F | 1 |
| Jao, T; Jeng, JS; Tsai, TH | 1 |
| Minnerup, J; Schäbitz, WR | 1 |
| Lane, DA; Lip, GY; Tay, KH | 1 |
| de Boer, A; Klungel, OH; Schalekamp, T; Souverein, PC | 1 |
| Hart, RG | 1 |
| Claes, C; Grond, M; Mittendorf, T; von der Schulenburg, JM | 1 |
| Hegge, KA | 1 |
| Irsara, S; Liessi, G; Marigo, L; Tonello, D; Visonà, A; Zalunardo, B; Zotta, L | 1 |
| Balucani, C; Cordonnier, C; Leys, D | 1 |
| Brahin, E; Dessain, S; Ezekowitz, MD; Gracely, E; Nagarakanti, R; Notaro, LA; Usman, MH | 1 |
| Biller, J | 1 |
| Berger, JS; Hiatt, WR; Kittelson, JM; Krantz, MJ | 1 |
| Haq, S; Khalil, S; Mohanaruban, K | 1 |
| Allon, M; Beck, GJ; Braden, GL; Cotton, JR; Davidson, IJ; Delmez, JA; Dember, LM; Dixon, BS; Feldman, HI; Fenves, AZ; Gassman, JJ; Greenberg, A; Greene, T; Himmelfarb, J; Hu, B; Ikizler, TA; Kaufman, JS; Kusek, JW; Lawson, JH; Martin, KJ; McNeil, JW; Meyers, CM; Radeva, MK; Rahman, A; Vazquez, MA; Whiting, JF | 1 |
| Lok, CE | 1 |
| Algra, A; De Schryver, EL | 1 |
| Lökk, J | 1 |
| Beckman, JA | 1 |
| Spinler, SA | 1 |
| Breitkreutz, J | 1 |
| Cooper, DG; Weale, AR | 1 |
| Hentschel, DM | 1 |
| Atar, OD; Booze, C; Eisert, C; Hanley, D; Sabaeva, E; Serebruany, V | 1 |
| Schwab, S | 1 |
| Takagi, H; Umemoto, T | 1 |
| Gomez, CR; Qureshi, AI | 1 |
| Ross, IN; Sharma, JC; Vassallo, M | 1 |
| Meyer, D | 1 |
| Anjum, N; Child, N; Cooper, HL; Keohane, SG | 1 |
| Ahmed, N; Diedler, J; Ford, GA; Lees, KR; Luijckx, GJ; Overgaard, K; Ringleb, P; Soinne, L; Sykora, M; Uyttenboogaart, M; Wahlgren, N | 1 |
| Dengler, R; Diener, HC; Eschenfelder, CC; Grond, M; Haberl, R; Kastrup, A; Leonard, J; Machnig, T; Schumacher, H; Schwartz, A; Weissenborn, K | 1 |
| Bath, PM; Cotton, D; Diener, HC; Estol, C; Martin, RH; Palesch, Y; Roberts, R; Sacco, R; Yusuf, S | 1 |
| Burke, JP; Henk, H; Sander, S; Shah, H; Zarotsky, V | 1 |
| Fung, K; Simmons, BB; Yeo, A | 1 |
| Bello, RA; D'Alessandro, DA; Edwards, P; Goldstein, DJ; Kazam, J; Maybaum, S; Stern, DR | 1 |
| Christensen, S; Christiansen, CF; Johansen, MB; Lash, TL; Schmidt, M; Sørensen, HT | 1 |
| Crown, N; Mysak, T | 1 |
| Birnbaum, Y; Long, B; Perez-Polo, JR; Qian, J; Ye, Y | 1 |
| Bédard, M; Dubois, S; Gibbons, C; Hargadon, J; Joy, K | 1 |
| Hara, T; Hoshina, T; Ikeda, K; Ishimura, M; Kusuhara, K; Muneuchi, J; Ohga, S; Takada, H; Utsunomiya, R; Yamaguchi, K | 1 |
| Diener, HC; Weber, R | 1 |
| Amat, G; Brahic, H; Eschalier, A; Eschalier, R; Marcaggi, X; Ravan, R | 1 |
| Algra, A; Dippel, DW; Halkes, P; Kappelle, LJ; Koudstaal, PJ; Maasland, L | 1 |
| Greer, DM | 1 |
| Birnbaum, Y; Perez-Polo, JR; Ye, Y | 1 |
| Hillege, HL; van der Meer, J; Veeger, NJ; Zijlstra, F | 1 |
| Hiratzka, LF | 1 |
| Eisert, C; Fong, A; Hanley, D; Sani, Y; Schevchuck, A; Serebruany, V | 1 |
| Bartkova, A; Herzig, R; Hlustik, P; Kanovsky, P; Kovacik, M; Kral, M; Sanak, D; Skoloudik, D; Vlachova, I | 1 |
| Goldhaber, SZ; Maron, BA; Shekar, PS | 1 |
| Benavente, OR; Field, TS | 1 |
| Collins, DR; Coughlan, T; Egan, B; Feeley, TM; Kinsella, JA; McCabe, DJ; Murphy, RP; O'Neill, D; Tierney, S; Tobin, WO | 1 |
| Bath, PM; King, A; Markus, HS | 1 |
| Charles, J; Miller, G; Pan, Y | 1 |
| Agirbasli, M; Cem Mat, M; Demirkesen, C; Eren, F; Eren, M; Murphy, SB; Seckin, D; Serdar, ZA; Vaughan, DE; Zara, T | 1 |
| Fong, A; Hanley, D; Pokov, I; Sani, Y; Schevchuck, A; Serebruany, V; Thevathasan, L | 1 |
| Dawson, J; Stewart, K; Walters, M | 1 |
| Kamal, AK; Khan, M | 2 |
| Bech, FR; Chertow, GM | 1 |
| Allon, M; Beck, GJ; Braden, GL; Cotton, JR; Davidson, IJ; Delmez, JA; Dember, LM; Dixon, BS; Feldman, HI; Greenberg, A; Greene, T; Himmelfarb, J; Hu, B; Ikizler, TA; Kusek, JW; Lawson, JH; Radeva, MK; Vazquez, MA | 1 |
| Jørgensen, NR; Schwarz, P; Steinberg, TH; Vestergaard, P | 1 |
| Diener, HC; Röther, J; Weber, R; Weimar, C | 1 |
| Horie, Y; Ikeda, Y; Uchiyama, S; Urano, Y; Yamaguchi, T | 1 |
| Chootrakool, H; Shi, JQ; Yue, R | 1 |
| Guthrie, R | 1 |
| Bath, P; Hogg, C; Pocock, S; Tracy, M | 1 |
| Hayreh, SS; Podhajsky, PA; Zimmerman, MB | 1 |
| Bidarmaghz, B; Ebadi, MR; Motamedi, MH; Nazerani, S; Nazerani, T | 1 |
| Bhattacharya, P; Chaturvedi, S | 1 |
| Bagust, A; Blundell, M; Boland, A; Dickson, R; Dundar, Y; Fisher, M; Greenhalgh, J; Martin Saborido, C; Oyee, J; Proudlove, C | 1 |
| Bath, PM; Cotton, D; Diener, HC; Donnan, GA; Martin, RH; Ovbiagele, B; Vinisko, R; Yusuf, S | 1 |
| Copeland, H; Copeland, JG; Covington, D; Gustafson, M; Nolan, PE; Smith, R | 1 |
| Aw, D; Sharma, JC | 1 |
| Doney, AS; Flynn, RW; MacDonald, TM; MacWalter, RS; Murray, GD | 1 |
| Blatchford, J; Demchuk, AM; Diehl, A; Diener, HC; Forsting, M; Gizewski, ER; Hermansson, K; Möller-Hartmann, C; Sacco, RL; Saver, JL; Wanke, I; Warach, S; Weber, R; Weimar, C | 1 |
| Acelajado, MC; Oparil, S | 1 |
| Allon, M; Bray, MS; Fernandez, JR; Maya, ID; Zhang, L | 1 |
| Algra, A; Bath, MW; Bath, PM; Chen, C; Dengler, R; Diener, HC; Geeganage, CM; Markus, HS; Topol, EJ | 1 |
| Baglin, TP; Eikelboom, JW; Hirsh, J; Spencer, FA; Weitz, JI | 1 |
| Cipriano, A; Furtado, E; Gomes, AC; Gonçalves, I; Pinto, C; Rubino, G | 1 |
| Bassareo, PP; Fanos, V; Iacovidou, N; Mercuro, G | 1 |
| Dewilde, S; Hawkins, N | 1 |
| Andersson, B; Arnarsdottir, L; Bokemark, L; Hjalmarsson, C | 1 |
| Brenck, J; Diener, HC; Weber, R | 1 |
| Acciarresi, M; Caso, V; Paciaroni, M; Pezzella, FR; Santalucia, P | 1 |
| Dengler, R; Eisert, WG; Lichtinghagen, R; Schumacher, H; Schwartz, A; Weissenborn, K; Worthmann, H | 1 |
| Karagüzel, E; Kazaz, İO; Kutlu, Ö; Mungan, S; Özgür, GK; Tok, DS; Yuluğ, E | 1 |
| Collins, R; Coughlan, T; Cox, D; Kinsella, JA; McCabe, DJ; Murphy, RP; O'Neill, D; Tobin, WO | 1 |
| Molenberghs, G; Vanstreels, L; Voigt, JU | 1 |
| Brown, RD; Christianson, TJ; Flemming, KD; Link, MJ | 1 |
| Collins, DR; Coughlan, T; Egan, B; Feeley, TM; Kavanagh, GF; Kinsella, JA; McCabe, DJ; McGrath, RA; Murphy, RP; O'Donnell, JS; O'Neill, D; Tierney, S; Tobin, WO | 1 |
| Kamal, AK; Wadiwala, MF | 1 |
| Valentine, N; Van de Laar, FA; van Driel, ML | 1 |
| Michel, P; Milionis, H | 1 |
| Brickl, R; Ehrlich, J; Eisert, W; Offman, E; Schobelock, MJ; VanderMaelen, CP | 1 |
| Algra, A; Hilkens, PH; Roos, YB; Vermeer, SE; Zuurbier, SM | 1 |
| Bath, PM; Cotton, D; Diener, HC; Sacco, RL; Sha, N; Weber, R; Weimar, C | 1 |
| Cohn, S; Deller, R; Edwards, D; Fletcher, K; Giles, M; Hobbs, V; Lasserson, D; Mant, J; McGuire, G; McManus, R; Norrie, J; Sims, D; Weir, C; Whittle, F | 1 |
| Li, X; Zhou, G; Zhou, S; Zhou, X | 1 |
| Dodd, JM; Kingdom, J; McLeod, A; Windrim, RC | 1 |
| Douiri, A; Emmett, ES; McKevitt, C; Rudd, AG; Wolfe, CD | 1 |
| Alasty, P; Hamishehkar, H; Monajjemzadeh, F; Valizadeh, H | 1 |
| Hong, KS; Lee, M; Ovbiagele, B; Rao, NM; Saver, JL; Wu, YL | 1 |
| Donovan, JL; Kanaan, AO; Malloy, RJ; Silva, MA | 1 |
| Ding, D | 1 |
| Abbott, KC; Himmelfarb, J; Little, DJ; Lowe, SR; Nee, R; Parker, AL; Yuan, CM | 1 |
| Mansoor, AH; Mujtaba, MT; Silver, B | 1 |
| Inuyama, L; Mizuno, O; Sakaguchi, T; Takahashi, S; Yamada, T | 1 |
| Arnao, V; Clemente, G; Della Corte, V; Di Raimondo, D; Licata, G; Maida, C; Pecoraro, R; Pinto, A; Simonetta, I; Tuttolomondo, A | 1 |
| Cecconi, E; Counsell, C; Sandercock, PA; Tseng, MC | 1 |
| Collins, DR; Coughlan, T; Egan, B; Feeley, TM; Kavanagh, GF; Kinsella, JA; McCabe, DJ; McGrath, RT; Murphy, RP; O'Donnell, JS; O'Neill, D; Tierney, S; Tobin, WO | 1 |
| Asher, CR; Buitrago, I; Wolinsky, D | 1 |
| de Vogel, EM; de Vos-Koppelaar, NC; Dieleman, HG; Kerkhoff, H; Zock, E | 1 |
| Alraies, MC | 1 |
| Asher, C; Buitrago, I; Wolinsky, D | 1 |
| Bath, PM; Cotton, D; Davidai, G; Diener, HC; Gorelick, P; Lipton, RB; Sacco, R | 1 |
| Azarbal, A; Clavijo, L; Gaglia, MA | 1 |
| Figueredo, VM; Inamura, Y; Kaneda, K; Miyamae, M; Okusa, C | 1 |
| Ahn, JH; Gurbel, PA; Hwang, JY; Hwang, SJ; Jeong, YH; Kim, KH; Koh, JS; Kwak, CH; Park, JR; Park, Y; Tantry, US | 1 |
| Mavridis, D; Salanti, G; Sutton, A; Welton, NJ | 1 |
| Bath, PM; Dineen, R; Pocock, S; Robson, K; Sprigg, N; Woodhouse, LJ | 1 |
| Acosta, S; Bedenis, R; Lethaby, A; Maxwell, H; Prins, MH | 1 |
| Albuquerque, FC; Gross, BA | 1 |
| Ovbiagele, B; Rothlisberger, JM | 1 |
| Ang, ES; De Silva, DA; Fabiaña, N; Ramaswami, AP | 1 |
| Carlson, N; Christiansen, CB; Gerds, TA; Gislason, G; Jørgensen, ME; Kristensen, SL; Numé, AK; Olesen, JB; Pallisgaard, J; Torp-Pedersen, C | 1 |
| Algra, A; Greving, JP; Hilkens, NA | 1 |
| D'Alessandro, D; Goldstein, DJ; Guerrero, C; Jermyn, R; Jorde, UP; Kargoli, F; Levin, AP; Madan, S; Nguyen, J; Patel, SR; Saeed, O; Shah, A; Shin, J; Sims, DB | 1 |
| Coughlan, CA; Gutkin, M; Kinsella, J; Lonergan, R; McCabe, DJ; Murphy, SJ; Tobin, O | 1 |
| Guo, ZN; Jin, H; Niu, PP; Xing, YQ; Yang, Y | 1 |
| Abdelkawy, M; El-Ragehy, NA; Hassan, NY; Tantawy, MA | 1 |
| Appleton, JP; Bath, PM; Beridze, M; Christensen, H; Dineen, RA; Duley, L; England, TJ; Flaherty, K; Heptinstall, S; James, M; Krishnan, K; Markus, HS; Pocock, S; Ranta, A; Robinson, TG; Scutt, P; Sprigg, N; Venables, GS; Woodhouse, LJ | 1 |
| Askie, LA; Mol, BWJ; Oudijk, MA; van Vliet, EOG | 1 |
| Bastiaannet, E; Frouws, MA; Lemmens, VE; Liefers, GJ; Portielje, JEA; Rademaker, E; Van de Velde, CJH; van Herk-Sukel, MPP | 1 |
| Chang, S; Chang, Y; Lu, S; Sun, Q; Zhang, Y | 1 |
| Appleton, JP; Bath, PM; Beridze, M; Christensen, H; Dineen, RA; Duley, L; England, TJ; Flaherty, K; Havard, D; Heptinstall, S; James, M; Krishnan, K; Markus, HS; Montgomery, AA; Pocock, SJ; Randall, M; Ranta, A; Robinson, TG; Scutt, P; Sprigg, N; Venables, GS; Woodhouse, LJ | 1 |
| Liu, X; Zhang, JJ | 1 |
| Deng, H; Du, M; Fu, J; Liu, R; Wan, H; Wang, X; Zhang, Y | 1 |
| Dawood, BB; Hayes, J; Hoskins, HC; Protty, MB; Wilkins, SJ | 1 |
| Andreozzi, L; Castelli, B; De Rosa, G; Piastra, M; Rigante, D | 1 |
| Barlas, RS; Bettencourt-Silva, JH; Bowles, KM; Clark, AB; Ford, I; Loke, YK; Mamas, MA; Metcalf, AK; Myint, PK; Potter, JF | 1 |
| de Borst, GJ; Halliday, A; Hamilton, G; Kakkos, S; McCabe, DJH; Murphy, SJX; Naylor, AR; Ricco, JB; Sillesen, H; Vega de Ceniga, M | 1 |
| King, A; Levi, C; Madigan, J; Markus, HS; Norris, J | 1 |
| Chen, CH; Chou, SH; Ho, CJ; Huang, HT; Lin, SY; Liu, ZM; Lu, CC | 1 |
| Khong, T; Kimpton, J | 1 |
| Andersen, G; Iversen, HK; Kasner, SE; Randall, B; Rhodes, JF; Roine, RO; Sjostrand, C; Søndergaard, L | 1 |
| Berthelot, JM; Drouet, L; Lioté, F | 1 |
| Avramoff, O; Czeiger, D; Dahan, A; Dukhno, O; Gibori, R; Porat, D; Sebbag, G; Shaked, G; Vaynshtein, J | 1 |
| Hanley, J; Hoather, TJ; Surianarayanan, V; Thompson, ER; Tingle, SJ; Wilson, CH | 1 |
| Allahham, M; Atar, D; Birnbaum, Y; Lerman, A | 1 |
| Algra, A; Bath, PM; Csiba, L; Diener, HC; Greving, JP; Hacke, W; Hilkens, NA; Kappelle, LJ; Koudstaal, PJ; Leys, D; Mas, JL; Sacco, RL | 1 |
| Huang, W; Ji, J; Sundquist, J; Sundquist, K | 1 |
| Cha, JK; Chang, DI; Chang, JY; Chung, JW; Hong, KS; Jung, KH; Kang, MK; Kim, BK; Kim, HY; Lee, KY; Lee, SJ; Park, JM; Park, MS; Rha, JH; Shin, DI; Yoon, BW | 1 |
| Liu, S; Shah, J; Yu, W | 1 |
| Collins, DR; Coughlan, T; Cox, D; Egan, B; Lim, ST; Lim, SY; McCabe, DJH; McCarthy, AJ; Murphy, SJX; Murphy, SM; O'Neill, D; Smith, DR; Tierney, S | 1 |
| Calderone, D; Capodanno, D; Scalia, L | 1 |
| Hsu, WH; Huang, HY; Lee, MY; Liang, HL; Lu, TW; Sung, YW | 1 |
| Cairat, M; Dossus, L; Fournier, A; Hicks, B; Olesen, M; Pottegård, A | 1 |
| Hu, LP; Huang, S; Huang, WQ; Ji, J; Jiang, SH; Li, DX; Li, J; Sundquist, J; Sundquist, K; Xing, X; Xu, CJ; Yao, LL; Zhang, NQ; Zhang, XL; Zhang, ZG | 1 |
| Appleton, JP; Bath, PM; Christensen, H; Dineen, RA; England, TJ; James, M; Krishnan, K; Montgomery, AA; Ranta, A; Robinson, TG; Sprigg, N; Woodhouse, LJ | 1 |
345 review(s) available for dipyridamole and aspirin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Analgesics; Anti-Inflammatory Agents; Arteriosclerosis; Aspirin; Blood Coagulation; Blood Platelets; Cardiovascular Diseases; Dipyridamole; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; In Vitro Techniques; Indomethacin; Oxyphenbutazone; Phenylbutazone; Platelet Adhesiveness; Platelet Aggregation; Sulfinpyrazone; Thromboembolism; Time Factors | 1976 |
[Inhibition of blood platelet function].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antimalarials; Aspirin; Chloroquine; Dipyridamole; Female; Humans; Maternal-Fetal Exchange; Platelet Aggregation; Pregnancy; Sulfinpyrazone; Vasodilator Agents | 1979 |
Role of blood platelets in coronary artery disease.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Evaluation; Humans; Myocardial Infarction; Placebos; Platelet Aggregation; Prostaglandins, Synthetic; Spasm; Sulfinpyrazone | 1979 |
The role of prostacyclin in vascular tissue.
Topics: Animals; Arachidonic Acids; Aspirin; Blood Coagulation; Blood Platelets; Blood Vessels; Cyclic AMP; Dipyridamole; Epoprostenol; Linolenic Acids; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Thrombosis; Thromboxane A2; Vasodilation | 1979 |
Clinical pharmacology of platelets.
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation; Blood Platelets; Cell Membrane; Clofibrate; Cyproheptadine; Dipyridamole; Drug Therapy, Combination; Furosemide; Halofenate; Heparin; Humans; Hydrocortisone; Hydroxychloroquine; Methylprednisolone; Penicillin G; Platelet Aggregation; Propranolol; Prostaglandins; Sulfinpyrazone; Vitamin E | 1977 |
[Prevention of thrombosis with coumarin, low doses of heparin, dextran and inhibitors of platelet function].
Topics: Aspirin; Coumarins; Dextrans; Dipyridamole; Heart Valve Prosthesis; Heparin; Humans; Lipids; Platelet Aggregation; Postoperative Care; Preoperative Care; Sulfinpyrazone; Thrombosis; Xanthinol Niacinate | 1977 |
Actions and clinical status of platelet-suppressive agents.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Sulfinpyrazone; Thrombosis | 1978 |
Platelet function inhibitors: their clinical use.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Platelet Aggregation; Renal Dialysis; Sulfinpyrazone; Thromboembolism | 1978 |
[Indications and uncertainties of antiaggregating agents].
Topics: Anticoagulants; Aspirin; Clofibrate; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1977 |
Platelet suppressive therapy.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Sulfinpyrazone; Thrombophlebitis; Thrombosis | 1978 |
Platelets and thrombosis in the development of atherosclerosis and its complications.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Dipyridamole; Endothelium; Humans; Hyperlipidemias; Lipids; Rabbits; Sulfinpyrazone; Thrombosis | 1978 |
Use of platelet inhibitor drugs in peripheral and cerebral vascular disorders.
Topics: Arterial Occlusive Diseases; Aspirin; Blood Platelets; Brain Ischemia; Cell Survival; Clinical Trials as Topic; Dipyridamole; Extremities; Humans; Kidney Diseases; Thrombosis | 1977 |
[is there a treatment for peripheral arterial insufficiency?].
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Clofibrate; Dipyridamole; Fibrinolytic Agents; Humans; Pentoxifylline; Snake Venoms; Xanthinol Niacinate | 1979 |
[Prophylaxis of thromboembolism using low dosage heparin (author's transl)].
Topics: Antithrombins; Aspirin; Blood Coagulation; Dipyridamole; Drug Therapy, Combination; Heparin; Humans; Thromboembolism; Thrombosis | 1979 |
[Thrombosis prevention and platelet functions following heart valve replacement].
Topics: Adult; Anticoagulants; Aspirin; Blood Flow Velocity; Blood Platelets; Dipyridamole; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Platelet Adhesiveness; Platelet Aggregation; Postoperative Complications; Pyridines; Thrombosis | 1978 |
[Clinical application and evaluation of anti-platelet agents].
Topics: Aged; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Female; Humans; Intracranial Embolism and Thrombosis; Male; Myocardial Infarction; Prostheses and Implants; Sulfinpyrazone; Thrombophlebitis | 1978 |
[Thrombosis prevention and treatment in pediatrics].
Topics: Adolescent; Arterial Occlusive Diseases; Aspirin; Bioprosthesis; Child; Child, Preschool; Coumarins; Dipyridamole; Disseminated Intravascular Coagulation; Heart Valve Prosthesis; Hemolytic-Uremic Syndrome; Heparin; Humans; Infant; Infant, Newborn; Intracranial Embolism and Thrombosis; Renal Veins; Shock, Septic; Streptokinase; Thrombosis | 1979 |
[Pharmacological inhibition of platelet aggregation in primary and secondary prevention of ischemic heart disease].
Topics: Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Drug Evaluation; Humans; Platelet Aggregation | 1979 |
Recent therapeutic advances in thrombotic thrombocytopenic purpura.
Topics: Adolescent; Adult; Aspirin; Blood Transfusion; Dextrans; Dipyridamole; Exchange Transfusion, Whole Blood; Female; Glucocorticoids; Humans; Male; Plasma; Plasmapheresis; Platelet Aggregation; Purpura, Thrombotic Thrombocytopenic; Splenectomy; Sulfinpyrazone | 1979 |
[Platelet aggregation inhibitors. Their possible use in pediatric pathology].
Topics: Age Factors; Anti-Inflammatory Agents; Aspirin; Child; Clofibrate; Dextrans; Diabetes Mellitus, Type 1; Dipyridamole; Glomerulonephritis; Hemolytic-Uremic Syndrome; Heparin; Humans; Hyperlipidemias; Platelet Aggregation; Polycythemia Vera; Prostaglandins E | 1979 |
Antiplatelet drugs in thromboembolism.
Topics: Anticoagulants; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Heart Valve Prosthesis; Humans; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1979 |
[Prevention of thrombosis and embolism in digestive surgery].
Topics: Anticoagulants; Aspirin; Coumarins; Dextrans; Digestive System Surgical Procedures; Dipyridamole; Heparin; Humans; Hydroxychloroquine; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Random Allocation; Thromboembolism; Thrombophlebitis | 1979 |
Pharmacology of platelet-suppressive agents.
Topics: Adenosine Diphosphate; Anti-Inflammatory Agents; Arachidonic Acids; Aspirin; Blood Platelets; Calcium; Cell Membrane; Clofibrate; Dipyridamole; Epoprostenol; Halofenate; Heparin; Humans; Imidazoles; Platelet Adhesiveness; Platelet Aggregation; Prostaglandins E; Prostaglandins, Synthetic | 1979 |
Platelet inhibitors in the treatment of thrombosis.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Double-Blind Method; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Ischemic Attack, Transient; Male; Middle Aged; Postoperative Complications; Random Allocation; Sulfinpyrazone; Thromboembolism; Thrombosis | 1978 |
[Treatment with antiplatelet drugs. Current status of knowledge].
Topics: Aspirin; Blood Platelet Disorders; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dextrans; Dipyridamole; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Platelet Aggregation; Postoperative Complications; Sulfinpyrazone; Thromboembolism | 1979 |
[Clinical prevention of thrombosis by antiplatelet agents].
Topics: Aspirin; Blood Platelets; Clofibrate; Dipyridamole; Humans; Hydroxychloroquine; Sulfinpyrazone; Thrombosis | 1979 |
[State of thrombosis risk: diagnostic and preventive possibilities].
Topics: Anticoagulants; Aspirin; Dipyridamole; Humans; Platelet Aggregation; Risk; Sulfinpyrazone; Thrombosis | 1979 |
[Prophylactic value of platelet anti-aggregants in coronary disease].
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Embolism; Heart Valve Prosthesis; Humans; Myocardial Infarction; Platelet Aggregation; Postoperative Complications; Sulfinpyrazone | 1979 |
[Prospects of antiaggregant therapy in prevention of atherosclerosis].
Topics: Animals; Anti-Inflammatory Agents; Anticoagulants; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Dipyridamole; Epoprostenol; Humans; Hyperlipidemias; Indomethacin; Papaverine; Platelet Aggregation; Prostaglandins; Prostaglandins, Synthetic; Sulfinpyrazone; Xanthines | 1979 |
Prostaglandins in circulatory disorders.
Topics: Angiotensin II; Antihypertensive Agents; Arachidonic Acids; Arteriosclerosis; Aspirin; Blood Platelets; Diet; Dipyridamole; Eicosanoic Acids; Humans; Hypertension; Platelet Aggregation; Prostaglandins; Thrombosis; Thromboxanes; Vascular Diseases | 1979 |
Antiplatelet agents: a review.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Female; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Male; Myocardial Infarction; Postoperative Complications; Sulfinpyrazone; Thromboembolism | 1979 |
[Anticoagulation therapy in myocardial infarction (author's transl)].
Topics: Anticoagulants; Aspirin; Coumarins; Dipyridamole; Fibrinolysis; Heparin; Humans; Leg; Myocardial Infarction; Platelet Aggregation; Recurrence; Thromboembolism; Thrombophlebitis | 1975 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Drug Combinations; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Kidney Diseases; Kidneys, Artificial; Male; Silicone Elastomers; Sulfinpyrazone; Thromboembolism; Thrombosis; Vascular Diseases | 1975 |
Platelets and thrombosis.
Topics: Aspirin; Blood Platelets; Depression, Chemical; Dipyridamole; Humans; Thrombosis | 1976 |
[Current trends in anticoagulant and thrombolytic therapy of thrombosis].
Topics: Anticoagulants; Aspergillus; Aspirin; Brinolase; Coumarins; Dipyridamole; Disseminated Intravascular Coagulation; Drug Evaluation; Fibrinolytic Agents; Heparin; Humans; Peptide Hydrolases; Streptokinase; Thrombophlebitis; Thrombosis; Urokinase-Type Plasminogen Activator | 1975 |
Clinical trials in thrombosis: secondary prevention of myocardial infarction.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Humans; Male; Myocardial Infarction; Prospective Studies; Sulfinpyrazone; Thromboembolism | 1976 |
Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Brain; Clofibrate; Dextrans; Dipyridamole; Humans; Ischemia; Kidney Diseases; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Serotonin Antagonists; Sulfinpyrazone; Sympathomimetics; Thrombosis | 1976 |
Antithrombotic drugs: part II.
Topics: Anabolic Agents; Ancrod; Animals; Aspirin; Blood Platelets; Clofibrate; Dextrans; Dipyridamole; Fibrinolytic Agents; Humans; Hydroxychloroquine; Myocardial Infarction; Plasminogen Activators; Streptokinase; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Urokinase-Type Plasminogen Activator | 1976 |
Are agents affecting platelet functions clinically useful?
Topics: Aged; Animals; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Clofibrate; Dextrans; Dipyridamole; Dogs; Heparin; Humans; Male; Platelet Aggregation; Thromboembolism; Thrombophlebitis; Thrombosis | 1976 |
Platelets and thromboembolism.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Dextrans; Dipyridamole; Graft Rejection; Heart Valve Prosthesis; Hemostasis; Humans; Kidney Transplantation; Myocardial Infarction; Platelet Aggregation; Serotonin Antagonists; Thromboembolism; Thrombosis; Transplantation, Homologous | 1976 |
Deep vein thrombosis. Detection and prevention.
Topics: Administration, Oral; Anticoagulants; Aspirin; Dextrans; Dipyridamole; Female; Fibrinogen; Heparin; Humans; Infusions, Parenteral; Injections, Subcutaneous; Iodine Radioisotopes; Male; Phlebography; Plethysmography, Impedance; Postoperative Complications; Thrombophlebitis; Ultrasonography; Venous Insufficiency; Wounds and Injuries | 1975 |
Low dose heparin in the prevention of venous thromboembolism. Rationale and results.
Topics: Acenocoumarol; Adult; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Heparin; Hip; Humans; Injections, Subcutaneous; Middle Aged; Postoperative Complications; Thrombophlebitis; United Kingdom | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Prospective Studies; Pyrimidines; Retrospective Studies; Sulfinpyrazone; Thromboembolism; Warfarin | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Graft Rejection; Humans; Kidney Transplantation; Male; Myocardial Infarction; Sulfinpyrazone; Thromboembolism; Thrombosis; Transplantation, Homologous | 1975 |
Hypoxemia in thalassemia.
Topics: Aspirin; Blood Gas Analysis; Dipyridamole; Follow-Up Studies; Heart Failure; Humans; Hypoxia; Platelet Aggregation; Pulmonary Circulation; Pulmonary Heart Disease; Splenectomy; Thalassemia | 1992 |
Aspirin and other platelet-active drugs. The relationship between dose, effectiveness, and side effects.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Myocardial Infarction; Thrombosis; Ticlopidine | 1992 |
Consultation section. Attitudes regarding the concomitant use of anti-coagulants with elective cataract surgery.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Cataract Extraction; Contraindications; Dipyridamole; Eye Hemorrhage; Humans; Platelet Aggregation; Thrombosis; Warfarin | 1992 |
[Coronary thrombolysis in patients with acute myocardial infarction].
Topics: Animals; Aspirin; Dipyridamole; Heparin; Humans; Myocardial Infarction; Plasminogen Activators; Recombinant Proteins; Streptokinase; Thrombolytic Therapy; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1992 |
[The use of drugs that affect thrombocytes in cerebral ischemia].
Topics: Aspirin; Blood Platelets; Brain Ischemia; Dipyridamole; Female; Humans; Male; Ticlopidine | 1990 |
Antiplatelet therapy in the prevention of stroke.
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Sulfinpyrazone; Ticlopidine | 1991 |
[Platelet antiaggregants in the treatment of arterial thrombosis].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Cerebrovascular Disorders; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Follow-Up Studies; Heart Valve Prosthesis; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Sulfinpyrazone; Thrombosis | 1991 |
Antiplatelet and anticoagulant therapy in acute myocardial infarction.
Topics: Aspirin; Dipyridamole; Heparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Sulfinpyrazone; Warfarin | 1991 |
[Anticoagulant or antiplatelet aggregation treatment after aortocoronary bypass].
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Sulfinpyrazone; Ticlopidine; Vitamin K | 1991 |
Aspirin in transient ischemic attacks and minor stroke: a meta-analysis.
Topics: Adult; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Meta-Analysis as Topic; Middle Aged; Randomized Controlled Trials as Topic; Sulfinpyrazone | 1991 |
Intravenous prostacyclin in thrombotic thrombocytopenic purpura: case report and review of the literature.
Topics: Adult; Aspirin; Blood Transfusion; Combined Modality Therapy; Dipyridamole; Epoprostenol; Humans; Infusions, Intravenous; Male; Methylprednisolone; Plasma; Plasmapheresis; Purpura, Thrombotic Thrombocytopenic | 1991 |
Erythromelalgia.
Topics: Aspirin; Dipyridamole; Erythromelalgia; Female; Humans; Middle Aged; Propranolol | 1991 |
A review of secondary coronary prevention with dipyridamole and aspirin.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Risk Factors | 1990 |
[Study Group: "Evaluation of the efficacy of therapeutic treatments in cerebrovascular diseases"].
Topics: Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Double-Blind Method; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Male; Middle Aged; Prognosis; Sulfinpyrazone | 1990 |
Aspirin and dipyridamole and their limitations in the therapy of coronary artery disease.
Topics: Animals; Aspirin; Coronary Disease; Coronary Thrombosis; Dipyridamole; Dogs; Drug Therapy, Combination; Humans | 1990 |
[Current aspects of arterial anti-thrombosis prophylaxis].
Topics: Adult; Aged; Aspirin; Contraindications; Dipyridamole; Humans; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Thrombosis | 1990 |
Pharmacology of the interaction between platelets and vessel wall.
Topics: Animals; Aspirin; Blood Platelets; Blood Vessels; Dextrans; Diltiazem; Dipyridamole; Epoprostenol; Humans; Imidazoles; Ketanserin; Piperidines; Pyrazoles; Pyrazolones; Sulfinpyrazone; Sulfonamides; Thiophenes; Ticlopidine | 1986 |
Antiplatelet therapy in thrombotic thrombocytopenic purpura.
Topics: Aspirin; Blood Platelets; Dextrans; Dipyridamole; Epoprostenol; Humans; Microcirculation; Platelet Aggregation; Purpura, Thrombotic Thrombocytopenic; Sulfinpyrazone; Ticlopidine | 1987 |
Role of platelet inhibitor therapy in myocardial infarction.
Topics: Aspirin; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Sulfinpyrazone | 1989 |
Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects.
Topics: Aspirin; Blood Platelets; Dipyridamole; Epoprostenol; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Stomach Diseases; Thromboxane A2 | 1989 |
Thrombotic thrombocytopenic purpura.
Topics: Adult; Aspirin; Combined Modality Therapy; Dipyridamole; Humans; Male; Plasma Exchange; Plasmapheresis; Purpura, Thrombotic Thrombocytopenic | 1989 |
[Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
Topics: Aspirin; Canada; Clinical Trials as Topic; Coronary Disease; Coronary Thrombosis; Dipyridamole; Drug Evaluation; Humans; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Sulfinpyrazone; United States | 1989 |
[Necrobiosis lipoidica without diabetes mellitus (diagnostic and therapeutic possibilities)].
Topics: Aspirin; Basement Membrane; Capillaries; Diabetic Angiopathies; Diagnosis, Differential; Dipyridamole; Female; Humans; Male; Microscopy, Electron; Necrobiosis Lipoidica; Platelet Aggregation | 1989 |
Secondary prevention of coronary events after myocardial infarction. Beta-blockers and/or anti-platelets: to whom, when and for how long. A review.
Topics: Adrenergic beta-Antagonists; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Humans; Myocardial Infarction; Sulfinpyrazone | 1985 |
Platelets and prostaglandins in sudden death: therapeutic implications.
Topics: Adrenergic beta-Antagonists; Animals; Arachidonic Acid; Arachidonic Acids; Arteriosclerosis; Aspirin; Blood Platelets; Coronary Disease; Death, Sudden; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Prostaglandins; Risk; Sulfinpyrazone; Thrombosis | 1985 |
[Platelet function inhibitors in peripheral arteriopathies].
Topics: Adrenal Cortex Hormones; Adrenergic alpha-Antagonists; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Arteriosclerosis Obliterans; Aspirin; Blood Platelets; Calcium Channel Blockers; Clinical Trials as Topic; Cyclic AMP; Dipyridamole; Extremities; Heparin; Humans; Imidazoles; Prostaglandins; Prostanoic Acids; Pyrazoles; Pyrazolones; Quinacrine; Thiophenes; Thromboembolism; Thrombosis; Ticlopidine; Vascular Diseases | 1986 |
Platelets and antiplatelet therapy in ischemic heart disease.
Topics: Angina Pectoris; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Humans; Myocardial Infarction; Platelet Adhesiveness; Sulfinpyrazone; Thromboxanes | 1986 |
[Thrombosis in various diseases: myocardial infarct].
Topics: Angioplasty, Balloon; Aspirin; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Thiophenes; Thrombosis; Ticlopidine | 1986 |
[Thrombosis in various diseases: myeloproliferative disorders].
Topics: Aspirin; beta-Thromboglobulin; Blood Coagulation Factors; Busulfan; Carbazilquinone; Dipyridamole; Humans; Myeloproliferative Disorders; Platelet Factor 3; Platelet Factor 4; Thrombosis | 1986 |
Platelet-inhibitor drugs before and after coronary artery bypass surgery and coronary angioplasty: the basis of their use, data from animal studies, clinical trial data, and current recommendations.
Topics: Angioplasty, Balloon; Animals; Aspirin; Clinical Trials as Topic; Combined Modality Therapy; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Graft Occlusion, Vascular; Humans | 1986 |
Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty.
Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Aspirin; Clinical Trials as Topic; Dipyridamole; Humans; Macrophages; Muscle, Smooth, Vascular; Platelet Adhesiveness; Platelet Aggregation; Recurrence; Thrombosis | 1987 |
[Hypercoagulability and cerebral infarction].
Topics: Aspirin; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cerebral Infarction; Clinical Trials as Topic; Dipyridamole; Glycoproteins; Humans; Platelet Aggregation; Sulfinpyrazone; Suloctidil; Thromboxanes; von Willebrand Factor | 1986 |
Antiplatelet drugs in the management of patients with thrombotic disorders.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelets; Catheterization; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Glomerulonephritis; Humans; Sulfinpyrazone; Suloctidil; Thiophenes; Thrombophlebitis; Thrombosis; Ticlopidine; Vascular Diseases; Vascular Surgical Procedures | 1986 |
Preventive cardiology: what is the value of antiplatelet agents and fish oils?
Topics: Aspirin; Cardiovascular Diseases; Coronary Thrombosis; Dipyridamole; Fish Oils; Humans; Platelet Aggregation Inhibitors; Thromboembolism | 1988 |
A contemporary overview of ischaemic heart disease and anti-platelet therapy.
Topics: Aspirin; Coronary Disease; Dipyridamole; Female; Humans; Male; Platelet Aggregation Inhibitors | 1988 |
Coronary artery bypass grafting. A model for the understanding of the progression of atherosclerotic disease and the role of pharmacological intervention.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Cell Division; Collagen; Coronary Artery Bypass; Dipyridamole; Elastin; Endothelium; Graft Occlusion, Vascular; Hemodynamics; Humans; Lipoproteins; Models, Cardiovascular; Muscle, Smooth, Vascular; Risk; Saphenous Vein; Thrombosis | 1985 |
Platelets, antiplatelet therapy, and diabetic nephropathy.
Topics: Aspirin; Diabetic Nephropathies; Dipyridamole; Humans; Kidney Failure, Chronic; Platelet Aggregation Inhibitors; Platelet-Derived Growth Factor | 1988 |
[Antiplatelet drugs and prevention of aortocoronary bypass occlusion].
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Sulfinpyrazone; Thrombosis; Ticlopidine | 1988 |
Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Follow-Up Studies; Humans; Male; Myocardial Infarction; Random Allocation; Sulfinpyrazone | 1987 |
Antiplatelet agents and diabetic vascular disease.
Topics: Aspirin; Blood Platelets; Diabetic Angiopathies; Dipyridamole; Humans | 1987 |
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Female; Glomerulonephritis; Graft Occlusion, Vascular; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Postoperative Complications; Random Allocation; Sulfinpyrazone; Thiophenes; Ticlopidine | 1986 |
Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease.
Topics: Animals; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Dogs; Double-Blind Method; Graft Occlusion, Vascular; Humans; Postoperative Complications; Swine | 1986 |
Dose antiplatelet agents; the relationship among side effects, and antithrombotic effectiveness.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Dipyridamole; Dose-Response Relationship, Drug; Epoprostenol; Fibrinolytic Agents; Gastric Mucosa; Humans; Sulfinpyrazone | 1986 |
Antithrombotic agents in coronary artery disease.
Topics: Angina, Unstable; Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Sulfinpyrazone; Thromboembolism; Time Factors | 1986 |
[New theories on the pathogenesis and methods of treating thrombotic thrombocytopenic purpura (Moschkowitz disease)].
Topics: Adolescent; Adult; Aspirin; Blood Coagulation Disorders; Child; Dipyridamole; Epoprostenol; Female; Humans; Immunologic Deficiency Syndromes; Male; Plasmapheresis; Purpura, Thrombotic Thrombocytopenic; Thromboxane A2 | 1986 |
[Thrombocyte aggregation inhibitors--a new class of active substances. 2. Chemical and pharmacologic aspects of some agents].
Topics: Anti-Inflammatory Agents; Aspirin; Chemical Phenomena; Chemistry; Dipyridamole; Heterocyclic Compounds; Humans; Imidazoles; Phthalazines; Platelet Aggregation; Pyridazines; Pyridines; Pyrimidines; Quinazolines; Quinolines; Sulfinpyrazone | 1986 |
Aspirin for the prevention of coronary thrombosis: current facts and perspectives.
Topics: Angina, Unstable; Animals; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Epoprostenol; Graft Occlusion, Vascular; Humans; Myocardial Infarction; Platelet Aggregation | 1986 |
The management of TIAs in 1986.
Topics: Arterial Occlusive Diseases; Aspirin; Carotid Artery Diseases; Cerebrovascular Disorders; Dipyridamole; Endarterectomy; Female; Heparin; Humans; Ischemic Attack, Transient; Male; Risk; Warfarin | 1986 |
[Thrombosis in various diseases: arteriosclerosis and thrombosis].
Topics: Animals; Arteriosclerosis; Aspirin; Dipyridamole; Humans; Sulfinpyrazone; Thrombosis | 1986 |
VA cooperative study on antiplatelet agents in diabetic patients after amputation for gangrene. IV. Issues in design, interpretation, and analysis.
Topics: Amputation, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Dipyridamole; Gangrene; Hospitals, Veterans; Humans; Male; Myocardial Infarction | 1986 |
Aspirin and other platelet-aggregation inhibiting drugs.
Topics: Aspirin; Blood Platelets; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Female; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Kinetics; Male; Platelet Aggregation; Sulfinpyrazone; Thrombophlebitis | 1985 |
Thrombotic thrombocytopenic purpura.
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Diagnosis, Differential; Dipyridamole; Female; Humans; Plasmapheresis; Platelet Aggregation; Prednisone; Purpura, Thrombotic Thrombocytopenic | 1985 |
Clinical aspects of antiplatelet therapy.
Topics: Angina Pectoris; Aspirin; Blood Coagulation Disorders; Clinical Trials as Topic; Dipyridamole; Female; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thromboembolism | 1985 |
[Long-term antithrombotic treatment in patients with valve prostheses. Practical management and complications].
Topics: Anticoagulants; Aspirin; Bioprosthesis; Dipyridamole; Heart Valve Prosthesis; Hemorrhage; Humans; Thromboembolism; Vitamin K | 1985 |
The human pharmacology of platelet inhibition: pharmacokinetics relevant to drug action.
Topics: Aspirin; Blood Platelets; Dipyridamole; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; Kinetics; Models, Biological; Sulfinpyrazone; Thromboxane-A Synthase | 1985 |
Aortocoronary artery vein-graft disease: experimental and clinical approach for the understanding of the role of platelets and platelet inhibitors.
Topics: Animals; Aspirin; Blood Platelets; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Dogs; Graft Occlusion, Vascular; Humans; Hyperplasia; Muscle, Smooth, Vascular; Postoperative Care; Swine; Time Factors | 1985 |
Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences.
Topics: Animals; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Hyperplasia; Muscle, Smooth, Vascular; Prognosis; Saphenous Vein; Time Factors | 1985 |
The pharmacology of platelet inhibition.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Blood Platelets; Citric Acid Cycle; Collagen; Cyclic AMP; Dipyridamole; Hexosephosphates; Histamine H1 Antagonists; Microscopy, Electron; Platelet Adhesiveness; Prostaglandins; Serotonin; Xanthines | 1972 |
[The importance of thrombocytes for thrombogenesis and the pharmacological influencing of thrombocyte function (author's transl)].
Topics: Animals; Anticoagulants; Aspirin; Blood Platelet Disorders; Blood Platelets; Clinical Trials as Topic; Cold Temperature; Dextrans; Dipyridamole; Disease Models, Animal; Dogs; Heparin; Humans; Placebos; Platelet Adhesiveness; Postoperative Care; Rabbits; Rats; Thromboembolism; Thrombosis; Warfarin | 1974 |
[Aggregation inhibitors. The inhibition of platelet function by means of chemical substances].
Topics: Adenosine Diphosphate; Adenylyl Cyclases; Aspirin; Blood Proteins; Calcium; Collagen; Dipyridamole; Epinephrine; Humans; Molecular Conformation; Phenothiazines; Phosphoric Diester Hydrolases; Platelet Adhesiveness; Platelet Aggregation; Sympatholytics; Thrombin; Thrombosis | 1973 |
Management of thrombotic diseases.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Coumarins; Dextrans; Dipyridamole; Drug Antagonism; Drug Hypersensitivity; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Heart Valve Prosthesis; Hemorrhage; Heparin; Histamine H1 Antagonists; Humans; Hydrocortisone; Indenes; Intracranial Embolism and Thrombosis; Iodine Isotopes; Platelet Adhesiveness; Prostaglandins; Reserpine; Rheumatic Heart Disease; Streptokinase; Sulfinpyrazone; Thrombosis | 1971 |
Trends in the development of antithrombotic agents.
Topics: Adenine Nucleotides; Animals; Anti-Inflammatory Agents; Anticholesteremic Agents; Anticoagulants; Aspirin; Blood Platelets; Butyrates; Dextrans; Dietary Fats; Dipyridamole; Ethylestrenol; Fibrin; Fibrinolytic Agents; Histamine H1 Antagonists; Humans; Phenformin; Phenylbutazone; Platelet Adhesiveness; Povidone; Prostaglandins; Pulmonary Embolism; Rabbits; Streptodornase and Streptokinase; Thrombophlebitis; Thrombosis; Vasodilator Agents; Venoms | 1971 |
Antiplatelet aggregant agents and thrombolytic compounds in myocardial infarction: current status.
Topics: Anticoagulants; Aspirin; Blood Coagulation Factors; Coumarins; Dextrans; Dipyridamole; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Platelet Adhesiveness; Prostaglandins; Streptokinase; Thromboembolism | 1972 |
Prevention and management of venous thrombosis and pulmonary embolism.
Topics: Anticoagulants; Aspirin; Coumarins; Dextrans; Dipyridamole; Female; Heparin; Humans; Male; Methods; Pulmonary Embolism; Thromboembolism; Thrombophlebitis | 1973 |
Thromboembolism. Diagnosis and treatment.
Topics: Adult; Aspirin; Dipyridamole; Femoral Vein; Fibrinogen; Heparin; Humans; Iliac Vein; Iodine Radioisotopes; Methods; Phlebography; Plethysmography, Impedance; Postoperative Complications; Radionuclide Imaging; Thromboembolism; Thrombophlebitis; Ultrasonography | 1974 |
The prevention of thrombosis.
Topics: Anti-Inflammatory Agents; Anticoagulants; Aspirin; Coumarins; Dipyridamole; Heparin; Humans; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1974 |
[Summary: Drugs affecting platelet behaviour; experimental and clinical data (author's transl)].
Topics: Adult; Aspirin; Blood Platelets; Child; Clofibrate; Dextrans; Dipyridamole; Drug Combinations; Graft Rejection; Heart Valve Prosthesis; Humans; Platelet Adhesiveness; Platelet Aggregation; Thromboembolism; Thrombophlebitis; Thrombosis | 1974 |
Platelet inhibition in the management of thrombosis.
Topics: Aspirin; Blindness; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Dextrans; Dipyridamole; Fibrinogen; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Iodine Radioisotopes; Molecular Weight; Myocardial Infarction; Phlebography; Renal Dialysis; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Thrombosis | 1974 |
Anticoagulants.
Topics: Anticoagulants; Aspirin; Blood Platelet Disorders; Dipyridamole; Enzyme Therapy; Factor IX; Factor VII; Factor X; Hemolysin Proteins; Hemorrhage; Heparin; Heparin Antagonists; Humans; Infusions, Parenteral; Phenindione; Protamines; Prothrombin; Streptokinase; Sulfinpyrazone; Thrombophlebitis; Thrombosis; Venoms; Warfarin | 1974 |
[Method for preventing postoperative thrombophlebitis].
Topics: Aerosols; Anticoagulants; Aspirin; Dextrans; Dipyridamole; Heparin; Humans; Injections, Subcutaneous; Postoperative Complications; Preoperative Care; Thrombophlebitis | 1984 |
[Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
Topics: Adrenergic beta-Antagonists; Alprenolol; Anti-Arrhythmia Agents; Aspirin; Dipyridamole; Female; Fibrinolytic Agents; Humans; Male; Myocardial Infarction; Phenprocoumon; Platelet Aggregation; Practolol; Propranolol; Recurrence; Sex Factors; Sulfinpyrazone; Time Factors | 1981 |
Drug therapy of hypertension and ischaemic heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Antihypertensive Agents; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Diuretics; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Sulfinpyrazone | 1981 |
[Prevention of myocardial infarction by chemotherapy].
Topics: Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Blood Platelets; Dipyridamole; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Recurrence; Sulfinpyrazone | 1982 |
Changing concepts of pathophysiology, prognosis, and therapy in acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aspirin; Coronary Disease; Coronary Vasospasm; Death, Sudden; Dipyridamole; Humans; Monitoring, Physiologic; Myocardial Infarction; Prognosis; Recurrence; Sulfinpyrazone | 1983 |
Antiplatelet agents: rationale and results.
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Animals; Arachidonic Acids; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cerebrovascular Disorders; Collagen; Coronary Disease; Dipyridamole; Female; Heart Valve Prosthesis; Hemostasis; Humans; Intracranial Embolism and Thrombosis; Male; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Sex Factors; Sulfinpyrazone; Thrombosis | 1983 |
Bleeding associated with antithrombotic therapy.
Topics: 4-Hydroxycoumarins; Aspirin; Dextrans; Dipyridamole; Dose-Response Relationship, Drug; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Myocardial Infarction; Risk; Streptodornase and Streptokinase; Sulfinpyrazone; Thrombocytopenia; Thrombosis | 1980 |
Therapy of thrombotic thrombocytopenic purpura: an overview.
Topics: Adrenal Cortex Hormones; Aspirin; Blood Transfusion; Dextrans; Dipyridamole; Humans; Immunosuppressive Agents; Plasmapheresis; Purpura, Thrombotic Thrombocytopenic; Renal Dialysis; Retrospective Studies; Splenectomy; Sulfinpyrazone | 1981 |
[Peripheral arterial occlusions. Principles, possibilities and limits of conservative therapy].
Topics: Ancrod; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cardiomyopathies; Dextrans; Digitalis Glycosides; Dilatation; Dipyridamole; Exercise Therapy; Gangrene; Hemodilution; Humans; Hypertension; Infusions, Intra-Arterial; Infusions, Parenteral; Intermittent Claudication; Mineralocorticoids; Motivation; Nafronyl; Pentoxifylline; Risk; Streptokinase | 1981 |
Prevention of venous thromboembolism.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Dextrans; Dihydroergotamine; Dipyridamole; Hemorrhage; Hemostasis; Heparin; Humans; Pulmonary Embolism; Thrombophlebitis | 1981 |
[Role of antiaggregant platelet drugs in thromboembolism].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anti-Bacterial Agents; Aspirin; Cerebrovascular Disorders; Dextrans; Dipyridamole; Humans; Mitral Valve; Platelet Aggregation; Platelet Function Tests; Pyridines; Pyridinolcarbamate; Random Allocation; Sulfinpyrazone; Suloctidil; Thiophenes; Thromboembolism; Ticlopidine | 1981 |
[Disseminated intravascular coagulation. II. Therapeutic problems].
Topics: Antifibrinolytic Agents; Antithrombin III Deficiency; Anuria; Aprotinin; Aspirin; Blood Transfusion; Dipyridamole; Disseminated Intravascular Coagulation; Factor VIII; Female; Heparin; Humans; Leukemia, Myeloid, Acute; Male; Platelet Aggregation; Pregnancy; Pregnancy Complications, Hematologic; Shock, Septic; Thromboembolism | 1982 |
Adjuvant drug therapy for decompression sickness: a review.
Topics: Adrenal Cortex Hormones; Animals; Anti-Arrhythmia Agents; Aspirin; Bronchodilator Agents; Coumarins; Cyproheptadine; Decompression Sickness; Dextrans; Diazepam; Dipyridamole; Fluid Therapy; Heparin; Humans; Indomethacin; Levodopa; Niacin; Vasoconstrictor Agents; Vasodilator Agents | 1982 |
[Thrombotic thrombopenic purpura. Description of 2 cases and review of the literature].
Topics: Adult; Aspirin; Autoimmune Diseases; Bacterial Infections; Blood Transfusion; Dextrans; Dipyridamole; Female; Humans; Middle Aged; Plasmapheresis; Prednisolone; Purpura, Thrombotic Thrombocytopenic; Virus Diseases | 1982 |
Pharmacological prevention of thrombotic occlusion in arterial reconstructive surgery.
Topics: Arachidonic Acid; Arachidonic Acids; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Cyclic AMP; Dextrans; Dipyridamole; Heparin; Humans; Risk; Thrombin; Thrombosis; Vascular Surgical Procedures | 1983 |
Pharmacology and pharmacokinetics of platelet-active drugs under current clinical investigation.
Topics: Absorption; Animals; Aspirin; Biotransformation; Blood Platelets; Cyclooxygenase Inhibitors; Dipyridamole; Humans; Kinetics; Prostaglandins; Structure-Activity Relationship; Sulfinpyrazone | 1982 |
Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Double-Blind Method; Humans; Myocardial Infarction; Postoperative Complications; Sulfinpyrazone; Thromboembolism | 1982 |
Current therapy of cerebrovascular disease.
Topics: Adult; Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Risk; Sulfinpyrazone | 1984 |
Percutaneous transluminal coronary angioplasty.
Topics: Angina, Unstable; Angioplasty, Balloon; Animals; Aspirin; Calcium Channel Blockers; Coronary Artery Bypass; Coronary Disease; Coronary Vasospasm; Dipyridamole; Emergencies; Graft Occlusion, Vascular; Hemodynamics; Humans; Recurrence; Risk | 1984 |
[Pharmacology of anti-platelet agents].
Topics: Animals; Anticoagulants; Aspirin; Blood Platelets; Cyclic AMP; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Female; Fibrinolytic Agents; Humans; In Vitro Techniques; Intestinal Absorption; Kinetics; Male; Papio; Platelet Aggregation; Prostaglandin Antagonists; Rabbits; Sulfinpyrazone; Thiophenes; Thrombosis; Thromboxane A2; Ticlopidine | 1983 |
[Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone; Time Factors | 1983 |
Therapeutical aspects of cerebrovascular disease.
Topics: Aspirin; Blood Coagulation; Cerebrovascular Disorders; Clofibrate; Dipyridamole; Erythrocyte Aggregation; Erythrocytes; Humans; Ischemic Attack, Transient; Pentoxifylline; Plasma; Platelet Aggregation; Sulfinpyrazone | 1983 |
Role of platelet-active drugs in coronary artery disease.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Europe; Female; Humans; Male; Myocardial Infarction; Prospective Studies; Research Design; Sulfinpyrazone; Time Factors; United States | 1983 |
Kawasaki disease in Nebraska: a review of the literature.
Topics: Adrenal Cortex Hormones; Aneurysm; Anticoagulants; Aspirin; Blood Sedimentation; Child; Child, Preschool; Coronary Disease; Dipyridamole; Echocardiography; Female; Humans; Infant; Male; Mucocutaneous Lymph Node Syndrome | 1983 |
Eicosanoids and venous thromboembolism.
Topics: Animals; Arachidonic Acids; Aspirin; Dipyridamole; Dogs; Epoprostenol; Hemostasis; Humans; Platelet Adhesiveness; Platelet Aggregation; Pulmonary Embolism; Thromboembolism; Thrombophlebitis; Thromboxane A2 | 1983 |
Platelet inhibitors for TIAs. A review of prospective drug trial results.
Topics: Aged; Aspirin; Clofibrate; Dipyridamole; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Platelet Aggregation; Prospective Studies; Recurrence; Sulfinpyrazone | 1984 |
Therapy of ischemic cerebral vascular disease due to atherothrombosis. (2).
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Auscultation; Basilar Artery; Blood Platelets; Carotid Arteries; Carotid Artery Diseases; Cerebral Arteries; Cerebrovascular Disorders; Dipyridamole; Endarterectomy; Humans; Intracranial Arteriosclerosis; Ischemic Attack, Transient; Vertebral Artery | 1984 |
[Primary thrombocyte reactions in hemostasis and thrombogenesis and the possibilities of influencing them by drugs].
Topics: Animals; Aspirin; Blood Platelets; Dipyridamole; Dose-Response Relationship, Drug; Drug Evaluation; Drug Evaluation, Preclinical; Female; Fibrinolytic Agents; Hemostasis; Humans; Male; Myocardial Infarction; Platelet Aggregation; Platelet Function Tests; Recurrence; Sex Characteristics; Thrombosis; Time Factors | 1984 |
Platelets, carotids, and coronaries. Critique on antithrombotic role of antiplatelet agents, exercise, and certain diets.
Topics: Angina Pectoris; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Carotid Artery Thrombosis; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Endothelium; Exercise Therapy; Female; Humans; Ischemic Attack, Transient; Life Style; Male; Platelet Aggregation; Sex Factors; Sulfinpyrazone | 1984 |
Cardiogenic cerebral embolism.
Topics: Anticoagulants; Aspirin; Cardiac Surgical Procedures; Cerebral Hemorrhage; Cerebral Infarction; Dipyridamole; Echocardiography; Endocarditis; Gastrointestinal Hemorrhage; Heart Diseases; Humans; Intracranial Embolism and Thrombosis; Mitral Valve Prolapse; Myocardial Infarction; Risk; Time Factors | 1984 |
Dipyridamole: a critical evaluation.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Heart Valve Prosthesis; Hemodynamics; Humans; Kinetics; Myocardial Infarction; Platelet Aggregation; Postoperative Complications; Vascular Diseases | 1984 |
[Current clinical results of antiplatelet medication].
Topics: Animals; Anticoagulants; Aspirin; Blood Platelets; Brain Ischemia; Coronary Disease; Dipyridamole; Drug Evaluation; Heart Valve Prosthesis; Humans; Myocardial Infarction; Platelet Aggregation; Platelet Function Tests; Postoperative Complications; Rabbits; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Vascular Surgical Procedures | 1984 |
[Blood platelets and myocardial infarction].
Topics: Aspirin; Blood Platelets; Dipyridamole; Epoprostenol; Humans; Myocardial Infarction; Platelet Aggregation; Prostaglandins, Synthetic; Sulfinpyrazone; Thromboxane A2 | 1984 |
Aspirin in the treatment of cardiovascular disease: a review.
Topics: Aspirin; Blood Platelets; Blood Vessels; Cell Adhesion; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Dipyridamole; Humans; Myocardial Infarction; Thrombosis | 1983 |
Efficacy of antiplatelet drugs in the maintenance of aortocoronary vein bypass graft patency.
Topics: Animals; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Cyclooxygenase Inhibitors; Dipyridamole; Humans; Saphenous Vein; Sulfinpyrazone | 1983 |
Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
Topics: Animals; Anticoagulants; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Female; Humans; In Vitro Techniques; Male; Placebos; Platelet Adhesiveness; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1980 |
[Prevention of thrombosis by thrombocyte inhibition. 2. Clinical results].
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofibrate; Dextrans; Dipyridamole; Humans; Kidney Diseases; Sulfinpyrazone; Thrombosis | 1980 |
[Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
Topics: Anticoagulants; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Flurbiprofen; Humans; Hydroxychloroquine; Lidocaine; Platelet Aggregation; Postoperative Complications; Pulmonary Embolism; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1980 |
[Congenital and acquired thrombocyte function disorders].
Topics: Aspirin; Blood Platelet Disorders; Dipyridamole; Fibrin Fibrinogen Degradation Products; Heart Defects, Congenital; Heart Valve Prosthesis; Hemolytic-Uremic Syndrome; Homocystinuria; Humans; Kidney Failure, Chronic; Penicillins; Postoperative Complications; Purpura, Thrombotic Thrombocytopenic; Renal Dialysis | 1980 |
Platelet-active drugs in the secondary prevention of cardiovascular events: an overview.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Coronary Disease; Dipyridamole; Sulfinpyrazone; Thrombophlebitis; Thrombosis | 1980 |
Antithrombotic drugs in relation to prostaglandin metabolism.
Topics: Aspirin; Coronary Disease; Dipyridamole; Extracorporeal Circulation; Fibrinolytic Agents; Heparin; Humans; Inuit; Platelet Aggregation; Prostaglandins; Sulfinpyrazone; Thromboembolism | 1980 |
Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Topics: Adult; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infarction; Sex Factors; Sulfinpyrazone | 1981 |
10. Antithrombotic therapy: role of platelet-inhibitor drugs. II. Pharmacologic effects of platelet-inhibitor drugs (second of three parts).
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Epoprostenol; Fibrinolytic Agents; Gastrointestinal Diseases; Humans; Platelet Aggregation; Prostaglandins; Sulfinpyrazone; Thrombosis | 1981 |
[Myocardial infarct: secondary prevention with drugs and their effects].
Topics: Alprenolol; Aspirin; Dipyridamole; Humans; Myocardial Infarction; Prognosis; Sulfinpyrazone | 1980 |
The role of prostacyclin and thromboxane A2 in the regulation of platelet behaviour.
Topics: Aspirin; Dipyridamole; Epoprostenol; Hemorrhage; Humans; Platelet Aggregation; Prostaglandins; Thrombosis; Thromboxane A2; Thromboxanes | 1980 |
[Platelet antiaggregants and arteriopathies].
Topics: Arterial Occlusive Diseases; Aspirin; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1981 |
Antiplatelet therapy.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Heart Valve Diseases; Humans; Sulfinpyrazone; Thrombophlebitis; Thrombosis | 1981 |
Myocardial infarction.
Topics: Anticoagulants; Aspirin; Blood Platelets; Death, Sudden; Dipyridamole; Fibrinolytic Agents; Humans; Myocardial Infarction; Sulfinpyrazone | 1981 |
Antiplatelet agents: their role in the prevention of sudden death.
Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Clinical Trials as Topic; Coronary Circulation; Coronary Disease; Death, Sudden; Dipyridamole; Dogs; Endothelium; Humans; Male; Muscle, Smooth; Myocardial Infarction; Papio; Platelet Adhesiveness; Prostaglandins; Rabbits; Sulfinpyrazone | 1982 |
[Platelets and prostaglandins in ischemic cardiopathy. Theoretical and practical aspects and research prospects].
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Humans; Platelet Aggregation; Platelet Count; Prostaglandins; Sulfinpyrazone; Thromboxanes | 1982 |
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cell Division; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Heart Diseases; Humans; Hydroxychloroquine; Neoplasms; Sulfinpyrazone; Thromboembolism; Thrombosis | 1982 |
Antiplatelet drugs.
Topics: Animals; Arterial Occlusive Diseases; Aspirin; Dipyridamole; Humans; Integrins; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine | 1994 |
Secondary prevention of stroke: does dipyridamole add to aspirin?
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Humans; Randomized Controlled Trials as Topic | 1994 |
[Advances in prophylactic treatment of cerebrovascular diseases].
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Endarterectomy, Carotid; Humans | 1994 |
[Blood platelet aggregation inhibitors in the treatment of heart diseases].
Topics: Angina, Unstable; Aspirin; Coronary Artery Disease; Coronary Disease; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Primary Prevention; Ticlopidine | 1993 |
The role of dipyridamole in the therapy of vascular disease.
Topics: Animals; Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Survival; Heart Valve Prosthesis; Humans; Recurrence; Vascular Diseases | 1993 |
When do vascular surgeons prescribe antiplatelet therapy? Current attitudes.
Topics: Angioplasty, Balloon; Arteriosclerosis; Aspirin; Dipyridamole; Graft Occlusion, Vascular; Humans; Ischemia; Leg; Platelet Aggregation; Platelet Aggregation Inhibitors; Postoperative Complications; Recurrence; Reoperation | 1993 |
Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis.
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; Graft Occlusion, Vascular; Logistic Models; Postoperative Complications; Randomized Controlled Trials as Topic; Risk; Treatment Outcome; Warfarin | 1993 |
Therapy and prevention of thrombotic thrombocytopenic purpura during pregnancy: a clinical study of 16 pregnancies.
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Combined Modality Therapy; Diagnostic Errors; Dipyridamole; Fatal Outcome; Female; Fetal Death; Humans; Plasma; Plasma Exchange; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Puerperal Disorders; Purpura, Thrombotic Thrombocytopenic; Recurrence | 1996 |
Oral anticoagulant treatment with and without aspirin.
Topics: Administration, Oral; Angina, Unstable; Anticoagulants; Aspirin; Clinical Trials as Topic; Dipyridamole; Embolism; Follow-Up Studies; Heart Valve Prosthesis; Hemorrhage; Humans; Incidence; Meta-Analysis as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Thromboembolism; Thrombophlebitis | 1995 |
Use of cumulative meta-analysis in the design, monitoring, and final analysis of a clinical trial: a case study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Protocols; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Humans; Meta-Analysis as Topic; Placebos; Platelet Aggregation Inhibitors; Saphenous Vein; Sulfinpyrazone; Uricosuric Agents | 1995 |
An ounce of prevention. Toward preventing gastrointestinal endoscopic complications.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibiotic Prophylaxis; Anticoagulants; Aspirin; Diagnostic Tests, Routine; Dipyridamole; Endocarditis, Bacterial; Endoscopy, Gastrointestinal; Humans; Hypoglycemic Agents; Insulin; Medical History Taking; Physical Examination; Platelet Aggregation Inhibitors; Ticlopidine; Vasodilator Agents; Warfarin | 1996 |
Antiplatelet therapy.
Topics: Aspirin; Dipyridamole; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine | 1996 |
The role of dipyridamole in stroke prevention.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic | 1996 |
Essential thrombocythemia and pregnancy.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Aspirin; Busulfan; Combined Modality Therapy; Dipyridamole; Female; Fetal Death; Fetal Growth Retardation; Hemorrhage; Humans; Hydroxyurea; Infarction; Interferon-alpha; Placenta; Platelet Aggregation Inhibitors; Plateletpheresis; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Thrombocythemia, Essential | 1996 |
[Large trials in the secondary prevention of stroke].
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Cost-Benefit Analysis; Dipyridamole; Endarterectomy; Humans; Odds Ratio; Platelet Aggregation Inhibitors; Treatment Outcome | 1996 |
Safer anticoagulant therapy after heart valve replacement. Recommendations for less intense regimens.
Topics: Anticoagulants; Aspirin; Dipyridamole; Drug Therapy, Combination; Heart Valve Prosthesis; Humans; Platelet Aggregation Inhibitors; Warfarin | 1997 |
[Antiplatelet agents (inhibitors of platelet function) orally administered. Bases for their practical use in coronary artery disease].
Topics: Administration, Oral; Aspirin; Coronary Disease; Dipyridamole; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Drug Tolerance; Humans; Platelet Activation; Platelet Aggregation Inhibitors | 1996 |
Essential thrombocythemia during pregnancy.
Topics: Adult; Anticoagulants; Aspirin; Dipyridamole; Female; Heparin; Humans; Platelet Aggregation Inhibitors; Plateletpheresis; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Thrombocythemia, Essential; Vasodilator Agents | 1997 |
Antiplatelet therapy with glycoprotein IIb/IIIa receptor inhibitors and other novel agents.
Topics: Aspirin; Dipyridamole; Hemorrhage; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Ticlopidine | 1997 |
Dipyridamole: an unfulfilled promise?
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Fibrinolytic Agents; Heart Valve Prosthesis Implantation; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Thrombosis | 1997 |
[Antithrombotic therapy after cerebral ischemia].
Topics: Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Heparinoids; Humans; Intracranial Embolism and Thrombosis; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine; Treatment Outcome | 1997 |
Therapy for intrauterine growth restriction: current options and future directions.
Topics: Adrenergic beta-Agonists; Aspirin; Atrial Natriuretic Factor; Bed Rest; Cyclooxygenase Inhibitors; Dipyridamole; Female; Fetal Growth Retardation; Humans; Maternal Welfare; Nutritional Physiological Phenomena; Oxygen Inhalation Therapy; Pregnancy; Somatomedins; Vasodilator Agents | 1997 |
[Secondary prevention following cerebral ischemia: is monotherapy with acetylsalicylic acid still first choice?].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Cerebrovascular Disorders; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Recurrence; Ticlopidine | 1998 |
Antiplatelet drugs in secondary prevention of stroke.
Topics: Aged; Aspirin; Cerebrovascular Disorders; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Ticlopidine | 1998 |
Low-dose and high-dose acetylsalicylic acid, with and without dipyridamole: a review of clinical trial results.
Topics: Aspirin; Cerebrovascular Disorders; Controlled Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors | 1998 |
Antiplatelet therapy in coronary artery disease: review and update of efficacy studies.
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Clopidogrel; Coronary Disease; Dipyridamole; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation Inhibitors; Ticlopidine | 1998 |
Clinical considerations in selecting antiplatelet therapy in cerebrovascular disease.
Topics: Aspirin; Cerebrovascular Disorders; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 1998 |
Platelet-active drugs: the relationships among dose, effectiveness, and side effects.
Topics: Aspirin; Cyclooxygenase Inhibitors; Dipyridamole; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine | 1998 |
Antiplatelet agents and stroke prevention.
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Female; Humans; Male; Platelet Aggregation Inhibitors; Ticlopidine | 1998 |
Antiplatelet drugs.
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Cardiovascular Diseases; Dipyridamole; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation Inhibitors; Ticlopidine | 1999 |
Antiplatelet therapy for secondary stroke prevention.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Risk Factors; Survival Rate; Ticlopidine | 1999 |
Dipyridamole plus aspirin in cerebrovascular disease.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Odds Ratio; Platelet Aggregation Inhibitors; Risk; Vasodilator Agents | 1999 |
Extended-release dipyridamole/aspirin.
Topics: Animals; Aspirin; Clinical Trials as Topic; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Humans; Platelet Aggregation Inhibitors | 1999 |
Pharmacologic prevention of vascular access stenosis.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Vessels; Catheters, Indwelling; Constriction, Pathologic; Dipyridamole; Genetic Therapy; Humans; Renal Dialysis | 1999 |
[Aspirin and cerebral ischemic accidents].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Cerebral Infarction; Clinical Trials as Topic; Clopidogrel; Cyclooxygenase Inhibitors; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Phosphodiesterase Inhibitors; Placebos; Platelet Aggregation Inhibitors; Primary Prevention; Recurrence; Risk Factors; Stroke; Ticlopidine; Vasodilator Agents; Warfarin | 2000 |
[Transient ischemic attacks and prolonged reversible ischemic neurologic deficit. Diagnosis, differential diagnosis and treatment].
Topics: Aspirin; Brain Ischemia; Cerebral Infarction; Diagnosis, Differential; Dipyridamole; Endarterectomy, Carotid; Humans; Ischemic Attack, Transient; Neurologic Examination | 2000 |
Update on antiplatelet therapy for stroke prevention.
Topics: Aspirin; Clinical Trials as Topic; Delayed-Action Preparations; Dipyridamole; Dose-Response Relationship, Drug; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Risk Factors; Stroke | 2000 |
[Platelet antiaggregants].
Topics: Aspirin; Cardiovascular Diseases; Cyclooxygenase Inhibitors; Dipyridamole; Drug Utilization; Fibrinolytic Agents; Humans; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Risk Factors; Spain; Ticlopidine | 2000 |
Antiplatelet agents for stroke prevention.
Topics: Aspirin; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Ticlopidine | 2000 |
Prevention of ischaemic stroke--antiplatelets.
Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine | 2000 |
Update on clinical trials of antiplatelet therapy for cerebrovascular diseases.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine | 2000 |
Antiplatelet agents in stroke prevention. combination therapy: present and future.
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Clopidogrel; Dipyridamole; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Stroke; Ticlopidine | 2000 |
Aggrenox: a fixed-dose combination of aspirin and dipyridamole.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Aspirin, Dipyridamole Drug Combination; Clinical Trials as Topic; Dipyridamole; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Stroke | 2000 |
Platelet-active drugs : the relationships among dose, effectiveness, and side effects.
Topics: Aspirin; Cyclooxygenase Inhibitors; Dipyridamole; Female; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pre-Eclampsia; Pregnancy; Thrombosis | 2001 |
Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Aspirin; Bioprosthesis; Child; Dipyridamole; Fibrinolytic Agents; Heart Valve Prosthesis; Humans | 2001 |
Stroke prevention: antiplatelet and antithrombolytic therapy.
Topics: Anticoagulants; Aspirin; Brain Damage, Chronic; Carotid Stenosis; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Endarterectomy, Carotid; Fibrinolytic Agents; Gastritis; Goals; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Ischemic Attack, Transient; Meta-Analysis as Topic; Multicenter Studies as Topic; Neutropenia; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Risk; Safety; Single-Blind Method; Stroke; Thrombolytic Therapy; Ticlopidine; Treatment Failure; Treatment Outcome | 2000 |
[Clinical features of essential thrombocythemia in three children].
Topics: Aspirin; Child; Dipyridamole; Female; Humans; Male; Thrombocythemia, Essential; Thrombopoietin | 2000 |
Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis.
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Heart Valve Prosthesis; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Thromboembolism; Treatment Outcome; Warfarin | 2001 |
[Pharma-clinics. The drug of the month. Dipyridamole-acetylsalicylic acid combination (Aggrenox)].
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Primary Prevention; Stroke; Treatment Outcome | 2000 |
Antithrombotic drugs for secondary stroke prophylaxis.
Topics: Adult; Aspirin; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Platelet Aggregation; Stroke; Structure-Activity Relationship | 2001 |
Aspirin in patients with coronary artery disease: is it simply irresistible?
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Benzamidines; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Cyclooxygenase Inhibitors; Diabetes Complications; Dipyridamole; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Endothelium, Vascular; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Oximes; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Randomized Controlled Trials as Topic; Stroke; Thrombosis; Thromboxane-A Synthase; Ticlopidine; Vasodilator Agents | 2001 |
Complications of oral antiplatelet medications.
Topics: Administration, Oral; Aspirin; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine | 2001 |
Inhibition of thrombus formation by low-dose acetylsalicylic acid, dipyridamole, and their combination in a model of platelet-vessel wall interaction.
Topics: Aspirin; Blood Platelets; Cell Communication; Cerebral Arteries; Clinical Trials, Phase I as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Intracranial Thrombosis; Platelet Aggregation Inhibitors; Stroke | 2001 |
Analysis of trials evaluating combinations of acetylsalicylic acid and dipyridamole in the secondary prevention of stroke.
Topics: Aged; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Patient Compliance; Treatment Outcome | 2001 |
Antiplatelet agents for secondary prevention of ischemic stroke.
Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Cost-Benefit Analysis; Dipyridamole; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2001 |
Antiplatelet therapy in secondary stroke prevention.
Topics: Aspirin; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke | 2001 |
Four patients with both thrombotic thrombocytopenic purpura and autoimmune thrombocytopenic purpura: the concept of a mixed immune thrombocytopenia syndrome and indications for plasma exchange.
Topics: Adult; Arthritis, Rheumatoid; Aspirin; Autoimmune Diseases; Blood Platelets; Combined Modality Therapy; Death, Sudden, Cardiac; Diabetes Mellitus, Type 1; Dipyridamole; Fatal Outcome; Female; Heparin; HIV Seronegativity; Humans; Immunoglobulins, Intravenous; Middle Aged; Mixed Connective Tissue Disease; Plasma; Plasma Exchange; Platelet Count; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Purpura, Thrombotic Thrombocytopenic; Treatment Outcome | 2001 |
The role of platelets in peripheral arterial disease: therapeutic implications.
Topics: Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Peripheral Vascular Diseases; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine | 2002 |
Antithrombotic drugs for prevention of recurrent stroke.
Topics: Adult; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome | 2002 |
Aspirin in the prophylaxis of coronary artery disease.
Topics: Aspirin; Brain Ischemia; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Risk Factors; Stroke | 2002 |
A benefit-risk assessment of agents used in the secondary prevention of stroke.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Aspirin; Clinical Trials as Topic; Clopidogrel; Coumarins; Dipyridamole; Humans; Hypertension; Hypoglycemic Agents; Insulin; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Smoking Cessation; Stroke; Ticlopidine; Warfarin | 2002 |
[Anticoagulants and antiplatelets].
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Heparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Warfarin | 1994 |
Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Vascular Diseases | 2003 |
Preventing stroke in patients with atrial fibrillation: current treatments and new concepts.
Topics: Aspirin; Atrial Appendage; Atrial Fibrillation; Azetidines; Benzylamines; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Prodrugs; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Ticlopidine; Treatment Outcome; Warfarin | 2003 |
[Platelet inhibitors: old and new].
Topics: Abciximab; Antibodies, Monoclonal; Arteriosclerosis; Aspirin; Clopidogrel; Coronary Disease; Dipyridamole; Drug Monitoring; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Membrane Proteins; Patient Selection; Peptides; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thrombosis; Thromboxanes; Ticlopidine | 2002 |
[Anticoagulant, antiplatelet agents].
Topics: Anticoagulants; Aspirin; Death, Sudden, Cardiac; Dipyridamole; Drug Therapy, Combination; Heparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Ticlopidine; Warfarin | 2003 |
Pharmacogenetics of antiplatelet drugs.
Topics: Animals; Aspirin; Dipyridamole; Humans; Pharmacogenetics; Pyridines | 2002 |
Clinical pharmacokinetics of antiplatelet agents used in the secondary prevention of stroke.
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2003 |
Potential value of triple antiplatelet therapy for secondary stroke prevention.
Topics: Adenosine Monophosphate; Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Risk; Stroke; Treatment Outcome | 2003 |
Antiplatelet and anticoagulation for patients with prosthetic heart valves.
Topics: Anticoagulants; Aspirin; Dipyridamole; Heart Valve Prosthesis; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Thromboembolism | 2003 |
Aspirin and stroke prevention.
Topics: Aspirin; Clopidogrel; Dipyridamole; Dose-Response Relationship, Drug; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Treatment Failure; Treatment Outcome | 2003 |
Aggrenox((R)) versus other pharmacotherapy in preventing recurrent stroke.
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Cost-Benefit Analysis; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Secondary Prevention; Stroke; Ticlopidine | 2004 |
Antiplatelet agents in atherothrombotic diseases.
Topics: Arteriosclerosis; Aspirin; Clopidogrel; Dipyridamole; Humans; Ischemia; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Ticlopidine | 2004 |
Antiplatelet therapy in cardiovascular disease.
Topics: Aspirin; Cardiovascular Diseases; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines | 2004 |
Antiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of use.
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Dipyridamole; Drug Combinations; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine | 2003 |
[The value of platelet inhibitors in the secondary prophylaxis of stroke -- a review].
Topics: Aspirin; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Dose-Response Relationship, Drug; Humans; Platelet Aggregation Inhibitors; Secondary Prevention; Ticlopidine; Treatment Outcome | 2004 |
[EBM of cerebral infarction: message from mega-studies].
Topics: Anticoagulants; Aspirin; Azetidines; Benzylamines; Cerebral Infarction; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Secondary Prevention; Ticlopidine; Warfarin | 2003 |
Combined antithrombotic therapy for acute coronary syndrome.
Topics: Administration, Oral; Angina, Unstable; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine | 2003 |
Antiplatelet therapy in peripheral arterial disease.
Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Dipyridamole; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine; Treatment Outcome | 2004 |
Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.
Topics: Aspirin; Clopidogrel; Cost-Benefit Analysis; Delayed-Action Preparations; Diarrhea; Dipyridamole; Drug Costs; Drug Eruptions; Dyspepsia; Evidence-Based Medicine; Hemorrhage; Humans; Ischemia; Models, Econometric; Nausea; Platelet Aggregation Inhibitors; Research Design; Risk Factors; Ticlopidine; Treatment Outcome; Vascular Diseases; Vomiting | 2004 |
Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
Topics: Administration, Oral; Angina Pectoris; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clopidogrel; Coronary Artery Disease; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Stroke; Thrombosis; Ticlopidine | 2004 |
Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials.
Topics: Aspirin; Blood Pressure; Brain Ischemia; Dipyridamole; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Treatment Outcome | 2005 |
Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment.
Topics: Angioplasty, Balloon; Anticoagulants; Aspirin; Dipyridamole; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention | 2005 |
Combination antiplatelet agents in ischemic cerebrovascular disease.
Topics: Aspirin; Brain Ischemia; Cardiovascular Diseases; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine | 2005 |
Adverse effects and drug interactions of antithrombotic agents used in prevention of ischaemic stroke.
Topics: Anticoagulants; Aspirin; Clopidogrel; Dipyridamole; Drug Interactions; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Salicylates; Stroke; Ticlopidine; Warfarin | 2005 |
Efficacy and costs of secondary prevention with antiplatelets after ischaemic stroke.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Cost-Benefit Analysis; Dipyridamole; Health Care Costs; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2005 |
Vascular complications of Fabry disease: enzyme replacement and other therapies.
Topics: alpha-Galactosidase; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Blood Coagulation Disorders; Blood Flow Velocity; Dipyridamole; Endothelium, Vascular; Fabry Disease; Humans; Metabolic Clearance Rate; Platelet Aggregation Inhibitors; Trihexosylceramides; Vascular Diseases; Vasodilator Agents | 2005 |
Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
Topics: Aspirin; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Recurrence; Salicylates; Stroke; Ticlopidine | 2005 |
What is the role of dipyridamole in long-term secondary prevention after an ischemic stroke or transient ischemic attack?
Topics: Aspirin; Dipyridamole; Evidence-Based Medicine; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke | 2005 |
[Current concepts of the antiplatelet and anticoagulant treatment in the prevention of stroke].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Evidence-Based Medicine; Fibrinolytic Agents; Humans; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Recurrence; Stroke; Ticlopidine; Warfarin | 2005 |
Antiplatelet drugs.
Topics: Animals; Aspirin; Clinical Trials as Topic; Dipyridamole; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Thrombosis | 2006 |
Primary and secondary stroke prevention with antiplatelet drugs.
Topics: Aspirin; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Stroke; Treatment Failure | 2006 |
Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Vascular Diseases | 2006 |
Prevention of vascular events in patients with cerebrovascular disease: efficacy and appropriate duration of antiplatelet therapy.
Topics: Aspirin; Cerebrovascular Disorders; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2006 |
How much esprit is in ESPRIT?
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Humans; Randomized Controlled Trials as Topic; Stroke | 2006 |
[Platelet-function inhibitors in the secondary prevention of ischemic stroke].
Topics: Aged; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Secondary Prevention; Stroke; Ticlopidine | 2006 |
[Antiplatelet agents--problem for cardiac surgeon].
Topics: Anticoagulants; Aspirin; Coronary Thrombosis; Dipyridamole; Fibrinolytic Agents; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Ticlopidine | 2006 |
[Update on antithrombotic treatments in arterial diseases].
Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Arteriosclerosis; Aspirin; Dipyridamole; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Pyridines; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine | 2007 |
Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?
Topics: Aspirin; Atherosclerosis; Cilostazol; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Dipyridamole; Disease Susceptibility; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Hemorrhage; Humans; Ischemic Attack, Transient; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome; Vasodilator Agents | 2007 |
Dipyridamole with aspirin is better than aspirin alone in preventing vascular events after ischaemic stroke or TIA.
Topics: Aspirin; Brain Ischemia; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Stroke | 2007 |
Clinical aspects of platelet inhibitors and thrombus formation.
Topics: Aspirin; Atherosclerosis; Blood Platelets; Cardiovascular Diseases; Cilostazol; Clopidogrel; Dipyridamole; Drug Resistance; Humans; Pentanoic Acids; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Pyridines; Receptor, PAR-1; Stents; Tetrazoles; Thrombosis; Thromboxanes; Ticlopidine | 2007 |
Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Vascular Diseases | 2007 |
[Current aspects of secondary prevention of ischemic stroke].
Topics: Aspirin; Cerebral Infarction; Cholesterol, LDL; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Evidence-Based Medicine; Feeding Behavior; Humans; Life Style; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention; Ticlopidine | 2007 |
Antiplatelet therapy in cerebrovascular disease: implications of Management of Artherothrombosis with Clopidogrel in High-risk Patients and the Clopidogrel for High Artherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance studies' resu
Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Embolism, Cholesterol; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Stroke; Ticlopidine | 2007 |
The PRoFESS trial: future impact on secondary stroke prevention.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Forecasting; Humans; Internationality; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Telmisartan; Ticlopidine; Treatment Outcome; Vasodilator Agents | 2007 |
Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
Topics: Aged; Aspirin; Clopidogrel; Cost-Benefit Analysis; Dipyridamole; Drug Therapy, Combination; Family Practice; Humans; Ischemic Attack, Transient; Middle Aged; Physician's Role; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome | 2007 |
[Antiplatelet and anticoagulant treatment after percutaneous transluminal angioplasty for peripheral arteriosclerosis. Survey of a Cochrane review].
Topics: Angioplasty, Balloon; Anticoagulants; Arteriosclerosis; Aspirin; Dipyridamole; Evidence-Based Medicine; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence | 2007 |
Anticoagulants, aspirin and dipyridamole in the secondary prevention of cerebral ischaemia: which is the best for which patient?
Topics: Anticoagulants; Aspirin; Brain Ischemia; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Stroke | 2007 |
Antiplatelet therapy for stroke prevention.
Topics: Anticoagulants; Aspirin; Atherosclerosis; Atrial Fibrillation; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2007 |
Antiplatelet agents and randomized trials.
Topics: Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Ticlopidine | 2007 |
[Pretreatment with cilostazol protects against the vascular endothelial damage after ischemia/reperfusion].
Topics: Animals; Aspirin; Cilostazol; Dipyridamole; Endothelial Cells; Ischemic Preconditioning; Mice; Phosphodiesterase Inhibitors; Reperfusion Injury; Tetrazoles | 2008 |
Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA: a meta-analysis.
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke | 2008 |
Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke.
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Treatment Outcome | 2008 |
Use of antiplatelet agents to prevent stroke: what is the role for combinations of medications?
Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Interactions; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Assessment; Stroke; Ticlopidine | 2008 |
Update on antiplatelet agents, including MATCH, CHARISMA, and ESPRIT.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Coronary Artery Disease; Dipyridamole; Female; Humans; Ischemic Attack, Transient; Male; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine | 2008 |
Dipyridamole plus aspirin versus aspirin alone in secondary prevention after TIA or stroke: a meta-analysis by risk.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Risk Factors; Stroke | 2008 |
Oral antiplatelet agents and bleeding risk in relation to major cardiovascular surgery.
Topics: Aspirin; Cardiovascular Surgical Procedures; Cilostazol; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Risk; Tetrazoles; Ticlopidine | 2006 |
Acetylsalicylic acid + extended-release dipyridamole combination therapy for secondary stroke prevention.
Topics: Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Secondary Prevention; Stroke; Ticlopidine | 2008 |
The approach to optimizing stroke care.
Topics: Aspirin; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Emergency Service, Hospital; Fibrinolytic Agents; Guidelines as Topic; Humans; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine | 2008 |
Combination antiplatelet agents for secondary prevention of ischemic stroke.
Topics: Aspirin; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2008 |
ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke | 2008 |
[Current issues of anticoagulation therapy in the course of dental treatment and oral surgery].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Dental Care; Dipyridamole; Drug Administration Schedule; Drug Combinations; Humans; Oral Surgical Procedures; Platelet Aggregation Inhibitors; Ticlopidine | 2008 |
Multifunctional actions of approved and candidate stroke drugs.
Topics: Albumins; Animals; Antihypertensive Agents; Aspirin; Brain Ischemia; Clopidogrel; Cytidine Diphosphate Choline; Dipyridamole; Erythropoietin; Granulocyte Colony-Stimulating Factor; Humans; Hypolipidemic Agents; Neuroprotective Agents; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2009 |
What's new in stroke? The top 10 studies of 2006-2008. Part I.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Evidence-Based Medicine; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Ticlopidine; Treatment Outcome | 2008 |
Antiplatelet agents for prevention of recurrent ischemic stroke.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Stroke; Ticlopidine | 2009 |
Antithrombotic treatment before and after peripheral artery percutaneous angioplasty.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Coronary Restenosis; Dipyridamole; Drug Combinations; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Thrombolytic Therapy | 2009 |
Antiplatelet drugs for ischemic stroke prevention.
Topics: Aged; Anticoagulants; Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Patient Selection; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Primary Prevention; Risk Assessment; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome | 2009 |
Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?
Topics: Anticoagulants; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Treatment Outcome | 2009 |
Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Atherosclerosis; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Confounding Factors, Epidemiologic; Decision Making; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Evidence-Based Medicine; Female; Follow-Up Studies; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Middle Aged; Multicenter Studies as Topic; Patient Selection; Platelet Aggregation Inhibitors; Research Design; Secondary Prevention; Ticlopidine | 2009 |
Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.
Topics: Aspirin; Cardiovascular Diseases; Dipyridamole; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic | 2009 |
Secondary stroke prevention with antithrombotic drugs.
Topics: Arterial Occlusive Diseases; Aspirin; Brain Ischemia; Cyclooxygenase Inhibitors; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heart Diseases; Humans; International Normalized Ratio; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke | 2010 |
Antithrombotic therapies in cerebrovascular disease: what should we use as secondary prevention in patients with carotid artery disease?
Topics: Anticoagulants; Aspirin; Brain Ischemia; Carotid Stenosis; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Male; Patient Selection; Risk Assessment; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome | 2009 |
Safety and tolerability of antiplatelet therapies for the secondary prevention of atherothrombotic disease.
Topics: Aspirin; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Secondary Prevention; Ticlopidine | 2009 |
[Technological and biopharmaceutical aspects. Antiplatelet agents for oral administration].
Topics: Administration, Oral; Animals; Aspirin; Clopidogrel; Dipyridamole; Humans; Patents as Topic; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Thiophenes; Ticlopidine | 2009 |
Antiplatelets and stroke outcomes: state of the science.
Topics: Arachidonic Acid; Aspirin; Aspirin, Dipyridamole Drug Combination; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Combinations; Evidence-Based Practice; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Risk Reduction Behavior; Safety; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome | 2009 |
A guide to anticoagulation and endocarditis prophylaxis during cutaneous surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibiotic Prophylaxis; Anticoagulants; Aspirin; Calcium Channel Blockers; Clopidogrel; Dipyridamole; Endocarditis, Bacterial; Humans; International Normalized Ratio; Perioperative Care; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Skin Diseases; Ticlopidine; Warfarin | 2010 |
Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review.
Topics: American Heart Association; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Risk Factors; Secondary Prevention; Stroke; Ticlopidine; United States; Vasodilator Agents | 2010 |
Heterogeneity of efficacy and safety of antiplatelet therapy in cardiovascular and cerebrovascular disease.
Topics: Acute Coronary Syndrome; Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Secondary Prevention; Ticlopidine | 2010 |
Safety of fixed-dose aspirin-extended-release dipyridamole in patients with ischemic heart disease.
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Humans; Meta-Analysis as Topic; Myocardial Ischemia; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke | 2010 |
Controversies and future perspectives of antiplatelet therapy in secondary stroke prevention.
Topics: Aspirin; Blood-Brain Barrier; Cilostazol; Clopidogrel; Dipyridamole; Drug Interactions; Drug Therapy, Combination; Humans; Lactones; Naphthalenes; Platelet Aggregation Inhibitors; Propionates; Pyridines; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Succinates; Tetrazoles; Thrombosis; Ticlopidine | 2010 |
Aspirin and antiplatelet agent resistance: implications for prevention of secondary stroke.
Topics: Aspirin; Clopidogrel; Dipyridamole; Drug Resistance; Humans; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine | 2010 |
Protecting against ischemia-reperfusion injury: antiplatelet drugs, statins, and their potential interactions.
Topics: Aspirin; Cilostazol; Dipyridamole; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Models, Cardiovascular; Myocardial Infarction; Myocardial Reperfusion Injury; Platelet Aggregation Inhibitors; Simvastatin; Tetrazoles | 2010 |
Oral antiplatelet therapy in stroke prevention. Minireview.
Topics: Administration, Oral; Aspirin; Clopidogrel; Dipyridamole; Drug Combinations; Humans; Ischemic Attack, Transient; Isoindoles; Phenylbutyrates; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2010 |
Current status of antiplatelet agents to prevent stroke.
Topics: Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention; Stroke; Ticlopidine | 2011 |
Secondary prevention in the acute and early chronic phase after ischaemic stroke and transient ischaemic attacks with antiplatelet drugs--is antiplatelet monotherapy still reasonable?
Topics: Abciximab; Acute Disease; Antibodies, Monoclonal; Aspirin; Chronic Disease; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Humans; Immunoglobulin Fab Fragments; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome | 2011 |
Review and management of side effects associated with antiplatelet therapy for prevention of recurrent cerebrovascular events.
Topics: Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Headache; Hemorrhage; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Recurrence; Risk Factors; Stroke; Ticlopidine | 2011 |
New insights in antiplatelet therapy for patients with ischemic stroke.
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Dipyridamole; Dose-Response Relationship, Drug; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2011 |
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.
Topics: Arterial Occlusive Diseases; Aspirin; Brain Ischemia; Clopidogrel; Cost-Benefit Analysis; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Humans; Models, Economic; Myocardial Infarction; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Ticlopidine | 2011 |
Antiplatelets in secondary stroke prevention: should clopidogrel be the first choice?
Topics: Aspirin; Clopidogrel; Dipyridamole; Humans; Ischemia; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome | 2012 |
Dual or mono antiplatelet therapy for patients with acute ischemic stroke or transient ischemic attack: systematic review and meta-analysis of randomized controlled trials.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Clopidogrel; Databases, Factual; Dipyridamole; Disease-Free Survival; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Stroke; Survival Rate; Ticlopidine | 2012 |
Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Topics: Aspirin; Cilostazol; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Societies, Medical; Tetrazoles; Thienopyridines; Thrombosis; United States | 2012 |
Antiplatelet therapy in children: why so different from adults'?
Topics: Adult; Age Factors; Aspirin; Blood Platelets; Child Development; Child, Preschool; Dipyridamole; Humans; Pediatrics; Platelet Aggregation Inhibitors; Reye Syndrome; Thrombosis | 2012 |
Investigating incoherence gives insight: clopidogrel is equivalent to extended-release dipyridamole plus aspirin in secondary stroke prevention.
Topics: Aspirin; Clopidogrel; Confounding Factors, Epidemiologic; Dipyridamole; Drug Therapy, Combination; Humans; Logistic Models; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2012 |
Antiplatelet therapy in cerebrovascular disorders.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2012 |
Antiplatelet treatment in primary and secondary stroke prevention in women.
Topics: Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Humans; Naphthalenes; Platelet Aggregation Inhibitors; Primary Prevention; Propionates; Salicylates; Secondary Prevention; Sex Factors; Stroke; Ticlopidine | 2012 |
Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus.
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Diabetes Mellitus, Type 2; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Ticlopidine | 2012 |
Acute ischemic cerebrovascular events on antiplatelet therapy: what is the optimal prevention strategy?
Topics: Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Dose-Response Relationship, Drug; Humans; Life Style; Medication Adherence; Patient Education as Topic; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Stroke; Ticlopidine | 2013 |
[Secondary prevention with clopidogrel after TIA or stroke].
Topics: Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Netherlands; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome | 2013 |
Antiplatelet and anticoagulation for patients with prosthetic heart valves.
Topics: Administration, Oral; Anticoagulants; Aspirin; Dipyridamole; Drug Therapy, Combination; Heart Valve Prosthesis; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Thromboembolism | 2013 |
The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: a meta-analysis of randomized controlled trials.
Topics: Aged; Aspirin; Dipyridamole; Female; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Male; Middle Aged; Randomized Controlled Trials as Topic; Stroke | 2013 |
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.
Topics: Aspirin; Dipyridamole; Eclampsia; Female; Fibrinolytic Agents; Heparin; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Placenta Diseases; Pre-Eclampsia; Pregnancy; Randomized Controlled Trials as Topic; Thrombosis; Trapidil; Treatment Outcome | 2013 |
Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.
Topics: Anticoagulants; Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Risk Assessment; Secondary Prevention; Stroke; Ticlopidine | 2013 |
Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysis.
Topics: Aged; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Precision Medicine; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention; Stroke; Ticlopidine | 2013 |
Antiplatelet therapy to prevent recurrent stroke: Three good options.
Topics: Aspirin; Carotid Stenosis; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Secondary Prevention; Stents; Stroke; Ticlopidine | 2013 |
Stroke subtypes and their possible implication in stroke prevention drug strategies.
Topics: Animals; Antihypertensive Agents; Aspirin; Atherosclerosis; Blood Pressure; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke | 2013 |
Oral antiplatelet therapy for acute ischaemic stroke.
Topics: Aspirin; Brain Ischemia; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk; Stroke; Ticlopidine; Time-to-Treatment | 2014 |
Antiplatelet therapy for peripheral arterial disease and critical limb ischemia: guidelines abound, but where are the data?
Topics: Aspirin; Cilostazol; Dipyridamole; Endovascular Procedures; Extremities; Humans; Ischemia; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prostaglandins; Tetrazoles | 2015 |
Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.
Topics: Anastomosis, Surgical; Anticoagulants; Arteriosclerosis; Aspirin; Dipyridamole; Graft Occlusion, Vascular; Humans; Intermittent Claudication; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Thrombosis; Vascular Patency | 2015 |
Antiplatelet therapies for secondary stroke prevention: an update on clinical and cost-effectiveness.
Topics: Aspirin; Clopidogrel; Cost-Benefit Analysis; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine | 2015 |
Prediction models for intracranial hemorrhage or major bleeding in patients on antiplatelet therapy: a systematic review and external validation study.
Topics: Algorithms; Anticoagulants; Aspirin; Brain Ischemia; Calibration; Cerebral Hemorrhage; Dipyridamole; Europe; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Platelet Aggregation Inhibitors; Regression Analysis; Risk | 2016 |
Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Topics: Aspirin; Cilostazol; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Hemorrhage; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Tetrazoles; Ticlopidine | 2016 |
Antiplatelet Agents and the Prevention of Spontaneous Preterm Birth: A Systematic Review and Meta-analysis.
Topics: Adult; Aspirin; Dipyridamole; Female; Gestational Age; Humans; Logistic Models; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Premature Birth; Risk Factors; Treatment Outcome | 2017 |
The Efficacy and Safety of 3 Types of Interventions for Stroke Prevention in Patients With Cardiovascular and Cerebrovascular Diseases: A Network Meta-analysis.
Topics: Anticoagulants; Aspirin; Bayes Theorem; Cardiovascular Diseases; Clopidogrel; Dabigatran; Dipyridamole; Hemorrhage; Humans; Odds Ratio; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Thiazoles; Ticlopidine; Treatment Outcome; Warfarin | 2017 |
Aspirin plus dipyridamole has the highest surface under the cumulative ranking curves (SUCRA) values in terms of mortality, intracranial hemorrhage, and adverse event rate among 7 drug therapies in the treatment of cerebral infarction.
Topics: Aspirin; Cerebral Infarction; Cilostazol; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Hematologic Agents; Humans; Intracranial Hemorrhages; Tetrazoles; Ticlopidine; Warfarin | 2018 |
Optimal Antiplatelet Therapy in Moderate to Severe Asymptomatic and Symptomatic Carotid Stenosis: A Comprehensive Review of the Literature.
Topics: Aspirin; Asymptomatic Diseases; Carotid Stenosis; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Endarterectomy, Carotid; Endovascular Procedures; Humans; Platelet Aggregation Inhibitors; Recurrence; Stroke | 2019 |
Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?
Topics: Angiotensin II; Animals; Aspirin; Blood Coagulation Disorders; Coronavirus Infections; COVID-19; Dipyridamole; Humans; Immunoglobulins, Intravenous; Interferons; Membrane Proteins; Mice; Mucocutaneous Lymph Node Syndrome; Pandemics; Platelet Aggregation Inhibitors; Pneumonia, Viral; Signal Transduction; Thrombosis | 2020 |
Interventions for preventing thrombosis in solid organ transplant recipients.
Topics: Anticoagulants; Aspirin; Bias; Dipyridamole; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Kidney Transplantation; Liver Transplantation; Placebos; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Thrombosis; Transplant Recipients; Warfarin | 2021 |
Why Not Dipyridamole: a Review of Current Guidelines and Re-evaluation of Utility in the Modern Era.
Topics: Adenosine; Animals; Aspirin; Dipyridamole; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Rats; Vasodilator Agents | 2022 |
Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines.
Topics: Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Dipyridamole; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke; Ticagrelor | 2022 |
Antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attack.
Topics: Anticoagulants; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Factor XI; Fibrinolytic Agents; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke; Ticagrelor | 2022 |
362 trial(s) available for dipyridamole and aspirin
| Article | Year |
|---|---|
Role of blood platelets in coronary artery disease.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Evaluation; Humans; Myocardial Infarction; Placebos; Platelet Aggregation; Prostaglandins, Synthetic; Spasm; Sulfinpyrazone | 1979 |
[Secondary prevention of coronary disease with platelet aggregation inhibiting drugs. Preliminary report].
Topics: Aspirin; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Female; Humans; Male; Middle Aged; Oxazoles; Platelet Adhesiveness; Platelet Aggregation | 1979 |
[Possibilities and limits of controlled clinical therapy studies for the demonstration of the effectiveness of antithrombotic therapy].
Topics: Adult; Anticoagulants; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy; Early Ambulation; Exercise Therapy; Fibrinogen; Fibrinolysis; Heparin; Humans; Myocardial Infarction; Physical Therapy Modalities; Platelet Aggregation; Postoperative Complications; Posture; Pulmonary Embolism; Streptokinase; Sulfinpyrazone; Thromboembolism; Thrombosis | 1975 |
'Persantin'-aspirin reinfarction study.
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Drug Combinations; Drug Evaluation; Female; Humans; International Cooperation; Long-Term Care; Male; Middle Aged; Random Allocation; United Kingdom; United States | 1976 |
[Pharmacological action on the thrombocyte link in hemostasis in the treatment of ischemic heart disease].
Topics: Aspirin; Blood Platelet Disorders; Blood Platelets; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Drug Evaluation; Hemostasis; Humans; Pentoxifylline; Phenothiazines; Piperazines; Pyridinolcarbamate | 1978 |
Three large-scale clinical trials of aspirin in the USA.
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction | 1977 |
Guidelines for the management of transient ischemic attacks.
Topics: Anticoagulants; Aspirin; Blood Platelets; Carotid Arteries; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Endarterectomy; Humans; Ischemic Attack, Transient; Placebos; Sulfinpyrazone | 1978 |
Use of platelet inhibitor drugs in peripheral and cerebral vascular disorders.
Topics: Arterial Occlusive Diseases; Aspirin; Blood Platelets; Brain Ischemia; Cell Survival; Clinical Trials as Topic; Dipyridamole; Extremities; Humans; Kidney Diseases; Thrombosis | 1977 |
Preliminary study of effect of aspirin and dipyridamole on platelet adhesiveness and fibrinolytic activity in acute myocardial infarction.
Topics: Acute Disease; Aspirin; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Drug Evaluation; Fibrinolysis; Humans; Male; Myocardial Infarction; Platelet Adhesiveness | 1978 |
[Clinical application and evaluation of anti-platelet agents].
Topics: Aged; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Female; Humans; Intracranial Embolism and Thrombosis; Male; Myocardial Infarction; Prostheses and Implants; Sulfinpyrazone; Thrombophlebitis | 1978 |
Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: a controlled, randomized study.
Topics: Aged; Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Female; Humans; Male; Middle Aged; Random Allocation; Warfarin | 1979 |
Platelet inhibitors in the treatment of thrombosis.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Double-Blind Method; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Ischemic Attack, Transient; Male; Middle Aged; Postoperative Complications; Random Allocation; Sulfinpyrazone; Thromboembolism; Thrombosis | 1978 |
An investigation of the effect on platelet function of acetylsalicylic acid, dipyridamole and the two drugs in combination in patients with transient attacks of ischaemia.
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation; Platelet Factor 4; Random Allocation | 1979 |
Does aspirin prevent stroke?
Topics: Anticoagulants; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Drug Interactions; Female; Health Promotion; Humans; Ischemic Attack, Transient; Male; Sulfinpyrazone | 1979 |
Accentuated hypoxemia at high altitude in subjects susceptible to high-altitude pulmonary edema.
Topics: Adolescent; Altitude; Aspirin; Blood Coagulation; Child; Dipyridamole; Fibrinolysis; Humans; Oxygen; Oxyhemoglobins; Pulmonary Edema; Respiration; Syndrome; Vasopressins | 1979 |
The interaction of varying doses of dipyridamole and acetyl salicylic acid on the inhibition of platelet functions and their effect on bleeding time.
Topics: Adult; Aspirin; Bleeding Time; Blood Coagulation; Blood Platelets; Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Male; Middle Aged; Platelet Aggregation | 1979 |
Effects of aspirin and dipyridamole on platelet function, hematology, and blood chemistry of saturation divers.
Topics: Adult; Aspartate Aminotransferases; Aspirin; Blood Cell Count; Blood Platelets; Cell Survival; Cholesterol; Decompression Sickness; Depression, Chemical; Dipyridamole; Diving; Guanosine Triphosphate; Hematocrit; Hemoglobins; Humans; Male; Platelet Aggregation; Platelet Factor 4; Thrombin Time; Triglycerides | 1979 |
[Prevention of re-occlusion after recanalisation of occluded arteries by the catheter method (author's transl)].
Topics: Arterial Occlusive Diseases; Aspirin; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Humans; Recurrence | 1978 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Drug Combinations; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Kidney Diseases; Kidneys, Artificial; Male; Silicone Elastomers; Sulfinpyrazone; Thromboembolism; Thrombosis; Vascular Diseases | 1975 |
Prevention of postoperative deep vein thrombosis with dipyridamole and aspirin.
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Humans; Male; Middle Aged; Platelet Aggregation; Postoperative Complications; Radionuclide Imaging; Thrombophlebitis | 1976 |
Clinical trials in thrombosis: secondary prevention of myocardial infarction.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Humans; Male; Myocardial Infarction; Prospective Studies; Sulfinpyrazone; Thromboembolism | 1976 |
Proceedings: Prevention of ischemic cerebro vascular accident: a long term clinical trial with vasodilator and antiaggregating drugs.
Topics: Aspirin; Brain; Clinical Trials as Topic; Dihydroergotoxine; Dipyridamole; Ergoloid Mesylates; Humans; Ischemia; Platelet Aggregation | 1975 |
Preventing venous thromboembolism in elderly patients with hip fractures: studies of low-dose heparin, dipyridamole, aspirin, and flurbiprofen.
Topics: Age Factors; Aged; Aspirin; Dipyridamole; Drug Evaluation; Femoral Neck Fractures; Flurbiprofen; Heparin; Humans; Middle Aged; Propionates; Prospective Studies; Thromboembolism; Thrombophlebitis | 1977 |
[Double-blind study for the prevention of postoperative thrombosis].
Topics: Abdomen; Aspirin; Dipyridamole; Humans; Platelet Aggregation; Postoperative Complications; Thrombosis | 1976 |
[Thrombosis, embolism and aggregation inhibitors in surgery].
Topics: Aged; Anticoagulants; Aspirin; Dipyridamole; Female; Humans; Male; Platelet Aggregation; Postoperative Complications; Pulmonary Embolism; Sex Factors; Thrombophlebitis | 1976 |
Low dose heparin in the prevention of venous thromboembolism. Rationale and results.
Topics: Acenocoumarol; Adult; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Heparin; Hip; Humans; Injections, Subcutaneous; Middle Aged; Postoperative Complications; Thrombophlebitis; United Kingdom | 1975 |
The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits.
Topics: Adenosine Diphosphate; Animals; Aspirin; Blood Platelets; Clinical Trials as Topic; Collagen; Dipyridamole; Female; Male; Platelet Adhesiveness; Platelet Aggregation; Rabbits; Sulfinpyrazone; Thrombophlebitis; Tromethamine | 1975 |
The current status of platelet suppressive drugs in the treatment of thrombosis.
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cardiac Catheterization; Cell Survival; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Myocardial Infarction; Postoperative Complications; Renal Dialysis; Sulfinpyrazone; Thrombocytosis; Thromboembolism | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Prospective Studies; Pyrimidines; Retrospective Studies; Sulfinpyrazone; Thromboembolism; Warfarin | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Graft Rejection; Humans; Kidney Transplantation; Male; Myocardial Infarction; Sulfinpyrazone; Thromboembolism; Thrombosis; Transplantation, Homologous | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Fibrinolytic Agents; Humans; Hydroxychloroquine; Postoperative Complications; Pulmonary Embolism; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Thrombosis | 1975 |
Proceedings: Failure of aspirin and dipyridamole to influence the incidence of leg scan detected venous thrombosis after elective hip surgery.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Hip; Humans; Leg; Postoperative Complications; Thrombophlebitis | 1975 |
Controlled trial of platelet anti-aggregating agents and subcutaneous heparin in prevention of postoperative deep vein thrombosis in high risk patients.
Topics: Aged; Aspirin; Blood Platelets; Dipyridamole; Female; Heparin; Humans; Injections, Subcutaneous; Male; Middle Aged; Platelet Aggregation; Postoperative Complications; Prospective Studies; Thromboembolism | 1975 |
[Prevention of intrauterine growth retardation and pre-eclampsia by small doses of aspirin. Results of the french multicenter trial EPREDA and comparison with data in the literature; value of uterine Doppler].
Topics: Aspirin; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Prospective Studies; Ultrasonography, Prenatal | 1992 |
Efficacy and safety of anticoagulant therapy started pre-operatively in preventing coronary vein graft occlusion.
Topics: Aspirin; Cardiac Catheterization; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Premedication; Reoperation; Warfarin | 1992 |
The role of dipyridamole in addition to low dose aspirin in the prevention of occlusion of coronary artery bypass grafts.
Topics: Aged; Aspirin; Cardiac Catheterization; Cineangiography; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; New Zealand; Postoperative Complications | 1992 |
Indobufen versus dipyridamole plus aspirin in the treatment of patients with peripheral atherosclerotic disease.
Topics: Aged; Arteriosclerosis; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Random Allocation | 1992 |
Second European Stroke Prevention Study. ESPS-2 Working Group.
Topics: Aspirin; Brain Ischemia; Computer Simulation; Dipyridamole; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Electronic Data Processing; Follow-Up Studies; Humans; Models, Biological; Sensitivity and Specificity; Survival Analysis; Therapy, Computer-Assisted | 1992 |
Failure of aspirin plus dipyridamole to prevent restenosis after carotid endarterectomy.
Topics: Aged; Aspirin; Carotid Stenosis; Combined Modality Therapy; Dipyridamole; Drug Therapy, Combination; Endarterectomy, Carotid; Female; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence; Statistics as Topic; Treatment Outcome | 1992 |
Effects of aspirin, dipyridamole, nifedipine and cavinton which act on platelet aggregation induced by different aggregating agents alone and in combination.
Topics: Adenosine Diphosphate; Arteriosclerosis; Aspirin; Collagen; Dipyridamole; Double-Blind Method; Epinephrine; Humans; In Vitro Techniques; Middle Aged; Nifedipine; Platelet Aggregation; Platelet Aggregation Inhibitors; Vinca Alkaloids | 1992 |
European stroke prevention study: effectiveness of antiplatelet therapy in diabetic patients in secondary prevention of stroke.
Topics: Aged; Aspirin; Cerebrovascular Disorders; Diabetes Complications; Diabetes Mellitus; Dipyridamole; Drug Combinations; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors | 1992 |
[The effect of low-dose acetylsalicylic acid on platelet aggregation parameters in vitro].
Topics: Aspirin; Dipyridamole; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Platelet Aggregation; Preoperative Care; Thromboxane A2; Time Factors | 1992 |
Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial.
Topics: Adult; Aspirin; Birth Weight; Dipyridamole; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Evaluation; Drug Synergism; Female; Fetal Growth Retardation; Gestational Age; Humans; Infant, Newborn; Male; Pregnancy; Proteinuria; Recurrence | 1991 |
Erythropoietin and spontaneous platelet aggregation in haemodialysis patients.
Topics: Anemia; Aspirin; Blood Coagulation; Dipyridamole; Erythropoietin; Humans; In Vitro Techniques; Kidney Failure, Chronic; Platelet Aggregation; Renal Dialysis | 1991 |
Prevention of perinatal consequences of pre-eclampsia with low-dose aspirin: results of the epreda trial. The Epreda Trial Study Group.
Topics: Abruptio Placentae; Aspirin; Birth Weight; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Fetal Death; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy | 1991 |
Antiplatelet therapy is effective in the prevention of stroke or death in women: subgroup analysis of the European Stroke Prevention Study (ESPS).
Topics: Aspirin; Cause of Death; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Survival Rate; Vertebrobasilar Insufficiency | 1991 |
Ticlopidine, a new anti-thrombotic drug.
Topics: Aspirin; Dipyridamole; Humans; Intracranial Embolism and Thrombosis; Long-Term Care; Recurrence; Ticlopidine | 1991 |
Nd:YAG laser with sapphire tip combined with balloon angioplasty in peripheral arterial occlusions. Long-term results.
Topics: Aged; Angioplasty, Balloon; Angioplasty, Laser; Arterial Occlusive Diseases; Aspirin; Dipyridamole; Female; Femoral Artery; Follow-Up Studies; Humans; Male; Phenprocoumon; Popliteal Artery; Recurrence; Time Factors | 1991 |
[Anticoagulant or antiplatelet aggregation treatment after aortocoronary bypass].
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Sulfinpyrazone; Ticlopidine; Vitamin K | 1991 |
Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Disease; Dipyridamole; Double-Blind Method; Female; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Recurrence; Risk Factors | 1991 |
Physical training and antiplatelet treatment in stage II peripheral arterial occlusive disease: alone or combined?
Topics: Aspirin; Combined Modality Therapy; Dipyridamole; Exercise Therapy; Female; Humans; Intermittent Claudication; Male; Middle Aged; Time Factors; Walking | 1991 |
The European Stroke Prevention Study: results according to sex.
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Female; Humans; Ischemic Attack, Transient; Male; Platelet Aggregation Inhibitors; Sex Characteristics; Survival Analysis | 1991 |
The European Stroke Prevention Study (ESPS): results by arterial distribution.
Topics: Aspirin; Carotid Arteries; Cerebrovascular Disorders; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Humans; Incidence; Ischemic Attack, Transient; Male; Risk; Vertebrobasilar Insufficiency | 1991 |
A randomized comparison of intravenous heparin with oral aspirin and dipyridamole 24 hours after recombinant tissue-type plasminogen activator for acute myocardial infarction. National Heart Foundation of Australia Coronary Thrombolysis Group.
Topics: Administration, Oral; Anticoagulants; Aspirin; Dipyridamole; Female; Heparin; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Recombinant Proteins; Tissue Plasminogen Activator; Vascular Patency | 1991 |
PTFE or HUV for femoro-popliteal bypass: a multi-centre trial.
Topics: Arterial Occlusive Diseases; Aspirin; Bioprosthesis; Blood Vessel Prosthesis; Combined Modality Therapy; Dipyridamole; Femoral Artery; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Ischemia; Polytetrafluoroethylene; Popliteal Artery; Postoperative Complications | 1991 |
A linear model suitable for assessing graft patency in controlled clinical trials. SINBA Group.
Topics: Anastomosis, Surgical; Angiography; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; Graft Occlusion, Vascular; Humans; Isoindoles; Models, Statistical; Phenylbutyrates; Platelet Aggregation Inhibitors; Probability; Regression Analysis; Vascular Patency | 1990 |
Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Disease; Dipyridamole; Equipment Design; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Stents; Time Factors; Warfarin | 1991 |
Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial.
Topics: Aspirin; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Femoral Artery; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Patient Compliance; Platelet Aggregation Inhibitors; Popliteal Artery; Postoperative Complications; Saphenous Vein; Vascular Patency | 1991 |
Effects of diltiazem on complications and restenosis after coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Constriction, Pathologic; Coronary Angiography; Coronary Disease; Diltiazem; Dipyridamole; Double-Blind Method; Female; Follow-Up Studies; Humans; Incidence; Male; Recurrence | 1991 |
Comparison of two levels of anticoagulant therapy in patients with substitute heart valves.
Topics: Acenocoumarol; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Valve Prosthesis; Humans; Male; Middle Aged; Thromboembolism; Time Factors | 1991 |
Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation, PGI2 generation, and red cell deformability ex vivo in man.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Dipyridamole; Double-Blind Method; Drug Synergism; Epoprostenol; Erythrocyte Deformability; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests | 1991 |
Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.
Topics: Adult; Aspirin; Blood Transfusion; Dipyridamole; Female; Humans; Male; Monitoring, Physiologic; Plasma; Plasma Exchange; Platelet Count; Prospective Studies; Purpura, Thrombotic Thrombocytopenic | 1991 |
Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients.
Topics: Adolescent; Adult; Aged; Aspirin; Blood Transfusion; Dipyridamole; Female; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Monitoring, Physiologic; Plasma; Plasma Exchange; Prednisone; Pregnancy; Pregnancy Complications, Hematologic; Purpura, Thrombotic Thrombocytopenic; Research Design; Splenectomy | 1991 |
[Permeability of aortocoronary bypass after 6 months. A multicenter French study].
Topics: Adult; Aged; Aspirin; Coronary Angiography; Coronary Artery Bypass; Dipyridamole; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Risk Factors; Vitamin K | 1991 |
Prevention of aortocoronary vein bypass graft occlusion: which antithrombotic treatment and for how long?
Topics: Adult; Aged; Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Time Factors | 1990 |
Does low-dose aspirin prevent aortocoronary vein bypass graft occlusion? The Spanish Group for Aortocoronary Bypass Follow-up (GESIC Study).
Topics: Aged; Aspirin; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Saphenous Vein | 1990 |
Effect of dipyridamole and aspirin on vein graft patency after coronary bypass operations.
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; Graft Occlusion, Vascular; Humans; Risk Factors; Saphenous Vein; Vascular Patency | 1990 |
Prevention of acute complications after percutaneous transluminal coronary angioplasty.
Topics: Acute Disease; Adult; Angioplasty, Balloon, Coronary; Aspirin; Creatine Kinase; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors | 1990 |
Secondary prevention of myocardial infarction in the first European Stroke Prevention Study.
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Europe; Humans; Myocardial Infarction | 1990 |
Effect of short-term prostacyclin administration on restenosis after percutaneous transluminal coronary angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Combined Modality Therapy; Coronary Angiography; Coronary Disease; Dipyridamole; Drug Administration Schedule; Epoprostenol; Female; Humans; Injections, Intra-Arterial; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence | 1990 |
Effect of aspirin and dipyridamole treatment on prostacyclin production by human veins.
Topics: Aspirin; Dipyridamole; Double-Blind Method; Endothelium, Vascular; Epoprostenol; Humans; Prospective Studies; Randomized Controlled Trials as Topic; Saphenous Vein; Thromboxane A2; Varicose Veins | 1990 |
Reocclusion prophylaxis with dipyridamole combined with acetylsalicylic acid following PTA.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon; Arteriosclerosis Obliterans; Aspirin; Dipyridamole; Double-Blind Method; Female; Femoral Artery; Fibrinolytic Agents; Humans; Male; Middle Aged; Popliteal Artery; Radiography; Randomized Controlled Trials as Topic; Recurrence; Vascular Patency | 1990 |
[Study Group: "Evaluation of the efficacy of therapeutic treatments in cerebrovascular diseases"].
Topics: Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Double-Blind Method; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Male; Middle Aged; Prognosis; Sulfinpyrazone | 1990 |
A specific thromboxane receptor blocking drug, AH23848, reduces platelet deposition on vascular grafts in man.
Topics: Aged; Aspirin; Biphenyl Compounds; Blood Vessel Prosthesis; Cell Survival; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polyethylene Terephthalates; Receptors, Prostaglandin; Receptors, Thromboxane | 1990 |
European Stroke Prevention Study. ESPS Group.
Topics: Age Factors; Aspirin; Brain Ischemia; Carotid Artery Diseases; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Drug Combinations; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Recurrence; Sex Factors; Survival Analysis; Vertebrobasilar Insufficiency | 1990 |
Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Grupo Español para el Seguimiento del Injerto Coronario (GESIC)
Topics: Aged; Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Combinations; Graft Occlusion, Vascular; Humans; Middle Aged; Randomized Controlled Trials as Topic; Vascular Patency | 1990 |
Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo.
Topics: Adult; Aspirin; Blood Platelets; Dipyridamole; Double-Blind Method; Drug Interactions; Endothelium, Vascular; Female; Humans; In Vitro Techniques; Male; Malondialdehyde; Middle Aged; Platelet Aggregation; Thrombosis | 1990 |
The effect of ibustrin on early aortocoronary bypass patency.
Topics: Angiography, Digital Subtraction; Aspirin; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Graft Occlusion, Vascular; Humans; Isoindoles; Phenylbutyrates; Platelet Aggregation Inhibitors; Prospective Studies | 1990 |
[Anticoagulantion and antiaggregation therapy in patients with unstableangina pectoris].
Topics: Angina, Unstable; Aspirin; Dipyridamole; Drug Therapy, Combination; Electrocardiography; Female; Heparin; Humans; Male; Middle Aged; Myocardial Infarction | 1990 |
Effect of eicosapentaenoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplasty.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Disease; Dipyridamole; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Humans; Lipids; Male; Middle Aged; Postoperative Care; Recurrence | 1990 |
Internal mammary artery and saphenous vein graft patency. Effects of aspirin.
Topics: Aspirin; Coronary Angiography; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Graft Occlusion, Vascular; Humans; Internal Mammary-Coronary Artery Anastomosis; Male; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Saphenous Vein; Vascular Patency | 1990 |
Effect of dipyridamole (Persantin) on blood flow and patency of aortocoronary vein bypass grafts.
Topics: Aspirin; Blood Flow Velocity; Coronary Artery Bypass; Dipyridamole; Female; Humans; Male; Middle Aged; Postoperative Complications; Risk Factors; Vascular Patency | 1990 |
Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy.
Topics: Aspirin; Blood Transfusion; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Graft Occlusion, Vascular; Hemorrhage; Humans; Male; Middle Aged; Premedication; Randomized Controlled Trials as Topic; Reoperation; Sulfinpyrazone; Vascular Patency | 1990 |
The role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplasty.
Topics: Adult; Angioplasty, Balloon, Coronary; Aspirin; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Randomized Controlled Trials as Topic; Recurrence; Time Factors | 1990 |
Effect of pretreatment with aspirin versus aspirin plus dipyridamole on frequency and type of acute complications of percutaneous transluminal coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; Emergencies; Female; Humans; Male; Middle Aged; Myocardial Infarction; Premedication; Prospective Studies; Randomized Controlled Trials as Topic | 1990 |
Administration of aspirin-dipyridamole reduces proteinuria in diabetic nephropathy.
Topics: Adult; Aspirin; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dipyridamole; Double-Blind Method; Drug Combinations; Glomerular Filtration Rate; Humans; Middle Aged; Proteinuria | 1989 |
A trial of dipyridamole and aspirin in the prevention of smoking-induced changes in platelets and endothelium in men with coronary artery disease.
Topics: Aged; Aspirin; beta-Thromboglobulin; Carboxyhemoglobin; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Humans; Male; Middle Aged; Nicotine; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Factor 4; Random Allocation; Smoking | 1989 |
Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion.
Topics: 4-Hydroxycoumarins; Adult; Aged; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Coronary Thrombosis; Dipyridamole; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Phenprocoumon; Platelet Aggregation; Platelet Aggregation Inhibitors; Postoperative Complications; Premedication; Prospective Studies; Random Allocation; Saphenous Vein | 1989 |
Comparative study of pentoxifylline vs antiaggregants in patients with transient ischaemic attacks.
Topics: Aged; Aspirin; Dipyridamole; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Pentoxifylline; Platelet Aggregation Inhibitors; Theobromine | 1989 |
Usefulness of aspirin plus dipyridamole in reducing left ventricular thrombus formation in anterior wall acute myocardial infarction.
Topics: Aspirin; Blood Coagulation; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Heart Diseases; Humans; Myocardial Infarction; Random Allocation; Thrombosis; Time Factors | 1989 |
Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Patient Compliance; Prospective Studies; Random Allocation; Salicylates; Vascular Patency | 1989 |
Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial. The DAMAD Study Group.
Topics: Adult; Aspirin; Blood Pressure; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Dipyridamole; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Middle Aged; Random Allocation | 1989 |
Idiopathic recurrent fetal growth retardation and aspirin-dipyridamole therapy.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Female; Fetal Growth Retardation; Humans; Pregnancy; Recurrence | 1989 |
Comparative study of heparin and antiplatelets in treatment of preinfarction angina.
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Female; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Random Allocation | 1989 |
Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Graft Occlusion, Vascular; Humans; Middle Aged; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Saphenous Vein; Sulfinpyrazone; Time Factors; Vascular Patency | 1989 |
[Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
Topics: Aspirin; Canada; Clinical Trials as Topic; Coronary Disease; Coronary Thrombosis; Dipyridamole; Drug Evaluation; Humans; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Sulfinpyrazone; United States | 1989 |
[How long should antithrombotic therapy be continued following aortocoronary bypass surgery?].
Topics: 4-Hydroxycoumarins; Adult; Aged; Aspirin; Coronary Angiography; Coronary Artery Bypass; Dipyridamole; Female; Humans; Male; Middle Aged; Phenprocoumon; Prospective Studies; Randomized Controlled Trials as Topic; Vascular Patency | 1989 |
Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids.
Topics: Angioplasty, Balloon; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Angiography; Coronary Disease; Coronary Vessels; Diet; Dipyridamole; Eicosapentaenoic Acid; Fatty Acids; Humans; Male; Middle Aged; Random Allocation; Recurrence; Time Factors | 1988 |
Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective double-blind arteriographically controlled trial.
Topics: Arterial Occlusive Diseases; Aspirin; Blood Platelets; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Extremities; Female; Femoral Artery; Humans; Male; Middle Aged; Placebos; Popliteal Artery; Prospective Studies; Radiography; Random Allocation | 1985 |
Prevention of pre-eclampsia by early antiplatelet therapy.
Topics: Adult; Aspirin; Dipyridamole; Female; Humans; Pre-Eclampsia; Pregnancy | 1985 |
Prevention of coronary heart disease in practice. Implications of the results of recent clinical trials.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina, Unstable; Aspirin; Blood Platelets; Cholesterol; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Myocardial Infarction; Primary Prevention; Recurrence; Research Design; Risk; Smoking | 1985 |
Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Adult; Aged; Aspirin; Clinical Trials as Topic; Digitalis Glycosides; Dipyridamole; Double-Blind Method; Drug Combinations; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Random Allocation; Recurrence | 1986 |
[Platelet function inhibitors in peripheral arteriopathies].
Topics: Adrenal Cortex Hormones; Adrenergic alpha-Antagonists; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Arteriosclerosis Obliterans; Aspirin; Blood Platelets; Calcium Channel Blockers; Clinical Trials as Topic; Cyclic AMP; Dipyridamole; Extremities; Heparin; Humans; Imidazoles; Prostaglandins; Prostanoic Acids; Pyrazoles; Pyrazolones; Quinacrine; Thiophenes; Thromboembolism; Thrombosis; Ticlopidine; Vascular Diseases | 1986 |
The European Stroke Prevention Study (ESPS). Principal end-points. The ESPS Group.
Topics: Actuarial Analysis; Aspirin; Capsules; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Follow-Up Studies; Humans; Male; Prospective Studies; Random Allocation | 1987 |
Platelets and antiplatelet therapy in ischemic heart disease.
Topics: Angina Pectoris; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Humans; Myocardial Infarction; Platelet Adhesiveness; Sulfinpyrazone; Thromboxanes | 1986 |
Platelet-inhibitor drugs before and after coronary artery bypass surgery and coronary angioplasty: the basis of their use, data from animal studies, clinical trial data, and current recommendations.
Topics: Angioplasty, Balloon; Animals; Aspirin; Clinical Trials as Topic; Combined Modality Therapy; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Graft Occlusion, Vascular; Humans | 1986 |
Secondary prevention of strokes: role of platelet antiaggregant drugs in diabetic and non-diabetic patients.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Diabetic Angiopathies; Dipyridamole; Double-Blind Method; Humans | 1985 |
Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty.
Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Aspirin; Clinical Trials as Topic; Dipyridamole; Humans; Macrophages; Muscle, Smooth, Vascular; Platelet Adhesiveness; Platelet Aggregation; Recurrence; Thrombosis | 1987 |
Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.
Topics: Administration, Oral; Angioplasty, Balloon; Aspirin; Clinical Trials as Topic; Coronary Angiography; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Patient Compliance; Random Allocation; Recurrence | 1988 |
[Hypercoagulability and cerebral infarction].
Topics: Aspirin; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cerebral Infarction; Clinical Trials as Topic; Dipyridamole; Glycoproteins; Humans; Platelet Aggregation; Sulfinpyrazone; Suloctidil; Thromboxanes; von Willebrand Factor | 1986 |
Long term clinical outcome of coronary surgery and assessment of the benefit obtained with postoperative aspirin and dipyridamole.
Topics: Angina Pectoris; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Postoperative Care; Random Allocation | 1988 |
Prospective controlled study of early antiplatelet therapy in prevention of preeclampsia.
Topics: Adult; Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Fetal Growth Retardation; Humans; Parity; Plasma Volume; Platelet Count; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Random Allocation; Risk; Uric Acid | 1986 |
A comparison of the effects of a thromboxane antagonist and cyclo-oxygenase inhibitor on platelet accumulation in arterial grafts.
Topics: Aorta; Aspirin; Biphenyl Compounds; Blood Platelets; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Dipyridamole; Femoral Artery; Humans; Thrombosis; Thromboxanes; Vascular Surgical Procedures | 1987 |
Platelet-inhibitory therapy in reconstructive arterial surgery.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Sulfinpyrazone; Thrombosis | 1985 |
Antiplatelet agents in the secondary prevention of stroke: meta-analysis of the randomized control trials.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Drug Combinations; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Random Allocation; Sulfinpyrazone | 1988 |
A double-blind controlled trial of low dose acetylsalicylic acid and dipyridamole in the treatment of Raynaud's phenomenon.
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Raynaud Disease | 1987 |
Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Follow-Up Studies; Humans; Male; Myocardial Infarction; Random Allocation; Sulfinpyrazone | 1987 |
Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole.
Topics: Adult; Aspirin; Birth Weight; Clinical Trials as Topic; Dipyridamole; Epoprostenol; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Pregnancy; Recurrence; Thromboxane A2 | 1987 |
Low-dose acetylsalicylic acid (ASA) plus dipyridamole versus dipyridamole alone in the prevention of stroke in patients with reversible ischemic attacks.
Topics: Adult; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Function Tests; Prospective Studies; Risk Factors | 1987 |
Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass.
Topics: Administration, Oral; Aspirin; Blood Platelets; Blood Transfusion; Cardiopulmonary Bypass; Dipyridamole; Erythrocyte Count; Female; Hemorrhage; Humans; Infusions, Intravenous; Leukocyte Count; Male; Middle Aged; Platelet Count; Platelet Factor 4; Postoperative Complications; Prospective Studies; Random Allocation; Thromboxane B2 | 1988 |
Improved patency of the aortocoronary bypass by antithrombotic drugs.
Topics: Aspirin; Coronary Artery Bypass; Coronary Circulation; Dipyridamole; Follow-Up Studies; Humans; Random Allocation | 1986 |
[Anticoagulants vs. low-dose aggregation inhibitors in the prevention of perioperative occlusion of aortocoronary bypass grafts. Preliminary results of a prospective randomized study].
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans; Platelet Aggregation; Prospective Studies; Random Allocation | 1987 |
[Dipyridamole and low-dose aspirin in patients with aortocoronary bypass--comparison with anticoagulation].
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Dose-Response Relationship, Drug; Humans; Postoperative Care | 1987 |
Failure of combined acetylsalicylic acid and dipyridamole to prevent occlusion of aortocoronary venous bypass graft.
Topics: Aspirin; Coronary Angiography; Coronary Artery Bypass; Dipyridamole; Drug Combinations; Graft Occlusion, Vascular; Humans; Middle Aged; Postoperative Complications; Random Allocation | 1987 |
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Female; Glomerulonephritis; Graft Occlusion, Vascular; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Postoperative Complications; Random Allocation; Sulfinpyrazone; Thiophenes; Ticlopidine | 1986 |
Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease.
Topics: Animals; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Dogs; Double-Blind Method; Graft Occlusion, Vascular; Humans; Postoperative Complications; Swine | 1986 |
Dose antiplatelet agents; the relationship among side effects, and antithrombotic effectiveness.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Dipyridamole; Dose-Response Relationship, Drug; Epoprostenol; Fibrinolytic Agents; Gastric Mucosa; Humans; Sulfinpyrazone | 1986 |
Antithrombotic agents in coronary artery disease.
Topics: Angina, Unstable; Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Sulfinpyrazone; Thromboembolism; Time Factors | 1986 |
The role of aspirin in enhancing arterial graft patency.
Topics: Animals; Arteries; Aspirin; Blood Vessel Prosthesis; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Graft Occlusion, Vascular; Humans; Papio; Platelet Aggregation; Random Allocation | 1986 |
Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion.
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fibrinolytic Agents; Graft Occlusion, Vascular; Heparin; Humans; Platelet Aggregation; Saphenous Vein; Sulfinpyrazone; Thiophenes; Ticlopidine | 1986 |
Treatment of claudication with dipyridamole and aspirin.
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intermittent Claudication; Male; Middle Aged; Random Allocation | 1986 |
[Randomized clinical study of the efficacy of buflomedil in the prevention of recurrence of cerebral ischemia in comparison with anti-platelet aggregation agents].
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Humans; Ischemic Attack, Transient; Pyrrolidines; Random Allocation; Recurrence; Vasodilator Agents | 1986 |
[Secondary prevention of ischemic heart disease. Evaluation of platelet function in patients treated with anticoagulants and cod liver oil].
Topics: Adult; Aged; Anticoagulants; Aspirin; Clinical Trials as Topic; Cod Liver Oil; Coronary Disease; Dipyridamole; Fish Oils; Humans; Middle Aged; Platelet Aggregation; Recurrence; Sulfinpyrazone | 1986 |
Aspirin for the prevention of coronary thrombosis: current facts and perspectives.
Topics: Angina, Unstable; Animals; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Epoprostenol; Graft Occlusion, Vascular; Humans; Myocardial Infarction; Platelet Aggregation | 1986 |
Treatment of claudication with dipyridamole and aspirin.
Topics: Adult; Aged; Arteriosclerosis; Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Intermittent Claudication; Male; Middle Aged; Random Allocation | 1986 |
Improvement of aortocoronary bypass patency by antiplatelet drug administration. Preliminary communication.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Follow-Up Studies; Graft Occlusion, Vascular; Humans | 1986 |
Pathogenesis and prevention of aortocoronary bypass graft occlusion.
Topics: Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Graft Occlusion, Vascular; Humans; Postoperative Period; Premedication; Prospective Studies; Random Allocation | 1986 |
A critical appraisal of the clinical efficiency of anti-platelet drugs.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Double-Blind Method; Hemorrhage; Humans; Myocardial Revascularization; Prospective Studies; Sulfinpyrazone; Thromboxanes | 1986 |
Effect of preoperative antiplatelet drugs on vascular prostacyclin synthesis.
Topics: Aspirin; Blood Platelets; Blood Vessels; Coronary Disease; Dipyridamole; Drug Evaluation; Drug Therapy, Combination; Epoprostenol; Humans; Platelet Aggregation; Premedication; Thromboxane A2; Thromboxane B2 | 1987 |
Controlled trial of antiplatelet agents in mesangial IgA glomerulonephritis.
Topics: Adult; Aspirin; Blood Platelets; Clinical Trials as Topic; Creatinine; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Female; Glomerular Mesangium; Glomerulonephritis, IGA; Humans; Immunoglobulin G; Male; Random Allocation | 1987 |
Random control trial of a short course of aspirin and dipyridamole (Persantin) for femorodistal grafts.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Postoperative Period; Premedication; Prosthesis Failure; Random Allocation; Vascular Patency; Veins | 1987 |
VA cooperative study on antiplatelet agents in diabetic patients after amputation for gangrene. IV. Issues in design, interpretation, and analysis.
Topics: Amputation, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Dipyridamole; Gangrene; Hospitals, Veterans; Humans; Male; Myocardial Infarction | 1986 |
Reduction of exercise-induced albuminuria by aspirin-dipyridamole in patients with diabetes mellitus.
Topics: Adult; Albuminuria; Aspirin; Diabetes Mellitus, Type 1; Dipyridamole; Drug Therapy, Combination; Humans; Kinetics; Male; Physical Exertion | 1987 |
[Effect of dipyridamole (225 mg/day) and acetylsalicylic acid (150 mg/day) on various platelet parameters in non-complicated diabetes mellitus].
Topics: Aspirin; Blood Platelets; Diabetes Mellitus, Type 1; Dipyridamole; Humans; Malondialdehyde; Platelet Aggregation | 1986 |
Renal scintigraphy and survival of indium-111-labelled platelets in patients with diabetic nephropathy.
Topics: Aspirin; Blood Glucose; Blood Platelets; Cell Survival; Diabetic Nephropathies; Dipyridamole; Double-Blind Method; Humans; Indium; Kidney; Radioisotopes; Radionuclide Imaging | 1986 |
Effects of dipyridamole and low-dose aspirin therapy on platelet adhesion to vascular subendothelium.
Topics: Adult; Aspirin; Blood Vessels; Dipyridamole; Drug Combinations; Endothelium; Humans; Male; Platelet Adhesiveness; Platelet Aggregation | 1986 |
Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery.
Topics: Adult; Aged; Angina Pectoris; Aspirin; Blood Platelets; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Exercise Test; Graft Occlusion, Vascular; Humans; Male; Middle Aged | 1985 |
Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion.
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Random Allocation | 1985 |
Preventive treatment of cerebral transient ischemia: comparative randomized trial of pentoxifylline versus conventional antiaggregants.
Topics: Aged; Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Combinations; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Pentoxifylline; Random Allocation; Recurrence; Theobromine | 1985 |
Clinical aspects of antiplatelet therapy.
Topics: Angina Pectoris; Aspirin; Blood Coagulation Disorders; Clinical Trials as Topic; Dipyridamole; Female; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thromboembolism | 1985 |
Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass grafts. A double-blind, placebo-controlled, randomized trial.
Topics: Adult; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Graft Occlusion, Vascular; Humans; Middle Aged; Placebos; Random Allocation | 1985 |
Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial.
Topics: Adult; Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Combinations; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Pentoxifylline; Postoperative Complications; Prospective Studies; Random Allocation; Theobromine; Thromboembolism; Warfarin | 1985 |
[Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct].
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Fibrinolytic Agents; Humans; Myocardial Infarction; Platelet Aggregation; Recurrence; Sulfinpyrazone | 1985 |
Effect of perioperative platelet inhibition on postcarotid endarterectomy mural thrombus formation. Results of a prospective randomized controlled trial using aspirin and dipyridamole in humans.
Topics: Aged; Aspirin; Blood Platelets; Carotid Arteries; Carotid Artery Diseases; Cerebrovascular Disorders; Clinical Trials as Topic; Constriction, Pathologic; Dipyridamole; Drug Therapy, Combination; Endarterectomy; Female; Humans; Intraoperative Period; Male; Middle Aged; Postoperative Complications; Prospective Studies; Random Allocation; Thrombosis | 1985 |
Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences.
Topics: Animals; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Hyperplasia; Muscle, Smooth, Vascular; Prognosis; Saphenous Vein; Time Factors | 1985 |
Secondary prevention of myocardial infarction.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Myocardial Infarction; Random Allocation; Sulfinpyrazone | 1985 |
V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: III. Definitions and review of design and baseline characteristics.
Topics: Amputation, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Diabetic Angiopathies; Dipyridamole; Drug Therapy, Combination; Gangrene; Humans; Myocardial Infarction | 1985 |
[Eicosanoids, myocardial ischemia and sudden death].
Topics: Animals; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Coronary Disease; Cyclooxygenase Inhibitors; Death, Sudden; Dipyridamole; Dogs; Epoprostenol; Hemodynamics; Humans; Myocardial Infarction; Random Allocation; Sulfinpyrazone | 1985 |
Initial experience with sequential internal mammary artery bypass grafts to the left anterior descending and left anterior descending diagonal coronary arteries.
Topics: Angiography; Aspirin; Coronary Angiography; Coronary Circulation; Dipyridamole; Drug Therapy, Combination; Humans; Internal Mammary-Coronary Artery Anastomosis; Male; Middle Aged; Myocardial Revascularization; Premedication; Saphenous Vein | 1986 |
[Effect on various platelet parameters of dipyridamole (225 mg/day) acetylsalicylic acid (150 mg/day) and their combination in healthy volunteers].
Topics: Aspirin; Blood Platelets; Dipyridamole; Drug Combinations; Humans; Male; Platelet Aggregation | 1985 |
[The importance of thrombocytes for thrombogenesis and the pharmacological influencing of thrombocyte function (author's transl)].
Topics: Animals; Anticoagulants; Aspirin; Blood Platelet Disorders; Blood Platelets; Clinical Trials as Topic; Cold Temperature; Dextrans; Dipyridamole; Disease Models, Animal; Dogs; Heparin; Humans; Placebos; Platelet Adhesiveness; Postoperative Care; Rabbits; Rats; Thromboembolism; Thrombosis; Warfarin | 1974 |
Review of present status of prophylaxis of venous thromboembolism.
Topics: Adult; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Fibrinolysis; Heparin; Humans; Physical Therapy Modalities; Postoperative Complications; Pulmonary Embolism; Thrombophlebitis | 1974 |
Effect of acetylsalicylic acid and dipyridamole on platelet survival and aggregation in patients with atherosclerosis obliterans.
Topics: Aged; Arteriosclerosis Obliterans; Aspirin; Blood Cell Count; Blood Platelets; Cell Survival; Clinical Trials as Topic; Depression, Chemical; Dipyridamole; Drug Therapy, Combination; Gastrointestinal Diseases; Half-Life; Humans; Male; Middle Aged; Placebos; Platelet Adhesiveness; Platelet Aggregation; Prothrombin Time; Stimulation, Chemical; Time Factors | 1974 |
Trial of aspirin and RA 233 in prevention of post-operative deep vein thrombosis.
Topics: Aspirin; Dipyridamole; Femoral Neck Fractures; Fibrinogen; Humans; Iodine Radioisotopes; Placebos; Postoperative Complications; Thrombophlebitis; Time Factors | 1973 |
Controlled, double-blind trial of antiplatelet aggregating agents in vascular renal allograft rejection.
Topics: Animals; Anticoagulants; Aspirin; Azathioprine; Blood Platelets; Clinical Trials as Topic; Dipyridamole; Dogs; Drug Synergism; Graft Rejection; Histocompatibility; Kidney Transplantation; Methods; Prednisone; Transplantation Immunology; Transplantation, Homologous | 1971 |
Reduction in venous thromboembolism by agents affecting platelet function.
Topics: Adult; Aged; Arthroplasty; Aspirin; Blood Platelets; Chromium Alloys; Dextrans; Dipyridamole; Female; Hemorrhage; Hip; Humans; Joint Prosthesis; Male; Middle Aged; Platelet Adhesiveness; Postoperative Complications; Pulmonary Embolism; Thromboembolism; Thrombophlebitis; Veins; Warfarin | 1971 |
A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
Topics: Adrenergic beta-Antagonists; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Death, Sudden; Dipyridamole; Female; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Risk; Sulfinpyrazone; Thrombophlebitis | 1980 |
Randomised trial of pentoxifylline versus acetylsalicylic acid plus dipyridamole in preventing transient ischaemic attacks.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Male; Pentoxifylline; Random Allocation; Theobromine | 1981 |
Prophylaxis of myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aspirin; Clinical Trials as Topic; Dipyridamole; Humans; Myocardial Infarction; Sulfinpyrazone; Timolol | 1981 |
Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link.
Topics: Acetylation; Aspirin; Blood Platelets; Blood Vessels; Clinical Trials as Topic; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone; Thrombosis; Thromboxane-A Synthase | 1982 |
[Aftercare of heart infarct patients to reduce the risk of a subsequent infarction].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Clinical Trials as Topic; Dipyridamole; Humans; Hypolipidemic Agents; Myocardial Infarction; Patient Care Planning; Platelet Aggregation; Recurrence; Risk; Sulfinpyrazone; Thiophenes; Ticlopidine | 1983 |
Thromboembolism after hip surgery.
Topics: Aspirin; Clinical Trials as Topic; Dextrans; Dihydroergotamine; Dipyridamole; Drug Therapy, Combination; Heparin; Hip Prosthesis; Humans; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Thromboembolism; Thrombophlebitis | 1981 |
A randomized double blind comparison of an aspirin dipyridamole combination versus a placebo in the treatment of necrobiosis lipoidica.
Topics: Adolescent; Adult; Aspirin; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Necrobiosis Lipoidica; Random Allocation | 1981 |
Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Double-Blind Method; Humans; Myocardial Infarction; Postoperative Complications; Sulfinpyrazone; Thromboembolism | 1982 |
Platelet tests and antiplatelet drugs in coronary artery disease.
Topics: Adult; Aspirin; beta-Thromboglobulin; Blood Platelets; Cell Survival; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Platelet Function Tests; Random Allocation; Sulfinpyrazone | 1983 |
Aspirin and dipyridamole reduce platelet deposition on prosthetic femoro-popliteal grafts in man.
Topics: Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Combinations; Femoral Artery; Humans; Middle Aged; Platelet Aggregation; Polyethylene Terephthalates; Polytetrafluoroethylene; Popliteal Artery; Saphenous Vein; Thrombosis | 1983 |
[Critical approach to a therapeutic trial in secondary prevention of cerebral ischemic accidents by antiaggregants].
Topics: Adult; Aged; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Dihydroergotoxine; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation; Sulfinpyrazone | 1983 |
[Controlled cooperative trial of secondary prevention of cerebral ischemic accidents caused by atherosclerosis, using aspirin and dipyridamole].
Topics: Aged; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Random Allocation | 1983 |
Platelets and platelet-inhibitor drugs in aortocoronary vein bypass operations.
Topics: Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Vessels; Dipyridamole; Double-Blind Method; Endothelium; Humans; Postoperative Complications; Prospective Studies; Random Allocation; Thrombosis; Veins | 1983 |
[Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
Topics: Adult; Aged; Anticoagulants; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Dipyridamole; Female; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation; Sulfinpyrazone | 1983 |
Platelets and prostaglandins in coronary artery disease. Rationale for use of platelet-suppressive drugs.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Dogs; Humans; Models, Biological; Platelet Aggregation; Prostaglandins; Sulfinpyrazone | 1983 |
Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial.
Topics: Adult; Aged; Angiography; Aspirin; Clinical Enzyme Tests; Clinical Trials as Topic; Coronary Circulation; Coronary Vessels; Dipyridamole; Female; Fibrinolytic Agents; Heart; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Placebos; Prospective Studies; Random Allocation; Streptokinase; Stroke Volume | 1983 |
Pharmacological trials: primary and secondary prevention of coronary heart disease.
Topics: Aspirin; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dipyridamole; Estrogens; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Sulfinpyrazone | 1983 |
Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Heart Valve Prosthesis; Hemorrhage; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Thromboembolism; Warfarin | 1983 |
The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.
Topics: Adult; Aged; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Double-Blind Method; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Saphenous Vein | 1983 |
[Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone; Time Factors | 1983 |
[The A.I.C.L.A. controlled cooperative trial. Secondary prevention of cerebral ischemic accidents due to atherosclerosis by aspirin and dipyridamole. 3: Results].
Topics: Aspirin; Brain Ischemia; Cerebral Infarction; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intracranial Arteriosclerosis; Male | 1983 |
Role of platelet-active drugs in coronary artery disease.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Europe; Female; Humans; Male; Myocardial Infarction; Prospective Studies; Research Design; Sulfinpyrazone; Time Factors; United States | 1983 |
Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations.
Topics: Adult; Aged; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Female; Humans; Lipids; Male; Middle Aged; Postoperative Complications; Prospective Studies; Random Allocation; Saphenous Vein; Time Factors | 1984 |
Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy.
Topics: Adolescent; Adult; Aged; Aspirin; Blood Platelets; Cell Survival; Child; Chromium Radioisotopes; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Glomerulonephritis; Half-Life; Humans; Iothalamic Acid; Male; Middle Aged; Prospective Studies; Random Allocation | 1984 |
V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: I. Design, methods, and baseline characteristics.
Topics: Amputation, Surgical; Aspirin; Clinical Trials as Topic; Diabetic Angiopathies; Dipyridamole; Epoprostenol; Gangrene; Humans; Male; Middle Aged; Platelet Aggregation; Random Allocation; Research Design | 1984 |
[Results of ambulatory follow-up of patients after myocardial infarction treated with platelet aggregation inhibitors and antithrombotic drugs].
Topics: Acenocoumarol; Adult; Ambulatory Care; Aspirin; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Follow-Up Studies; Humans; Middle Aged; Myocardial Infarction; Recurrence | 1983 |
Prevention of stroke.
Topics: Aged; Aspirin; Canada; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Female; Heparin; Humans; Intracranial Embolism and Thrombosis; Male; Middle Aged; Placebos; Platelet Aggregation; Random Allocation; Risk; Sex Factors; Sulfinpyrazone; United States; Warfarin | 1984 |
Trial of platelet-inhibiting drug in scleroderma. Double-blind study with dipyridamole and aspirin.
Topics: Aspirin; Biomechanical Phenomena; Blood Coagulation; Blood Platelets; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Fingers; Humans; Movement; Scleroderma, Systemic; Skin | 1984 |
Dipyridamole: a critical evaluation.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Heart Valve Prosthesis; Hemodynamics; Humans; Kinetics; Myocardial Infarction; Platelet Aggregation; Postoperative Complications; Vascular Diseases | 1984 |
[The antithrombotic action of oral anticoagulants, acetylsalicylic acid (Aspirin) and dipyridamole (Persantin)].
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Humans; Thrombosis | 1984 |
Aspirin in the treatment of cardiovascular disease: a review.
Topics: Aspirin; Blood Platelets; Blood Vessels; Cell Adhesion; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Dipyridamole; Humans; Myocardial Infarction; Thrombosis | 1983 |
Efficacy of antiplatelet drugs in the maintenance of aortocoronary vein bypass graft patency.
Topics: Animals; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Cyclooxygenase Inhibitors; Dipyridamole; Humans; Saphenous Vein; Sulfinpyrazone | 1983 |
Does 111indium-platelet deposition predict patency in prosthetic arterial grafts?
Topics: Aspirin; Blood Platelets; Blood Vessel Prosthesis; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Femoral Artery; Humans; Hydroxyquinolines; Indium; Male; Middle Aged; Organometallic Compounds; Oxyquinoline; Popliteal Artery; Postoperative Complications; Radioisotopes; Risk; Thrombosis | 1983 |
Plasma factor and platelet sensitivity to prostacyclin in patients with peripheral vascular disease before and after treatment with a combination of a cyclooxygenase and a phosphodiesterase inhibitor.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Dipyridamole; Drug Therapy, Combination; Epoprostenol; Humans; Male; Phosphodiesterase Inhibitors; Sulfinpyrazone; Vascular Diseases | 1984 |
[Controlled trial of preventive treatment of preeclampsia. Preliminary results].
Topics: Adult; Aspirin; Blood Volume; Clinical Trials as Topic; Dipyridamole; Female; Fetal Growth Retardation; Humans; Pre-Eclampsia; Pregnancy; Prognosis; Uric Acid | 1984 |
Prevention of post-operative thrombosis in peripheral arteriopathies. Pentoxifylline vs. conventional antiaggregants: a six-month randomized follow-up study.
Topics: Aged; Aspirin; Dipyridamole; Drug Tolerance; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pentoxifylline; Postoperative Complications; Recurrence; Theobromine; Thrombosis; Time Factors; Ultrasonography | 1984 |
Effects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency.
Topics: Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Humans; Leg; Placebos; Polytetrafluoroethylene; Random Allocation | 1982 |
[Controlled clinical trial of the effect of aspirin and aspirin + dipyridamole on the development of diabetic retinopathy. II. Ophthalmologic protocol].
Topics: Aspirin; Clinical Trials as Topic; Diabetic Retinopathy; Dipyridamole; Drug Therapy, Combination; Fluorescein Angiography; Humans | 1982 |
Platelet inhibitory drugs: an in vivo method of evaluation in patients.
Topics: Aorta, Abdominal; Aspirin; Blood Vessel Prosthesis; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Femoral Artery; Humans; Platelet Aggregation; Popliteal Artery; Postoperative Complications; Thrombosis | 1982 |
Registry of prospective clinical trials--fifth report.
Topics: Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Double-Blind Method; Heart Valve Prosthesis; Heparin; Humans; Intermittent Claudication; Myocardial Infarction; Prospective Studies; Registries; Thiophenes; Thromboembolism; Thrombophlebitis; Thrombosis; Ticlopidine | 1982 |
[Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Recurrence; Sulfinpyrazone | 1982 |
A randomized clinical trial of pentoxifylline and antiaggregants in recent transient ischemic attacks (TIA). A one year follow-up.
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Male; Middle Aged; Pentoxifylline; Random Allocation; Risk; Theobromine | 1981 |
Platelet inhibitors in human renal homotransplantation: randomized comparison of aspirin versus dipyridamole.
Topics: Aspirin; Cimetidine; Cost-Benefit Analysis; Dipyridamole; Graft Rejection; Humans; Kidney Transplantation; Renal Artery Obstruction | 1980 |
Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
Topics: Animals; Anticoagulants; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Female; Humans; In Vitro Techniques; Male; Placebos; Platelet Adhesiveness; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1980 |
[Persantin and aspirin in coronary heart disease. The persantin-aspirin reinfarction study group (PARIS)].
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Placebos; Recurrence; Statistics as Topic | 1980 |
Deep vein thrombosis in spinal cord injury: effect of prophylaxis with calf compression, aspirin, and dipyridamole.
Topics: Aspirin; Dipyridamole; Factor VIII; Humans; Leg; Platelet Aggregation; Pressure; Prospective Studies; Random Allocation; Spinal Cord Injuries; Thrombophlebitis | 1982 |
[Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial].
Topics: Aspirin; Clinical Trials as Topic; Dihydroergotoxine; Dipyridamole; Humans; Ischemic Attack, Transient; Platelet Aggregation; Recurrence; Time Factors | 1982 |
Platelet antagonists in migraine prophylaxis. A clinical trial using aspirin and dipyridamole.
Topics: Adult; Aspirin; Blood Platelets; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Migraine Disorders | 1980 |
Aspirin and recurrent myocardial infarction.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Recurrence; Sex Factors; Sulfinpyrazone | 1980 |
Secondary prevention of myocardial infarction--the present state of the ART.
Topics: Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Dipyridamole; Humans; Myocardial Infarction; Recurrence; Sulfinpyrazone; Thrombosis | 1980 |
Aspirin and dipyridamole ineffective in treatment of necrobiosis lipoidica.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Humans; Necrobiosis Lipoidica | 1980 |
Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease.
Topics: Adult; Aged; Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction | 1980 |
The Persantine-aspirin reinfarction study. The Persantine-aspirin Reinfarction Study (PARIS) research group.
Topics: Aspirin; Blood Pressure; Blood Urea Nitrogen; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Creatinine; Dipyridamole; Drug Therapy, Combination; Heart Failure; Humans; Myocardial Infarction; Placebos; Random Allocation; Uric Acid | 1980 |
Aspirin-dipyridamole prophylaxis of sickle cell disease pain crises.
Topics: Acute Disease; Anemia, Sickle Cell; Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Fibrinogen; Humans; Platelet Count | 1980 |
Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Topics: Adult; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infarction; Sex Factors; Sulfinpyrazone | 1981 |
[anti-platelet therapy or anti-coagulants as prevention in transient ischemic attacks and reversible ischemic stroke].
Topics: Aged; Anticoagulants; Aspirin; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation; Random Allocation | 1980 |
Influence of aspirin and dipyridamole on patency of coronary artery bypass grafts.
Topics: Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Random Allocation; Thrombosis | 1981 |
Effect of various doses of acetylsalicylic acid in combination with dipyridamole on the balance between prostacyclin and thromboxane in human serum.
Topics: Adult; Aspirin; Dipyridamole; Epoprostenol; Female; Humans; Middle Aged; Prostaglandins; Prostaglandins F, Synthetic; Thromboxanes; Time Factors | 1981 |
Series on pharmacology in practice. 10. Antithrombotic therapy: role of platelet-inhibitor drugs. III. Management of arterial thromboembolic and atherosclerotic disease (third of three parts).
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Sulfinpyrazone; Thromboembolism; Thrombosis | 1981 |
[Platelet antiaggregants: review of the literature (author's transl)].
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation; Sulfinpyrazone; Thromboembolism | 1981 |
[The antithrombotic effect of dipyridamole and acetylsalicylic acid. A prospective clinical examination].
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Postoperative Complications; Prospective Studies; Thrombosis; Vascular Surgical Procedures | 1981 |
[Platelets and coronary artery disease (CAD) (author's transl)].
Topics: Animals; Aspirin; Autopsy; Blood Platelets; Cardiomyopathies; Cell Wall; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Heparin Antagonists; Humans; Platelet Aggregation; Risk; Sulfinpyrazone | 1980 |
["A.I.C.L.A." controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Part I: Protocol (author's transl)].
Topics: Aspirin; Brain Ischemia; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Intracranial Arteriosclerosis; Ischemic Attack, Transient | 1981 |
[Various observations on the results of the "Aspirin myocardial infarction study" and the "Persantine-aspirin reinfarction study" in the United States].
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Random Allocation; United States | 1981 |
Drug trials in prevention of occlusion of aorta--coronary artery vein grafts.
Topics: Angiography; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Humans; Postoperative Care; Random Allocation; Risk; Sulfinpyrazone; Thrombosis; Veins; Warfarin | 1982 |
Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Collagen; Coronary Disease; Dipyridamole; Evaluation Studies as Topic; Humans; Myocardial Infarction; Platelet Aggregation; Prostaglandins; Recurrence; Sulfinpyrazone; Thromboxanes | 1981 |
E.P.S.I.M., the French oral anticoagulant--aspirin trial in post-myocardial infarction patients: design, organization and quality control procedures.
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Aspirin; Clinical Trials as Topic; Data Collection; Dipyridamole; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Prognosis; Random Allocation; Recurrence; Sulfinpyrazone | 1981 |
Antiplatelet agents: their role in the prevention of sudden death.
Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Clinical Trials as Topic; Coronary Circulation; Coronary Disease; Death, Sudden; Dipyridamole; Dogs; Endothelium; Humans; Male; Muscle, Smooth; Myocardial Infarction; Papio; Platelet Adhesiveness; Prostaglandins; Rabbits; Sulfinpyrazone | 1982 |
Aspirin, dipyridamole and platelet survival in patients with diabetes mellitus.
Topics: Adult; Aged; Aspirin; Blood Platelets; Cell Survival; Clinical Trials as Topic; Diabetic Retinopathy; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged | 1982 |
A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency.
Topics: Adult; Aged; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Female; Humans; Male; Middle Aged; Postoperative Care; Postoperative Complications; Prospective Studies; Random Allocation; Thrombosis | 1982 |
[Controlled cooperative trial. Secondary prevention of atherosclerosis-related cerebral ischemic accidents by aspirin dipyridamole. 2: Description of subjects at the beginning of the trial].
Topics: Aged; Aspirin; Brain Ischemia; Cerebral Infarction; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Female; Humans; Intracranial Arteriosclerosis; Male; Middle Aged; Risk | 1982 |
[Controlled clinical trial of the effect of aspirin and aspirin + dipyridamole on the development of diabetic retinopathy. I. General protocol. From the DAMAD Study Group (author's transl)].
Topics: Adolescent; Adult; Aged; Aspirin; Blood Platelets; Clinical Trials as Topic; Diabetic Retinopathy; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Hemostasis; Humans; Middle Aged | 1982 |
[Thrombosis prevention with thrombocyte aggregation inhibitors in the venous system].
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone; Thrombophlebitis | 1982 |
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cell Division; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Heart Diseases; Humans; Hydroxychloroquine; Neoplasms; Sulfinpyrazone; Thromboembolism; Thrombosis | 1982 |
Antiplatelet therapy and cerebrovascular diseases.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Humans; Sulfinpyrazone | 1982 |
Effect of aspirin and dipyridamole on the interaction of human platelets with sub-endothelium: studies using citrated and native blood.
Topics: Adult; Aspirin; Bleeding Time; Blood; Blood Coagulation Tests; Blood Platelets; Cell Adhesion; Citrates; Dipyridamole; Endothelium; Fibrin; Humans; Male; Platelet Aggregation; Platelet Count | 1981 |
Effect of platelet suppressant treatment with dipyridamole and aspirin on exercise performance and platelet survival time in coronary disease.
Topics: Aspirin; Blood Platelets; Blood Pressure; Cell Survival; Coronary Circulation; Coronary Disease; Dipyridamole; Heart Rate; Humans; Male; Physical Exertion; Platelet Aggregation | 1981 |
Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.
Topics: Actuarial Analysis; Adult; Aged; Aspirin; Blood Pressure; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Physician-Patient Relations; Placebos | 1980 |
Persantine-aspirin reinfarction study. Design, methods and baseline results. By the persantine-aspirin reinfarction study research group.
Topics: Adult; Aged; Animals; Aspirin; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Papio; Platelet Aggregation; Rats; Research Design; Research Support as Topic | 1980 |
[Long term prophylaxis of re-infarct. Results of the persantin-acetylsalicylic acid re-infarct study].
Topics: Adult; Aged; Aspirin; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence | 1980 |
Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy.
Topics: Aspirin; Coronary Angiography; Coronary Disease; Coronary Vessels; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prognosis; Recurrence; Risk Factors; Thrombolytic Therapy; Time Factors; Vascular Patency | 1995 |
Antiplatelet treatment in elderly people with transient ischaemic attacks or ischaemic strokes.
Topics: Age Factors; Aged; Aged, 80 and over; Aspirin; Cerebrovascular Disorders; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Finland; Humans; Ischemic Attack, Transient; Middle Aged | 1995 |
Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Inst
Topics: Acenocoumarol; Anticoagulants; Aspirin; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Internal Mammary-Coronary Artery Anastomosis; Male; Middle Aged; Phenprocoumon; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome; Vascular Patency | 1994 |
Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting.
Topics: Adult; Aged; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Femoral Artery; Graft Occlusion, Vascular; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Popliteal Artery; Postoperative Complications; Proportional Hazards Models; Prospective Studies; Survival Analysis; Vascular Patency | 1994 |
Effect of aspirin and dipyridamole on proteinuria in idiopathic membranoproliferative glomerulonephritis: a multicentre prospective clinical trial. Collaborative Glomerulonephritis Therapy Study Group (CGTS)
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Aspirin; Blood Pressure; Dietary Proteins; Dipyridamole; Drug Therapy, Combination; Female; Glomerulonephritis, Membranoproliferative; Humans; Male; Middle Aged; Prospective Studies; Proteinuria | 1994 |
Low-dose aspirin combined with dipyridamole versus anticoagulants after femoropopliteal percutaneous transluminal angioplasty.
Topics: Administration, Oral; Aged; Angioplasty, Balloon; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Femoral Artery; Humans; Life Tables; Male; Phenprocoumon; Popliteal Artery; Prospective Studies; Radiography; Vascular Patency | 1994 |
Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary artery bypass grafting.
Topics: Acenocoumarol; Adult; Aged; Anticoagulants; Aspirin; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Exercise Test; Female; Fibrinolytic Agents; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Phenprocoumon; Postoperative Complications; Prospective Studies; Radionuclide Imaging; Saphenous Vein; Thallium Radioisotopes; Treatment Outcome | 1994 |
Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Polytetrafluoroethylene; Prospective Studies; Renal Dialysis; Thrombectomy; Thrombolytic Therapy; Thrombosis; Treatment Outcome; Vascular Patency | 1994 |
Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Ne
Topics: Acenocoumarol; Administration, Oral; Aged; Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Phenprocoumon; Treatment Outcome; Vascular Patency | 1993 |
Effect on early acute occlusion rate of adjunctive antithrombotic treatment with intravenously administered dipyridamole during percutaneous transluminal coronary angioplasty.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Aspirin; Chemotherapy, Adjuvant; Coronary Thrombosis; Dipyridamole; Female; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Recurrence; Retrospective Studies; Thrombolytic Therapy | 1994 |
Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Recurrence; Risk Factors; Verapamil | 1994 |
Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.
Topics: Adolescent; Adult; Aged; Aspirin; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Postoperative Care; Prospective Studies; Time Factors | 1994 |
Factors influencing 1-year patency of coronary artery saphenous vein grafts. Studio Indobufene nel Bypass Aortocoronarico (SINBA).
Topics: Aspirin; Coronary Angiography; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Female; Graft Occlusion, Vascular; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Prospective Studies; Regression Analysis; Risk Factors; Saphenous Vein | 1993 |
[No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans | 1993 |
[No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery].
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; Graft Occlusion, Vascular; Humans | 1993 |
Platelet inhibition with ASA/dipyridamole after percutaneous balloon angioplasty in patients with symptomatic lower limb arterial disease. A prospective double-blind trial. Study group on pharmacological treatment after PTA.
Topics: Aged; Angiography; Angioplasty, Balloon; Aspirin; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Humans; Ischemia; Leg; Male; Prospective Studies; Recurrence; Vascular Patency | 1994 |
Antiplatelet therapy is effective in primary prevention of myocardial infarction in patients with a previous cerebrovascular ischemic event.
Topics: Aged; Aspirin; Cerebral Infarction; Dipyridamole; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction; Placebos | 1993 |
Placebo-controlled trial of enteric coated aspirin in coronary bypass graft patients. Effect on graft patency.
Topics: Aged; Aspirin; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Premedication; Saphenous Vein; Tablets, Enteric-Coated | 1993 |
[Acetylsalicylic acid and kurantil in the prevention of pregnancy complications in glomerulonephritis and hypertension].
Topics: Abortion, Spontaneous; Analysis of Variance; Aspirin; Chronic Disease; Dipyridamole; Drug Therapy, Combination; Female; Fetal Death; Glomerulonephritis; Humans; Hypertension; Pregnancy; Pregnancy Complications; Time Factors | 1993 |
[The effect of indobufen on aortocoronary bypass patency after 1 week and after 1 year].
Topics: Adult; Aged; Aspirin; Coronary Artery Bypass; Dipyridamole; Female; Graft Occlusion, Vascular; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Time Factors; Vascular Patency | 1993 |
European Stroke Prevention Study (ESPS): antithrombotic therapy is also effective in the elderly.
Topics: Actuarial Analysis; Aged; Aspirin; Cause of Death; Cerebral Infarction; Cerebrovascular Disorders; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intracranial Embolism and Thrombosis; Ischemic Attack, Transient; Male; Recurrence; Survival Rate | 1993 |
Subacute occlusion, bleeding complications, hospital stay and restenosis after Palmaz-Schatz coronary stenting under a new antithrombotic regimen.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anticoagulants; Aspirin; Coronary Angiography; Coronary Disease; Dextrans; Dipyridamole; Female; Hemorrhage; Heparin; Humans; Length of Stay; Male; Middle Aged; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Stents; Warfarin | 1996 |
[2nd European study on secondary prevention of stroke (ESPS 2). Respective roles of acetylsalicylic acid, dipyridamole and their combination].
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors | 1995 |
Haemodynamic changes induced by the correction of anaemia by erythropoietin: role of antiplatelet therapy.
Topics: Adult; Aged; Anemia; Aspirin; Dipyridamole; Erythropoietin; Female; Hemodynamics; Humans; Male; Middle Aged; Oxazoles; Platelet Aggregation Inhibitors; Prospective Studies; Recombinant Proteins; Renal Dialysis; Ticlopidine; Time Factors; Uremia | 1995 |
Second European Stroke Prevention Study.
Topics: Aspirin; Cerebrovascular Disorders; Delayed-Action Preparations; Dipyridamole; Humans | 1996 |
Use of cumulative meta-analysis in the design, monitoring, and final analysis of a clinical trial: a case study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Protocols; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Humans; Meta-Analysis as Topic; Placebos; Platelet Aggregation Inhibitors; Saphenous Vein; Sulfinpyrazone; Uricosuric Agents | 1995 |
[The effect of Taprostene on platelet activation and clinical course after percutaneous transluminal angioplasty].
Topics: Administration, Oral; Adult; Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Cardiovascular Agents; Dipyridamole; Drug Therapy, Combination; Epoprostenol; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Platelet Activation; Recurrence; Treatment Outcome | 1996 |
Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance.
Topics: Aged; Angioplasty, Balloon, Coronary; Arrhythmias, Cardiac; Aspirin; Coronary Vessels; Dipyridamole; Female; Heart; Hemodynamics; Heparin; Humans; Injections; Male; Middle Aged; Myocardial Contraction; Preoperative Care; Stroke Volume; Ventricular Function, Left | 1996 |
European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
Topics: Adult; Aged; Aspirin; Cerebrovascular Disorders; Demography; Dipyridamole; Double-Blind Method; Female; Follow-Up Studies; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Patient Compliance; Placebos; Platelet Aggregation Inhibitors; Survival Analysis | 1996 |
Aspirin plus either dipyridamole or ticlopidine is effective in preventing recurrent myocardial infarction. Secondary Prevention Group.
Topics: Aged; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Ticlopidine | 1997 |
[Primary and secondary prevention of ischemic cerebrovascular accidents of arteriosclerosis by platelet inhibitors].
Topics: Arteriosclerosis; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Platelet Aggregation Inhibitors; Primary Prevention; Ticlopidine | 1996 |
European Stroke Prevention Study 2. Efficacy and safety data.
Topics: Aged; Aspirin; Cerebrovascular Disorders; Data Interpretation, Statistical; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Compliance; Placebos; Platelet Aggregation Inhibitors; Safety | 1997 |
European stroke prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
Topics: Aged; Aspirin; Cerebrovascular Disorders; Dipyridamole; Disease-Free Survival; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Headache; Humans; Male; Platelet Aggregation Inhibitors; Risk Factors; Treatment Outcome | 1997 |
[Intracoronary dipyridamole reduces the incidence of acute coronary vessel occlusion in percutaneous transluminal coronary angioplasty--a prospective randomized study].
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Coronary Thrombosis; Coronary Vessels; Dipyridamole; Female; Heparin; Humans; Injections, Intra-Articular; Male; Middle Aged; Myocardial Infarction; Premedication; Prospective Studies; Recurrence; Vasodilation; Vasodilator Agents | 1997 |
European Stroke Prevention Study-2 results: serendipitous demonstration of neuroprotection induced by endogenous adenosine accumulation?
Topics: Adenosine; Aspirin; Blood-Brain Barrier; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Humans; Neuroprotective Agents; Placebos; Platelet Aggregation Inhibitors | 1998 |
Up to date review of the secondary preventive measures for recurrent ischaemic stroke and transient ischaemic episodes.
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors | 1998 |
Risk factors and antiplatelet therapy in TIA and stroke patients.
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Finland; Humans; Ischemic Attack, Transient; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Regression Analysis; Risk Factors | 1998 |
[Prevention of vascular complications following cerebral ischemia of arterial origin; the ESPRIT trial: mild anticoagulant therapy, combination treatment with acetylsalicylic acid plus dipyridamole or treatment with acetylsalicylic acid alone?].
Topics: Adult; Aged; Anticoagulants; Antifibrinolytic Agents; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Humans; Middle Aged; Platelet Aggregation Inhibitors | 1998 |
Efficacy of antiplatelet treatment in hypertensive patients with TIA or stroke.
Topics: Aspirin; Blood Pressure; Cerebrovascular Disorders; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors | 1998 |
Secondary stroke prevention with low-dose aspirin, sustained release dipyridamole alone and in combination. ESPS Investigators. European Stroke Prevention Study.
Topics: Aged; Aspirin; Cerebrovascular Disorders; Delayed-Action Preparations; Dipyridamole; Disease-Free Survival; Drug Synergism; Female; Fibrinolytic Agents; Headache; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence | 1998 |
[Long term effects of 50 mg acetylsalicylic acid alone and in combination with dipyridamole on platelet function after coronary bypass surgery].
Topics: Anticoagulants; Aspirin; Blood Platelets; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Phenprocoumon; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Thromboxane B2; Time Factors | 1998 |
Second European Stroke Prevention Study: antiplatelet therapy is effective regardless of age. ESPS2 Working Group.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Incidence; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors | 1999 |
[Secondary prevention after ischemic cerebral infarct. The ESPRIT Study: low dose anticoagulation, combined therapy with acetylsalicylic acid/dipyridamole or monotherapy with acetylsalicylic acid?].
Topics: Anticoagulants; Aspirin; Australia; Cerebral Infarction; Dipyridamole; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Europe; Follow-Up Studies; Humans; Recurrence; Survival Rate; Treatment Outcome | 1999 |
[Prevention of vascular complications after cerebral ischemia of arterial origin. European Stroke and Australian Stroke Prevention in Reversible Ischemia Trial (ESPRIT): moderated coagulation, aspirin-dipyridamole combination or aspirin alone?].
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Vasodilator Agents | 1999 |
Rapid development of tolerance to dipyridamole-associated headaches.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross-Over Studies; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Headache; Humans; Male; Middle Aged; Therapeutic Equivalency; Time Factors; Vasodilator Agents | 1999 |
Cost-effectiveness analysis of antiplatelet therapy in the prevention of recurrent stroke in the UK. Aspirin, dipyridamole and aspirin-dipyridamole.
Topics: Aged; Aged, 80 and over; Aspirin; Cost-Benefit Analysis; Decision Support Techniques; Dipyridamole; Drug Combinations; Female; Humans; Male; Models, Economic; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; United Kingdom | 1999 |
Intracoronary dipyridamole reduces the incidence of abrupt vessel closure following PTCA: a prospective randomised trial.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Vasodilator Agents | 2000 |
Cascade filtration for TTP: an effective alternative to plasma exchange with cryodepleted plasma.
Topics: Adult; Antineoplastic Agents, Phytogenic; Aspirin; Blood Component Removal; Dipyridamole; Female; Hemofiltration; Humans; Male; Middle Aged; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Vincristine | 1999 |
Plasma levels of C-reactive protein after coronary stent implantation.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Phenprocoumon; Platelet Aggregation Inhibitors; Prognosis; Stents; Ticlopidine | 2000 |
Cardiac safety in the European Stroke Prevention Study 2 (ESPS2).
Topics: Angina Pectoris; Aspirin; Dipyridamole; Humans; Ischemic Attack, Transient; Longitudinal Studies; Myocardial Infarction; Platelet Aggregation Inhibitors; Stroke; Treatment Outcome | 2001 |
[Does early high dosage dipyridamole in prevention of secondary stroke induce cardiac events?].
Topics: Administration, Oral; Angina Pectoris; Aspirin; Cause of Death; Cerebral Infarction; Delayed-Action Preparations; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Risk Factors | 2001 |
Inhibition of thrombus formation by low-dose acetylsalicylic acid, dipyridamole, and their combination in a model of platelet-vessel wall interaction.
Topics: Aspirin; Blood Platelets; Cell Communication; Cerebral Arteries; Clinical Trials, Phase I as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Intracranial Thrombosis; Platelet Aggregation Inhibitors; Stroke | 2001 |
A comparative randomized and placebo-controlled short-term trial of aspirin and dipyridamole for overt type-2 diabetic nephropathy.
Topics: Adult; Aged; Aspirin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipyridamole; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors | 2002 |
Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
Topics: Adenosine Diphosphate; Adult; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Platelets; Capsules; Dipyridamole; Dose-Response Relationship, Drug; Drug Combinations; Epinephrine; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk Factors; Stroke; Time Factors | 2003 |
Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct antithrombotic-drug regimen in coronary artery stenting.
Topics: Adult; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Angiography; Coronary Stenosis; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Factor Xa; Female; Follow-Up Studies; Hemorrhage; Heparin; Humans; Lipoproteins; Male; Middle Aged; Statistics as Topic; Stents; Thromboplastin; Thrombosis; Ticlopidine; Time Factors; Warfarin | 2003 |
Dipyridamole in stroke prevention: effect of dipyridamole on blood pressure.
Topics: Aspirin; Blood Pressure; Brain Ischemia; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stroke; Time; Treatment Outcome; Vasodilator Agents | 2003 |
Dipyridamole and headache--a pilot study of initial dose titration.
Topics: Aged; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Headache; Humans; Ischemia; Pilot Projects; Time Factors; Titrimetry; Vasodilator Agents | 2004 |
Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial.
Topics: Aged; Antigens, CD; Aspirin; Aspirin, Dipyridamole Drug Combination; Brain Ischemia; CD40 Ligand; Dipyridamole; Drug Combinations; Female; Flow Cytometry; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Endothelial Cell Adhesion Molecule-1; Platelet Function Tests; Platelet Membrane Glycoprotein IIb; Platelet Membrane Glycoproteins; Stroke; Tetraspanin 24; Time Factors; Treatment Outcome | 2004 |
Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination.
Topics: Acetaminophen; Aged; Analgesics, Non-Narcotic; Aspirin; Dipyridamole; Drug Combinations; Female; Headache; Humans; Incidence; Male; Middle Aged; Prevalence; Remission, Spontaneous; Risk; Treatment Failure | 2004 |
[The clinical study on Dan Shao Tang in treating simple hematuria of masked nephritis of deficiency of Yin with damp-heat symptom].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aspirin; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Hematuria; Humans; Male; Middle Aged; Nephritis; Phytotherapy; Yin Deficiency | 2002 |
Enhanced antiplatelet effects of clopidogrel plus acetylsalicylic acid compared with acetylsalicylic acid alone or combined with extended-release dipyridamole in healthy volunteers.
Topics: Adult; Arachidonic Acid; Aspirin; Blood Platelets; Clopidogrel; Collagen; Cross-Over Studies; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Humans; In Vitro Techniques; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine | 2005 |
Effects of aspirin, clopidogrel and dipyridamole administered singly and in combination on platelet and leucocyte function in normal volunteers and patients with prior ischaemic stroke.
Topics: Adult; Aged; Aspirin; Blood Platelets; Brain Ischemia; Case-Control Studies; Cell Adhesion; Clopidogrel; Cross-Over Studies; Dipyridamole; Drug Therapy, Combination; Female; Humans; Leukocytes; Male; Middle Aged; Platelet Aggregation; Stroke; Ticlopidine | 2005 |
Dipyridamole bioavailability in subjects with reduced gastric acidity.
Topics: Achlorhydria; Adult; Aspirin; Biological Availability; Cross-Over Studies; Dipyridamole; Drug Combinations; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Tablets, Enteric-Coated | 2005 |
Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers.
Topics: Adolescent; Adult; Arteries; Aspirin; Clopidogrel; Collagen; Cross-Over Studies; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Fibrin; Humans; Immunoenzyme Techniques; Male; Perfusion; Platelet Adhesiveness; Platelet Function Tests; Thrombosis; Ticlopidine | 2005 |
Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole.
Topics: Acetylcholine; Adenosine; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Flow Velocity; Cardiovascular System; Cross-Over Studies; Cyclic GMP; Dipyridamole; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Models, Biological; Nitric Oxide; Nitroprusside; Phosphoric Diester Hydrolases; Time Factors; Vasodilator Agents | 2005 |
Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke.
Topics: Adult; Arteriosclerosis; Aspirin; Biomarkers; Blood Platelets; Brain Ischemia; C-Reactive Protein; Clopidogrel; Cross-Sectional Studies; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Platelet Count; Platelet-Derived Growth Factor; Solubility; Stroke; Ticlopidine; Treatment Outcome; von Willebrand Factor | 2006 |
Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Stroke | 2006 |
Dose titration to reduce dipyridamole-related headache.
Topics: Aged; Aspirin; Dipyridamole; Drug Administration Schedule; Drug Therapy, Combination; Female; Headache; Humans; Ischemic Attack, Transient; Male; Middle Aged; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Prevalence; Stroke; Taiwan | 2006 |
Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers.
Topics: Adult; Aspirin; Aspirin, Dipyridamole Drug Combination; Body Weight; Cross-Over Studies; Dipyridamole; Dose-Response Relationship, Drug; Drug Combinations; Humans; Logistic Models; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Reference Values; Tablets, Enteric-Coated; Therapeutic Equivalency; Thromboxane B2; Treatment Outcome | 2006 |
Comparison between aspirin combined with dipyridamole versus aspirin alone within 48 hours after ischemic stroke event for prevention of recurrent stroke and improvement of neurological function: a preliminary study.
Topics: Aged; Aspirin; Brain Ischemia; Dipyridamole; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Treatment Outcome | 2005 |
Dipyridamole/aspirin combination in secondary stroke prevention: effects on absolute myocardial blood flow and coronary vascular resistance.
Topics: Aged; Aged, 80 and over; Aspirin; Coronary Circulation; Coronary Vessels; Dipyridamole; Drug Therapy, Combination; Female; Heart Rate; Humans; Male; Middle Aged; Stroke; Vascular Resistance | 2006 |
Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction.
Topics: Aspirin; Coronary Angiography; Coronary Disease; Dipyridamole; Disease Progression; Drug Therapy, Combination; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Prognosis; Proportional Hazards Models; Survival Analysis; Treatment Outcome | 2007 |
ESPRIT study design and outcomes--a critical appraisal.
Topics: Aspirin; Biomarkers; Brain Ischemia; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Patient Dropouts; Prospective Studies; Research Design; Stroke; Treatment Outcome; Vascular Diseases | 2007 |
Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Research Design; Secondary Prevention; Stroke; Telmisartan; Ticlopidine; Treatment Outcome | 2007 |
[Prevention of embolism due to chronic auricular fibrillation with persantin (dipyridamole) combined with aspirin].
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Dipyridamole; Embolism; Humans; Middle Aged; Platelet Aggregation Inhibitors | 2007 |
Influence of antiplatelet therapy on cerebral micro-emboli after carotid endarterectomy using postoperative transcranial Doppler monitoring.
Topics: Aged; Anticoagulants; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Dextrans; Dipyridamole; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Endarterectomy, Carotid; Female; Hemorrhage; Humans; Intracranial Embolism; Ischemic Attack, Transient; Male; Middle Aged; Middle Cerebral Artery; Pilot Projects; Platelet Aggregation Inhibitors; Postoperative Care; Prospective Studies; Stroke; Ticlopidine; Treatment Outcome; Ultrasonography, Doppler, Transcranial | 2007 |
[Effectiveness of treatment and prophylactic methods in persons with ischemic heart disease risk factors].
Topics: Adult; Aspirin; Dipyridamole; Drug Therapy, Combination; Exercise; Feeding Behavior; Female; Humans; Life Style; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Survival Rate; Ticlopidine | 2007 |
Magnitude and time course of platelet inhibition with extended release dipyridamole with or without aspirin in healthy Japanese volunteers. The AGgrenox versus Aspirin Therapy Evaluation (AGATE-Japan).
Topics: Adult; Antigens, CD; Asian People; Aspirin; Aspirin, Dipyridamole Drug Combination; Biomarkers; Blood Platelets; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Female; Flow Cytometry; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Membrane Glycoproteins; Reference Values; Research Design; Time Factors | 2008 |
Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events.
Topics: Age Factors; Aged; Anti-Inflammatory Agents; Arachidonic Acid; Aspirin; Blood Platelets; Clopidogrel; Collagen; Coronary Artery Disease; Dipyridamole; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Odds Ratio; Platelet Aggregation; Recurrence; Stroke; Ticlopidine; Time Factors; Treatment Failure | 2008 |
Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-b
Topics: Adult; Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Biomarkers; Clopidogrel; Diabetes Mellitus, Type 2; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Pilot Projects; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Single-Blind Method; Ticlopidine; Time Factors; Treatment Outcome | 2008 |
A randomised controlled trial of triple antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility.
Topics: Aged; Aspirin; Blood Pressure; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Drug Tolerance; Feasibility Studies; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Patient Selection; Platelet Aggregation Inhibitors; Pulse; Safety; Single-Blind Method; Stroke; Ticlopidine | 2008 |
Antiplatelet therapy vs. anticoagulation in cervical artery dissection: rationale and design of the Cervical Artery Dissection in Stroke Study (CADISS).
Topics: Anticoagulants; Aortic Dissection; Aspirin; Clinical Protocols; Clopidogrel; Diagnostic Imaging; Dipyridamole; Drug Therapy, Combination; Endpoint Determination; Feasibility Studies; Heparin; Humans; Patient Selection; Platelet Aggregation Inhibitors; Prospective Studies; Quality Assurance, Health Care; Research Design; Sample Size; Single-Blind Method; Stroke; Ticlopidine; United Kingdom; Warfarin | 2007 |
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Factor Analysis, Statistical; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk; Secondary Prevention; Stroke; Telmisartan; Ticlopidine; Vascular Diseases | 2008 |
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFE
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Aspirin; Benzimidazoles; Benzoates; Clopidogrel; Cognition; Dipyridamole; Disability Evaluation; Double-Blind Method; Drug Administration Schedule; Drug Delivery Systems; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; International Cooperation; Male; Mental Status Schedule; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Secondary Prevention; Severity of Illness Index; Stroke; Telmisartan; Ticlopidine | 2008 |
Treatment with aspirin and dipyridamole is more effective than aspirin in reducing low shear blood viscosity.
Topics: Adult; Aged; Aspirin; Blood Viscosity; Cardiovascular Diseases; Dipyridamole; Female; Hematocrit; Humans; Hyperhomocysteinemia; Male; Middle Aged; Platelet Aggregation Inhibitors | 2008 |
Low molecular weight heparin as an alternative to unfractionated heparin in the immediate postoperative period after left ventricular assist device implantation.
Topics: Aged; Anticoagulants; Aspirin; Dipyridamole; Heart Failure; Heart-Assist Devices; Heparin; Heparin, Low-Molecular-Weight; Humans; Middle Aged; Nadroparin; Outcome Assessment, Health Care; Postoperative Period; Prostheses and Implants; Thrombosis | 2008 |
Effect of dipyridamole plus aspirin on hemodialysis graft patency.
Topics: Aspirin; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Renal Dialysis; Thrombosis | 2009 |
Dipyridamole-associated headache in stroke patients--interindividual differences?
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Headache; Humans; Ischemic Attack, Transient; Male; Middle Aged; Pilot Projects; Risk Factors; Secondary Prevention; Sex Factors; Stroke; Time Factors; Vasodilator Agents | 2009 |
Distribution of dipyridamole in blood components among post-stroke patients treated with extended release formulation.
Topics: Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Platelets; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Erythrocytes; Female; Humans; Ischemia; Leukocytes; Male; Middle Aged; Risk Factors; Spectrometry, Fluorescence; Stroke; Time Factors; Treatment Outcome | 2009 |
Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Germany; Humans; Ischemic Attack, Transient; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Severity of Illness Index; Time Factors | 2010 |
Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis.
Topics: Aged; Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Female; Fibrinolytic Agents; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Recovery of Function; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome | 2010 |
Prevention with low-dose aspirin plus dipyridamole in patients with disabling stroke.
Topics: Aspirin; Dipyridamole; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Humans; Incidence; Platelet Aggregation Inhibitors; Proportional Hazards Models; Secondary Prevention; Stroke; Treatment Outcome | 2010 |
Fourteen-year follow-up from CABADAS: vitamin K antagonists or dipyridamole not superior to aspirin.
Topics: Acenocoumarol; Aged; Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Phenprocoumon; Vitamin K | 2010 |
Effects of Aggrenox and aspirin on plasma endothelial nitric oxide synthase and oxidised low-density lipoproteins in patients after ischaemic stroke. The AGgrenox versus aspirin therapy evaluation (AGATE) biomarker substudy.
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Atherosclerosis; Biomarkers; Case-Control Studies; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Humans; Lipoproteins, LDL; Male; Middle Aged; Nitric Oxide Synthase Type III; Pharmacokinetics; Platelet Aggregation Inhibitors; Stroke | 2011 |
Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) study.
Topics: Adult; Aged; Aspirin; Blood Platelets; Blood Specimen Collection; Dipyridamole; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Longitudinal Studies; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Stroke | 2011 |
Clopidogrel versus dipyridamole in addition to aspirin in reducing embolization detected with ambulatory transcranial Doppler: a randomized trial.
Topics: Aged; Aged, 80 and over; Ambulatory Care; Aspirin; Clopidogrel; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Stroke; Ticlopidine; Ultrasonography, Doppler, Transcranial | 2011 |
Use of aspirin associates with longer primary patency of hemodialysis grafts.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Aspirin, Dipyridamole Drug Combination; Chronic Disease; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kidney Diseases; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Renal Dialysis; Thrombosis; Treatment Outcome; Vascular Patency | 2011 |
The Japanese aggrenox (extended-release dipyridamole plus aspirin) stroke prevention versus aspirin programme (JASAP) study: a randomized, double-blind, controlled trial.
Topics: Aged; Asian People; Aspirin; Aspirin, Dipyridamole Drug Combination; Brain Ischemia; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Stroke; Treatment Outcome | 2011 |
Risk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudy.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; Cerebral Infarction; Clopidogrel; Dipyridamole; Female; Humans; Intracranial Embolism; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Secondary Prevention; Socioeconomic Factors; Stroke; Telmisartan; Ticlopidine; Tomography, X-Ray Computed; Treatment Outcome; Vasodilator Agents | 2012 |
Association of factor V gene polymorphism with arteriovenous graft failure.
Topics: Adult; Aged; Aspirin; Chronic Disease; Dipyridamole; DNA; Double-Blind Method; Factor V; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Kidney Diseases; Male; Middle Aged; Pharmacogenetics; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Renal Dialysis; Retrospective Studies; Vascular Grafting | 2012 |
Comparative evaluation of treatment with low-dose aspirin plus dipyridamole versus aspirin only in patients with acute ischaemic stroke.
Topics: Aged; Aspirin; Brain Ischemia; Comorbidity; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Platelet Aggregation Inhibitors; Prevalence; Stroke; Survival Analysis; Survival Rate; Sweden; Treatment Outcome | 2012 |
Monocyte chemotactic protein-1 as a potential biomarker for early anti-thrombotic therapy after ischemic stroke.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Biomarkers; Brain Ischemia; Chemokine CCL2; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stroke; Time Factors | 2012 |
What is better antiplatelet agent to prevent recurrent stroke?
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; Clopidogrel; Dipyridamole; Double-Blind Method; Evidence-Based Medicine; Humans; Male; Middle Aged; Patient Compliance; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Telmisartan; Ticlopidine; Treatment Outcome | 2012 |
Pharmacokinetics and pharmacodynamics of the antiplatelet combination aspirin (acetylsalicylic acid) plus extended-release dipyridamole are not altered by coadministration with the potent CYP2C19 inhibitor omeprazole.
Topics: Adolescent; Adult; Aspirin; Aspirin, Dipyridamole Drug Combination; Cross-Over Studies; Dipyridamole; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Omeprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Young Adult | 2013 |
Discontinuation of antiplatelet study medication and risk of recurrent stroke and cardiovascular events: results from the PRoFESS study.
Topics: Aged; Aged, 80 and over; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Dipyridamole; Drug Combinations; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome | 2013 |
RApid Primary care Initiation of Drug treatment for Transient Ischaemic Attack (RAPID-TIA): study protocol for a pilot randomised controlled trial.
Topics: Antihypertensive Agents; Aspirin; Cardiovascular Agents; Clinical Protocols; Dipyridamole; Drug Administration Schedule; Drug Therapy, Combination; Emergency Service, Hospital; England; Feasibility Studies; General Practice; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Pilot Projects; Primary Health Care; Referral and Consultation; Research Design; Secondary Prevention; Simvastatin; Time Factors; Treatment Outcome | 2013 |
Cost-effectiveness of antiplatelet therapy to prolong primary patency of hemodialysis graft.
Topics: Adult; Arteriovenous Shunt, Surgical; Aspirin; Aspirin, Dipyridamole Drug Combination; Cost-Benefit Analysis; Dipyridamole; Double-Blind Method; Drug Combinations; Graft Occlusion, Vascular; Humans; Monte Carlo Method; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Renal Dialysis | 2014 |
The effect of a slower than standard dose escalation scheme for dipyridamole on headaches in secondary prevention therapy of strokes: a randomized, open-label trial (DOSE).
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Headache; Humans; Ischemic Attack, Transient; Male; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke | 2014 |
Effect of adjunctive dipyridamole to DAPT on platelet function profiles in stented patients with high platelet reactivity. The result of the ACCEL-DIP Study.
Topics: Aged; Aspirin; ATP Binding Cassette Transporter, Subfamily B; Biomarkers; Blood Platelets; Cell Adhesion Molecules; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Dipyridamole; Drug Resistance; Drug Therapy, Combination; Female; Genotype; Humans; Male; Microfilament Proteins; Middle Aged; Percutaneous Coronary Intervention; Phosphodiesterase 5 Inhibitors; Phosphoproteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Republic of Korea; Stents; Ticlopidine; Time Factors; Treatment Outcome | 2014 |
Statistical analysis plan for the 'Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke' (TARDIS) trial.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Double-Blind Method; Female; Humans; International Cooperation; Male; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2015 |
Baseline characteristics of the 3096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischemic Stroke' trial.
Topics: Aged; Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Platelet Aggregation Inhibitors; Severity of Illness Index; Stroke; Ticlopidine; Treatment Outcome | 2017 |
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.
Topics: Acute Disease; Aged; Aspirin; Brain Ischemia; Clopidogrel; Denmark; Dipyridamole; Drug Therapy, Combination; Female; Georgia; Hemorrhage; Humans; Ischemia; Ischemic Attack, Transient; Male; Middle Aged; New Zealand; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Research Design; Risk Assessment; Stroke; Thrombolytic Therapy; Ticlopidine; Treatment Outcome; United Kingdom | 2018 |
Antiplatelet Therapy vs Anticoagulation Therapy in Cervical Artery Dissection: The Cervical Artery Dissection in Stroke Study (CADISS) Randomized Clinical Trial Final Results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Carotid Artery, Internal, Dissection; Clopidogrel; Dipyridamole; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Mortality; Platelet Aggregation Inhibitors; Recurrence; Secondary Prevention; Stroke; Treatment Outcome; Vertebral Artery Dissection; Warfarin; Young Adult | 2019 |
Comparison of Antiplatelet Therapies for Prevention of Patent Foramen Ovale-Associated Stroke.
Topics: Adolescent; Adult; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Foramen Ovale, Patent; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Progression-Free Survival; Prospective Studies; Recurrence; Risk Factors; Secondary Prevention; Stroke; Time Factors; Young Adult | 2020 |
Effects of Dose Titration on Dipyridamole-Induced Headache: A Randomized, Double-Blind Clinical Trial.
Topics: Aspirin; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Headache; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke | 2022 |
Bleeding with intensive versus guideline antiplatelet therapy in acute cerebral ischaemia.
Topics: Acute Disease; Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Prospective Studies; Quality of Life; Stroke | 2023 |
939 other study(ies) available for dipyridamole and aspirin
| Article | Year |
|---|---|
Synthesis, platelet aggregation inhibitory activity, and in vivo antithrombotic activity of new 1,4-dihydropyridines.
Topics: Animals; Cats; Collagen; Dihydropyridines; Humans; Kinetics; Male; Mice; Nitrendipine; Platelet Aggregation; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Thrombosis | 1988 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
[The use of platelet aggregation-inhibiting drugs in central vestibular pathology caused by atherosclerotic vascular diseases].
Topics: Aspirin; Dipyridamole; Drug Evaluation; Humans; Intracranial Arteriosclerosis; Labyrinth Diseases; Oxazoles; Platelet Aggregation; Vestibule, Labyrinth | 1975 |
[Antiaggregant therapy in cerebrovascular insufficiency in the aged].
Topics: Aged; Aspirin; Blood Platelet Disorders; Dipyridamole; Drug Evaluation; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Oxazoles; Platelet Aggregation | 1979 |
Antiplatelet drugs in a rat microsurgical model of arterial thrombosis.
Topics: Animals; Aspirin; Blood Coagulation; Blood Platelets; Carotid Artery Thrombosis; Dipyridamole; Disease Models, Animal; Hydrogen-Ion Concentration; Male; Polyethylene Glycols; Rats; Sodium Chloride; Sulfinpyrazone | 1979 |
[Is it worthwhile preventing postoperative thromboembolism?].
Topics: Anticoagulants; Aspirin; Dihydroergotamine; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Early Ambulation; Heparin; Humans; Plasma Substitutes; Platelet Aggregation; Postoperative Complications; Thromboembolism | 1979 |
Management of thrombo-embolism after aortic valve replacement with the Björk-Shiley tilting disc valve. Medicamental prevention with dicumarol in comparison with dipyridamole - acetylsalicylic acid. Surgical treatment of prosthetic thrombosis.
Topics: Adult; Aortic Valve; Aspirin; Cerebral Hemorrhage; Dicumarol; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Valve Prosthesis; Humans; Middle Aged; Postoperative Complications; Thromboembolism; Time Factors | 1975 |
Anti-platelet drugs and portacaval anastomosis for homozygous hypercholesterolaemia.
Topics: Adolescent; Adult; Aspirin; Child; Dipyridamole; Female; Homozygote; Humans; Hypercholesterolemia; Male; Platelet Aggregation; Portacaval Shunt, Surgical; Postoperative Complications; Thrombosis | 1976 |
Platelet activation in acute cerebral ischaemia. Serial measurements of platelet function in cerebrovascular disease.
Topics: Acute Disease; Adenosine Diphosphate; Aged; Aspirin; Blood Cell Count; Blood Platelets; Cerebrovascular Disorders; Chronic Disease; Collagen; Dipyridamole; Epinephrine; Humans; In Vitro Techniques; Ischemic Attack, Transient; Middle Aged; Platelet Aggregation | 1977 |
Degos' disease treated with platelet-suppressive drugs.
Topics: Adult; Aspirin; Dipyridamole; Drug Therapy, Combination; Humans; Male; Skin; Skin Diseases; Syndrome; Thrombosis | 1977 |
Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin.
Topics: Animals; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Depression, Chemical; Dipyridamole; Dose-Response Relationship, Drug; Drug Synergism; Epoprostenol; Fibrinolytic Agents; Phosphodiesterase Inhibitors; Platelet Aggregation; Prostaglandin Antagonists; Prostaglandins; Prostaglandins, Synthetic; Rabbits; Theophylline; Thrombosis | 1978 |
Circulating prostacyclin.
Topics: Aspirin; Dipyridamole; Drug Interactions; Epoprostenol; Fibrinolytic Agents; Humans; Platelet Aggregation; Prostaglandin Antagonists; Prostaglandins; Pulmonary Circulation | 1978 |
Aspirin dose in prevention of transient ischaemic attacks.
Topics: Aged; Anticoagulants; Aspirin; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient | 1979 |
[Interactions of platelet inhibitors].
Topics: Adenosine; Aspirin; Dipyridamole; Drug Interactions; Guanylate Cyclase; Humans; Nucleoside-Diphosphate Kinase; Oxygenases; Papaverine; Phospholipases A; Phosphoric Diester Hydrolases; Platelet Aggregation; Thromboxane-A Synthase | 1979 |
Drug-induced platelet surface alterations. A possible mechanism for impaired aggregation.
Topics: Aspirin; Blood Platelets; Chloramphenicol; Dipyridamole; Humans; Penicillin G; Platelet Aggregation; Pseudopodia | 1978 |
Experimental arterial thromboembolism in baboons. Mechanism, quantitation, and pharmacologic prevention.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Blood Transfusion; Dipyridamole; Disease Models, Animal; Femoral Artery; Femoral Vein; Fibrinogen; Haplorhini; Heparin; Kidney; Male; Papio; Platelet Adhesiveness; Polyurethanes; Regional Blood Flow; Silicone Elastomers; Sulfinpyrazone; Thromboembolism | 1979 |
Platelet turnover in metastatic cancer and the effect of platelet aggregation inhibitors.
Topics: Aspirin; Cell Survival; Dipyridamole; Humans; Neoplasm Metastasis; Platelet Aggregation | 1976 |
The influence of platelet aggregation inhibitors on metastasis formation in mice (3LL).
Topics: Animals; Aspirin; Bencyclane; Cyproheptadine; Dipyridamole; Female; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms, Experimental; Platelet Aggregation | 1976 |
Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Dogs; Femoral Artery; Hyperplasia; Platelet Adhesiveness; Platelet Aggregation; Polyethylene Terephthalates; Polytetrafluoroethylene | 1978 |
Effects of inhibitors of platelets aggregation on oxidative phosphorylation in rat liver mitochondria in vitro.
Topics: Adenosine Triphosphatases; Animals; Aspirin; Dipyridamole; In Vitro Techniques; Male; Mitochondria, Liver; Nicergoline; Oxidative Phosphorylation; Oxygen Consumption; Platelet Aggregation; Rats; Sulfinpyrazone | 1979 |
Effects of gliclazide, a new antidiabetic agent, on the platelet release reaction, role of adenylate cyclase.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adenylyl Cyclases; Aspirin; Carbon Radioisotopes; Collagen; Cyclic AMP; Dipyridamole; Gliclazide; Glucuronidase; Humans; Phosphoric Diester Hydrolases; Platelet Adhesiveness; Prostaglandins E; Serotonin; Sulfonylurea Compounds; Thrombin; Tritium | 1975 |
In vitro evaluation of inhibitors of platelet release and aggregation.
Topics: Adenosine; Adenosine Diphosphate; Anti-Inflammatory Agents; Antilymphocyte Serum; Aspirin; Blood Platelets; Collagen; Depression, Chemical; Dextrans; Dipyridamole; Epinephrine; Hematology; Humans; Molecular Weight; Phosphoric Monoester Hydrolases; Platelet Adhesiveness; Platelet Aggregation; Propionates; Prostaglandins E; Serotonin; Sulfinpyrazone; T-Lymphocytes | 1975 |
Platelet release and aggregation induced by antithymocyte globulin. In vitro effect of inhibitors.
Topics: Adenosine; Antilymphocyte Serum; Apyrase; Aspirin; Blood Platelets; Dipyridamole; Flurbiprofen; Humans; Phosphoric Monoester Hydrolases; Platelet Aggregation; Propionates; Prostaglandins E; Sulfinpyrazone; T-Lymphocytes | 1975 |
The effect of non-steroid anti-inflammatory drugs, dibutyryl cyclic 3',5'-adenosine monophosphate and phosphodiesterase inhibitors on platelet aggregation and the platelet release reaction in normal and essential fatty acid deficient rats.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Bucladesine; Caffeine; Depression, Chemical; Dipyridamole; Fatty Acids, Essential; Indomethacin; Papaverine; Phosphodiesterase Inhibitors; Platelet Aggregation; Rats | 1975 |
[Moschowitz's disease: efficacy of anti-platelet aggregation agents].
Topics: Adrenocorticotropic Hormone; Anemia, Hemolytic; Aspirin; Cosyntropin; Dipyridamole; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Intracranial Embolism and Thrombosis; Middle Aged; Purpura, Thrombotic Thrombocytopenic | 1977 |
[Sterologic evaluation on in vitro thrombin-induced platelet degranulation and contraction (author's transl)].
Topics: Aspirin; Blood Platelets; Bucladesine; Cytoplasmic Granules; Dipyridamole; Dose-Response Relationship, Drug; Humans; Oxygenases; Thrombin | 1978 |
Measurement of antithrombin III in healthy subjects studied before and after taking aspirin and dipyridamole.
Topics: Antithrombin III; Aspirin; Dipyridamole; Female; Humans; Male | 1979 |
Studies on the progression and regression of coronary and peripheral atherosclerosis in the cynomolgus monkey. I. Effects of dipyridamole and aspirin.
Topics: Animals; Aorta; Arteries; Arteriosclerosis; Aspirin; Calcium; Cholesterol; Cholesterol, Dietary; Collagen; Coronary Disease; Coronary Vessels; Diet, Atherogenic; Dipyridamole; Elastin; Haplorhini; Lipoproteins, LDL; Macaca fascicularis | 1979 |
Aggregation of gel-filtered guinea-pig platelets by lipoproteins.
Topics: Adenosine; Adenosine Diphosphate; Animals; Apyrase; Aspirin; Chromatography, Gel; Dipyridamole; Guinea Pigs; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Platelet Aggregation; Prostaglandins E | 1979 |
Evaluation of antiinflammatory and antithrombotic drugs in pulmonary and arterial thrombosis.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Anti-Inflammatory Agents; Arterial Occlusive Diseases; Aspirin; Benzophenones; Carotid Arteries; Cattle; Dipyridamole; Drug Evaluation; Fibrinolytic Agents; Humans; Imidazoles; Indoles; Indomethacin; Lung Diseases, Obstructive; Male; Mice; Platelet Aggregation; Prostaglandins; Pyridines; Quinazolines; Rats; Sulfinpyrazone; Sulfonamides; Suloctidil; Thiophenes | 1979 |
Migraine attacks and increased platelet aggregability induced by oral contraceptives.
Topics: Adult; Aspirin; Contraceptives, Oral; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Female; Humans; Mestranol; Migraine Disorders; Norethindrone; Platelet Aggregation | 1978 |
Treating thromboembolic disease.
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Fibrinolytic Agents; Heart Valve Prosthesis; Heparin; Humans; Ischemic Attack, Transient; Platelet Aggregation; Sulfinpyrazone; Thromboembolism | 1977 |
Reduction of intimal thickening in canine coronary bypass vein grafts with dipyridamole and aspirin.
Topics: Animals; Aspirin; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Dogs; Drug Therapy, Combination; Saphenous Vein; Veins | 1979 |
Lymphokines and thrombosis. Thrombocyte and coagulation activation by culture supernatants of concanavalin-A-stimulated human lymphocytes. Some physicochemical properties and inhibition by chemical compounds.
Topics: Adult; Aprotinin; Aspirin; Blood Coagulation; Blood Platelets; Cell Survival; Concanavalin A; Dipyridamole; Female; Humans; Lymphocyte Activation; Lymphokines; Male; Phenylmethylsulfonyl Fluoride; Platelet Aggregation; Thrombosis; Tranexamic Acid | 1979 |
Noninvasive radioisotopic technique for detection of platelet deposition in coronary artery bypass grafts in dogs and its reduction with platelet inhibitors.
Topics: Animals; Aspirin; Blood; Blood Platelets; Coronary Artery Bypass; Dipyridamole; Dogs; Indium; Kidney; Liver; Lung; Muscles; Radioisotopes; Saphenous Vein; Spleen | 1979 |
[Neonatal hemorrhage due to maternal antiplatelet therapy].
Topics: Acute Disease; Aspirin; Dipyridamole; Female; Gastrointestinal Hemorrhage; Humans; Infant, Newborn; Infant, Newborn, Diseases; Maternal-Fetal Exchange; Platelet Function Tests; Pregnancy | 1979 |
Thrombocyte migration inhibitory activity of concanavalin-A-stimulated human lymphocytes. In vivo and in vitro modifications by dipyridamole and acetylsalicylic acid.
Topics: Adult; Aged; Aspirin; Blood Platelets; Cell Migration Inhibition; Concanavalin A; Dipyridamole; Dose-Response Relationship, Immunologic; Female; Humans; Leukocyte Migration-Inhibitory Factors; Leukocytes; Lymphocytes; Lymphokines; Male; Middle Aged | 1979 |
Bleeding time in laboratory animals. IV. Effects of prostacyclin, pyrimido-pyrimidine compounds and aspirin in rats.
Topics: Animals; Aspirin; Bleeding Time; Dipyridamole; Dose-Response Relationship, Drug; Epoprostenol; Male; Morpholines; Piperazines; Prostaglandins; Pyrimidines; Rabbits; Rats; Time Factors | 1979 |
Rabbit lung microsomes: a rapid method for assaying simultaneously drug effects on thromboxane and prostacyclin synthesis.
Topics: Animals; Arachidonic Acids; Aspirin; Burimamide; Dipyridamole; Epoprostenol; Hydralazine; Imidazoles; Indomethacin; Lung; Microsomes; Prostaglandins; Rabbits; Thromboxanes | 1979 |
Platelet interactions with the endothelium and the subendothelium: the role of thrombin and prostacyclin.
Topics: Animals; Aorta; Aspirin; Blood Platelets; Depression, Chemical; Dipyridamole; Endothelium; Epoprostenol; Heparin; In Vitro Techniques; Platelet Adhesiveness; Prostaglandins; Prostaglandins E; Rabbits; Thrombin | 1979 |
[Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions].
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cerebral Infarction; Cerebrovascular Disorders; Dipyridamole; Heparin; Humans; Ischemic Attack, Transient; Platelet Aggregation; Sulfinpyrazone; Thromboembolism | 1979 |
Platelet consumption by arterial prostheses: the effects of endothelialization and pharmacologic inhibition of platelet function.
Topics: Aged; Animals; Arteries; Aspirin; Blood Coagulation Factors; Blood Platelets; Blood Vessel Prosthesis; Cell Survival; Dipyridamole; Endothelium; Female; Haplorhini; Humans; Male; Middle Aged; Papio; Thrombosis | 1977 |
Transient ischemic attacks due to increased platelet aggregation and adhesiveness. Ultrastructural and functional correlation.
Topics: Adolescent; Adult; Aspirin; Blood Coagulation Tests; Blood Platelet Disorders; Blood Platelets; Dipyridamole; Female; Hemostasis; Humans; Ischemic Attack, Transient; Male; Microscopy, Electron, Scanning; Middle Aged; Platelet Adhesiveness; Platelet Aggregation; Sulfinpyrazone | 1979 |
[Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
Topics: Anticoagulants; Aspirin; Coronary Disease; Dipyridamole; Humans; Ischemic Attack, Transient; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Sulfinpyrazone; Thrombophlebitis; Thrombosis | 1979 |
Reduced fibrinogen survival in diabetes mellitus. A reversible phenomenon.
Topics: Adult; Aged; Aspirin; Chromatography, DEAE-Cellulose; Chromatography, Gel; Diabetes Mellitus; Dipyridamole; Electrophoresis, Polyacrylamide Gel; Female; Fibrinogen; Heparin; Humans; Hyperglycemia; Male; Middle Aged; Time Factors | 1979 |
Effects of antiplatelet drugs on platelet function tests.
Topics: Acetaminophen; Adult; Aspirin; Blood Platelets; Dipyridamole; Female; Humans; Ibuprofen; Male; Platelet Adhesiveness; Platelet Aggregation | 1979 |
Platelet aggregation inhibition in human umbilical vein grafts and negatively charged bovine heterografts.
Topics: Animals; Aspirin; Cattle; Dipyridamole; Dogs; Femoral Artery; Humans; Platelet Aggregation; Transplantation, Autologous; Transplantation, Heterologous; Umbilical Veins | 1979 |
The treatment of the hemolytic-uremic syndrome with inhibitors of platelet function.
Topics: Adult; Aspirin; Blood Platelets; Cell Count; Dipyridamole; Female; Hemolytic-Uremic Syndrome; Humans; Kidney; Male; Pre-Eclampsia; Pregnancy | 1979 |
Status of antiplatelet drugs in coronary heart disease.
Topics: Aspirin; Blood Platelets; Clofibrate; Coronary Disease; Dipyridamole; Humans; Male; Models, Biological; Platelet Aggregation; Propranolol; Sulfinpyrazone | 1979 |
[Platelet function in patients with acute myocardial infarct following administration of acetylsalicylic acid and dipyridamole].
Topics: Adult; Aspirin; Blood Platelets; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infarction | 1979 |
Indobufen, a new inhibitor of platelet aggregation. Studies in guinea pigs.
Topics: Animals; Aspirin; Blood Platelets; Blood Specimen Collection; Dipyridamole; Guinea Pigs; In Vitro Techniques; Indoles; Indomethacin; Isoindoles; Phenylbutyrates; Platelet Aggregation; Prostaglandins; Prothrombin Time; Serotonin; Thrombin; Thromboxane A2; Time Factors | 1979 |
Is the antithrombotic activity of "antiplatelet" drugs based on protection of endothelium?
Topics: Animals; Aspirin; Citrates; Clofibrate; Dipyridamole; Endothelium; Female; Hydroxychloroquine; Platelet Aggregation; Rats; Sulfinpyrazone | 1979 |
[Inhibitors of platelet aggregation in the therapy of arteriosclerosis obliterans].
Topics: Arteriosclerosis Obliterans; Aspirin; Diabetic Angiopathies; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1979 |
Role of antiplatelet agents in cerebrovascular disease.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Dipyridamole; Fibrinolytic Agents; Humans; Platelet Aggregation | 1979 |
Increased dipyridamole plasma concentrations associated with salicylate administration. Relationship to effects on platelet aggregation in vivo.
Topics: Animals; Aspirin; Collagen; Dipyridamole; Drug Synergism; Drug Therapy, Combination; Glucuronates; Humans; Platelet Aggregation; Rabbits; Salicylates | 1979 |
Effects of heparin, aspirin and dipyridamole on thrombus formation on venous catheters.
Topics: Animals; Aspirin; Catheterization; Dipyridamole; Disease Models, Animal; Face; Heparin; Polyethylenes; Saphenous Vein; Sheep; Thrombosis; Veins | 1979 |
The effect of acetyl salicylic acid and dipyridamole on thromboembolic complications in splenectomized patients with myelofibrosis.
Topics: Aged; Aspirin; Blood Platelets; Cell Survival; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Plasminogen Activators; Platelet Aggregation; Primary Myelofibrosis; Splenectomy; Thromboembolism | 1979 |
The effect of agents which modify platelet behaviour and of magnesium ions on thrombus formation in vivo.
Topics: Animals; Aspirin; Blood Coagulation; Blood Platelets; Dipyridamole; Fibrinolytic Agents; Flurbiprofen; Heparin; Magnesium Sulfate; Morpholines; Pyrimidines; Rabbits; Sulfinpyrazone | 1979 |
Effects of acetylsalicylic acid, sulfinpyrazone and dipyridamole on platelet adhesion and aggregation in flowing native and anticoagulated blood.
Topics: Animals; Aspirin; Blood Platelets; Blood Vessels; Citrates; Dipyridamole; Dose-Response Relationship, Drug; Endothelium; Female; Male; Platelet Adhesiveness; Platelet Aggregation; Rabbits; Sulfinpyrazone; Thrombosis | 1979 |
Dipyridamole in the treatment of dengue haemorrhagic fever.
Topics: Adolescent; Aspirin; Child; Child, Preschool; Dengue; Dipyridamole; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Heparin; Humans; Infant | 1979 |
Dipyridamole levels in plasma of man and other species.
Topics: Administration, Oral; Animals; Aspirin; Columbidae; Dipyridamole; Dogs; Humans; Injections, Intravenous; Male; Species Specificity; Swine; Time Factors | 1979 |
[Antiplatelet drugs (author's transl)].
Topics: Aspirin; Blood Platelets; Clofibrate; Dipyridamole; Female; Humans; Hydroxychloroquine; Ischemic Attack, Transient; Male; Myocardial Infarction; Nicergoline; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1979 |
Inhibitors of platelet function and atherogenesis.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Dipyridamole; Disease Models, Animal; Humans; Platelet Adhesiveness; Platelet Aggregation; Thrombosis | 1979 |
[Transient cerebral ischemic attacks. Treatment program and comparison between anticoagulants and thrombocyte aggregation repressors].
Topics: Aged; Anticoagulants; Aspirin; Dipyridamole; Female; Humans; Ischemic Attack, Transient; Male; Time Factors | 1979 |
Approaches to the treatment of inborn errors of sulphur amino acid and peptide metabolism.
Topics: Amino Acids, Sulfur; Ascorbic Acid; Aspirin; Cysteamine; Cystinosis; Dipyridamole; Glutathione; Glutathione Synthase; Homocystinuria; Humans; Metabolism, Inborn Errors; Pyridoxine; Vitamin E | 1979 |
Thrombocytosis, circulating platelet aggregates, and neurological dysfunction.
Topics: Adolescent; Adult; Aged; Aspirin; Blood Platelet Disorders; Child; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nervous System Diseases; Platelet Aggregation; Thrombocytosis | 1979 |
[An adult case of hemolytic-uremic syndrome treated with inhibitors of platelet functions (author's transl)].
Topics: Aspirin; Blood Platelets; Dipyridamole; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Renal Dialysis | 1979 |
Hypercoagulability: a cause of vascular access failure.
Topics: Antithrombin III Deficiency; Aspirin; Dipyridamole; Humans; Intraoperative Period; Plasma; Renal Dialysis; Thrombosis; Time Factors; Veins | 1979 |
[Prevention and therapy with anticoagulants. Indications, experiences, results].
Topics: Anticoagulants; Aspirin; Blood Coagulation; Coumarins; Dipyridamole; Fibrinolysis; Heparin; Humans; Myocardial Infarction; Platelet Aggregation; Thrombosis | 1979 |
Thrombotic thrombocytopenic purpura. Remission following treatment with aspirin and dipyridamole.
Topics: Adolescent; Aspirin; Dipyridamole; Drug Therapy, Combination; Humans; Male; Purpura, Thrombotic Thrombocytopenic | 1977 |
Antiplatelet treatment of thrombotic thrombocytopenic purpura.
Topics: Adolescent; Adult; Aged; Aspirin; Blood Platelets; Cyproheptadine; Dextrans; Dipyridamole; Female; Humans; Male; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Splenectomy; Sulfinpyrazone | 1977 |
Therapy for thrombotic thrombocytopenic purpura.
Topics: Aspirin; Dextrans; Dipyridamole; Female; Humans; Hydrocortisone; Male; Methylprednisolone; Middle Aged; Purpura, Thrombotic Thrombocytopenic | 1977 |
Platelet-latelet-.
Topics: Adult; Aspirin; Blood Platelets; Depression, Chemical; Dipyridamole; Female; Humans; Methylprednisolone; Middle Aged; Prednisone; Purpura, Thrombotic Thrombocytopenic; Remission, Spontaneous; Sulfinpyrazone | 1977 |
Survival following thrombotic thrombocytopenic purpura in pregnancy.
Topics: Adult; Aspirin; Blood Coagulation Tests; Blood Transfusion; Blood Urea Nitrogen; Cesarean Section; Dexamethasone; Dipyridamole; Female; Fetal Distress; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Trimester, Second; Purpura, Thrombotic Thrombocytopenic | 1977 |
Thrombotic thrombocytopenic purpura: treatment with a combination of antiplatelet drugs.
Topics: Aspirin; Blood Platelets; Dextrans; Dipyridamole; Disseminated Intravascular Coagulation; Drug Evaluation; Drug Therapy, Combination; Humans; Male; Middle Aged; Purpura, Thrombotic Thrombocytopenic | 1979 |
Thrombotic thrombocytopenic purpura: failure of plasma infusion and antiplatelet agents.
Topics: Adult; Aspirin; Blood Platelets; Dipyridamole; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Plasmapheresis; Prednisone; Purpura, Thrombotic Thrombocytopenic; Sulfinpyrazone | 1979 |
TIA, stroke, and mitral valve prolapse.
Topics: Adult; Aged; Aspirin; Carotid Artery Thrombosis; Cerebrovascular Disorders; Dipyridamole; Echocardiography; Electrocardiography; Female; Heparin; Humans; Ischemic Attack, Transient; Male; Middle Aged; Mitral Valve Prolapse; Recurrence; Warfarin | 1979 |
Antiplatelet treatment in septic shock with severe bleeding and thrombocytopenia.
Topics: Adult; Aminocaproic Acid; Aspirin; Dipyridamole; Female; Humans; Lysine; Platelet Aggregation; Purpura, Thrombotic Thrombocytopenic; Shock, Septic | 1977 |
Effect of 1-methyl-2-mercapto-5-(3-pyridyl)-imidazole (KC-6141) on rabbit platelet aggregation in vitro and rat platelet retention.
Topics: Adenosine; Animals; Aspirin; Dipyridamole; Glass; Imidazoles; Platelet Adhesiveness; Platelet Aggregation; Pyridines; Rabbits; Rats | 1978 |
Effect of 1-methyl-2-mercapto-5-(3-pyridyl)-imidazole (KC-6141), an anti-aggregating compound, on experimental thrombosis in rats.
Topics: Animals; Aspirin; Dipyridamole; Imidazoles; Male; Pyridines; Rats; Thrombosis | 1978 |
Thrombocyte migration inhibitory activity of human lymphocytes stimulated with concanavalin-A antagonized by dipyridamole and acetylsalicylic-acid.
Topics: Aspirin; Blood Platelets; Cell Migration Inhibition; Concanavalin A; Dipyridamole; Humans; Lymphocyte Activation; Lymphokines | 1978 |
The retired breeder rat as a new model for antiplatelet drug discovery.
Topics: Animals; Aspirin; Breeding; Dipyridamole; Male; Platelet Aggregation; Prostaglandins E; Rats; Sulfinpyrazone | 1977 |
[Prevention of thromboembolism with antiaggregants (author's transl)].
Topics: Animals; Anticoagulants; Aspirin; Cats; Dipyridamole; Dogs; Drug Synergism; Heparin; Platelet Aggregation; Rabbits; Rats; Thromboembolism; Thrombophlebitis | 1977 |
[Ischemic lesions in polycythaemia vera (author's transl)].
Topics: Aspirin; Dipyridamole; Female; Foot; Humans; Ischemia; Male; Middle Aged; Pain; Polycythemia Vera; Skin; Thrombocytosis | 1977 |
Assessment of antithrombotic drugs ex vivo and in vivo.
Topics: Animals; Aspirin; Citrates; Collagen; Dipyridamole; Fibrinolytic Agents; Heparin; Platelet Aggregation; Rabbits; Sulfinpyrazone | 1977 |
The effects of aspirin and dipyridamole and its derivatives on platelet disaggregation.
Topics: Aspirin; Dipyridamole; Female; Humans; Male; Platelet Aggregation | 1977 |
[Experimental venous thrombosis in guinea pigs: effect of heparin and drugs affecting platelet function (author's transl)].
Topics: Animals; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Blood Platelets; Dextrans; Dipyridamole; Drug Evaluation; Guinea Pigs; Heparin; Phenylbutazone; Thrombophlebitis | 1977 |
[Platelet anti-aggregant and anticoagulant therapy in the secondary prevention of coronary disease. Preliminary note].
Topics: Anticoagulants; Aspirin; Coronary Disease; Dipyridamole; Drug Evaluation; Humans; Myocardial Infarction; Prognosis | 1977 |
Studies on platelet plasma membranes. III. Membrane glycoprotein loss from circulating platelets in rabbits: inhibition by aspirin-dipyridamole and acceleration by thrombin.
Topics: Animals; Aspirin; Blood Platelets; Cell Membrane; Cell Survival; Dipyridamole; Glycoproteins; Rabbits; Thrombin | 1978 |
Incidence of emboli with cloth-covered Starr-Edwards valve without anticoagulation and with varying forms of anticoagulation. Analysis of 183 patients followed for 3 1/2 years.
Topics: Anticoagulants; Aortic Valve; Aspirin; Connecticut; Dipyridamole; Embolism; Female; Follow-Up Studies; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Postoperative Complications; Warfarin | 1978 |
[Platelet-inhibiting drugs].
Topics: Anti-Bacterial Agents; Aspirin; Dextrans; Dipyridamole; Hemorrhage; Humans; Indomethacin; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1978 |
[Thrombocyte-aggregation inhibitors following open or semi-open endarterectomy-preliminary results of a prospective study].
Topics: Arterial Occlusive Diseases; Aspirin; Dipyridamole; Endarterectomy; Humans; Platelet Aggregation; Postoperative Complications; Prospective Studies | 1978 |
Treatment of diabetic necrobiosis with aspirin and dipyridamole.
Topics: Adult; Aspirin; Diabetes Mellitus, Type 1; Dipyridamole; Female; Humans; Necrobiosis Lipoidica | 1978 |
Effect of dipyridamole on platelet aggregation in cerebral microcirculation of the mouse.
Topics: Animals; Arterioles; Aspirin; Cerebrovascular Circulation; Dipyridamole; Drug Combinations; Mice; Platelet Aggregation; Venules | 1978 |
Antiplatelet therapy (first of two parts).
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Blood Coagulation; Blood Platelets; Cell Survival; Clofibrate; Dextrans; Dipyridamole; Heparin; Humans; Platelet Adhesiveness; Platelet Aggregation; Propranolol; Rabbits; Sulfinpyrazone; Thrombosis | 1978 |
Antiplatelet agents in coronary disease: are they of prophylactic value?
Topics: Angina Pectoris; Aspirin; Cardiopulmonary Bypass; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Myocardial Infarction; Recurrence; Sulfinpyrazone | 1978 |
Pulmonary embolism in a homocystinuric patient during treatment with dipyridamole and acetylsalicylic acid.
Topics: Adolescent; Aspirin; Dipyridamole; Homocystinuria; Humans; Male; Pulmonary Embolism | 1978 |
Platelet aggregation and vasoconstriction in undamaged microvessels on cerebral surface adjacent to brain traumatized by a penetrating needle.
Topics: Animals; Arterioles; Aspirin; Brain Injuries; Dipyridamole; Indomethacin; Male; Mice; Pia Mater; Platelet Aggregation; Vasoconstriction | 1978 |
Prevention of thromboembolic complications of valve prostheses by agents affecting platelet function.
Topics: Aspirin; Blood Cell Count; Blood Platelets; Child; Child, Preschool; Dipyridamole; Drug Therapy, Combination; Female; Heart Valve Prosthesis; Humans; Male; Platelet Adhesiveness; Postoperative Complications; Thromboembolism | 1978 |
[Correction of disorders of rheologic properties of blood in reconstructive operations on the abdominal aorta].
Topics: Adult; Aged; Aorta, Abdominal; Aortic Diseases; Arteriosclerosis; Aspirin; Blood Viscosity; Dipyridamole; Humans; Middle Aged; Postoperative Complications; Thrombosis | 1978 |
Treatment of diabetic necrobiosis with aspirin or dipyridamole.
Topics: Adolescent; Adult; Animals; Aspirin; Diabetes Complications; Diabetes Mellitus, Type 1; Dipyridamole; Female; Humans; Middle Aged; Necrobiosis Lipoidica; Rats | 1978 |
[Early diagnosis of postoperative venous thrombosis and evaluation of the effects of pharmacological prevention of thrombosis].
Topics: Aspirin; Dipyridamole; Heparin; Humans; Postoperative Complications; Thrombophlebitis | 1978 |
Malignant atrophic papulosis: treatment with aspirin and dipyridamole.
Topics: Adult; Aspirin; Dipyridamole; Humans; Infarction; Male; Platelet Aggregation; Skin; Skin Diseases; Thrombosis | 1978 |
A comparison of the effects of aspirin and dipyridamole on platelet aggregation in vivo and ex vivo.
Topics: Animals; Aspirin; Calcium; Citrates; Collagen; Dipyridamole; Heparin; In Vitro Techniques; Magnesium; Platelet Aggregation; Rabbits | 1978 |
[Influence of platelet anti-aggregants on mitochondrial respiration of platelets].
Topics: Adult; Aspirin; Blood Platelets; Dipyridamole; Humans; In Vitro Techniques; Middle Aged; Mitochondria; Oxygen Consumption; Theophylline | 1977 |
[Results of clinical studies on the effect of aggregation inhibitors in arterial diseases].
Topics: Arterial Occlusive Diseases; Aspirin; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1979 |
Antithrombotic therapy. Rationale and application.
Topics: Anticoagulants; Arteries; Arteriosclerosis; Aspirin; Blood Coagulation; Blood Coagulation Factors; Dipyridamole; Fibrinolytic Agents; Humans; Platelet Adhesiveness; Sulfinpyrazone; Thrombophlebitis; Thrombosis; Urokinase-Type Plasminogen Activator; Veins; Warfarin | 1979 |
[The effect of antiaggregating agents - acetylsalicylic acid (ASA) and dipyridamol - on the rejection of allotransplanted canine kidneys in presensitized animals (author's transl)].
Topics: Animals; Anuria; Aspirin; Dipyridamole; Dogs; Female; Graft Rejection; Kidney; Kidney Transplantation; Male; Platelet Aggregation; Regional Blood Flow; Time Factors; Transplantation, Homologous | 1976 |
[Prophylaxis and therapy of shunt thrombosis in terminal renal insufficiency (author's transl)].
Topics: Anticoagulants; Arteriovenous Shunt, Surgical; Aspirin; Dextrans; Dipyridamole; Hemorrhagic Disorders; Heparin; Humans; Renal Dialysis; Sulfinpyrazone; Thrombosis; Uremia | 1977 |
Transient ischaemic attacks and increased platelet aggregability associated with oral contraceptives. Treatment with dipyridamole and aspirin.
Topics: Adult; Aspirin; Contraceptives, Oral; Dipyridamole; Female; Humans; Ischemic Attack, Transient; Platelet Aggregation | 1977 |
Leucocyte migration inhibitory activity of concanavalin-A-stimulated lymphocytes. In vivo and in vitro modifications with dipyridamole and acetylsalicylic acid.
Topics: Adult; Aspirin; Cell Migration Inhibition; Concanavalin A; Dipyridamole; Female; Humans; Lymphocytes; Male; Time Factors | 1977 |
Platelet and fibrinogen survival in coronary atherosclerosis. Response to medical and surgical therapy.
Topics: Adult; Aged; Aspirin; Blood Platelets; Cell Survival; Coronary Disease; Dipyridamole; Fibrinogen; Humans; Male; Middle Aged; Myocardial Revascularization | 1977 |
Polyphloretine phosphate as an inhibitor of platelet adhesion. Comparison with acetylsalicylic acid and dipyridamole.
Topics: Animals; Aspirin; Batroxobin; Blood Cell Count; Blood Platelets; Dipyridamole; Dogs; Phloretin; Platelet Adhesiveness; Polyphloretin Phosphate | 1977 |
The synergistic effect of aspirin and dipyridamole upon platelet thrombi in living blood vessels.
Topics: Adenosine Diphosphate; Alloxan; Animals; Aspirin; Dipyridamole; Drug Synergism; Male; Platelet Aggregation; Rabbits; Thrombosis | 1977 |
Antithrombin III(AT-III) as a diagnostic aid in disseminated intravascular coagulation.
Topics: Antithrombins; Aspirin; Dipyridamole; Disseminated Intravascular Coagulation; Heparin; Humans | 1977 |
Effect of some antithrombogenic drugs on the polyethylene-Krebs solution interface.
Topics: Adsorption; Aspirin; Dipyridamole; Dose-Response Relationship, Drug; Heparin; Humans; Membrane Potentials; Models, Biological; Polyethylenes | 1977 |
Anticoagulants and platelet-inhibiting drugs in stroke.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1977 |
Effect of drugs of platelets and complications of vascular disease.
Topics: Animals; Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Clofibrate; Coronary Disease; Death, Sudden; Dipyridamole; Humans; Ischemic Attack, Transient; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1977 |
Using antithrombotic therapy in ischemic cerebrovascular disease.
Topics: Aspirin; Brain; Cerebrovascular Disorders; Dipyridamole; Fibrinolytic Agents; Heparin; Humans; Intracranial Embolism and Thrombosis; Ischemia; Sulfinpyrazone; Warfarin | 1977 |
Platelets, thrombosis and atherosclerosis.
Topics: Arteries; Arteriosclerosis; Aspirin; Blood Platelets; Cell Division; Cell Survival; Dipyridamole; Endothelium; Humans; Platelet Adhesiveness; Sulfinpyrazone; Thrombosis | 1977 |
[Thrombosis of intracraneal sinuses in homocystinuria (author's transl)].
Topics: Aspirin; Cerebral Angiography; Child, Preschool; Cranial Sinuses; Dipyridamole; Drug Therapy, Combination; Homocystinuria; Humans; Intracranial Embolism and Thrombosis; Male; Pyridoxine | 1977 |
[Pharmacology of aggregation inhibitors].
Topics: Aspirin; Dextrans; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1976 |
Thrombotic thrombocytopenic purpura in a previously splenectomized patient.
Topics: Adult; Aspirin; Dipyridamole; Humans; Male; Prednisone; Spleen; Splenectomy; Thrombocytopenia | 1976 |
[Platelet aggregation inhibitors and anticoagulant therapy].
Topics: Anticoagulants; Aspirin; Coumarins; Dipyridamole; Drug Antagonism; Humans; Platelet Aggregation | 1976 |
Hemostatic alterations accompanying sickle cell pain crises.
Topics: Acute Disease; Adult; Anemia, Sickle Cell; Aspirin; Blood Cell Count; Blood Platelets; Blood Transfusion; Cyanates; Dipyridamole; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Male; Middle Aged; Pain | 1976 |
Use of platelet antagonists in the treatment of migraine.
Topics: Aspirin; Blood Platelets; Dipyridamole; Migraine Disorders; Platelet Aggregation; Sulfinpyrazone | 1976 |
Evaluation of antithrombotic properties of suloctidil in comparison with aspirin and dipyridamole.
Topics: Animals; Aspirin; Dipyridamole; Disease Models, Animal; Drug Evaluation, Preclinical; Fibrinolytic Agents; Granulocytes; Parasympatholytics; Placebos; Platelet Aggregation; Propanolamines; Rabbits; Shock, Septic; Thrombosis | 1976 |
Effects of acetylsalicylic acid, dipyridamole, and hydrocortisone on epinephrine-induced myocardial injury in dogs.
Topics: Acute Disease; Animals; Aspartate Aminotransferases; Aspirin; Calcium; Calcium Chloride; Cardiomyopathies; Dipyridamole; Dogs; Drug Therapy, Combination; Electrolytes; Epinephrine; Hydrocortisone; Mitochondria, Muscle; Myocardial Contraction; Myocardial Infarction; Myocardium; Necrosis; Premedication | 1976 |
Thrombotic thrombocytopenic purpura--remission following splenectomy. Report of a case and review of the literature.
Topics: Adolescent; Aspirin; Dipyridamole; Humans; Male; Mycoplasma Infections; Purpura, Thrombotic Thrombocytopenic; Remission, Spontaneous; Spleen; Splenectomy; Syndrome | 1976 |
[Hamostasiological changes induced by platelet-aggregation-inhibitors, tested in children with congenital heart disease (in vitro and in vitro examinations) (author's transl)].
Topics: Adolescent; Aspirin; Child; Child, Preschool; Cyanosis; Dipyridamole; Heart Defects, Congenital; Hemostasis; Humans; Time Factors | 1976 |
Drugs with antithrombotic effect: experimental study.
Topics: Animals; Aspirin; Dipyridamole; Drug Synergism; Heparin; Hypoxia; Lysine; Mice; Platelet Aggregation; Promethazine; Rats; Thromboembolism | 1976 |
Spontaneous platelet aggregation in arterial insufficiency: mechanisms and implications.
Topics: Adenosine; Adult; Aged; Angina Pectoris; Apyrase; Arterial Occlusive Diseases; Aspirin; Coronary Disease; Dipyridamole; Heparin; Hirudins; Humans; Ischemic Attack, Transient; Middle Aged; Myocardial Infarction; Platelet Aggregation; Prostaglandins E | 1976 |
[Pulmonary hemodynamics, coagulation and morphological changes in the lung after thrombocyte aggregation inhibition and intravasal coagulation in experimental trauma and hemorrhagic shock].
Topics: Airway Resistance; Animals; Aspirin; Dipyridamole; Dogs; Hemodynamics; Lung; Platelet Aggregation; Shock, Hemorrhagic; Wounds and Injuries | 1976 |
Registry of prospective clinical trials second report.
Topics: Adult; Aged; Aspirin; Blood Platelets; Dipyridamole; Drug Evaluation; Female; Fibrinolytic Agents; Hemostatics; Humans; International Agencies; Male; Middle Aged; Plasminogen; Registries; Streptokinase; Sulfinpyrazone; Urokinase-Type Plasminogen Activator; Venoms | 1976 |
Inhibition of human and animal platelet adhesiveness to glass bead columns by adenosine, dipyridamole, chlorpromazine and acetylsalicylic acid.
Topics: Adenosine; Animals; Aspirin; Blood Flow Velocity; Chlorpromazine; Dipyridamole; Glass; Guinea Pigs; Heparin; Humans; In Vitro Techniques; Platelet Adhesiveness; Rabbits; Species Specificity | 1976 |
Drugs affecting platelet function tests: their effects on haemostasis and surgical bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Coagulation Disorders; Blood Donors; Blood Platelets; Clot Retraction; Dipyridamole; Drug Interactions; Ergolines; Female; Gastrointestinal Hemorrhage; Humans; Infant, Newborn; Infant, Newborn, Diseases; Maternal-Fetal Exchange; Membrane Potentials; Platelet Aggregation; Platelet Factor 3; Postoperative Complications; Pregnancy; Prostaglandins; Serotonin; Thrombocytopenia; Thromboembolism; Vitamin K Deficiency Bleeding | 1975 |
Lymphocyte membrane modifications induced by acetylasalicylic acid and dipyridamole.
Topics: Aspirin; B-Lymphocytes; Cell Membrane; Dipyridamole; Humans; In Vitro Techniques; Lymphocytes; T-Lymphocytes | 1976 |
Are agents affecting platelet function clinically useful in patients with coronary artery disease?
Topics: Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Clofibrate; Coronary Disease; Dipyridamole; Humans; Myocardial Infarction; Sulfinpyrazone | 1976 |
The treatment of rejection. A trial of acetylsalicylic acid, dipyridamole, and heparin.
Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Dipyridamole; Dogs; Fibrinogen; Graft Rejection; Heparin; Kidney; Kidney Transplantation; Transplantation, Autologous; Transplantation, Homologous | 1975 |
Prevention of stroke.
Topics: Age Factors; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Auscultation; Cerebral Angiography; Cerebral Hemorrhage; Cerebrovascular Disorders; Diabetes Complications; Diet Therapy; Dipyridamole; Electrocardiography; Ethnicity; Humans; Hypertension; Intracranial Embolism and Thrombosis; Ophthalmodynamometry; Sex Factors; Thermography | 1975 |
Letter: Treatment of hemolytic-uremic syndrome.
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Hemolytic-Uremic Syndrome; Heparin; Humans; Streptokinase | 1975 |
Platelet survival time following aortic valve replacement.
Topics: Adult; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Aspirin; Blood Platelets; Cell Survival; Chromium Radioisotopes; Dipyridamole; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Sulfinpyrazone; Thromboembolism; Time Factors; Transplantation, Autologous; Warfarin | 1975 |
Effects of dipyridamole and acetylsalicylic acid on platelet functions in patients with aortic ball-valve prostheses.
Topics: Aortic Valve; Aspirin; Blood Platelets; Cell Survival; Dipyridamole; Half-Life; Heart Valve Prosthesis; Hemolysis; Humans; Male; Middle Aged; Platelet Adhesiveness; Platelet Aggregation; Thromboembolism | 1975 |
Letter: Medical management of transient ischaemic attacks.
Topics: Anti-Inflammatory Agents; Anticoagulants; Aspirin; Dipyridamole; Humans; Ischemic Attack, Transient; Sulfinpyrazone | 1975 |
Prophylactic agents for thrombosis.
Topics: Aspirin; Dipyridamole; Fibrinolytic Agents; Humans; Platelet Adhesiveness; Platelet Aggregation; Thrombosis | 1975 |
Preliminary report: treatment of the hemolytic-uremic syndrome with aspirin and dipyridamole.
Topics: Acute Disease; Anemia, Hemolytic; Aspirin; Blood Platelet Disorders; Blood Platelets; Blood Transfusion; Child; Child, Preschool; Dipyridamole; Diuresis; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythrocyte Aggregation; Female; Fibrinogen; Hemolytic-Uremic Syndrome; Heparin; Humans; Infant; Kidney Diseases; Male; Platelet Adhesiveness; Remission, Spontaneous; Thrombocytopenia | 1975 |
[Pregnancy, heart valve prostheses and anti-platelet aggregation treatment].
Topics: Adult; Anticoagulants; Aspirin; Dipyridamole; Drug Combinations; Female; Heart Valve Prosthesis; Humans; Platelet Adhesiveness; Platelet Aggregation; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Hematologic; Thrombosis; Vitamin K | 1975 |
The effect of some antithrombotic drugs on experimental arterial thrombosis.
Topics: Acute Disease; Animals; Anticoagulants; Arteries; Aspirin; Dipyridamole; Drug Synergism; Fibrinolysis; Heparin; Models, Biological; Prothrombin Time; Rats; Streptokinase; Thrombosis | 1975 |
[Letter: Influence of dipyridamole and carbochromene on bleeding time in man].
Topics: Aspirin; Chromonar; Coumarins; Dipyridamole; Hemostasis; Humans; In Vitro Techniques; Platelet Adhesiveness; Platelet Aggregation | 1975 |
Proceedings: Response of normal and pathological platelets to heparin added in vitrio and in vivo.
Topics: Aspirin; Blood Platelet Disorders; Blood Platelets; Dipyridamole; Heparin; Heparin Antagonists; Humans; In Vitro Techniques; Platelet Aggregation | 1975 |
Proceedings: The anti-thrombotic effect of warfarin, dipyridamole and aspirin in the rat.
Topics: Animals; Aspirin; Dipyridamole; Disease Models, Animal; Rats; Thrombosis; Warfarin | 1975 |
[Susceptibility of platelet adhesiveness following bone surgery].
Topics: Aspirin; Blood Cell Count; Blood Platelets; Dextrans; Dipyridamole; Humans; Phenylbutazone; Platelet Adhesiveness; Postoperative Complications; Surgical Procedures, Operative; Thromboembolism | 1975 |
Prophylaxis of venous thromboembolism.
Topics: Aspirin; Blood Coagulation; Dextrans; Dipyridamole; Ethylestrenol; Fibrinolysis; Heparin; Humans; Phenformin; Platelet Adhesiveness; Postoperative Complications; Pulmonary Embolism; Pulmonary Veins; Thromboembolism; Thrombophlebitis | 1975 |
Proceedings: Comparison of in vivo and in vitro effects of platelet function suppressing drugs.
Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Dipyridamole; In Vitro Techniques; Platelet Aggregation; Rabbits; Sulfinpyrazone; Thromboembolism | 1975 |
Letter: Intervention of dipyridamole and acetylsalicylic acid in the development of thrombosis in cell-mediated immune reactions: possible mechanism of action.
Topics: Aspirin; Binding Sites, Antibody; Cell Migration Inhibition; Dipyridamole; Humans; Immunity, Cellular; Lymphocyte Activation; Lymphocytes; Lymphokines; Thromboembolism | 1975 |
[Acetylsalicylic acid and dipyridamole: aggregation inhibition in the rabbit experiment].
Topics: Administration, Oral; Animals; Aspirin; Dipyridamole; Drug Therapy, Combination; Injections, Intravenous; Rabbits; Thrombosis | 1975 |
Pharmacological properties of drug inhibiting platelet aggregation.
Topics: Aspirin; Dipyridamole; Humans; In Vitro Techniques; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1975 |
Clinical pharmacology of anti-aggregating substances.
Topics: Aspirin; Clofibrate; Dextrans; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1975 |
The antithrombotic properties of dipyridamole clinical investigations and results.
Topics: Aspirin; Cell Survival; Dipyridamole; Fibrinolytic Agents; Humans; Platelet Adhesiveness; Platelet Aggregation; Thromboembolism | 1975 |
[Professor van Cauwenberge's conclusion of the day, dedicated to platelet adhesiveness].
Topics: Aspirin; Dipyridamole; Platelet Adhesiveness; Thromboembolism | 1975 |
[Bleeding time and cardioactive drugs. Effects of dipyridamole and carbochromen].
Topics: Aspirin; Blood Coagulation; Chromonar; Coumarins; Dipyridamole; Female; Humans; Male; Middle Aged; Platelet Aggregation; Time Factors | 1975 |
Leucocyte migration inhibitory activity of concanavalin-A-stimulated human lymphocytes. Modification by dipyridamole, lysine-acetylsalicylate and heparin.
Topics: Aspirin; Cell Migration Inhibition; Concanavalin A; Dipyridamole; Heparin; Humans; Leukocytes; Lymphocyte Activation; Lymphocytes; Lysine | 1976 |
Platelet hyperaggregability in idiopathic recurrent deep vein thrombosis.
Topics: Adult; Aspirin; Blood Platelets; Dipyridamole; Female; Humans; Male; Methods; Middle Aged; Platelet Aggregation; Prospective Studies; Recurrence; Thrombophlebitis | 1976 |
Suloctidil: a novel inhibitor of platelet aggregation in human beings.
Topics: Adenosine Diphosphate; Adult; Aspirin; Blood Coagulation; Collagen; Dipyridamole; Dose-Response Relationship, Drug; Epinephrine; Female; Fibrinolytic Agents; Humans; Male; Platelet Adhesiveness; Platelet Aggregation; Time Factors | 1976 |
Thrombotic thrombocytopenic purpura: a multimodality model of treatment including plasma exchange, i.v. immunoglobulin, prednisone, antiplatelet agents, vincristine and splenectomy.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Combined Modality Therapy; Dipyridamole; Female; Hematocrit; Humans; Immunization, Passive; L-Lactate Dehydrogenase; Male; Middle Aged; Plasma; Plasma Exchange; Platelet Aggregation Inhibitors; Platelet Count; Prednisone; Purpura, Thrombotic Thrombocytopenic; Splenectomy; Vincristine | 1992 |
[Therapy of coronary disease].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Disease; Diltiazem; Dipyridamole; Drug Therapy, Combination; Humans; Isosorbide Dinitrate; Metoprolol; Nitrates; Smoking; Verapamil | 1992 |
Antiplatelet therapy in thrombotic thrombocytopenic purpura.
Topics: Administration, Oral; Adult; Aspirin; Dipyridamole; Female; Humans; Puerperal Disorders; Purpura, Thrombotic Thrombocytopenic | 1992 |
Effect of dipyridamole with or without aspirin on urine protein excretion in patients with membranous glomerulonephritis.
Topics: Adult; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Humans; Kidney Function Tests; Male; Platelet Aggregation; Proteinuria; Thromboxane A2 | 1992 |
The effect of antiplatelet therapy on platelet accumulation after experimental angioplasty in the rabbit iliac model.
Topics: Angioplasty, Balloon; Animals; Arteriosclerosis; Aspirin; Dipyridamole; Disease Models, Animal; Drug Combinations; Heparin; Imidazoles; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Rabbits; Recurrence; Thromboxane-A Synthase; Time Factors | 1992 |
Polypropylene small-diameter vascular grafts.
Topics: Adenosine Diphosphate; Animals; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Dogs; Foreign-Body Reaction; Microscopy, Electron; Microscopy, Electron, Scanning; Platelet Aggregation; Polyethylene Terephthalates; Polypropylenes; Polytetrafluoroethylene; Vascular Patency | 1992 |
[Prevention of thrombosis after surgical interventions on the venous system].
Topics: Anticoagulants; Aspirin; Coumarins; Dipyridamole; Drug Administration Schedule; Drug Therapy, Combination; Heparin; Humans; Postoperative Complications; Thrombectomy; Thrombophlebitis; Varicose Veins; Veins | 1992 |
Aspirin and dipyridamole in the prevention of coronary disease and coronary artery bypass graft occlusion.
Topics: Aspirin; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Graft Occlusion, Vascular; Humans | 1992 |
Maternal hemorrhagic complications following prophylactic low-dose aspirin and dipyridamole therapy.
Topics: Adult; Aspirin; Bleeding Time; Blood Component Transfusion; Blood Transfusion; Dipyridamole; Drug Therapy, Combination; Female; Hemoglobins; Humans; Postpartum Hemorrhage; Pre-Eclampsia; Pregnancy | 1992 |
Anti-platelet therapy in diabetic and non-diabetic progressive renal failure.
Topics: Aspirin; Blood Pressure; Creatinine; Diabetic Nephropathies; Dipyridamole; Docosahexaenoic Acids; Drug Combinations; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Fish Oils; Glomerular Filtration Rate; Hemostasis; Humans; Hypertension; Kidney Failure, Chronic; Male; Platelet Aggregation Inhibitors; Proteinuria | 1992 |
Prospective modulation of platelet function and volumes by aspirin and dipyridamole in an at-risk pregnancy.
Topics: Adult; Aspirin; Blood Platelets; Dipyridamole; Female; Humans; Platelet Aggregation; Platelet Count; Pregnancy; Pregnancy Complications, Hematologic | 1992 |
[Kidney diseases associated with hemolytic uremic syndrome,thrombotic thrombocytopenic purpura and disseminated intravascular coagulation].
Topics: Adolescent; Adult; Aspirin; Dipyridamole; Disseminated Intravascular Coagulation; Female; Hemolytic-Uremic Syndrome; Humans; Kidney Diseases; Middle Aged; Plasmapheresis; Prednisolone; Prognosis; Purpura, Thrombotic Thrombocytopenic | 1992 |
Complications after intracoronary stent implantation: three cases.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Disease; Coumarins; Dipyridamole; Drug Administration Schedule; Electrocardiography; Exercise Test; Follow-Up Studies; Heparin; Humans; Male; Middle Aged; Premedication; Recurrence; Stents | 1992 |
[Strategies for antiplatelet therapy-drug-fixed method and suppression-fixed method].
Topics: Aspirin; Cerebral Infarction; Dipyridamole; Drug Therapy, Combination; Humans; Myocardial Infarction; Platelet Aggregation; Recurrence; Sulfinpyrazone; Ticlopidine | 1992 |
Thrombotic thrombocytopenic purpura in early pregnancy with maternal and fetal survival.
Topics: Adult; Aspirin; Biomarkers; Dipyridamole; Female; Humans; Infant, Newborn; L-Lactate Dehydrogenase; Plasma Exchange; Platelet Count; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Pregnancy Trimester, First; Purpura, Thrombotic Thrombocytopenic | 1992 |
Effects of aspirin, dipyridamole, and dibutyryl cyclic adenosine monophosphate on platelet-derived growth factor A chain mRNA levels in human saphenous vein endothelial cells and smooth muscle cells.
Topics: Aspirin; Base Sequence; Bucladesine; Cells, Cultured; Dipyridamole; Endothelium, Vascular; Humans; Molecular Sequence Data; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Polymerase Chain Reaction; RNA, Messenger; Saphenous Vein; Transcription, Genetic | 1991 |
[Drug treatment of ischemic disturbances of circulation in the brain].
Topics: Aspirin; Brain Ischemia; Dipyridamole; Humans; Ticlopidine | 1990 |
Vincristine for thrombocytopenic purpura.
Topics: Adult; Aspirin; Christianity; Dipyridamole; Drug Administration Schedule; Female; Humans; Platelet Count; Purpura, Thrombocytopenic; Vincristine | 1991 |
[Disorders of organic hemodynamics of the liver and their correction in suppurative cholangitis].
Topics: Acute Disease; Animals; Aprotinin; Ascorbic Acid; Aspirin; Cholangitis; Cholestasis; Dextrans; Dipyridamole; Drainage; Drug Combinations; Heparin; Humans; Liver Circulation; Male; Microcirculation; Pentoxifylline; Pyridinolcarbamate; Rats; Rutin; Suppuration; Ultrasonography; Xanthinol Niacinate | 1991 |
Usefulness of antiplatelet drugs in the management of heparin-associated thrombocytopenia and thrombosis.
Topics: Aged; Aorta, Abdominal; Aspirin; Dipyridamole; Female; Femoral Vein; Heparin; Humans; Iliac Artery; Iliac Vein; Iloprost; Ischemia; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombocytopenia; Thrombosis; Vena Cava, Inferior | 1991 |
[The level of vasoactive prostanoids in patients with ischemic heart disease in the early period following aortocoronary bypass].
Topics: Aspirin; Combined Modality Therapy; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Epoprostenol; Humans; Phenindione; Postoperative Care; Postoperative Complications; Thromboxane A2; Time Factors | 1991 |
Anti-thrombotic drugs following angioplasty.
Topics: Aspirin; Dipyridamole; Humans; Postoperative Period; Vascular Surgical Procedures | 1991 |
[Duplex procedure in prevention of arteriosclerosis].
Topics: Adult; Arteriosclerosis; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Humans; Hypolipidemic Agents; Male; Middle Aged; Nafronyl; Prospective Studies; Ultrasonography | 1991 |
Effects of treatment with aspirin or aspirin/dipyridamole combination in heartworm-negative, heartworm-infected, and embolized heartworm-infected dogs.
Topics: Adenosine Diphosphate; Animals; Aspirin; Blood Platelets; Collagen; Dipyridamole; Dirofilariasis; Dog Diseases; Dogs; Drug Therapy, Combination; Embolism; Lung; Platelet Aggregation; Platelet Count; Serotonin | 1991 |
[Regression of coronary artery aneurysm in a patient with Kawasaki's disease].
Topics: Aspirin; Coronary Aneurysm; Dipyridamole; Echocardiography; Female; Humans; Infant; Mucocutaneous Lymph Node Syndrome | 1991 |
Antithrombotic therapy for deep arterial injury by angioplasty. Efficacy of common platelet inhibition compared with thrombin inhibition in pigs.
Topics: Angioplasty, Balloon; Animals; Arteries; Aspirin; Dipyridamole; Fibrinolytic Agents; Heart Diseases; Heparin; Hirudins; Platelet Aggregation Inhibitors; Swine; Thrombosis | 1991 |
Clinical aspects of 100 patients with Kawasaki disease.
Topics: Aspirin; Blood Sedimentation; Child; Child, Preschool; Coronary Aneurysm; Coronary Disease; Dipyridamole; Female; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Infant; Leukocyte Count; Male; Mucocutaneous Lymph Node Syndrome; Platelet Count; Retrospective Studies | 1991 |
Atrial fibrillation and embolic stroke.
Topics: Aged; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Dipyridamole; Embolism; Humans; Warfarin | 1991 |
Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation.
Topics: Administration, Oral; Aged; Aspirin; Atrial Fibrillation; Attitude of Health Personnel; Cerebrovascular Disorders; Dipyridamole; Drug Administration Schedule; Follow-Up Studies; Hemorrhage; Humans; Physicians; Platelet Aggregation Inhibitors; Surveys and Questionnaires; Warfarin | 1991 |
Comparison of in vitro platelet aggregation and its inhibition by three antithrombotic drugs between human and guinea pig.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acid; Aspirin; Collagen; Dipyridamole; Guinea Pigs; Humans; Pentoxifylline; Platelet Aggregation; Platelet Aggregation Inhibitors; Species Specificity; Thrombin | 1991 |
[Secondary prevention of ischemic heart disease].
Topics: Adult; Aged; Aspirin; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Female; Hemodynamics; Humans; Male; Middle Aged; Niacin | 1991 |
[Carotid endarterectomy for prevention of stroke: comparison of surgical and conservative therapy].
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Carotid Artery Diseases; Carotid Artery, Internal; Cerebral Infarction; Constriction, Pathologic; Dipyridamole; Drug Therapy, Combination; Endarterectomy; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Male; Middle Aged; Postoperative Complications; Survival Rate | 1991 |
Does the association dipyridamole-aspirin only act by a functional synergism?
Topics: Aspirin; Blood Platelets; Dipyridamole; Drug Combinations; Drug Synergism; Humans; In Vitro Techniques; Malondialdehyde; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors | 1991 |
[Early detection and modification of preclinical arteriosclerosis].
Topics: Anticholesteremic Agents; Arteriosclerosis; Aspirin; Dipyridamole; Drug Therapy, Combination; Endothelium, Vascular; Follow-Up Studies; Humans; Muscle, Smooth, Vascular; Nafronyl; Phosphatidylcholines; Prospective Studies; Risk Factors; Ultrasonography | 1990 |
Effect of the combination of antiplatelet agents in man: combination of aspirin, trapidil, ticlopidine and dipyridamole.
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Humans; In Vitro Techniques; Platelet Aggregation Inhibitors; Ticlopidine; Trapidil | 1990 |
Effect of antiplatelet drug therapy on the retinal vascular pattern in experimental diabetes mellitus.
Topics: Animals; Aspirin; Collagen; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dipyridamole; Drug Therapy, Combination; Epoprostenol; Male; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Strains; Retinal Vessels | 1990 |
[The drug prevention of thrombotic complications of the vascular approach--arteriovenous fistulae and synthetic prostheses in patients on hemodialysis with antistenocardin].
Topics: Adolescent; Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Vessel Prosthesis; Child; Dipyridamole; Drug Evaluation; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Incidence; Male; Middle Aged; Polytetrafluoroethylene; Renal Dialysis; Thrombosis | 1990 |
The effect of thromboxane receptor blockade versus thromboxane synthase inhibition on canine arterial graft patency.
Topics: Animals; Aspirin; Benzofurans; Bridged Bicyclo Compounds, Heterocyclic; Dipyridamole; Dogs; Fatty Acids, Unsaturated; Graft Occlusion, Vascular; Hydrazines; Male; Platelet Aggregation; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2; Thromboxane-A Synthase; Vascular Patency | 1990 |
Malignant atrophic papulosis: response to antiplatelet therapy.
Topics: Adult; Aspirin; Biopsy; Dipyridamole; Humans; Male; Platelet Aggregation Inhibitors; Skin Diseases, Vesiculobullous | 1990 |
[Conservative therapy of peripheral arterial occlusive disease].
Topics: Alprostadil; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Dipyridamole; Exercise; Humans; Life Style; Platelet Aggregation Inhibitors | 1990 |
Some acute effects of smoking on endothelial cells and platelets.
Topics: Aspirin; Blood Platelets; Blood Proteins; Carboxyhemoglobin; Coronary Disease; Dipyridamole; Endothelium, Vascular; Female; Humans; Hydroxyethylrutoside; Male; Nicotine; Platelet Aggregation; Smoking; Tobacco Smoke Pollution | 1990 |
Histologic, morphometric, and biochemical evolution of vein bypass grafts in a nonhuman primate model. II. Modification of early changes by platelet inhibition with aspirin and dipyridamole.
Topics: Animals; Arm; Aspirin; Blood Platelets; Cholesterol; Dipyridamole; Macaca; Models, Biological; Veins | 1990 |
Histologic, morphometric, and biochemical evolution of vein bypass grafts in a nonhuman primate model. III. Long-term changes and their modification by platelet inhibition with aspirin and dipyridamole.
Topics: Animals; Aspirin; Cholesterol; Dipyridamole; Drug Administration Schedule; Endothelium, Vascular; Femoral Artery; Fibrosis; Foam Cells; Forearm; Macaca; Platelet Aggregation; Platelet Aggregation Inhibitors; Time Factors; Veins | 1990 |
[Essential thrombocythemia. Case reports and clinico-therapeutic considerations].
Topics: Alkylating Agents; Antimetabolites; Aspirin; Bone Marrow; Dipyridamole; Drug Therapy, Combination; Humans; Phosphorus Radioisotopes; Platelet Count; Remission Induction; Thrombocythemia, Essential | 1990 |
IgA nephropathy: a long-term progressive study.
Topics: Adolescent; Adult; Aspirin; Child; Creatinine; Dipyridamole; Female; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Male; Prospective Studies | 1990 |
Blue rubber-bleb naevus syndrome: report of a case with consumption coagulopathy complicated by manifest thrombosis.
Topics: Anemia, Hemolytic; Aspirin; Dipyridamole; Disseminated Intravascular Coagulation; Female; Gastrointestinal Neoplasms; Hemangioma, Cavernous; Humans; Infant; Skin Neoplasms; Syndrome; Thrombophlebitis | 1990 |
[The effect of acetylsalicylic acid and dipyridamole on glomerular filtration and proteinuria in chronic glomerulonephritis].
Topics: Adult; Aspirin; Chronic Disease; Dipyridamole; Female; Glomerular Filtration Rate; Glomerulonephritis, Membranoproliferative; Humans; Male; Proteinuria | 1990 |
Human equivalent doses of platelet inhibitors and experimental atherosclerosis.
Topics: Animals; Aorta; Arteriosclerosis; Aspirin; Blood Platelets; Dipyridamole; Dose-Response Relationship, Drug; Rabbits; Sulfinpyrazone | 1990 |
Antiplatelet therapy to prevent coronary artery bypass graft occlusion.
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Combinations; Graft Occlusion, Vascular; Humans; Platelet Aggregation Inhibitors; Sulfinpyrazone | 1990 |
Influence of antiplatelet drugs on beta tg and PF4 levels in patients with transient ischemic attacks.
Topics: Adult; Aspirin; Beta-Globulins; beta-Thromboglobulin; Dipyridamole; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Factor 4 | 1985 |
The role of antiplatelet drugs in carotid reconstructive surgery.
Topics: Adult; Aged; Aspirin; Carotid Artery Thrombosis; Carotid Artery, Internal; Dextrans; Dipyridamole; Drug Evaluation; Endarterectomy; Female; Humans; Intraoperative Care; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation; Postoperative Complications; Premedication | 1985 |
Short-term outcome of medically treated patients with transient ischemic attacks, reversible ischemic neurologic deficits and strokes with minimum residuum.
Topics: Anticoagulants; Aspirin; Brain Ischemia; Dicumarol; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin; Humans; Ischemic Attack, Transient; Male; Middle Aged | 1985 |
PF 4 versus beta TG as evidence for platelet activation in myeloproliferative disorders.
Topics: Adult; Age Factors; Aged; Aspirin; Beta-Globulins; beta-Thromboglobulin; Dipyridamole; Female; Humans; Male; Middle Aged; Myeloproliferative Disorders; Platelet Count; Platelet Factor 4; Thromboxane B2 | 1985 |
[Thrombotic thrombocytopenic purpura. Treatment with anti-thrombocyte drugs].
Topics: Aged; Aspirin; Blood Platelets; Dextrans; Dipyridamole; Humans; Male; Middle Aged; Prednisolone; Prednisone; Purpura, Thrombotic Thrombocytopenic | 1986 |
Determinants of homologous blood usage utilizing autologous platelet-rich plasma in cardiac operations.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Blood Platelets; Blood Transfusion; Blood Transfusion, Autologous; Cardiac Surgical Procedures; Dipyridamole; Female; Hemostasis, Surgical; Humans; Intraoperative Care; Male; Plasma; Streptokinase; Tissue Plasminogen Activator | 1989 |
[Treatment of chronic proliferative glomerulonephritis using acetylsalicylic acid and dipyridamole].
Topics: Adult; Aspirin; Chronic Disease; Dipyridamole; Drug Therapy, Combination; Epoprostenol; Female; Glomerulonephritis, Membranoproliferative; Humans; Male; Platelet Aggregation; Thromboxane A2 | 1989 |
Spontaneous atherosclerotic lesions and prostacyclin formation in rabbits: effects of combined dipyridamole and aspirin.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta; Arteries; Arteriosclerosis; Aspirin; Dipyridamole; Drug Therapy, Combination; Epoprostenol; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Rabbits | 1989 |
The effect of dipyridamole and aspirin on postoperative blood loss after myocardial revascularization.
Topics: Administration, Oral; Aspirin; Blood Coagulation Factors; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass; Dipyridamole; Hematocrit; Humans; Platelet Count; Prospective Studies | 1989 |
[Prevention of complications of severe arterial hypertension in pregnancy using platelet antiaggregants].
Topics: Adult; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Humans; Hypertension; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Proteinuria | 1989 |
A sensitive in vivo platelet function test in rats based on intravenously injected collagenase.
Topics: Animals; Aspirin; Dipyridamole; Imidazoles; Indomethacin; Injections, Intravenous; Ketanserin; Microbial Collagenase; Mopidamol; Platelet Count; Platelet Function Tests; Rats; Rats, Inbred Strains | 1989 |
Dipyridamole.
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; Graft Occlusion, Vascular; Humans | 1989 |
Successful pregnancies of two patients with relapsing thrombotic thrombocytopenic purpura.
Topics: Adult; Aspirin; Blood Transfusion; Combined Modality Therapy; Dipyridamole; Drug Therapy, Combination; Female; Fetal Death; Glucocorticoids; Humans; Plasmapheresis; Pregnancy; Pregnancy Complications, Hematologic; Purpura, Thrombotic Thrombocytopenic; Recurrence; Vincristine | 1989 |
Dipyridamole plus aspirin.
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Humans; Research Design | 1989 |
Effects of cryptolepine alone and in combination with dipyridamole on a mouse model of arterial thrombosis.
Topics: Adrenergic alpha-Antagonists; Alkaloids; Animals; Aspirin; Dipyridamole; Fibrinolytic Agents; Indole Alkaloids; Indoles; Indomethacin; Male; Mice; Quinolines | 1989 |
Platelet release in coronary heart disease: effect of antiplatelet drugs and coronary artery bypass graft.
Topics: Adult; Aged; Aspirin; Beta-Globulins; beta-Thromboglobulin; Blood Platelets; Coronary Artery Bypass; Coronary Disease; Cytoplasmic Granules; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Factor 4; Postoperative Care; Postoperative Period; Preoperative Care; Radioimmunoassay | 1985 |
Platelet inhibitors and hydroxyethyl starch: safe and cost-effective interventions in coronary artery surgery.
Topics: Aspirin; Blood Platelets; Blood Transfusion; Coronary Artery Bypass; Cost-Benefit Analysis; Dipyridamole; Female; Humans; Hydroxyethyl Starch Derivatives; Male; Middle Aged; Plasma Substitutes; Postoperative Period; Starch | 1985 |
Reassessment of treatment results in membranoproliferative glomerulonephritis, with emphasis on life-table analysis.
Topics: Adult; Aspirin; Child; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Glomerulonephritis, Membranoproliferative; Humans; Life Tables; Meta-Analysis as Topic; Prednisone; Survival Rate; Time Factors; United States; Warfarin | 1989 |
[The effectiveness of antiplatelet therapy in ischemic cerebrovascular attacks in the chronic stage].
Topics: Aspirin; Brain Ischemia; Dipyridamole; Female; Hemiplegia; Humans; Male; Middle Aged; Pentoxifylline; Platelet Aggregation Inhibitors; Prognosis; Recurrence | 1989 |
[Use of aspirin in the primary prevention of vascular thrombi. A comparative study with other anti-aggregant drugs].
Topics: Animals; Aspirin; Dipyridamole; Dogs; Drug Evaluation; Drug Therapy, Combination; Platelet Aggregation Inhibitors; Salicylates; Thrombosis | 1989 |
Fetal demise associated with lupus anticoagulant: clinical features and results of treatment.
Topics: Adult; Aspirin; Autoantibodies; Blood Coagulation; Dipyridamole; Female; Heparin; Humans; Immunosuppression Therapy; Lupus Erythematosus, Systemic; Prednisone; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies | 1989 |
[Liberation of prostacyclin from human endothelial cells].
Topics: Aspirin; Cells, Cultured; Dipyridamole; Endothelium, Vascular; Epoprostenol; Ethinyl Estradiol; Humans; Methacrylates; Sodium Salicylate | 1989 |
Inhibition of accelerated cardiac allograft arteriosclerosis by fish oil.
Topics: Animals; Aspirin; Coronary Disease; Dipyridamole; Fish Oils; Heart Transplantation; Postoperative Complications; Rats; Rats, Inbred BN; Rats, Inbred Lew; Safflower Oil; Transplantation, Homologous | 1989 |
Necrobiosis lipoidica diabeticorum: platelet survival and response to platelet inhibitors.
Topics: Adult; Aspirin; Blood Platelets; Cell Survival; Dipyridamole; Drug Administration Schedule; Drug Therapy, Combination; Humans; Middle Aged; Necrobiosis Lipoidica; Skin | 1989 |
Healing of necrobiotic ulcers with antiplatelet therapy. Correlation with plasma thromboxane levels.
Topics: Adult; Aged; Aspirin; Blood Platelets; Dipyridamole; Drug Therapy, Combination; Humans; Leg Ulcer; Male; Middle Aged; Necrobiosis Lipoidica; Radioimmunoassay; Thromboxane B2 | 1989 |
Effect of therapy on platelet activating factor-induced aggregation in acute stroke.
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors | 1989 |
[Thrombocyte function and the repair of myocardial infarct].
Topics: Aspirin; Blood Platelets; Dipyridamole; Female; Heart Function Tests; Humans; Hydroxyproline; Male; Myocardial Infarction; Platelet Aggregation | 1989 |
Prevention of the formation of arterial thrombi using different antiplatelet drugs: experimental study in dogs.
Topics: Animals; Aspirin; Dipyridamole; Dogs; Indium Radioisotopes; Platelet Aggregation Inhibitors; Salicylates; Scintillation Counting; Thrombosis | 1989 |
[Chronic treatment of vascular diseases with indobufen].
Topics: Adult; Aged; Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Isoindoles; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Vascular Diseases; Veins | 1989 |
Thrombogenicity of canine free internal mammary artery autografts.
Topics: Animals; Aspirin; Blood Platelets; Coronary Artery Bypass; Dipyridamole; Dogs; Fibrinogen; Kinetics; Mammary Arteries; Thoracic Arteries; Thrombosis; Tissue Distribution; Vascular Patency | 1989 |
Model system to study interaction of platelets with damaged arterial wall. II. Inhibition of smooth muscle cell proliferation by dipyridamole and AH-P719.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Arteries; Arteriosclerosis; Aspirin; Blood Platelets; Cell Division; Dipyridamole; Endothelium, Vascular; Heparin; Imidazoles; Male; Microscopy, Electron, Scanning; Models, Cardiovascular; Muscle, Smooth, Vascular; Rabbits | 1988 |
Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs.
Topics: Animals; Antibodies, Monoclonal; Aspirin; Coronary Disease; Coronary Thrombosis; Dipyridamole; Dogs; Immunoglobulin Fab Fragments; Microscopy, Electron, Scanning; Platelet Aggregation; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Tissue Plasminogen Activator | 1988 |
Combining antiplatelet agents: potentiation between aspirin and dipyridamole.
Topics: Aspirin; Dipyridamole; Drug Synergism; Humans; In Vitro Techniques; Platelet Aggregation | 1985 |
[Ischemic cerebrovascular disease: treatment with various anti-platelet aggregation drugs. Clinical follow-up of 80 patients (22-34 months)].
Topics: Adenosine Diphosphate; Aspirin; Brain Ischemia; Dipyridamole; Female; Humans; Isoxsuprine; Male; Oxazoles; Platelet Aggregation; Recurrence | 1985 |
Clinical trials on the efficacy of pharmacologic intervention reducing mortality from cardiovascular diseases.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Clofibrate; Coronary Disease; Dextrothyroxine; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Estrogens; Humans; Hypertension; Myocardial Infarction; Niacin; Sulfinpyrazone | 1985 |
[Antiaggregants of thrombocytes in ischemic heart disease].
Topics: Adrenergic beta-Antagonists; Aspirin; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Humans; Molsidomine; Nitroprusside; Platelet Aggregation; Sulfinpyrazone; Sydnones; Verapamil | 1985 |
[Effect of the complex treatment of stable stenocardia on the status of the prostacyclin-thromboxane system].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Aspirin; Dipyridamole; Drug Therapy, Combination; Epoprostenol; Humans; In Vitro Techniques; Male; Middle Aged; Nitrates; Platelet Aggregation; Thromboxanes | 1986 |
Carotid and coronary artery involvement in infantile periarteritis nodosa possibly induced by Coxsackie B4 infection. Favourable course under corticosteroid treatment.
Topics: Aspirin; Carotid Artery Diseases; Coronary Disease; Coxsackievirus Infections; Dexamethasone; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enterovirus B, Human; Female; Humans; Infant; Polyarteritis Nodosa | 1987 |
Prophylactic low-dose aspirin and dipyridamole in pregnancy.
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Fetal Death; Fetal Growth Retardation; Humans; Infant, Newborn; Pregnancy | 1988 |
Mitral valve prolapse and thromboembolic disease in pregnancy: a case report.
Topics: Adult; Aspirin; Brain Ischemia; Contraceptives, Oral; Dipyridamole; Drug Therapy, Combination; Embolism; Female; Humans; Mitral Valve Prolapse; Pregnancy; Pregnancy Complications, Cardiovascular; Retinal Artery; Retinal Artery Occlusion | 1988 |
Whole blood platelet function in acute ischemic stroke. Importance of dense body secretion and effects of antithrombotic agents.
Topics: Acute Disease; Adult; Aspirin; Blood Platelets; Brain Ischemia; Cerebrovascular Disorders; Dipyridamole; Female; Fibrinolytic Agents; Heparin; Humans; Male; Middle Aged; Platelet Function Tests; Warfarin | 1989 |
Effects of antiplatelet agents in combination with endothelial cell seeding on small-diameter Dacron vascular graft performance in the canine carotid artery model.
Topics: Animals; Aspirin; Benzofurans; Blood Platelets; Blood Vessel Prosthesis; Carotid Arteries; Dipyridamole; Dogs; Endothelium; Female; Graft Occlusion, Vascular; Ibuprofen; Male; Polyethylene Terephthalates; Random Allocation; Thrombosis; Thromboxane-A Synthase | 1985 |
[Percutaneous transluminal recanalization of chronic stenoses and occlusions of peripheral arteries].
Topics: Angiography; Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Dipyridamole; Femoral Artery; Heparin; Humans; Iliac Artery; Pelvis; Popliteal Artery | 1985 |
The effects of thromboxane antagonism on the transit time of platelets through the spleen.
Topics: Aged; Aspirin; Biphenyl Compounds; Blood Circulation; Blood Platelets; Dipyridamole; Double-Blind Method; Humans; Kinetics; Middle Aged; Platelet Aggregation; Random Allocation; Receptors, Prostaglandin; Receptors, Thromboxane; Spleen; Thromboxane A2 | 1985 |
Reduction of indium-111 platelet deposition on Dacron vascular grafts in humans by aspirin plus dipyridamole.
Topics: Adult; Aged; Aspirin; Blood Platelets; Dipyridamole; Graft Occlusion, Vascular; Humans; Indium; Male; Middle Aged; Polyethylene Terephthalates; Radioisotopes; Tomography, Emission-Computed | 1986 |
A sensitive model of venous thrombosis in rats.
Topics: Animals; Anticoagulants; Aspirin; Dipyridamole; Disease Models, Animal; Female; Heparin; Ketanserin; Piperidines; Rats; Rats, Inbred Strains; Sulfinpyrazone; Thrombophlebitis; Time Factors | 1986 |
Antithrombotics in view of thrombosis models.
Topics: Animals; Anticoagulants; Arteries; Aspirin; Dipyridamole; Female; Hydroxyethylrutoside; Ketanserin; Piperidines; Pizotyline; Prenylamine; Rats; Rats, Inbred Strains; Sulfinpyrazone; Thrombophlebitis; Thrombosis | 1986 |
Comparison of the effects of acylpyrin, curantyl and ticlid on some platelet functions in patients with polycythemia vera.
Topics: Adult; Aged; Aspirin; Blood Platelets; Dipyridamole; Female; Humans; Male; Middle Aged; Platelet Aggregation; Polycythemia Vera; Ticlopidine | 1985 |
[Prevention of thrombosis in the after-care of coronary dilatation and thrombolysis].
Topics: Angioplasty, Balloon; Anticoagulants; Aspirin; Combined Modality Therapy; Coronary Circulation; Coronary Disease; Coronary Thrombosis; Coumarins; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Platelet Aggregation; Recurrence | 1986 |
Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty.
Topics: Acute Disease; Angioplasty, Balloon; Aspirin; Coronary Disease; Coronary Thrombosis; Dipyridamole; Humans; Retrospective Studies; Statistics as Topic | 1987 |
Reocclusions after percutaneous transluminal coronary angioplasty.
Topics: Angioplasty, Balloon; Animals; Aspirin; Constriction, Pathologic; Coronary Disease; Dipyridamole; Humans; Recurrence | 1987 |
Effect of a selective thromboxane synthase inhibitor on arterial graft patency and platelet deposition in dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Oral; Animals; Arteries; Aspirin; Benzofurans; Blood Platelets; Blood Vessel Prosthesis; Carotid Arteries; Dipyridamole; Dogs; Female; Indium; Polyethylene Terephthalates; Polytetrafluoroethylene; Radioisotopes; Random Allocation; Thromboxane B2; Thromboxane-A Synthase | 1987 |
Early and late results of intracoronary arterial stenting after coronary angioplasty in dogs.
Topics: Angiography; Angioplasty, Balloon; Animals; Aspirin; Coronary Angiography; Coronary Vessels; Dipyridamole; Dogs; Equipment Failure; Microscopy, Electron, Scanning; Time Factors; Warfarin | 1987 |
[Secondary prevention of peripheral arterial occlusive diseases].
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Coumarins; Dipyridamole; Humans; Sulfinpyrazone | 1987 |
Blue toe syndrome: treatment with anticoagulants and delayed percutaneous transluminal angioplasty.
Topics: Adult; Aged; Angioplasty, Balloon; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cyanosis; Dipyridamole; Drug Therapy, Combination; Embolism; Female; Femoral Artery; Humans; Iliac Artery; Leg; Male; Middle Aged; Popliteal Artery; Radiography; Syndrome; Toes | 1988 |
Evaluation of a low dose administration of aspirin, dipyridamol and steroid. Therapeutic effects on motor function and protective effects on Na+-K+-activated ATPase activity against lipid peroxidation in an experimental model of spinal cord injury.
Topics: Animals; Aspirin; Dipyridamole; Drug Therapy, Combination; Enzyme Activation; Lipid Peroxides; Methylprednisolone; Rats; Sodium-Potassium-Exchanging ATPase; Spinal Cord Injuries | 1985 |
Role of prostaglandins in the activity of some cardiovascular drugs.
Topics: Angiotensin II; Antihypertensive Agents; Aspirin; Captopril; Dinoprostone; Dipyridamole; Epoprostenol; Humans; Indomethacin; Kinins; Nitroglycerin; Peptidyl-Dipeptidase A; Platelet Aggregation; Prostaglandins; Prostaglandins E; Thromboxane-A Synthase | 1985 |
Differential effect of platelet inhibitors in normal and in hypercholesterolaemic subjects.
Topics: Adult; Aspirin; Cyclic AMP; Dipyridamole; Epoprostenol; Humans; Hypercholesterolemia; In Vitro Techniques; Indomethacin; Male; Platelet Aggregation | 1985 |
[Coagulation disorder following angiography with a nonionic tri-iodized contrast medium? Effect due to contrast medium or to heparin?].
Topics: Aortography; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Coagulation Disorders; Blood Coagulation Tests; Contrast Media; Dipyridamole; Drug Combinations; Heparin; Humans; Iopamidol; Iothalamic Acid; Male; Middle Aged | 1985 |
Effect of triflusal and other salicylic acid derivatives on cyclic AMP levels in rat platelets.
Topics: Alprostadil; Animals; Aspirin; Blood Platelets; Cyclic AMP; Dipyridamole; Drug Interactions; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Salicylates; Salicylic Acid | 1986 |
Circulating lupus type anticoagulant and pulmonary hypertension associated with mixed connective tissue disease.
Topics: Adult; Arterial Occlusive Diseases; Aspirin; Blood Coagulation Factors; Dipyridamole; Female; Hand; Hemostasis; Humans; Hypertension, Pulmonary; Lupus Coagulation Inhibitor; Methylprednisolone; Mixed Connective Tissue Disease; Vasodilator Agents | 1986 |
Prostacyclin and steroidogenesis in goat ovarian cell types in vitro.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Estradiol; Female; Goats; In Vitro Techniques; Indomethacin; Ovary; Progesterone; Prostaglandin-Endoperoxide Synthases; Prostaglandins H; Steroids; Trapidil | 1986 |
The effect of cyclo-oxygenase inhibition on thrombogenicity following carotid endarterectomy.
Topics: Aspirin; Carotid Arteries; Cyclooxygenase Inhibitors; Dipyridamole; Endarterectomy; Humans | 1987 |
A seemingly simple decision.
Topics: Aged; Aspirin; Auscultation; Carotid Artery Diseases; Decision Theory; Dipyridamole; Endarterectomy; Female; Follow-Up Studies; Humans | 1987 |
Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Combinations; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Prognosis; Random Allocation; Sulfinpyrazone | 1988 |
Sneddon's syndrome: an antiphospholipid antibody syndrome?
Topics: Antibodies; Aspirin; Blood Coagulation Factors; Cardiolipins; Cerebral Infarction; Dipyridamole; Female; Humans; Ischemic Attack, Transient; Lupus Coagulation Inhibitor; Middle Aged; Phospholipids; Skin Diseases; Syndrome; Tomography, X-Ray Computed | 1988 |
Successful combined medical and surgical treatment of a lower extremity sclerodermal ulcer.
Topics: Aged; Aspirin; Combined Modality Therapy; Debridement; Dipyridamole; Etidronic Acid; Female; Humans; Leg Ulcer; Nifedipine; Scleroderma, Systemic; Skin Transplantation; Wound Healing | 1988 |
[Risk factors and antiaggregant treatment in cerebrovascular diseases].
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Blood Coagulation Factors; Cerebrovascular Disorders; Dipyridamole; Humans; Lupus Coagulation Inhibitor; Risk Factors | 1988 |
Dipyridamole and aspirin in arteriosclerosis obliterans of the lower limbs.
Topics: Adenosine Diphosphate; Adult; Arteriosclerosis Obliterans; Aspirin; Dipyridamole; Drug Therapy, Combination; Epoprostenol; Female; Humans; Leg; Male; Middle Aged; Platelet Aggregation | 1985 |
Aspirin and dipyridamole reduce lipid accumulation in vein bypass grafts: combination versus single drug therapy.
Topics: Animals; Apolipoproteins B; Aspirin; Cholesterol; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; Lipid Metabolism; Macaca | 1985 |
Platelet-inhibitor therapy in cardiovascular disease. Effective defense against thromboembolism.
Topics: Angioplasty, Balloon; Anticoagulants; Aspirin; Bioprosthesis; Blood Platelets; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Graft Occlusion, Vascular; Heart Valve Prosthesis; Heparin; Humans; Prothrombin Time; Random Allocation; Sulfinpyrazone; Thromboembolism; Time Factors; Warfarin | 1985 |
Clinical experience of percutaneous transluminal coronary angioplasty--technique and results.
Topics: Adult; Aged; Angina Pectoris; Angioplasty, Balloon; Aspirin; Coronary Angiography; Coronary Disease; Dipyridamole; Female; Follow-Up Studies; Heparin; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nifedipine; Nitroglycerin; Recurrence | 1985 |
Platelet kinetics following carotid endarterectomy: the effect of aspirin and patch angioplasty.
Topics: Aspirin; Blood Vessel Prosthesis; Carotid Arteries; Carotid Artery Diseases; Dipyridamole; Endarterectomy; Humans; Indium Radioisotopes; Platelet Aggregation; Postoperative Period; Recurrence | 1988 |
Patency rate of small caliber fibrous polyurethane vascular prostheses implanted in the dog carotid and femoral artery improved by use of acetylsalicylic acid and dipyridamol.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Carotid Arteries; Dipyridamole; Dogs; Female; Femoral Artery; Graft Occlusion, Vascular; Male; Microscopy, Electron, Scanning; Polyurethanes; Vascular Patency | 1988 |
Effects of aspirin, dipyridamole, and cod liver oil on accelerated myointimal proliferation in canine veno-arterial allografts.
Topics: Animals; Aspirin; Cholesterol, Dietary; Cod Liver Oil; Dipyridamole; Dogs; Elastic Tissue; Endothelium, Vascular; Female; Femoral Vein; Fish Oils; Graft Occlusion, Vascular; Hemorrhage; Male; Thrombosis; Vascular Patency | 1988 |
[Anti-aggregation therapy of patients with ischemic heart disease].
Topics: Aspirin; Coronary Disease; Dipyridamole; Drug Evaluation; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Sulfinpyrazone; Ticlopidine | 1988 |
Implantation of 20 cm long polyurethane vascular prostheses in the femoral artery of dogs. Preliminary results.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Dogs; Femoral Artery; Vascular Patency | 1988 |
[Dipyridamole and low-dose aspirin in patients with aortocoronary bypass--comparison with anticoagulants].
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; Graft Occlusion, Vascular; Humans | 1988 |
Dipyridamole-thallium-201 tomography documenting improved myocardial perfusion with therapy in Kawasaki disease.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Child, Preschool; Coronary Circulation; Dipyridamole; Female; Heart; Humans; Male; Mucocutaneous Lymph Node Syndrome; Thallium Radioisotopes; Tomography, Emission-Computed | 1988 |
Thrombotic microangiopathy of the miscellaneous secondary type responding to plasma exchange in a liver transplant recipient.
Topics: Aspirin; Dipyridamole; Humans; Liver Transplantation; Male; Middle Aged; Plasma Exchange; Postoperative Complications; Purpura, Thrombotic Thrombocytopenic | 1988 |
The effect of antiplatelet drugs on graft atherosclerosis in rat heterotopic cardiac allografts.
Topics: Animals; Aspirin; Coronary Disease; Cyclosporins; Dipyridamole; Graft Rejection; Heart Transplantation; Rats; Rats, Inbred BN; Rats, Inbred Lew | 1987 |
Neoendothelialization of small-diameter polytetrafluoroethylene arterial grafts is not delayed by aspirin and dipyridamole.
Topics: Animals; Aorta, Thoracic; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Endothelium, Vascular; Male; Microscopy, Electron, Scanning; Polytetrafluoroethylene; Rabbits; Wound Healing | 1988 |
Platelet-inhibitor treatment of diabetic nephropathy: a 10-year prospective study.
Topics: Adult; Aspirin; Blood Platelets; Cell Survival; Creatinine; Diabetic Nephropathies; Dipyridamole; Drug Therapy, Combination; Female; Humans; Iothalamic Acid; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Proteinuria; Thromboxane B2 | 1988 |
Short-term infarct vessel patency with aspirin and dipyridamole started 24 to 36 hours after intravenous streptokinase.
Topics: Angiography; Aspirin; Dipyridamole; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Recurrence; Streptokinase | 1988 |
Perioperative suppression of platelet adherence to small-diameter polytetrafluoroethylene (PTFE) grafts.
Topics: Animals; Aorta; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Drug Combinations; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Polytetrafluoroethylene; Preoperative Care; Regional Blood Flow; Thromboxane B2; Vascular Patency | 1988 |
Livedo vasculitis. Therapy with pentoxifylline.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pentoxifylline; Skin Diseases; Theobromine; Vasculitis | 1988 |
Indications and results for splenectomy for beta thalassemia in two hundred and twenty-one pediatric patients.
Topics: Aspirin; Blood Transfusion; Cerebrovascular Disorders; Child; Dipyridamole; Female; Follow-Up Studies; Hemorrhage; Humans; Infections; Male; Postoperative Care; Postoperative Complications; Splenectomy; Thalassemia; Thrombosis | 1988 |
Effective antiplatelet drug concentrations in experimental arterial thromboembolism.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Dipyridamole; Kinetics; Male; Papio; Sulfinpyrazone; Thromboembolism | 1987 |
[Retrospective study of the use of dipyridamole and acetylsalicylic acid in the pre-, trans- and postoperative periods, in the prevention of thromboembolic complications, in high risk vascular surgery].
Topics: Aspirin; Dipyridamole; Humans; Platelet Aggregation; Postoperative Complications; Retrospective Studies; Thromboembolism; Vascular Surgical Procedures | 1987 |
Ameroid constriction of the proximal left circumflex coronary artery in swine. A model of limited coronary collateral circulation.
Topics: Animals; Aspirin; Collateral Circulation; Constriction; Coronary Circulation; Coronary Disease; Coronary Vessels; Dipyridamole; Female; Male; Models, Cardiovascular; Myocardial Infarction; Physical Exertion; Platelet Aggregation; Swine | 1987 |
Management of patients with heparin-associated thrombocytopenia and thrombosis requiring cardiac surgery.
Topics: Adult; Aged; Aspirin; Cardiopulmonary Bypass; Coronary Artery Bypass; Dipyridamole; Emergencies; Female; Femoral Vein; Heparin; Humans; Iliac Vein; Male; Platelet Aggregation; Platelet Count; Thrombocytopenia; Thrombosis | 1987 |
[Role of platelet anti-aggregants in cardiovascular surgery].
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans; Platelet Aggregation; Sulfinpyrazone; Ticlopidine | 1987 |
Childhood membranoproliferative glomerulonephritis: an approach to management.
Topics: Aspirin; Azathioprine; Child; Cyclophosphamide; Dipyridamole; Drug Administration Schedule; Drug Therapy, Combination; Glomerulonephritis; Humans; Kidney Transplantation; Male; Mechlorethamine; Prednisone; Recurrence | 1986 |
Effects of low doses of aspirin and dipyridamole on platelet aggregation in the dog coronary artery.
Topics: Animals; Aspirin; Coronary Circulation; Dipyridamole; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Epoprostenol; Female; Indomethacin; Male; Platelet Aggregation; Thromboxane B2 | 1987 |
Different effects of aspirin, dipyridamole and UD-CG 115 on platelet activation in a model of vascular injury: studies with extracellular matrix covered with endothelial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Platelets; Cattle; Cells, Cultured; Dipyridamole; Endothelium; Epoprostenol; Extracellular Matrix; Humans; Models, Biological; Platelet Aggregation; Pyridazines; Thromboxanes | 1986 |
Thrombogenicity of a fibronectin-coated, experimental polytetrafluoroethylene graft.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Dogs; Fibronectins; Platelet Adhesiveness; Polytetrafluoroethylene; Thrombosis; Vascular Patency | 1987 |
Thrombotic thrombocytopenic purpura: treatment with plasmapheresis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aspirin; Combined Modality Therapy; Dipyridamole; Female; Follow-Up Studies; Humans; Male; Plasmapheresis; Platelet Count; Purpura, Thrombotic Thrombocytopenic; Vincristine | 1987 |
Prevention of postoperative neurologic deficits after carotid endarterectomy. Is platelet inhibition beneficial?
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Carotid Artery Diseases; Cerebrovascular Disorders; Dipyridamole; Endarterectomy; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Postoperative Complications; Preoperative Care; Risk | 1987 |
Endothelial cell seeding improves 4 mm PTFE vascular graft performance in antiplatelet medicated dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Dipyridamole; Dogs; Endothelium; Graft Occlusion, Vascular; Graft Survival; Male; Microscopy, Electron; Polytetrafluoroethylene; Vascular Patency | 1987 |
Platelet aggregation behaviour in patients treated with ticlopidine.
Topics: Adult; Aged; Aspirin; Atrial Fibrillation; Bleeding Time; Dipyridamole; Female; Humans; Male; Middle Aged; Platelet Adhesiveness; Platelet Aggregation; Thromboembolism; Ticlopidine | 1987 |
Essential thrombocythemia associated with recurrent abortions and fetal growth retardation.
Topics: Abortion, Habitual; Adult; Aspirin; Dipyridamole; Female; Fetal Growth Retardation; Humans; Platelet Count; Pregnancy; Pregnancy Complications, Hematologic; Thrombocythemia, Essential | 1987 |
[Mode of action and clinical evaluation of platelet aggregation inhibitors].
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Graft Occlusion, Vascular; Humans; Ketanserin; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Ticlopidine | 1987 |
[Morphometric aspects of washed platelets and their differences in response to the action of dipyridamole and ASA/dipyridamole].
Topics: Adult; Aspirin; Blood Platelets; Dipyridamole; Humans | 1987 |
[Blood platelet function in patients treated with verapamil. Comparison with dipyridamole and acetyl salicylic acid].
Topics: Adult; Aspirin; Blood Platelets; Dipyridamole; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Platelet Aggregation; Prospective Studies; Verapamil | 1987 |
The effects of aspirin, dipyridamole and warfarin in femorodistal reconstruction: long-term results.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis Obliterans; Arteriovenous Shunt, Surgical; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Drug Evaluation; Female; Femoral Artery; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Popliteal Artery; Retrospective Studies; Saphenous Vein; Thrombosis; Umbilical Veins; Warfarin | 1987 |
Platelet aggregation and atherosclerosis.
Topics: Arteriosclerosis; Aspirin; Dipyridamole; Electrocardiography; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone | 1986 |
Pharmacologic approach to ischemic stroke management.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Dipyridamole; Drug Interactions; Heparin; Humans; Ischemic Attack, Transient; Monitoring, Physiologic; Risk; Warfarin | 1986 |
Use of antithrombotic agents in valvular heart disease.
Topics: Aspirin; Dipyridamole; Heart Valve Diseases; Humans; Patient Education as Topic; Warfarin | 1987 |
Inhibition of platelet aggregation in whole blood by dipyridamole and aspirin.
Topics: Aspirin; Blood Specimen Collection; Dipyridamole; Drug Interactions; Humans; In Vitro Techniques; Kinetics; Male; Platelet Aggregation; Platelet Count | 1986 |
Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
Topics: Anticoagulants; Aortic Valve; Aspirin; Atrial Fibrillation; Bioprosthesis; Dipyridamole; Drug Therapy, Combination; Follow-Up Studies; Heart Valve Diseases; Heart Valve Prosthesis; Hemorrhage; Humans; Mitral Valve; Platelet Aggregation; Postoperative Complications; Thromboembolism; Warfarin | 1986 |
Do all patients with mechanical heart valve prostheses need anticoagulant therapy?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Bioprosthesis; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Platelet Aggregation; Postoperative Complications; Prosthesis Design; Thromboembolism | 1986 |
Effect of the cyclo-oxygenase inhibitor indobufen on platelet accumulation in prosthetic vascular grafts.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Disease Models, Animal; Dogs; Drug Evaluation; Graft Occlusion, Vascular; Isoindoles; Phenylbutyrates; Platelet Aggregation | 1986 |
Ticlopidine versus aspirin and dipyridamole: influence on platelet deposition and three-month patency of polytetrafluoroethylene grafts.
Topics: Animals; Anticoagulants; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Dogs; Female; Femoral Artery; Graft Occlusion, Vascular; Indium; Male; Platelet Aggregation; Polytetrafluoroethylene; Radioisotopes; Thiophenes; Ticlopidine | 1986 |
The role of aspirin and dipyridamole on vascular DNA synthesis and intimal hyperplasia following deendothelialization.
Topics: Animals; Aorta, Abdominal; Aspirin; Blood Platelets; Cell Division; Dipyridamole; DNA; Endothelium; Male; Muscle, Smooth, Vascular; Platelet Adhesiveness; Platelet-Derived Growth Factor; Rabbits | 1986 |
Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera.
Topics: Aspirin; Dipyridamole; Female; Hemorrhage; Humans; Male; Phosphorus Radioisotopes; Platelet Aggregation; Platelet Count; Polycythemia Vera; Thrombosis | 1986 |
Sudden sensorineural hearing loss following manipulation of the cervical spine.
Topics: Adult; Aspirin; Audiometry; Basilar Artery; Cervical Vertebrae; Chiropractic; Dipyridamole; Female; Hearing Loss, Sensorineural; Humans; Iatrogenic Disease; Male; Manipulation, Orthopedic; Middle Aged; Osteopathic Medicine; Vertebral Artery | 1986 |
Comparative study of warfarin versus antiplatelet therapy in patients with a St. Jude Medical valve in the aortic position.
Topics: Adolescent; Adult; Aged; Anticoagulants; Aortic Valve; Aspirin; Cineradiography; Dipyridamole; Echocardiography; Embolism; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Postoperative Complications; Reoperation; Risk; Warfarin | 1986 |
Clinical spectrum of Kawasaki disease in infants younger than 6 months of age.
Topics: Aspirin; Coronary Aneurysm; Dipyridamole; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Fever; Humans; Infant; Male; Mucocutaneous Lymph Node Syndrome; Myocardium; Risk; Warfarin | 1986 |
Heparin-induced thrombocytopenia: further studies of the effects of heparin-dependent antibodies on platelets.
Topics: Adenosine Diphosphate; Antibodies; Aspirin; Bernard-Soulier Syndrome; Dipyridamole; Heparin; Humans; In Vitro Techniques; Platelet Aggregation; Prostaglandin Antagonists; Prostaglandins E; Thrombasthenia; Thrombocytopenia | 1986 |
Aspirin anticoagulation in children with mechanical aortic valves.
Topics: Adolescent; Adult; Anticoagulants; Aortic Valve; Aspirin; Child; Child, Preschool; Dipyridamole; Female; Follow-Up Studies; Heart Valve Prosthesis; Hemorrhage; Humans; Infant; Male; Thromboembolism | 1986 |
Spontaneous dissection of the carotid artery: an unusual cause of stroke in younger patients.
Topics: Adult; Aspirin; Carotid Artery Diseases; Carotid Artery, Internal; Cerebral Angiography; Cerebrovascular Disorders; Dipyridamole; Humans; Ischemic Attack, Transient; Male; Middle Aged | 1987 |
Platelet antagonists eliminate thromboembolic complications of small-diameter arterial prostheses.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Graft Occlusion, Vascular; Male; Platelet Aggregation; Polytetrafluoroethylene; Postoperative Complications; Rabbits; Thromboembolism; Thromboxane B2; Vascular Patency | 1987 |
Adenosine diphosphate (ADP)-induced alpha-granules release from platelets of native whole blood is reduced by ticlopidine but not by aspirin or dipyridamole.
Topics: Adenosine Diphosphate; Adult; Aspirin; Blood Platelets; Cytoplasmic Granules; Dipyridamole; Female; Humans; Kinetics; Male; Ticlopidine | 1986 |
The idling retina: reversible visual loss in central retinal artery obstruction.
Topics: Acetazolamide; Aged; Aspirin; Dipyridamole; Humans; Male; Retinal Artery; Retinal Diseases; Vision, Ocular | 1987 |
[Prevention and medical treatment of polyregional vascular lesions].
Topics: Adult; Anticoagulants; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Diet; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Risk; Sulfinpyrazone; Thiophenes; Thrombosis; Ticlopidine | 1985 |
The longer term patency of a compliant small diameter arterial prosthesis: the effect of the withdrawing of aspirin and dipyridamole therapy: the effect of reduced compliance.
Topics: Animals; Arteries; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Dogs; Elasticity; Prosthesis Design; Regional Blood Flow; Time Factors | 1985 |
[Computer-assisted in vivo study of capillary permeability].
Topics: Adolescent; Adult; Aged; Alprostadil; Arterial Occlusive Diseases; Aspirin; Capillary Permeability; Collagen Diseases; Computers; Cyanosis; Dipyridamole; Drug Therapy, Combination; Factor XIII; Female; Heparin; Humans; Male; Microcomputers; Middle Aged; Nails; Phenprocoumon; Raynaud Disease; Rheology; Streptokinase | 1985 |
A cooperative study of polycythemia vera.
Topics: Aspirin; Chlorambucil; Dipyridamole; Humans; Leukemia; Polycythemia Vera; Prognosis | 1985 |
Late postoperative tamponade following coronary artery bypass grafting in patients on antiplatelet therapy.
Topics: Adult; Aspirin; Cardiac Tamponade; Coronary Artery Bypass; Dipyridamole; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation; Preoperative Care | 1985 |
Drug effects on platelet deposition after endothelial injury of the rabbit aorta.
Topics: Animals; Aorta; Arteriosclerosis; Aspirin; Dipyridamole; Endothelium; Epoprostenol; Ibuprofen; Platelet Adhesiveness; Rabbits; Verapamil | 1985 |
Adverse effects of high dose aspirin on platelet adhesion to experimental autogenous vein grafts.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Autoradiography; Carotid Arteries; Dipyridamole; Epoprostenol; Graft Occlusion, Vascular; Jugular Veins; Models, Biological; Platelet Adhesiveness; Rabbits | 1985 |
Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.
Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Cyclooxygenase Inhibitors; Dipyridamole; Drug Synergism; Femoral Artery; Fibrinolytic Agents; Imidazoles; Male; Papio; Sulfinpyrazone; Thromboembolism | 1985 |
Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
Topics: Adolescent; Adult; Aortic Valve; Aspirin; Blood Platelets; Dipyridamole; Female; Follow-Up Studies; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Postoperative Complications; Prosthesis Design; Rheumatic Heart Disease; Risk; Thromboembolism; Time Factors; Warfarin | 1986 |
Comparison of cod-liver oil and aspirin-dipyridamole for the prevention of intimal hyperplasia in autologous vein grafts.
Topics: Animals; Aspirin; Blood Platelets; Cod Liver Oil; Dietary Fats; Dipyridamole; Dogs; Drug Combinations; Endothelium; Fish Oils; Graft Occlusion, Vascular; Hyperplasia; Myocardial Revascularization; Transplantation, Autologous; Veins | 1986 |
Valvar aortic stenosis in adults: an update.
Topics: Adult; Anticoagulants; Aortic Valve Stenosis; Aspirin; Calcinosis; Dipyridamole; Echocardiography; Electrocardiography; Female; Humans; Pain | 1986 |
Protein/platelet interaction with an artificial surface: effect of vitamins and platelet inhibitors.
Topics: Adsorption; Amino Sugars; Animals; Aspirin; Blood Platelets; Blood Proteins; Cattle; Dipyridamole; Fibrinogen; In Vitro Techniques; Kinetics; Platelet Adhesiveness; Polycarboxylate Cement; Thrombosis; Vitamins | 1986 |
Thrombocythaemia and recurrent late abortions: normal outcome of pregnancies after antiaggregatory treatment. Case report.
Topics: Abortion, Habitual; Adult; Aspirin; Dipyridamole; Female; Humans; Pregnancy; Pregnancy Trimester, Second; Thrombocythemia, Essential | 1986 |
Prostaglandin synthesis inhibition reduces platelet aggregation in diabetes mellitus.
Topics: Aspirin; Diabetes Mellitus, Type 1; Dipyridamole; Humans; Platelet Aggregation; Prostaglandins | 1985 |
Aspirin or dipyridamole individually prevent lipid accumulation in primate vein bypass grafts.
Topics: Animals; Apolipoproteins B; Arteriovenous Shunt, Surgical; Aspirin; Cholesterol; Dipyridamole; Drug Therapy, Combination; Femoral Artery; Graft Occlusion, Vascular; Lipid Metabolism; Macaca; Veins | 1985 |
Antiplatelet aggregators inhibit development of stress ulcers in Sprague-Dawley rats.
Topics: Animals; Anticoagulants; Aspirin; Capillaries; Dipyridamole; Gastric Mucosa; Male; Platelet Aggregation; Pyridines; Rats; Rats, Inbred Strains; Stomach Ulcer; Stress, Physiological; Sulfinpyrazone; Thiophenes; Thrombosis; Ticlopidine | 1985 |
Pharmacokinetic interaction of acetylsalicylic acid and dipyridamole.
Topics: Adult; Aspirin; Dipyridamole; Drug Interactions; Humans; Kinetics; Male | 1985 |
[Site of action of anticoagulant drugs].
Topics: Administration, Oral; Anticoagulants; Aspirin; Dipyridamole; Hemostasis; Heparin; Humans; Sulfinpyrazone | 1985 |
Complete patency in thrombus-occluded arteries two weeks after laser recanalization.
Topics: Animals; Aspirin; Dipyridamole; Dogs; Femoral Artery; Laser Therapy; Thrombosis; Time Factors | 1985 |
Enteric-coated acetylsalicylic acid plus dipyridamole compared with anticoagulants in the prevention of ischemic events in patients with transient ischemic attacks.
Topics: Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Male; Middle Aged; Tablets, Enteric-Coated; Vision Disorders | 1985 |
Anticoagulation therapy in children with mechanical prosthetic cardiac valves.
Topics: Aspirin; Child; Child, Preschool; Dipyridamole; Heart Valve Prosthesis; Hemorrhage; Humans; Thromboembolism; Warfarin | 1985 |
Thrombotic thrombocytopenic purpura in early pregnancy.
Topics: Adult; Aspirin; Combined Modality Therapy; Dipyridamole; Female; Gestational Age; Hematocrit; Humans; Infant, Newborn; Labor, Induced; Male; Plasma Exchange; Platelet Aggregation; Platelet Count; Prednisone; Pregnancy; Pregnancy Complications, Hematologic; Prognosis; Purpura, Thrombotic Thrombocytopenic | 1985 |
High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trial.
Topics: Adult; Aged; Aspirin; Coronary Angiography; Dipyridamole; Drug Evaluation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heparin; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Infarction; Perfusion; Plasminogen; Streptokinase | 1985 |
Does dipyridamole have antithrombotic potential?
Topics: Aspirin; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Humans; Myocardial Infarction; Placebos; Thromboembolism | 1985 |
Antiplatelet drugs improve the patency rates after femoro-popliteal endarterectomy.
Topics: Arterial Occlusive Diseases; Aspirin; Blood Platelets; Dipyridamole; Endarterectomy; Female; Femoral Artery; Humans; Male; Middle Aged; Popliteal Artery; Recurrence; Warfarin | 1985 |
The influence of antiplatelet drugs on injury-stimulated migration of cultured smooth muscle cells.
Topics: Animals; Arteriosclerosis; Aspirin; Catheterization; Cell Movement; Cells, Cultured; Dipyridamole; Hypophysectomy; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred Strains; Sulfinpyrazone | 1985 |
[Anti-platelet therapy in ischemic cerebrovascular disorder--clinical and hematological study].
Topics: Adult; Aged; Aspirin; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Dipyridamole; Female; Humans; Male; Middle Aged; Platelet Aggregation | 1985 |
Interaction of platelets with subendothelium in humans treated with aspirin and dipyridamole alone or in combination.
Topics: Adenosine Triphosphate; Adult; Animals; Aorta, Abdominal; Aspirin; Blood Platelets; Chymotrypsin; Dipyridamole; Drug Interactions; Endothelium; Humans; Middle Aged; Platelet Adhesiveness; Platelet Aggregation; Rabbits; Thrombosis | 1985 |
White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction.
Topics: Adult; Aged; Aspirin; Cholesterol; Coronary Disease; Dipyridamole; Diuretics; Female; Hematocrit; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Prognosis; Recurrence; Risk; Sex Factors; Smoking; Uric Acid | 1985 |
Early platelet-collagen interactions in whole blood and their modifications by aspirin and dipyridamole evaluated by a new method (BASIC wave).
Topics: Adult; Animals; Aspirin; Blood Platelets; Collagen; Dipyridamole; Female; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation; Rats; Rats, Inbred Strains | 1985 |
Inhibitors of "spontaneous" platelet aggregation in whole blood.
Topics: Aspirin; Blood Physiological Phenomena; Chlorpromazine; Dipyridamole; Drug Interactions; Female; Humans; In Vitro Techniques; Male; Platelet Aggregation | 1985 |
Effect of aspirin in amaurosis fugax.
Topics: Aspirin; Blindness; Dipyridamole; Recurrence; Retinal Vessels; Thrombosis | 1971 |
[The inhibition of thrombocyte aggregation in vitro and in vivo].
Topics: Anti-Inflammatory Agents; Arachidonic Acids; Aspirin; Blood Platelets; Dipyridamole; Fatty Acids, Essential; Fibrinogen; Fluorides; Gentisates; Humans; In Vitro Techniques; Iodoacetates; Nicotinic Acids; Papaverine; Phenylbutazone; Platelet Adhesiveness; Prostaglandins; Sodium; Thrombosis; Vasodilator Agents | 1969 |
[The effect of various drugs in clinical use on thrombocyte functions].
Topics: Adolescent; Adult; Aged; Aminobenzoates; Aminocaproates; Arthritis, Rheumatoid; Aspirin; Blood Coagulation Tests; Blood Platelets; Digitoxin; Dipyridamole; Female; Gastrointestinal Hemorrhage; Headache; Humans; Male; Middle Aged; Papaverine; Phenylbutazone; Platelet Adhesiveness; Spinal Osteophytosis; Streptokinase; Strophanthins; Thrombelastography | 1969 |
Experimental digital replantation after prolonged cooling.
Topics: Animals; Arteries; Aspirin; Autopsy; Cold Temperature; Dipyridamole; Fingers; Graft Rejection; Haplorhini; Heparin; Ischemia; Macaca; Magnesium Sulfate; Necrosis; Replantation; Tissue Preservation; Veins | 1974 |
[Differential treatment of coronary heart disease].
Topics: Angina Pectoris; Aspirin; Cardiac Glycosides; Coronary Disease; Dipyridamole; Furosemide; Heparin; Humans; Lidocaine; Methods; Myocardial Infarction; Nitroglycerin; Pentaerythritol Tetranitrate; Prenylamine; Propranolol | 1974 |
Relation of microcirculatory thrombosis to thrombus in the proximal coronary artery: effect of aspirin, dipyridamole, and thrombolysis.
Topics: Animals; Aspirin; Blood Platelets; Chromium Isotopes; Coronary Circulation; Coronary Disease; Dipyridamole; Dogs; Fibrinolysin; Male; Methods; Microcirculation; Myocardium; Thrombosis | 1973 |
Future directions in the development of arterial prostheses for small and medium caliber arteries.
Topics: Animals; Arteries; Aspirin; Blood Flow Velocity; Blood Vessel Prosthesis; Dipyridamole; Endothelium; Fibrin; Forecasting; Hematoma; Humans; Platelet Adhesiveness; Polyethylene Terephthalates; Prosthesis Design; Sutures; Textiles; Thrombosis; Time Factors; Wound Healing | 1974 |
Modification of platelet function.
Topics: Animals; Antigen-Antibody Complex; Aspirin; Blood Coagulation; Blood Platelets; Calcium; Cell Movement; Cyclic AMP; Dipyridamole; Energy Transfer; Fibrinogen; Histamine H1 Antagonists; Humans; Platelet Adhesiveness; Prostaglandins; Rabbits; Thrombosis; Xanthines | 1972 |
Thrombotic thrombocytopenic purpura. Survival following treatment with aspirin, dipyridamole, and prednisone.
Topics: Acute Disease; Adolescent; Aspirin; Blood Platelets; Dipyridamole; Drug Synergism; Hemoglobins; Humans; Male; Prednisone; Purpura, Thrombotic Thrombocytopenic; Remission, Spontaneous; Reticulocytes; Syndrome; Time Factors | 1974 |
Platelet destruction during 24 hour membrane lung perfusion.
Topics: Animals; Aspirin; Biphenyl Compounds; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Dipyridamole; Fluorine; Oxygenators, Membrane; Platelet Adhesiveness; Propionates; Serum Albumin; Sheep; Silicone Elastomers; Time Factors | 1974 |
Effect of antilymphocyte globulin on platelets.
Topics: Antilymphocyte Serum; Aspirin; Blood Platelets; Cross Reactions; Dipyridamole; Flurbiprofen; Humans; Platelet Aggregation; Prostaglandins E; Serotonin; Sulfinpyrazone | 1974 |
Antithrombotic drugs and experimental thrombosis.
Topics: Animals; Aspirin; Dextrans; Dipyridamole; Disease Models, Animal; Drug Combinations; Fibrinolytic Agents; Flavonoids; Molecular Weight; Rats; Thrombosis | 1972 |
Editorial: Anticoagulation IV: Preventing thrombosis by modifying platelet behavior.
Topics: Anticoagulants; Aspirin; Blood Platelets; Dipyridamole; Drug Therapy, Combination; Hemorrhagic Disorders; Humans; Thrombosis | 1974 |
The experimental evaluation of prophylaxis in venous thrombosis by the use of antiplatelet agents.
Topics: Animals; Aspirin; Blood Coagulation Tests; Dextrans; Dipyridamole; Drug Therapy, Combination; Heparin; Platelet Aggregation; Rabbits; Thrombophlebitis; Venae Cavae | 1974 |
[Thromboembolism prevention after heart valve prosthesis in an experimental model].
Topics: Animals; Anticoagulants; Aspirin; Dipyridamole; Disease Models, Animal; Dogs; Heart Valve Prosthesis; Mitral Valve; Platelet Adhesiveness; Thromboembolism | 1972 |
Pharmacological investigation of substances affecting platelet function.
Topics: Animals; Aspirin; Blood Cell Count; Blood Coagulation; Blood Platelets; Dipyridamole; Naphthyridines; Platelet Adhesiveness; Platelet Aggregation; Rats | 1974 |
Clinical replantation of digits.
Topics: Adolescent; Adult; Amputation, Traumatic; Anesthesia, General; Aspirin; Child; Debridement; Dipyridamole; Fingers; Hand Injuries; Heparin; Humans; Immobilization; Microsurgery; Middle Aged; Penicillins; Postoperative Care; Postoperative Complications; Preoperative Care; Replantation; Sensation; Surgical Instruments; Suture Techniques; Temperature; Time Factors | 1973 |
A kinetic evaluation of hemostasis in renal disease.
Topics: Aspirin; Blood Coagulation; Complement System Proteins; Diabetic Nephropathies; Dipyridamole; Fibrin; Fibrinogen; Glomerulonephritis; Hemolytic-Uremic Syndrome; Heparin; Humans; Iodine Radioisotopes; Kidney; Kidney Diseases; Kidney Glomerulus; Kidney Transplantation; Plasminogen; Proteinuria; Thrombosis; Transplantation, Homologous; Uremia; Warfarin | 1974 |
Protection against epinephrine-induced myocardial necrosis by drugs that inhibit platelet aggregation.
Topics: Animals; Arteriosclerosis; Aspirin; Catecholamines; Dipyridamole; Dogs; Epinephrine; Heart; Myocardial Infarction; Myocardium; Necrosis; Platelet Adhesiveness; Stress, Physiological | 1972 |
[Platelet function disorders and ischemic cerebral accidents. Therapeutic prospects].
Topics: Adult; Aspirin; Blood Coagulation Tests; Blood Platelet Disorders; Cerebrovascular Disorders; Dipyridamole; Humans; Intracranial Embolism and Thrombosis; Ischemic Attack, Transient; Middle Aged; Platelet Adhesiveness | 1972 |
The effect of acetylsalicylic acid and dipyridamole on platelet economy in metastatic cancer.
Topics: Aspirin; Blood Cell Count; Blood Platelets; Cell Survival; Dipyridamole; Half-Life; Humans; Neoplasm Metastasis; Neoplasms; Platelet Adhesiveness; Time Factors | 1972 |
Influence of some drugs on platelet aggregation: a study in hypertensive patients.
Topics: Adenosine Diphosphate; Anti-Inflammatory Agents; Aspirin; Benzyl Compounds; Blood Cell Count; Blood Coagulation; Blood Platelets; Dimethylamines; Dipyridamole; Humans; Hypertension; In Vitro Techniques; Indazoles; Indomethacin; Phenylbutazone; Platelet Adhesiveness; Reserpine; Thrombosis; Time Factors | 1972 |
Potentiation of the inhibitory effect of some antiaggregating drugs in " vitro".
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Carbon Radioisotopes; Collagen; Densitometry; Dipyridamole; Dose-Response Relationship, Drug; Drug Synergism; Epinephrine; Ergolines; Humans; In Vitro Techniques; Methods; Nicotinic Acids; Platelet Adhesiveness; S-Adenosylmethionine; Serotonin | 1972 |
Effects of drugs on platelet aggregation: attempt at quantitative comparison of inhibitory effects.
Topics: Adenine; Adenosine Diphosphate; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Cardiac Glycosides; Collagen; Coumarins; Depression, Chemical; Dipyridamole; Dose-Response Relationship, Drug; Epinephrine; Humans; In Vitro Techniques; Methods; Papaverine; Platelet Adhesiveness; Pyrazoles; Xanthines | 1972 |
The effect of antiadhesive drugs on platelet function and metabolism.
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation Factors; Blood Platelets; Cell Membrane; Collagen; Cytoplasmic Granules; Densitometry; Dipyridamole; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Glucose; Glycolysis; Humans; In Vitro Techniques; Lactates; Lipoproteins; Microscopy, Electron; Mitochondria; Platelet Adhesiveness; Pyruvate Kinase | 1972 |
Platelets.
Topics: Aspirin; Blood Platelets; Dipyridamole; Humans; Sulfinpyrazone; Thromboembolism | 1973 |
Chronic intravascular coagulation syndrome associated with atherosclerotic aortic aneurysm.
Topics: Aged; Aortic Aneurysm; Arteriosclerosis; Aspirin; Blood Cell Count; Blood Platelets; Chronic Disease; Coronary Disease; Dipyridamole; Disseminated Intravascular Coagulation; Female; Fibrinogen; Heparin; Humans; Time Factors | 1973 |
[New possibilities in the prevention of thrombosis].
Topics: Aspirin; Dextrans; Dipyridamole; Heparin; Humans; Thrombosis | 1973 |
Clinical application of platelet aggregation.
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Dipyridamole; Epinephrine; Humans; Intracranial Embolism and Thrombosis; Platelet Adhesiveness; Thrombin; Thrombosis; Warfarin | 1973 |
Effect of temperature on ADP-induced platelet aggregation. Its significance in studying anti-aggregating drugs.
Topics: Adenosine Diphosphate; Aspirin; Dipyridamole; Ergolines; Humans; In Vitro Techniques; Platelet Adhesiveness; Temperature; Time Factors | 1973 |
Haemolytic-uraemic syndrome in an adult with pericarditis and pleurisy.
Topics: Adult; Alopecia; Anemia, Hemolytic; Aspirin; Dipyridamole; Female; Hemolytic-Uremic Syndrome; Heparin; Humans; Pericarditis; Platelet Adhesiveness; Pleurisy; Renal Dialysis; Streptokinase; Uremia | 1973 |
Dipyridamole and aspirin tested against an experimental model of thrombosis.
Topics: Animals; Aspirin; Blood Vessels; Dipyridamole; Disease Models, Animal; Dogs; Hematoma; Hemorrhagic Disorders; Methods; Perfusion; Postoperative Complications; Pronase; Thrombosis; Time Factors | 1973 |
Treatment of thrombotic thrombocytopenic purpura with antiplatelet drugs.
Topics: Adolescent; Aspirin; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Cell Aggregation; Dipyridamole; Disseminated Intravascular Coagulation; Female; Fibrin; Hematocrit; Heparin; Humans; Hydrocortisone; Purpura, Thrombotic Thrombocytopenic; Remission, Spontaneous; Reticulocytes; Spleen; Splenectomy | 1973 |
[Hemolytic-uremic syndrome and microangiopathic hemolytic anemia].
Topics: Adrenal Cortex Hormones; Anemia, Hemolytic; Aspirin; Dextrans; Dipyridamole; Drug Hypersensitivity; Female; Hemolytic-Uremic Syndrome; Heparin; Humans; Infant; Infant, Newborn; Infections; Neoplasms; Pregnancy; Pregnancy Complications, Hematologic; Purpura, Thrombocytopenic; Sepsis; Splenectomy; Streptokinase; Uremia | 1973 |
[Neuropsychiatry in 1973].
Topics: Aspirin; Bipolar Disorder; Dipyridamole; Heart Diseases; Humans; Hydrocephalus; Hypoxia, Brain; Ischemic Attack, Transient; Memory Disorders; Myoclonus; Neurologic Manifestations; Psychophysiologic Disorders | 1973 |
Drug influence on platelet loss during extracorporeal circulation.
Topics: Amides; Animals; Anti-Inflammatory Agents; Aspirin; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Cell Aggregation; Dipyridamole; Dogs; Extracorporeal Circulation; Glycols; Oxygenators, Membrane; Platelet Adhesiveness; Polymers; Surface-Active Agents; Thiazines; Thiazoles; Time Factors | 1973 |
Preventing thrombosis.
Topics: Aspirin; Dipyridamole; Humans; Thrombosis | 1973 |
[Clinical use of anti-aggregative agents].
Topics: Aspirin; Dipyridamole; Humans; Hydroxychloroquine; Platelet Adhesiveness; Thromboembolism; Thrombophlebitis; Thrombosis | 1973 |
Address of the president-elect: the indication for various methods of treatment of occlusive cerebrovascular disease.
Topics: Anticoagulants; Aspirin; Blood Pressure; Cardiac Output; Carotid Arteries; Cerebral Angiography; Cerebrovascular Circulation; Cerebrovascular Disorders; Dipyridamole; Electroencephalography; Giant Cell Arteritis; Humans; Intracranial Arteriosclerosis; Intracranial Embolism and Thrombosis; Ischemic Attack, Transient; Methods; Neurologic Examination; Polycythemia; Radionuclide Imaging; Sulfinpyrazone | 1973 |
Leucocytes and thrombosis. 3. Effect on white cell behaviour of substances which induce or inhibit platelet aggregation.
Topics: Adenosine; Aspirin; Catecholamines; Collagen; Dipyridamole; Epinephrine; Isoproterenol; Leukocytes; Norepinephrine; Serotonin; Tendons; Thrombosis | 1973 |
The measurement of intravascular aggregation by continuous platelet counting.
Topics: Adenosine; Adenosine Diphosphate; Animals; Aspirin; Blood Cell Count; Blood Platelets; Catheterization; Citrates; Dipyridamole; Dogs; Guinea Pigs; Methysergide; Platelet Adhesiveness; Prostaglandins; Rabbits; Serotonin; Serotonin Antagonists | 1973 |
Thrombotic thrombocytopenic purpura--coagulation parameters in twelve patients.
Topics: Adolescent; Adult; Anemia, Hemolytic; Antigens; Aspirin; Blood Coagulation; Blood Coagulation Tests; Bone Marrow Examination; Dipyridamole; Disseminated Intravascular Coagulation; Female; Fibrinogen; Glucocorticoids; Hemagglutination Inhibition Tests; Heparin; Humans; Male; Middle Aged; Prothrombin Time; Purpura, Thrombotic Thrombocytopenic; Spleen; Splenectomy | 1973 |
Effect of 4,5-diphenyl-2-bis-(2-hydroxyethyl)aminoxazol (ditazol) on platelet aggregation, adhesiveness and bleeding time.
Topics: Adenosine; Adenosine Diphosphate; Adult; Analysis of Variance; Animals; Anti-Inflammatory Agents; Aspirin; Blood Coagulation; Collagen; Dipyridamole; Drug Interactions; Epinephrine; Ethanol; Ethanolamines; Humans; Male; Mice; Middle Aged; Oxazoles; Phenylbutazone; Platelet Adhesiveness; Rabbits; Time Factors | 1973 |
[Animal experiment studies on the inhibition of platelet aggregation by verapamil in vitro and in vivo].
Topics: Adenosine Diphosphate; Animals; Aspirin; Depression, Chemical; Dipyridamole; Dogs; Fatty Acids; Humans; In Vitro Techniques; Male; Papaverine; Platelet Adhesiveness; Rats; Thrombocytopenia; Time Factors; Verapamil | 1973 |
Dipyridamole ("Persantin") and aspirin and the prevention of post-operative deep-vein thrombosis.
Topics: Adult; Aspirin; Dextrans; Dipyridamole; Drug Therapy, Combination; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Platelet Aggregation; Postoperative Complications; Thrombophlebitis | 1973 |
Prevention of early vein graft thrombosis by drugs altering platelet function.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Dextrans; Dipyridamole; Dogs; Femoral Vein; Iliac Artery; Iliac Vein; Platelet Adhesiveness; Thrombophlebitis; Transplantation, Autologous | 1973 |
Postoperative deep vein thrombosis and pulmonary embolism: a selective review and personal viewpoint.
Topics: Adult; Age Factors; Aged; Aspirin; Clothing; Dextrans; Dipyridamole; Exercise Therapy; Heparin; Humans; Iodine Radioisotopes; Middle Aged; Phlebography; Plethysmography, Impedance; Postoperative Complications; Pulmonary Embolism; Radionuclide Imaging; Thrombophlebitis; Ultrasonography; Warfarin | 1974 |
Inhibition of platelet-induced thrombus formation.
Topics: Adenosine; Adenosine Diphosphate; Aspirin; Blood Platelets; Brain Diseases; Dipyridamole; Epinephrine; Glomerulonephritis; Heart Valve Prosthesis; Humans; Hypertension, Malignant; Ischemia; Myocardial Infarction; Platelet Adhesiveness; Postoperative Complications; Prostaglandins; Pyrimidines; Thromboembolism; Thrombophlebitis; Thrombosis; Xanthines | 1974 |
[Drug-induced modification of thrombocyte turnover in patients with artificial heart valves].
Topics: Aortic Valve; Aspirin; Blood Platelets; Cell Survival; Chromium Radioisotopes; Dipyridamole; Heart Valve Prosthesis; Humans; Mitral Valve; Thromboembolism; Tricuspid Valve | 1974 |
Streptokinase and anti-thrombotic therapy in the hemolytic-uremic syndrome.
Topics: Aspirin; Biopsy; Child; Child, Preschool; Dipyridamole; Hemolytic-Uremic Syndrome; Hemorrhage; Heparin; Humans; Hypotension; Infant; Injections, Intravenous; Kidney Failure, Chronic; Kidney Glomerulus; Peritoneal Dialysis; Retrospective Studies; Streptokinase | 1974 |
Prevention of thrombosis with agents which reduce platelet adhesiveness.
Topics: Animals; Anticoagulants; Aspirin; Dextrans; Dipyridamole; Dogs; Femoral Artery; Molecular Weight; Platelet Adhesiveness; Surface-Active Agents; Thrombosis | 1974 |
[Therapy of the hemolytic-uremic syndrome].
Topics: Aspirin; Dipyridamole; Hemolytic-Uremic Syndrome; Heparin; Humans; Methods; Peritoneal Dialysis; Platelet Adhesiveness; Streptokinase | 1974 |
[Role of thrombotic agent in coronary insufficiency--therapeutic implications (author's transl)].
Topics: Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelet Disorders; Coronary Disease; Dipyridamole; Humans; Platelet Adhesiveness; Thrombosis | 1974 |
Arterial and venous thromboembolism: kinetic characterization and evaluation of therapy.
Topics: Adult; Aged; Arteriosclerosis; Aspirin; Blood Cell Count; Blood Platelets; Dipyridamole; Drug Synergism; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Plasminogen; Thromboembolism; Thrombophlebitis; Warfarin | 1974 |
Thrombotic thrombocytopenic purpura. Three cases with platelet and fibrinogen survival studies.
Topics: Adolescent; Antibodies; Aspirin; Blood Coagulation Tests; Blood Platelets; Cell Survival; Child; Chromium Radioisotopes; Dipyridamole; Enterovirus; Female; Fibrinogen; Heparin; Humans; Iodine Radioisotopes; Kidney; Male; Purpura, Thrombotic Thrombocytopenic; Thrombin | 1974 |
Shortened platelet lifespan in patients with hydrocephalus and ventriculojugular shunts: results of preliminary attempts at correction.
Topics: Aspirin; Blood Coagulation Tests; Blood Platelets; Catheterization; Cerebral Ventricles; Cerebrospinal Fluid Shunts; Child, Preschool; Chromium Isotopes; Dipyridamole; Disseminated Intravascular Coagulation; Heart Atria; Humans; Hydrocephalus; Infant; Platelet Adhesiveness; Thromboembolism | 1972 |
Effect of dipyridamole and aspirin in thrombotic microangiopathy.
Topics: Adult; Anemia, Hemolytic; Aspirin; Dipyridamole; Humans; Male; Platelet Adhesiveness; Purpura, Thrombotic Thrombocytopenic; Thrombosis | 1972 |
Antiplatelet therapy for thrombotic thrombocytopenic purpura.
Topics: Aspirin; Blood Cell Count; Blood Platelets; Dipyridamole; Female; Humans; Hydrocortisone; Middle Aged; Prednisone; Purpura, Thrombotic Thrombocytopenic | 1971 |
Inhibition of experimental arterial thrombosis in dogs with platelet-deaggregating agents.
Topics: Administration, Oral; Animals; Aspirin; Blood Cell Count; Blood Platelets; Carotid Arteries; Cyproheptadine; Dipyridamole; Dogs; Femoral Artery; Heparin; Injections, Intravenous; Lactose; Methods; Platelet Adhesiveness; Thrombosis; Time Factors | 1971 |
[Pharmacodynamic prevention of thrombosis].
Topics: Adenosine Diphosphate; Amitriptyline; Anticoagulants; Aspirin; Collagen; Dipyridamole; Guanethidine; Humans; Imipramine; Papaverine; Thrombin; Thrombosis | 1971 |
[Prevention of thrombosis using aspirin? nfluence of acetylsalicylic acid on thrombocyte aggregation in vitro and in vivo].
Topics: Aspirin; Blood Coagulation Tests; Blood Platelets; Dipyridamole; Female; Humans; Middle Aged; Papaverine; Phenylbutazone; Platelet Adhesiveness; Salicylates; Thrombosis | 1969 |
Effect of acetylsalicylic acid, other nonsteroidal anti-inflammatory agents, and dipyridamole on human blood platelets.
Topics: Adenine Nucleotides; Anti-Inflammatory Agents; Aspirin; Blood Platelets; Carbon Isotopes; Centrifugation; Connective Tissue; Dipyridamole; Drug Synergism; Epinephrine; Flufenamic Acid; Humans; Indomethacin; Mefenamic Acid; Phenylbutazone; Serotonin; Sodium Salicylate; Sulfinpyrazone | 1970 |
Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves.
Topics: Aortic Valve; Aspirin; Blood Cell Count; Blood Platelets; Chromium Isotopes; Dipyridamole; Drug Synergism; Fibrinogen; Heart Valve Prosthesis; Humans; Kinetics; Mitral Valve; Postoperative Complications; Spectrophotometry; Thromboembolism; Transplantation, Homologous | 1970 |
Thromboembolism--a continuing challenge.
Topics: Arteries; Aspirin; Blood Coagulation; Dipyridamole; Drug Synergism; Heart Valve Prosthesis; Humans; Thromboembolism; Veins | 1970 |
[Anti-adhesion and anti-coagulant substances in thrombosis therapy. Acetylsalicylic acid and Persantin in the spotlight].
Topics: Animals; Aspirin; Coronary Disease; Dipyridamole; Humans; Thrombophlebitis; Thrombosis | 1971 |
Platelet response to induction of hemorrhagic pancreatitis.
Topics: Animals; Anti-Bacterial Agents; Aspirin; Blood Cell Count; Dipyridamole; Disease Models, Animal; Dogs; Duodenal Obstruction; Hemorrhage; Intestinal Secretions; Pancreatitis; Sodium Salicylate; Thrombocytopenia | 1971 |
Thrombosis prevention.
Topics: Animals; Arteries; Arthroplasty; Aspirin; Blood Platelets; Dextrans; Dipyridamole; Hemorrhage; Hip; Humans; Joint Prosthesis; Postoperative Complications; Pulmonary Embolism; Thromboembolism; Thrombophlebitis; Veins; Warfarin | 1971 |
Inhibition by dipyridamole of arterial thrombosis in rats.
Topics: Animals; Aspirin; Dipyridamole; Heparin; Mesenteric Arteries; Rats; Thrombosis; Warfarin | 1968 |
Antiplatelet drugs in the secondary prevention of myocardial infarction. One view of the present position.
Topics: Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Humans; Myocardial Infarction; Recurrence; Risk; Sulfinpyrazone; Thrombosis | 1980 |
Prostacyclin therapy of thrombotic thrombocytopenic purpura.
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Epoprostenol; Female; Humans; Middle Aged; Prostaglandins; Purpura, Thrombotic Thrombocytopenic | 1980 |
[Inhibitors of thrombocytic function for prophylaxis of coronary heart disease (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anticoagulants; Arteriosclerosis; Aspirin; Coronary Disease; Dipyridamole; Female; Humans; Male; Middle Aged; Platelet Aggregation; Prospective Studies; Sulfinpyrazone | 1982 |
[Infarction prophylaxis--prevention of the sudden heart death? An alternative].
Topics: Adrenergic beta-Antagonists; Anticoagulants; Aspirin; Dipyridamole; Female; Heart Arrest; Humans; Male; Myocardial Infarction; Sulfinpyrazone | 1982 |
Laser-induced thrombi in rat mesenteric vessels and antithrombotic drugs.
Topics: Animals; Aspirin; Blood Platelets; Dipyridamole; Disease Models, Animal; Fibrinolytic Agents; Heparin; Lasers; Male; Mesenteric Arteries; Mesenteric Vascular Occlusion; Molsidomine; Oxazoles; Platelet Aggregation; Propionates; Pyrazoles; Pyrazolones; Rats; Rats, Inbred Strains; Sydnones; Thiophenes; Thrombosis; Ticlopidine | 1983 |
Therapeutic interventions in acute myocardial infarction. Survey of the ACCP Section on Clinical Cardiology.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Calcium Channel Blockers; Digitalis Glycosides; Dipyridamole; Drug Utilization; Hospitalization; Humans; Myocardial Infarction; Nitrates; Societies, Medical; Sulfinpyrazone; United States | 1984 |
Thrombotic thrombocytopenic purpura: a ten-year experience.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aspirin; Dextrans; Dipyridamole; Female; Heparin; Humans; Male; Middle Aged; Nervous System Diseases; Purpura, Thrombotic Thrombocytopenic; Splenectomy | 1980 |
Platelet changes after placement of aortic prostheses in dogs. I. Biochemical and functional alterations.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Aorta; Aspirin; Blood Platelets; Blood Transfusion; Cell Survival; Chemical Phenomena; Chemistry; Dipyridamole; Dogs; Female; Hydroxyindoleacetic Acid; Male; Platelet Aggregation; Platelet Transfusion; Prostheses and Implants; Serotonin | 1981 |
Transient contralateral hemiplegia after ophthalmic zoster. Therapeutic problems in elderly patients.
Topics: Aged; Arteritis; Aspirin; Carotid Artery Diseases; Dipyridamole; Hemiplegia; Herpes Zoster Ophthalmicus; Humans; Male | 1981 |
[Benefits and dangers of preventive thinking in medicine--prevention of thromboembolism].
Topics: Adult; Aspirin; Bandages; Blood Flow Velocity; Coumarins; Dextrans; Dihydroergotamine; Dipyridamole; Hemodilution; Humans; Middle Aged; Myocardial Infarction; Streptokinase; Sulfinpyrazone; Thromboembolism | 1981 |
Treatment of cerebral ischemia.
Topics: Aspirin; Brain Ischemia; Carotid Arteries; Dicumarol; Dipyridamole; Endarterectomy; Heart Murmurs; Heparin; Humans; Hypertension; Ischemic Attack, Transient; Risk; Sulfinpyrazone; Warfarin | 1981 |
Elevated levels of circulating platelet aggregates and beta-thromboglobulin in scleroderma.
Topics: Aspirin; Beta-Globulins; beta-Thromboglobulin; Dipyridamole; Female; Humans; Male; Platelet Aggregation; Scleroderma, Systemic | 1982 |
Preliminary experience with aspirin for anticoagulation in children with prosthetic cardiac valves.
Topics: Adolescent; Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Child; Child, Preschool; Dicumarol; Dipyridamole; Drug Therapy, Combination; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Infant; Mitral Valve; Postoperative Complications; Retrospective Studies; Thromboembolism; Warfarin | 1982 |
Pharmacology of angioplasty and intravascular thrombolysis.
Topics: Angioplasty, Balloon; Anticoagulants; Arteriosclerosis; Aspirin; Blood Platelets; Dextrans; Dipyridamole; Heparin; Humans; Middle Aged; Prostaglandins; Streptokinase; Sulfinpyrazone; Thromboembolism; Urokinase-Type Plasminogen Activator; Warfarin | 1982 |
Antithrombotic treatment.
Topics: Ancrod; Aspirin; Cerebrovascular Disorders; Dextrans; Dipyridamole; Drug Administration Schedule; Heparin; Humans; Myocardial Infarction; Recurrence; Sulfinpyrazone; Thrombosis | 1983 |
Antiplatelet drugs.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Dextrans; Dipyridamole; Epoprostenol; Humans; Sulfinpyrazone; Vascular Diseases | 1983 |
Prognostic value of beta-thromboglobulin in patients with transient cerebral ischaemia.
Topics: Adult; Age Factors; Aged; Aspirin; Beta-Globulins; beta-Thromboglobulin; Blood Platelets; Cerebrovascular Disorders; Dipyridamole; Female; Fibrinopeptide A; Humans; Ischemic Attack, Transient; Male; Middle Aged; Prognosis; Risk; Time Factors | 1983 |
[Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
Topics: Adrenergic beta-Antagonists; Aged; Anticoagulants; Aspirin; Coumarins; Dicumarol; Dipyridamole; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Platelet Aggregation; Streptokinase; Sulfinpyrazone | 1984 |
Efficacy of adjunctive dextran during percutaneous transluminal coronary angioplasty.
Topics: Angioplasty, Balloon; Aspirin; Coronary Disease; Dextrans; Dipyridamole; Female; Humans; Male; Middle Aged; Prospective Studies; Random Allocation | 1984 |
Plasma thromboglobulin and platelet aggregation index in transient ischaemic attack: effect of aspirin and dipyridamole therapy.
Topics: Adult; Aged; Aspirin; Beta-Globulins; beta-Thromboglobulin; Dipyridamole; Humans; Ischemic Attack, Transient; Middle Aged; Platelet Aggregation | 1983 |
Heritable alpha 2-macroglobulin deficiency in a patient with arterial thrombosis: alpha 2-macroglobulin deficiency Irvine.
Topics: alpha-Macroglobulins; Arteriosclerosis; Aspirin; Dipyridamole; Female; Gangrene; Humans; Immunoelectrophoresis; Male; Middle Aged | 1984 |
[Changes in mucopolysaccharides and ultrastructural alterations in experimental atheromatosis].
Topics: Animals; Aorta; Arteriosclerosis; Aspirin; Diet, Atherogenic; Dipyridamole; Endothelium; Fibrinolytic Agents; Glycosaminoglycans; Rabbits; Tranexamic Acid; Urokinase-Type Plasminogen Activator | 1982 |
Enhanced patency of small-diameter, externally supported Dacron iliofemoral grafts seeded with endothelial cells.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Dogs; Endothelium; Evaluation Studies as Topic; Femoral Artery; Iliac Artery; Microscopy, Electron, Scanning; Polyethylene Terephthalates; Thrombosis | 1982 |
In vivo quantitation of platelet deposition on human peripheral arterial bypass grafts using indium-111-labeled platelets. Effect of dipyridamole and aspirin.
Topics: Adult; Aged; Aorta; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Dipyridamole; Female; Femoral Artery; Humans; Indium; Male; Middle Aged; Polyethylene Terephthalates; Polytetrafluoroethylene; Popliteal Artery; Radioisotopes | 1983 |
Platelet factor 4 (PF4) and heparin-released platelet factor 4 (HR-PF4) in patients with cardiovascular disorders.
Topics: Adult; Aged; Aspirin; beta-Thromboglobulin; Blood Coagulation Factors; Cardiovascular Diseases; Dipyridamole; Female; Heparin; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Count; Platelet Factor 4 | 1983 |
Serial angiographic evidence of rapid resolution of coronary artery stenosis.
Topics: Angina Pectoris; Angiography; Angioplasty, Balloon; Aspirin; Coronary Disease; Dipyridamole; Humans; Male; Middle Aged; Nitroglycerin; Remission, Spontaneous | 1983 |
[Effect of aspirin and dipyridamole on platelet functions in Macaca fascicularis].
Topics: Animals; Arachidonic Acids; Aspirin; Blood Platelets; Dipyridamole; Macaca fascicularis; Serotonin | 1983 |
[Therapy of peripheral arterial occlusive diseases. Round table conference].
Topics: Alprostadil; Angioplasty, Balloon; Anti-Bacterial Agents; Anticoagulants; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Dipyridamole; Endarterectomy; Exercise Therapy; Fibrinolysis; Humans; Hyperlipidemias; Hypertension; Infusions, Intra-Arterial; Intermittent Claudication; Prostaglandins E; Serotonin Antagonists; Sympathectomy; Thromboxane A2 | 1983 |
Effect of antiplatelet therapy on restenosis after experimental angioplasty.
Topics: Angioplasty, Balloon; Animals; Arteriosclerosis; Aspirin; Blood Platelets; Dipyridamole; Iliac Artery; Rabbits; Radiography; Recurrence; Sulfinpyrazone | 1984 |
The thrombogenicity of Dacron arterial grafts and its modification by platelet inhibitory drugs.
Topics: Arteries; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Dipyridamole; Drug Therapy, Combination; Humans; Microscopy, Electron; Platelet Adhesiveness; Platelet Aggregation; Polyethylene Terephthalates; Sulfinpyrazone; Thiophenes; Thrombosis; Ticlopidine | 1984 |
In vivo platelet activation in lower limbs thrombophlebitis. A longitudinal study.
Topics: Adult; Aspirin; beta-Thromboglobulin; Blood Platelets; Dipyridamole; Female; Heparin; Humans; Longitudinal Studies; Male; Middle Aged; Platelet Aggregation; Thrombophlebitis; Warfarin | 1984 |
[Prevention of thrombosis by thrombocyte inhibitors. 1. Cell regulation mechanisms and pharmacological modification].
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Cyclic AMP; Dextrans; Dipyridamole; Humans; Hydroxychloroquine; Indomethacin; Platelet Aggregation; Prostaglandins; Sulfinpyrazone; Thrombosis; Thromboxane A2 | 1980 |
A biphasic effect of prostacyclin (PGI2) on platelet aggregation.
Topics: Adenosine Diphosphate; Animals; Aspirin; Cyclic AMP; Dipyridamole; Epoprostenol; Humans; Imidazoles; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandins; Rabbits; Rats; Thrombin; Thromboxane-A Synthase | 1980 |
[The circadian rhythm of the absorptive function of the small intestine in man in pharmacokinetic and histochemical studies].
Topics: Adult; Aspirin; Circadian Rhythm; Dipyridamole; Histocytochemistry; Humans; Intestinal Absorption; Intestine, Small; Male; Phosphoric Monoester Hydrolases; Propranolol; Vitamin B 12; Xylose | 1981 |
Effects of drugs on adhesion of human platelets.
Topics: Adenosine; Aspirin; Chlorpromazine; Cyclic IMP; Dipyridamole; Glass; Humans; Platelet Adhesiveness | 1981 |
Antithrombotic activity and the mechanism of action of trapidil (Rocornal).
Topics: Adenosine Triphosphate; Animals; Aspirin; Blood Coagulation; Blood Platelets; Dipyridamole; Disease Models, Animal; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Platelet Aggregation; Prostaglandins; Pyrimidines; Rats; Thrombosis; Thromboxane-A Synthase; Trapidil | 1982 |
Modification of angiotensin II-induced relaxation by dipyridamole, phthalazinol and aspirin in isolated dog renal arteries.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Angiotensin II; Animals; Aspirin; Cyclooxygenase Inhibitors; Dipyridamole; Dogs; Epoprostenol; Female; In Vitro Techniques; Indomethacin; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Phthalazines; Pyridazines; Renal Artery | 1983 |
Unstable angina in a patient with mucocutaneous lymph node syndrome.
Topics: Aneurysm; Angina Pectoris; Angina, Unstable; Aspirin; Child; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Echocardiography; Electrocardiography; Humans; Male; Mucocutaneous Lymph Node Syndrome; Nifedipine | 1984 |
[Surveillance of treatment with antiaggregating agents].
Topics: Aspirin; Blood Coagulation Tests; Dipyridamole; Epoprostenol; Humans; Platelet Aggregation; Prostaglandins; Thromboxane A2; Thromboxanes | 1983 |
Plasmapheresis as a therapeutic measure in hemolytic-uremic syndrome in children.
Topics: Aspirin; Child, Preschool; Dipyridamole; Epoprostenol; Female; Hemolytic-Uremic Syndrome; Humans; Infant; Male; Plasmapheresis; Renal Dialysis | 1983 |
The antithrombotic effect of aspirin and dipyridamole in relation to prostaglandin synthesis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Dipyridamole; Epoprostenol; Fibrinolytic Agents; Male; Prostaglandins; Rabbits; Thrombosis; Thromboxanes | 1983 |
[Blood thromboxane A2 and prostaglandin I2 levels and platelet phospholipid fatty acid composition ratios in ischemic heart disease and cerebral infarction--with special reference to the effect of antiplatelet agents].
Topics: Aged; Aspirin; Blood Platelets; Cerebral Infarction; Coronary Disease; Dipyridamole; Epoprostenol; Fatty Acids; Female; Humans; Male; Middle Aged; Phospholipids; Thromboxane A2; Thromboxanes; Trapidil | 1983 |
Thrombotic thrombocytopenic purpura in southeastern New England.
Topics: Adolescent; Adult; Aspirin; Dipyridamole; Disease Outbreaks; Female; Humans; Male; Methylprednisolone Hemisuccinate; Middle Aged; Plasmapheresis; Prognosis; Purpura, Thrombotic Thrombocytopenic; Rhode Island; Splenectomy | 1983 |
[Aggressive therapy in a case of Moschowitz syndrome].
Topics: Adrenal Cortex Hormones; Aspirin; Dipyridamole; Drug Therapy, Combination; Epoprostenol; Female; Humans; Middle Aged; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic | 1984 |
The effects of aspirin and dipyridamole on the metabolism of arachidonic acid in human platelets.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adult; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Dipyridamole; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Humans; In Vitro Techniques; Leukotrienes; Male; Thromboxane B2 | 1983 |
Aspirin and dipyridamole inhibition of collagen-induced platelet aggregation and release in cynomolgus monkeys.
Topics: Animals; Aspirin; Blood Platelets; Collagen; Dipyridamole; Macaca fascicularis; Male; Platelet Aggregation; Serotonin | 1984 |
[Divergence between the pharmacologic and clinical effects of inhibitors of prostaglandin synthesis].
Topics: Aspirin; Blood Platelets; Dipyridamole; Drug Interactions; Epoprostenol; Humans; Platelet Aggregation; Prostaglandin Antagonists; Prostaglandin-Endoperoxide Synthases; Salicylates; Salicylic Acid; Sulfinpyrazone; Thrombosis; Thromboxanes | 1984 |
Prostaglandin endoperoxides and thromboxane A2 in thrombus formation in the hamster cheek pouch in vivo.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Cheek; Cricetinae; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Male; Mesocricetus; Microscopy, Electron; Platelet Aggregation; Sulfinpyrazone; Thrombosis; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1984 |
Antithrombotic therapy for vascular prosthesis: an experimental model testing platelet inhibitory drugs.
Topics: Aspirin; Blood Circulation; Blood Platelets; Blood Vessel Prosthesis; Dipyridamole; Humans; Methods; Microscopy, Electron, Scanning; Platelet Adhesiveness; Platelet Aggregation; Polyethylene Terephthalates; Sulfinpyrazone; Thrombosis | 1980 |
Inhibition of thrombocytopenic episodes caused by the Arthus reaction, the sub-lethal Forssman reaction and ADP.
Topics: Adenosine Diphosphate; Animals; Antibodies; Arthus Reaction; Aspirin; Dipyridamole; Forssman Antigen; Guinea Pigs; Humans; Nervous System Diseases; Platelet Count; Pyridines; Sulfides; Sulfinpyrazone; Thiophenes; Thrombocytopenia; Ticlopidine | 1980 |
An unusual case of Bjork-Shiley mitral valve dysfunction corrected nonsurgically.
Topics: Aspirin; Cardiomegaly; Dipyridamole; Echocardiography; Female; Furosemide; Heart Murmurs; Heart Valve Prosthesis; Humans; Hypotension; Middle Aged; Mitral Valve Prolapse; Phenylephrine; Prothrombin Time; Warfarin | 1981 |
Effects of various antiplatelet drugs and defibrinating agent on experimental glomerulonephritis in rats.
Topics: Animals; Anticoagulants; Aspirin; Batroxobin; Blood Platelets; Dipyridamole; Glomerulonephritis; Immune Complex Diseases; Kidney; Nephritis; Proteinuria; Pyridines; Rats; Rats, Inbred Strains; Thiophenes; Ticlopidine | 1982 |
Percutaneous transluminal coronary angioplasty at a community hospital--initial experience.
Topics: Adult; Angioplasty, Balloon; Aspirin; Coronary Vessels; Dipyridamole; Female; Hospitals, Community; Humans; Ischemia; Male; Middle Aged; New Jersey; Premedication; Risk; Smoking | 1982 |
Imaging of platelets in right-sided extracardiac conduits in humans.
Topics: Adolescent; Adult; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Child; Dipyridamole; Evaluation Studies as Topic; Female; Heart Defects, Congenital; Heart Valve Prosthesis; Humans; Indium; Male; Polyethylene Terephthalates; Radioisotopes; Radionuclide Imaging; Time Factors | 1982 |
Intimal thickening in autogenous vein grafts in rabbits: influence of aspirin and dipyridamole.
Topics: Animals; Aspirin; Dipyridamole; Jugular Veins; Rabbits | 1984 |
Morphologic quantitation of pseudointima and effects of antiplatelet drugs on vascular prostheses in goats.
Topics: Animals; Aorta; Arteries; Aspirin; Blood Vessel Prosthesis; Carotid Arteries; Dipyridamole; Endothelium; Female; Goats; Ibuprofen; Models, Biological; Nifedipine; Platelet Aggregation; Polytetrafluoroethylene; Wound Healing | 1984 |
Model system to study interaction of platelets with damaged arterial wall. I. Inhibition of platelet adhesion to subendothelium by aspirin and dipyridamole.
Topics: Animals; Arteries; Aspirin; Dipyridamole; Endothelium; Heparin; Male; Microscopy, Electron; Platelet Adhesiveness; Rabbits; Vascular Diseases | 1984 |
Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts.
Topics: Aged; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Double-Blind Method; Female; Graft Survival; Humans; Intermittent Claudication; Leg; Male; Middle Aged; Polytetrafluoroethylene; Postoperative Care; Prospective Studies; Random Allocation; Saphenous Vein; Time Factors | 1984 |
[Inhibition of collagen-induced platelet aggregation and release function by aspirin and dipyridamole in cynomolgus monkey].
Topics: Animals; Aspirin; Blood Platelets; Collagen; Dipyridamole; Macaca fascicularis; Male; Platelet Aggregation; Serotonin | 1984 |
[Improvement of walking disability and conservative treatment. Guiding principles for drug treatment of chronic arterial occlusive disease (stage I and IIb)].
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Dipyridamole; Fibrinolytic Agents; Humans; Intermittent Claudication; Leg; Plant Extracts | 1984 |
Surgical management of the occluded carotid artery.
Topics: Adult; Aged; Arterial Occlusive Diseases; Aspirin; Carotid Arteries; Carotid Artery Diseases; Cerebral Revascularization; Cerebrovascular Disorders; Dipyridamole; Endarterectomy; Humans; Ischemic Attack, Transient; Male; Middle Aged; Retrospective Studies | 1984 |
[Aspirin and dipyridamol or preventive diet].
Topics: Arteriosclerosis; Aspirin; Dietary Fats; Dipyridamole; Humans; Platelet Aggregation; Prostanoic Acids | 1984 |
[Use of disaggregants in treating diabetic retinopathy].
Topics: Ascorbic Acid; Aspirin; Calcium Dobesilate; Diabetic Angiopathies; Diabetic Retinopathy; Dipyridamole; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Humans; Pentoxifylline; Platelet Aggregation; Rutin; Thrombelastography; Vision, Ocular | 1984 |
Pharmacological control of platelet-vessel wall interactions in patients with chronic obstructive airway disease.
Topics: Aspirin; Blood Platelets; Blood Vessels; Dipyridamole; Hematopoiesis; Humans; Lung Diseases, Obstructive; Malondialdehyde; Pulmonary Embolism | 1984 |
Thrombotic thrombocytopenic purpura mimicking toxemia of pregnancy.
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Diagnosis, Differential; Dipyridamole; Female; Fetal Death; Humans; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Hematologic; Purpura, Thrombotic Thrombocytopenic | 1984 |
Plasma exchange and concomitant therapy in TTP.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aspirin; Dipyridamole; Female; Fibrin Fibrinogen Degradation Products; Humans; Male; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Vincristine | 1984 |
[Differential therapy of thrombotic-thrombopenic purpura. Administration of fresh plasma versus plasma separation].
Topics: Acute Kidney Injury; Adult; Aspirin; Blood Platelets; Blood Transfusion; Dipyridamole; Erythrocytes; Heparin; Humans; Immunoglobulin G; Male; Methylprednisolone; Plasma; Plasma Exchange; Plasmapheresis; Platelet Count; Proteinuria; Purpura, Thrombotic Thrombocytopenic; Renal Dialysis; Syncope; Urine | 1984 |
Effect of prolonged treatment with acetylsalicylic acid and dipyridamole on platelet thromboxane A2 production in atherosclerotic subjects.
Topics: Aged; Arteriosclerosis; Aspirin; Blood Platelets; Dipyridamole; Female; Humans; Kinetics; Male; Thromboxane A2; Thromboxane B2; Thromboxanes | 1983 |
Dipyridamole disposition after chronic administration: effect of aspirin.
Topics: Aspirin; Blood Proteins; Dipyridamole; Drug Interactions; Female; Half-Life; Humans; Kinetics; Male; Protein Binding | 1983 |
The lame brain at the crossroads: which therapeutic road?
Topics: Aged; Aspirin; Carotid Artery Diseases; Cerebral Infarction; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Vertebral Artery | 1984 |
Ex vivo and in vivo evaluation of drugs that inhibit platelet function.
Topics: Adenosine Diphosphate; Animals; Aspirin; Bleeding Time; Blood Platelets; Collagen; Dipyridamole; Imidazoles; Male; Papio; Platelet Aggregation; Sulfinpyrazone; Thiazines; Thiophenes; Ticlopidine | 1983 |
Drugs in the treatment of thrombo-embolic disease--part I.
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Platelets; Carotid Artery Diseases; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Dose-Response Relationship, Drug; Gastrointestinal Hemorrhage; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1983 |
Use of common antiplatelet drugs for vascular diseases.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Artery Bypass; Coronary Disease; Coumarins; Dipyridamole; Fibrinolytic Agents; Heart Valve Prosthesis; Heart Valves; Humans; Postoperative Care; Sulfinpyrazone | 1983 |
Quantification of platelet retention in aortocoronary femoral vein bypass graft in dogs treated with dipyridamole and aspirin.
Topics: Animals; Aspirin; Coronary Artery Bypass; Dipyridamole; Dogs; Endothelium; Femoral Vein; Indium; Platelet Adhesiveness; Platelet Count | 1984 |
Dipyridamole and aspirin and patency of coronary bypass grafts.
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Humans; Postoperative Complications | 1984 |
Coronary artery bypass and antiplatelet therapy.
Topics: Anticoagulants; Aspirin; Blood Platelets; Coronary Artery Bypass; Dipyridamole; Humans; Warfarin | 1984 |
[The effect of antithrombocyte drugs on the patency of aortocoronary bypass].
Topics: Aspirin; Blood Platelets; Coronary Artery Bypass; Coronary Circulation; Dipyridamole; Graft Survival; Humans | 1984 |
Polytetrafluoroethylene grafts in the peripheral venous circulation of rabbits.
Topics: Animals; Aspirin; Dipyridamole; Female; Graft Survival; Jugular Veins; Male; Polytetrafluoroethylene; Rabbits; Warfarin | 1983 |
Thrombotic etiology of stress ulcers. 1. The effect of anticoagulant and antiplatelet aggregators in the development of stress ulcers in rats.
Topics: Animals; Anticoagulants; Aspirin; Dipyridamole; Gastric Acidity Determination; Gastric Mucosa; Heparin; Male; Peptic Ulcer Hemorrhage; Platelet Aggregation; Platelet Count; Rats; Rats, Inbred Strains; Stomach Ulcer; Stress, Physiological; Thiophenes; Thrombosis; Ticlopidine | 1983 |
[Effect of the single administration of acetylsalicylic acid and dipyridamole on microcirculation in patients with diabetes mellitus].
Topics: Adolescent; Adult; Aged; Aspirin; Diabetes Mellitus; Dipyridamole; Female; Humans; Male; Microcirculation; Middle Aged | 1983 |
[Combination therapy with prednisone, chlorambucil, dipyridamole and aspirin in various glomerular diseases. Experience with 33 patients].
Topics: Aspirin; Chlorambucil; Dipyridamole; Drug Therapy, Combination; Humans; Kidney Diseases; Prednisone | 1983 |
[Effect of acetylsalicylic acid and dipyridamole on the microcirculatory state of diabetes mellitus patients based on biomicroscopy and rheography data].
Topics: Adolescent; Adult; Aged; Aspirin; Chronic Disease; Conjunctiva; Diabetic Angiopathies; Dipyridamole; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Microcirculation; Middle Aged; Plethysmography, Impedance; Time Factors | 1983 |
[Platelet antiaggregants in post-myocardial infarct patients: why, which and in what doses?].
Topics: Aspirin; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Recurrence; Sulfinpyrazone | 1983 |
[Case of mitral stenosis with regression and elimination of left atrial thrombus after combined therapy of urokinase, dipyridamole and aspirin].
Topics: Aged; Aspirin; Dipyridamole; Drug Therapy, Combination; Echocardiography; Female; Heart Atria; Heart Diseases; Humans; Mitral Valve Stenosis; Thromboembolism; Urokinase-Type Plasminogen Activator | 1983 |
[Platelet anti-aggregants as a treatment for thrombotic thrombocytopenic purpura. Apropos of a case].
Topics: Aspirin; Dipyridamole; Humans; Male; Middle Aged; Platelet Aggregation; Purpura, Thrombotic Thrombocytopenic | 1983 |
[Primary thrombocythemia in childhood].
Topics: Adolescent; Aspirin; Child; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Platelet Aggregation; Platelet Count; Thrombocythemia, Essential; Thrombocytosis | 1983 |
The effects of antithrombotic drugs in patients with left ventricular thrombi: assessment with indium-111 platelet imaging and two-dimensional echocardiography.
Topics: Adult; Aged; Anticoagulants; Aspirin; Dipyridamole; Echocardiography; Heart Ventricles; Humans; Indium; Male; Middle Aged; Platelet Aggregation; Prospective Studies; Radioisotopes; Radionuclide Imaging; Sulfinpyrazone; Thrombosis; Warfarin | 1984 |
Dimethylsulfoxide-treated, cryopreserved venous allografts in the arterial and venous systems.
Topics: Animals; Arteries; Aspirin; Dimethyl Sulfoxide; Dipyridamole; Dogs; Freezing; Graft Survival; Jugular Veins; Male; Saphenous Vein; Tissue Preservation; Transplantation, Homologous; Veins | 1984 |
Prevention of platelet deposition and thrombus formation on hemodialysis membranes: a double-blind randomized trial of aspirin and dipyridamole.
Topics: Adult; Aspirin; Blood Platelets; Cellulose; Dipyridamole; Double-Blind Method; Female; Humans; Male; Membranes, Artificial; Random Allocation; Renal Dialysis; Thrombosis | 1984 |
Role of platelets in glomerulonephritis.
Topics: Aspirin; Blood Platelets; Dipyridamole; Glomerulonephritis; Humans | 1984 |
Transient ischemic attacks. Strategies for minimizing stroke risk.
Topics: Aged; Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Ischemic Attack, Transient; Middle Aged; Neurologic Examination; Risk; Warfarin | 1984 |
[Antiaggregant drugs in traumatic shock lung. Experimental study].
Topics: Animals; Anticoagulants; Aspirin; Crush Syndrome; Dipyridamole; Female; Lung; Male; Platelet Aggregation; Rabbits; Respiratory Distress Syndrome | 1984 |
Activation of platelets by autogenous vein grafts is not prevented by acetylsalicylic acid and dipyridamole.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acids; Aspirin; Dipyridamole; Dose-Response Relationship, Drug; Jugular Veins; Platelet Aggregation; Rabbits; Time Factors | 1984 |
[Is modern anti-aggregation therapy effective?].
Topics: Aspirin; Dipyridamole; Fibrinolytic Agents; Humans; Platelet Aggregation; Sulfinpyrazone; Thromboembolism | 1984 |
[Use of calciparin, curantyl and polopirin S in the treatment of retinal vein thrombosis].
Topics: Adult; Aged; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heparin; Humans; Male; Middle Aged; Retinal Vein; Thrombosis | 1984 |
Hemostasis, Prostacyclin and Preeclampsia.
Topics: Aspirin; Dipyridamole; Epoprostenol; Female; Hemostasis; Humans; Imidazoles; Pre-Eclampsia; Pregnancy; Prostaglandins; Salicylates | 1982 |
[A case of thrombotic thrombocytopenic purpura (TTP), clinically diagnosed and cured by dipyridamole, urokinase and aspirin].
Topics: Adult; Aspirin; Dipyridamole; Endopeptidases; Female; Humans; Purpura, Thrombotic Thrombocytopenic; Urokinase-Type Plasminogen Activator | 1982 |
Bleeding time in rats: a comparison of different experimental conditions.
Topics: Anesthetics; Animals; Aspirin; Bleeding Time; Blood Coagulation; Blood Platelet Disorders; Dipyridamole; Disease Models, Animal; Epoprostenol; Heparin; Indomethacin; Rats; Tail; Thromboxane B2 | 1982 |
A study of the stimulation of human venous prostacyclin synthesis by dipyridamole.
Topics: Aspirin; Dipyridamole; Dose-Response Relationship, Drug; Epoprostenol; Humans; Platelet Aggregation; Prostaglandins; Prostaglandins F; Stimulation, Chemical; Veins | 1982 |
Anticoagulants and platelet-active agents in the secondary prevention of coronary artery disease.
Topics: Aged; Anticoagulants; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Epoprostenol; Humans; Middle Aged; Myocardial Infarction; Netherlands; Recurrence; Sulfinpyrazone | 1982 |
Aspirin and dipyridamole decrease intimal hyperplasia in experimental vein grafts.
Topics: Animals; Aspirin; Carotid Arteries; Dipyridamole; Femoral Vein; Haplorhini; Hyperplasia; Iliac Artery; Macaca mulatta; Male; Platelet Count; Transplantation, Autologous; Veins | 1980 |
Thrombotic thrombocytopenic purpura successfully treated with a combination of dipyridamole and aspirin.
Topics: Adult; Aspirin; Dipyridamole; Humans; Male; Purpura, Thrombotic Thrombocytopenic | 1980 |
Platelet adhesion to collagen in normal and von Willebrand's disease subjects.
Topics: Animals; Aspirin; Blood Platelets; Collagen; Diabetes Mellitus; Dipyridamole; Factor VIII; Humans; Kidney Diseases; Platelet Adhesiveness; Platelet Count; Rats; Sulfinpyrazone; Temperature; von Willebrand Diseases | 1980 |
The effect of acetylsalicylic acid. Dipyridamole and K 3920 on the secretion of platelet factor 4.
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation Factors; Blood Platelets; Collagen; Dipyridamole; Epinephrine; Humans; Indoles; Isoindoles; Phenylbutyrates; Platelet Factor 4 | 1980 |
Non-surgical management of peripheral vascular disease.
Topics: Aspirin; Dipyridamole; Female; Humans; Male; Vascular Diseases | 1981 |
[Influence of platelet aggregation inhibitors on platelet damage at prosthetic heart valves in-vitro (author's transl)].
Topics: Aspirin; Blood Platelets; Dipyridamole; Heart Valve Prosthesis; Hemolysis; Humans; Lysine; Platelet Aggregation; Propionates; Sulfinpyrazone | 1981 |
Conservative treatment of Budd-Chiari syndrome in polycythemia vera.
Topics: Aspirin; Budd-Chiari Syndrome; Busulfan; Dipyridamole; Female; Furosemide; Humans; Leukapheresis; Middle Aged; Polycythemia Vera | 1981 |
[Two cases with microangiopathic hemolytic anemia caused by anti-cancer drugs who improved rapidly after administration of aspirin and dipyridamole].
Topics: Adult; Aged; Anemia, Hemolytic; Antineoplastic Agents; Aspirin; Chromomycin A3; Dipyridamole; Female; Fluorouracil; Humans; Male; Mitomycin; Mitomycins; Stomach Neoplasms | 1982 |
Use of aspirin and dipyridamole in children with platelet trapping syndromes.
Topics: Aspirin; Blood Platelets; Dipyridamole; Female; Hemangioma; Humans; Infant; Male; Platelet Count; Telangiectasia, Hereditary Hemorrhagic | 1983 |
Veno-venous allografts: patency, subendothelial proliferation, and the role of platelet-active agents.
Topics: Animals; Aspirin; Blood Platelets; Cell Division; Dipyridamole; Dogs; Female; Graft Survival; Male; Muscle, Smooth, Vascular; Phthalazines; Sulfinpyrazone; Thrombosis; Transplantation, Autologous; Transplantation, Homologous; Veins | 1983 |
Antithrombotic therapy.
Topics: Anticoagulants; Aspirin; Blood Platelets; Dipyridamole; Fibrinolytic Agents; Humans; Sulfinpyrazone; Thrombosis | 1983 |
Coagulopathy of peritoneovenous shunts: studies on the pathogenic role of ascitic fluid collagen and value of antiplatelet therapy.
Topics: Adult; Animals; Ascitic Fluid; Aspirin; Blood Coagulation Tests; Collagen; Dipyridamole; Disseminated Intravascular Coagulation; Female; Humans; Male; Middle Aged; Peritoneovenous Shunt; Rabbits; Vascular Surgical Procedures | 1983 |
Dermatomyositis associated with platelet thrombi formation and responsive to antiplatelet therapy.
Topics: Adult; Aspirin; Blood Platelets; Dermatomyositis; Dipyridamole; Female; Humans; Sulfinpyrazone; Thrombosis | 1983 |
Noninvasive radioisotopic technique for detection of platelet deposition in mitral valve prostheses and quantitation of visceral microembolism in dogs.
Topics: Animals; Aspirin; Blood Platelets; Brain Diseases; Dipyridamole; Dogs; Embolism; Heart Valve Prosthesis; In Vitro Techniques; Indium; Isotope Labeling; Kidney Diseases; Lung Diseases; Mitral Valve; Radioisotopes; Radionuclide Imaging; Time Factors; Tissue Distribution | 1983 |
The prevention of prosthetic valve thromboembolism. Uses and limitations of anti-platelet drugs.
Topics: Anticoagulants; Aspirin; Bioprosthesis; Dipyridamole; Drug Therapy, Combination; Heart Valve Prosthesis; Humans; Sulfinpyrazone; Thromboembolism | 1983 |
[Blood platelet function in patients with coronary disease after administration of acetylsalicylic acid and dipyridamole].
Topics: Adult; Aged; Aspirin; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation | 1983 |
[Conservative therapy of stroke from an internist's viewpoint].
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Digitalis Glycosides; Dipyridamole; Diuretics; Heart Failure; Heme; Humans; Mitral Valve Prolapse; Platelet Aggregation; Sulfinpyrazone; Vasodilator Agents | 1983 |
Management of transient cerebral ischaemic attacks by hospital doctors in Scotland.
Topics: Anticoagulants; Aspirin; Carotid Arteries; Cerebrovascular Disorders; Dipyridamole; Female; Humans; Ischemic Attack, Transient; Male; Risk; Scotland; Surveys and Questionnaires | 1983 |
Successful treatment of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura with fresh frozen plasma and plasma exchange.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aspirin; Child; Child, Preschool; Dipyridamole; Female; Hemolytic-Uremic Syndrome; Humans; Infant; Male; Middle Aged; Plasma; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic | 1982 |
The effect of antiaggregating drugs on the patency of grafts in the arterial system.
Topics: Animals; Anticoagulants; Aorta, Abdominal; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Dogs; Ergolines; Female; Iliac Artery; Jugular Veins; Male; Papaverine; Premedication; Preoperative Care; Thrombosis; Transplantation, Autologous | 1980 |
Non-steroidal anti-inflammatory agents and coronary heart disease.
Topics: Animals; Anti-Inflammatory Agents; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Carotid Artery Diseases; Coronary Disease; Dipyridamole; Female; Fibrin; Humans; Male; Prostaglandins; Sex Factors; Sulfinpyrazone; Thrombosis | 1980 |
Therapeutic briefs. I.
Topics: Adult; Anti-Bacterial Agents; Aspirin; Child; Cimetidine; Cyclophosphamide; Dipyridamole; Female; Humans; Infant; Isotretinoin; Pruritus; Skin Diseases; Tretinoin; Ultraviolet Therapy | 1980 |
Studies on platelet aggregation and antiplatelet therapy in blackfoot disease.
Topics: Adult; Aged; Aspirin; Dipyridamole; Female; Foot Diseases; Gangrene; Humans; Male; Middle Aged; Platelet Aggregation; Taiwan; Vascular Diseases | 1981 |
Significance of platelet function and thromboxane B2 levels across the human myocardial vascular bed.
Topics: Arteriosclerosis; Aspirin; Coronary Circulation; Coronary Disease; Coronary Vessels; Dipyridamole; Humans; Platelet Aggregation; Propranolol; Tachycardia; Thromboxane B2; Thromboxanes | 1981 |
[Association of hemorrhagic and thrombotic phenomena in myeloproliferative syndromes].
Topics: Adult; Aspirin; Blood Platelet Disorders; Dipyridamole; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Myeloproliferative Disorders; Platelet Aggregation; Platelet Count; Polycythemia Vera; Thrombocythemia, Essential; Thrombocytosis | 1981 |
[Present situation of therapy with platelet aggregation inhibitors].
Topics: Adult; Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Middle Aged; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thromboembolism; Vascular Diseases | 1982 |
Antiplatelet and anticoagulant therapy after coronary bypass.
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Embolism; Humans; Postoperative Care; Postoperative Complications | 1980 |
Gore-Tex (polytetrafluoroethylene) in canine coronary artery bypass.
Topics: Animals; Anti-Bacterial Agents; Aspirin; Blood Vessel Prosthesis; Coronary Angiography; Coronary Artery Bypass; Coronary Vessels; Dipyridamole; Dogs; Evaluation Studies as Topic; Platelet Adhesiveness; Polytetrafluoroethylene; Thrombosis | 1980 |
Reduction of thrombosis in canine coronary bypass vein grafts with dipyridamole and aspirin.
Topics: Animals; Aspirin; Coronary Artery Bypass; Dipyridamole; Dogs; Femoral Vein; Thrombosis | 1981 |
[A case of necrobiosis lipoidica diabeticorum (author's transl)].
Topics: Adult; Aspirin; Dipyridamole; Humans; Male; Necrobiosis Lipoidica | 1981 |
Assessment of the interaction of warfarin with aspirin and dipyridamole.
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Interactions; Heart Valve Prosthesis; Humans; Postoperative Complications; Warfarin | 1982 |
Prevention of lipid accumulation in experimental vein bypass grafts by antiplatelet therapy.
Topics: Animals; Arteriosclerosis; Aspirin; Coronary Artery Bypass; Dipyridamole; Hyperlipidemias; Lipid Metabolism; Macaca; Male; Platelet Adhesiveness; Saphenous Vein | 1982 |
[Problems of the operated patient and suggestions for their treatment].
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Anticoagulants; Anxiety Disorders; Arrhythmias, Cardiac; Aspirin; Coronary Artery Bypass; Dipyridamole; Hepatitis B; Humans; Pericarditis; Postoperative Care; Postoperative Complications; Transfusion Reaction; Vasodilator Agents | 1982 |
Focal mesangial proliferative glomerulonephritis in the rat caused by Habu venom: the effect of antiplatelet agents.
Topics: Animals; Aspirin; Blood Platelets; Dipyridamole; Epoprostenol; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Male; Platelet Count; Prostaglandins; Rats; Rats, Inbred Lew; Snake Venoms | 1980 |
The anti-thrombotic effects of prostacyclin.
Topics: Animals; Arteries; Aspirin; Cardiovascular Diseases; Dipyridamole; Epoprostenol; Fatty Acids; Hemostasis; Homeostasis; Humans; Lipid Peroxides; Platelet Aggregation; Prostaglandins; Thrombosis; Thromboxane A2 | 1980 |
Antiplatelet therapy.
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Epoprostenol; Female; Heart Valve Prosthesis; Humans; Male; Platelet Aggregation; Sulfinpyrazone; Thrombophlebitis | 1981 |
Ineffectiveness of aspirin and dipyridamole in the treatment of thrombotic thrombocytopenic purpura.
Topics: Adolescent; Adult; Aged; Aspirin; Dipyridamole; Epistaxis; Epoprostenol; Female; Gastrointestinal Hemorrhage; Glucocorticoids; Humans; Male; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Subarachnoid Hemorrhage | 1982 |
Effect of dipyridamole and prostacyclin on rabbit platelet adherence in vitro and in vivo.
Topics: Animals; Aorta; Aspirin; Blood Platelets; Cell Adhesion; Dipyridamole; Endothelium; Epoprostenol; In Vitro Techniques; Microscopy, Electron; Prostaglandins; Rabbits; Thrombosis | 1982 |
Platelets and coronary heart disease: therapy update.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Epoprostenol; Hemostasis; Humans; Propranolol; Prostaglandin Antagonists; Risk; Sulfinpyrazone; Thromboxane A2 | 1982 |
The use of platelet inhibitors in migraine.
Topics: Adult; Aged; Aspirin; Blood Platelets; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Migraine Disorders; Platelet Aggregation; Serotonin | 1982 |
Antiplatelet therapy reduces aortic intimal hyperplasia distal to small diameter vascular prostheses (PTFE) in nonhuman primates.
Topics: Animals; Aorta, Abdominal; Aortic Diseases; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Dipyridamole; Hyperplasia; In Vitro Techniques; Macaca fascicularis; Male; Polytetrafluoroethylene | 1982 |
Platelet aggregation in focal cerebral ischemia -a clinical study.
Topics: Adult; Aged; Aspirin; Brain Ischemia; Dipyridamole; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation | 1982 |
Aspirin to prevent arterial thrombosis.
Topics: Arteries; Aspirin; Blood Platelets; Dipyridamole; Female; Humans; Male; Thrombosis | 1982 |
[Intraocular hemorrhage due to systemic drugs].
Topics: Adult; Aged; Aspirin; Dipyridamole; Eye Diseases; Female; Hemorrhage; Humans; Male; Middle Aged; Quinidine; Warfarin | 1982 |
[Platelet function inhibition and anticoagulation in coronary, cerebral and peripheral arterial occlusive disease. 2. Secondary prevention].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Dipyridamole; Female; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Platelet Aggregation; Sex Factors; Thrombosis | 1982 |
Atrophie blanche. Report of two patients treated with aspirin and dipyridamole.
Topics: Aged; Aspirin; Atrophy; Dipyridamole; Female; Humans; Middle Aged; Platelet Aggregation; Skin; Vasculitis | 1982 |
[Inhibition of platelet function in pediatric medicine (author's transl)].
Topics: Age Factors; Aspirin; Child; Dipyridamole; Glomerulonephritis; Graft Rejection; Heart Defects, Congenital; Heart Valve Prosthesis; Hemolytic-Uremic Syndrome; Humans; Mucocutaneous Lymph Node Syndrome; Renal Dialysis; Thrombosis | 1982 |
Bioavailability of acetylsalicylic acid and salicylic acid from rapid-and slow-release formulations, and in combination with dipyridamol.
Topics: Adult; Aspirin; Biological Availability; Delayed-Action Preparations; Dipyridamole; Female; Humans; Kinetics; Male; Salicylates; Salicylic Acid | 1982 |
[Prevention of cardiovascular diseases by inhibitors of platelet aggregation (author's transl)].
Topics: Anti-Inflammatory Agents; Aspirin; Cardiovascular Diseases; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1982 |
Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension.
Topics: Adolescent; Adult; Aspirin; Diazoxide; Dipyridamole; Female; Hemodynamics; Humans; Hydralazine; Hypertension, Pulmonary; Indomethacin; Isoproterenol; Isosorbide Dinitrate; Middle Aged; Phentolamine; Prostaglandin Antagonists; Tolazoline; Vascular Resistance; Vasodilator Agents | 1982 |
Antiplatelet therapy in atrophie blanche and livedo vasculitis.
Topics: Adult; Aged; Aspirin; Atrophy; Blood Platelets; Dipyridamole; Female; Humans; Male; Middle Aged; Platelet Function Tests; Skin Diseases; Vasculitis | 1982 |
New approach in migraine prevention.
Topics: Aspirin; Dipyridamole; Humans; Migraine Disorders | 1982 |
Effect of platelet aggregation inhibitors on the rate of thrombectomy following arterial reconstructions with Gore-Tex prostheses: a retrospective study.
Topics: Aspirin; Blood Vessel Prosthesis; Dipyridamole; Humans; Ischemia; Leg; Platelet Aggregation; Postoperative Complications; Retrospective Studies; Thrombophlebitis | 1982 |
Aspirin and dipyridamole inhibit endothelial healing.
Topics: Animals; Aorta, Thoracic; Aspirin; Dipyridamole; Endothelium; Male; Rabbits; Regeneration | 1982 |
Blood platelets and neurological dysfunction.
Topics: Aspirin; Blood Platelets; Child; Dipyridamole; Humans; Ischemic Attack, Transient; Migraine Disorders; Nervous System Diseases; Platelet Adhesiveness; Platelet Aggregation; Serotonin | 1982 |
[Preventive drug therapy of transient cerebral ischemic attacks].
Topics: Anticoagulants; Aspirin; Dipyridamole; Humans; Ischemic Attack, Transient; Platelet Aggregation; Sulfinpyrazone | 1982 |
Immunosuppression and the additive effect of plasma exchange in treatment of rapidly progressive glomerulonephritis.
Topics: Adult; Aged; Anti-Glomerular Basement Membrane Disease; Antibodies; Aspirin; Azathioprine; Cyclophosphamide; Dipyridamole; Female; Follow-Up Studies; Glomerulonephritis; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Plasma Exchange; Prednisolone; Prognosis | 1982 |
[The course of pregnancy in patients with artificial valves].
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Heart Valve Prosthesis; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Cardiovascular | 1982 |
Inhibitors of immune complex induced human platelet aggregation and release in plasma.
Topics: Antibodies; Antigen-Antibody Complex; Aspirin; Blood Platelets; Depression, Chemical; Dipyridamole; DNA; Humans; Imidazoles; Indomethacin; Lupus Erythematosus, Systemic; Male; Platelet Aggregation; Quinazolines; Receptors, Fc; Sulfinpyrazone | 1982 |
Thrombotic thrombocytopenic purpura: combined treatment with plasmapheresis and antiplatelet agents.
Topics: Adult; Aged; Aspirin; Dipyridamole; Female; Humans; Male; Middle Aged; Plasmapheresis; Prednisone; Purpura, Thrombotic Thrombocytopenic; Splenectomy | 1980 |
Thrombotic thrombocytopenic purpura.
Topics: Adrenal Cortex Hormones; Aspirin; Dipyridamole; Exchange Transfusion, Whole Blood; Humans; Plasmapheresis; Purpura, Thrombotic Thrombocytopenic; Splenectomy | 1980 |
Thrombotic thrombocytopenic purpura.
Topics: Adult; Aspirin; Blood Transfusion; Dipyridamole; Female; Humans; Prednisone; Purpura, Thrombotic Thrombocytopenic; Sulfinpyrazone | 1980 |
[Thrombotic thrombocytopenic purpura: report on 5 cases and current therapy concepts].
Topics: Adult; Aspirin; Dipyridamole; Evaluation Studies as Topic; Exchange Transfusion, Whole Blood; Female; Humans; Male; Prednisone; Pregnancy; Pregnancy Complications, Hematologic; Prognosis; Purpura, Thrombotic Thrombocytopenic; Splenectomy; Sulfinpyrazone | 1981 |
Treatment of thrombotic thrombocytopenic purpura with combined exchange plasmapheresis and anti-platelet agents.
Topics: Adult; Aged; Aspirin; Dipyridamole; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Plasma Exchange; Plasmapheresis; Platelet Count; Purpura, Thrombotic Thrombocytopenic; Retrospective Studies | 1981 |
Thrombotic thrombocytopenic purpura: prolonged coma with recovery of neurologic function with intensive plasma exchange.
Topics: Aspirin; Coma; Dipyridamole; Female; Humans; Middle Aged; Plasma Exchange; Platelet Count; Prednisolone; Purpura, Thrombotic Thrombocytopenic; Sulfinpyrazone; Vincristine | 1981 |
Elevated platelet-bound IgG associated with an episode of thrombotic thrombocytopenic purpura.
Topics: Aspirin; Blood Platelets; Dipyridamole; Female; Humans; Immunoglobulin G; Middle Aged; Plasma Exchange; Platelet Count; Prednisone; Purpura, Thrombotic Thrombocytopenic | 1981 |
[Thrombotic thrombocytopenic purpura--successful treatment by warfarin and antiplatelet drugs (author's transl)].
Topics: Adult; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Humans; Prednisolone; Purpura, Thrombotic Thrombocytopenic; Warfarin | 1981 |
Aspirin dipyridamole, and thrombotic thrombocytopenic purpura.
Topics: Aspirin; Dipyridamole; Humans; Platelet Aggregation; Purpura, Thrombotic Thrombocytopenic | 1982 |
Modulation of the inhibitory action of prostaglandin E1 on platelet aggregation in rats: a study with ticlopidine, aspirin, dipyridamole and sulfinpyrazone.
Topics: Adenosine Diphosphate; Alprostadil; Animals; Aspirin; Dipyridamole; Male; Phosphorylation; Platelet Aggregation; Prostaglandins E; Rats; Rats, Inbred Strains; Sulfinpyrazone; Thiophenes; Ticlopidine | 1982 |
Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.
Topics: Adult; Aged; Aortic Valve; Aortic Valve Stenosis; Aspirin; Bioprosthesis; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Valve Prosthesis; Humans; Male; Middle Aged; Prospective Studies; Thromboembolism; Warfarin | 1981 |
Scanning electron microscopic and X-ray energy spectrographic analysis of the inner surface of human atherosclerotic carotid plaques.
Topics: Aspirin; Carotid Artery Diseases; Carotid Artery, Internal; Dipyridamole; Female; Humans; Intracranial Arteriosclerosis; Male; Microscopy, Electron, Scanning; Middle Aged; Thrombosis | 1981 |
Indium-111 platelet imaging for detection of platelet deposition in abdominal aneurysms and prosthetic arterial grafts.
Topics: Abdomen; Aged; Aneurysm; Aortic Aneurysm; Arteries; Aspirin; Bioprosthesis; Blood Coagulation; Blood Platelets; Dipyridamole; Humans; Indium; Male; Middle Aged; Radioisotopes; Radionuclide Imaging; Sulfinpyrazone | 1981 |
Gangrene of the toes with palpable peripheral pulses.
Topics: Aged; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Gangrene; Humans; Ischemia; Male; Middle Aged; Platelet Aggregation; Pulse; Tablets, Enteric-Coated; Thrombocytosis; Toes | 1981 |
[Ischemic cerebro-vascular accidents: usefulness of anticoagulant and antiaggregating agents (author's transl)].
Topics: Aged; Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Dipyridamole; Humans; Platelet Aggregation | 1981 |
Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acids; Aspirin; Blood Platelets; Collagen; Dipyridamole; Dose-Response Relationship, Drug; Female; Humans; Male; Platelet Aggregation; Sulfinpyrazone; Thromboxane B2; Thromboxanes | 1981 |
[Treatment and prevention of thromboembolism with anti-aggregation drugs].
Topics: Aspirin; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone; Thromboembolism | 1981 |
Dietary and pharmacologic control of atherosclerosis regression in cynomolgus macaques (Macaca fascicularis).
Topics: Animals; Antihypertensive Agents; Aorta; Arteriosclerosis; Aspirin; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Collagen; Coronary Vessels; Dextrothyroxine; Dipyridamole; Elastin; Lipids; Lipoproteins, LDL; Macaca fascicularis; Pyrimidines | 1981 |
[Platelet anti-aggregants in the prevention of disseminated intravascular coagulation in severe burns].
Topics: Aspirin; Burns; Dipyridamole; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Humans; Platelet Aggregation; Prothrombin Time | 1981 |
Hypoxaemia and the effect of aspirin in thalassaemia.
Topics: Adolescent; Adult; Aspirin; Dipyridamole; Female; Humans; Hypoxia; Male; Middle Aged; Splenectomy; Thalassemia | 1981 |
Actions of aspirin and dipyridamole on lymphocyte activation.
Topics: Animals; Aspirin; Dipyridamole; DNA; Dose-Response Relationship, Drug; Guinea Pigs; In Vitro Techniques; Lymphocyte Activation; Protein Biosynthesis | 1980 |
Endotoxic shock in the primate: effects of aspirin and dipyridamole administration.
Topics: Animals; Aspirin; Blood Coagulation; Blood Pressure; Depression, Chemical; Dipyridamole; Disease Models, Animal; Female; Hemodynamics; Papio; Platelet Aggregation; Regional Blood Flow; Renal Artery; Shock, Septic | 1981 |
Heparin-induced thrombocytopenia: effect of heparin platelet antibody on platelets.
Topics: Adenosine Diphosphate; Adult; Antibodies; Aspirin; Blood Platelets; Complement Fixation Tests; Dipyridamole; Female; Heparin; Humans; Indomethacin; Male; Malondialdehyde; Middle Aged; Platelet Aggregation; Platelet Factor 3; Thrombocytopenia; Thromboxane B2 | 1981 |
[Thrombocytosis. Considerations on a case with intestinal thrombosis diagnosed at the age of 4 months and treated with platelet anti-aggregants].
Topics: Aspirin; Dipyridamole; Female; Humans; Infant; Intestinal Diseases; Thrombocytosis; Thrombosis | 1981 |
The effect of low-dose aspirin and dipyridamole upon atherosclerosis in the rabbit.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Muscle, Smooth, Vascular; Platelet Aggregation; Rabbits | 1981 |
Circulating platelet aggregates: a chronic platelet activation in patients with transient ischaemic attacks.
Topics: Aspirin; Cerebral Angiography; Dipyridamole; Humans; Intracranial Arteriosclerosis; Ischemic Attack, Transient; Middle Aged; Platelet Aggregation | 1980 |
A new therapeutic approach of nephrotic syndrome associated with focal segmental glomerulosclerosis.
Topics: Adolescent; Anticoagulants; Aspirin; Child; Child, Preschool; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Heparin; Humans; Male; Nephrotic Syndrome; Platelet Count; Prednisone | 1980 |
Migraine prophylaxis: a new approach.
Topics: Adult; Aged; Aspirin; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Migraine Disorders; Platelet Adhesiveness; Random Allocation | 1981 |
For your stroke-prone patients: a guide to drug treatment.
Topics: Aged; Antihypertensive Agents; Aspirin; Brain Diseases; Cerebral Angiography; Cerebrovascular Disorders; Diagnosis, Differential; Dipyridamole; Humans; Hypertension; Intracranial Arteriosclerosis; Ischemic Attack, Transient; Platelet Aggregation | 1980 |
Antiplatelet drugs after myocardial infarction.
Topics: Aspirin; Dipyridamole; Humans; Ischemic Attack, Transient; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone | 1980 |
Relationship of plasma anti-heparin activity and platelet survival time in coronary disease.
Topics: Aspirin; Blood Coagulation Factors; Blood Platelets; Cell Survival; Coronary Disease; Dipyridamole; Double-Blind Method; Humans; Indomethacin; Male; Platelet Factor 4; Sulfinpyrazone; Time Factors | 1980 |
Pulmonary thromboembolism. 2. New trends in prophylaxis and therapy.
Topics: Aspirin; Dipyridamole; Fibrinolytic Agents; Heparin; Humans; Platelet Aggregation; Pulmonary Embolism; Vena Cava, Inferior | 1980 |
Prevention of thrombosis with antiplatelet drugs.
Topics: Aspirin; Blood Platelets; Dipyridamole; Humans; Sulfinpyrazone; Thrombosis | 1980 |
Antithrombotic effects of ticlopidine, acetylsalicyclic acid and dipyridamole in vascular shunt model in rats.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Coagulation; Blood Coagulation Tests; Dipyridamole; Fibrinogen; Fibrinolytic Agents; Hematocrit; Male; Platelet Aggregation; Platelet Count; Pyridines; Rats; Serum Globulins; Thiophenes; Ticlopidine | 1980 |
[Effectiveness of the combined use of cardiac glycosides and de-aggregating agents in chronic pulmonary cardiac insufficiency].
Topics: Adult; Aged; Aspirin; Cardiac Glycosides; Chronic Disease; Dipyridamole; Drug Evaluation; Drug Therapy, Combination; Female; Hemodynamics; Humans; Male; Middle Aged; Platelet Aggregation; Pulmonary Heart Disease | 1980 |
Radioimmunoassay of serum thromboxane B2: a simple method of assessing pharmacologic effects on platelet function.
Topics: Aspirin; Blood Coagulation; Blood Platelets; Cross Reactions; Diflunisal; Dipyridamole; Humans; Platelet Aggregation; Radioimmunoassay; Thromboxane B2; Thromboxanes | 1980 |
Studies of myocardial infarction.
Topics: Aspirin; Dipyridamole; Drug Combinations; Gastrointestinal Diseases; Humans; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone | 1980 |
Newer drug therapies for headache.
Topics: Antidepressive Agents; Aspirin; Bromocriptine; Clonidine; Cluster Headache; Dipyridamole; Headache; Humans; Indomethacin; Lithium; Migraine Disorders; Pizotyline; Prednisone; Propranolol | 1980 |
Effects of aspirin and dipyridamole on the degradation of adenosine diphosphate by cultured cells derived from bovine pulmonary artery.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Animals; Aspirin; Cattle; Cells, Cultured; Dipyridamole; Platelet Aggregation; Pulmonary Artery | 1980 |
Hemolytic-uremic syndrome.
Topics: Aspirin; Child; Dipyridamole; Hemolytic-Uremic Syndrome; Humans; Peritoneal Dialysis; Plasma Exchange | 1980 |
Aspirin and dipyridamole therapy in the hemolytic-uremic syndrome.
Topics: Aspirin; Child; Child, Preschool; Dipyridamole; Evaluation Studies as Topic; Female; Hemolytic-Uremic Syndrome; Humans; Infant; Male | 1980 |
[The value of anti-thrombosis agents in acute peripheral obstructions in the extremities].
Topics: Anticoagulants; Aspirin; Dipyridamole; Embolism; Fibrinolytic Agents; Humans; Streptokinase; Thrombosis | 1980 |
[Indications for surgical treatment and medical treatment of atherosclerosis].
Topics: Arteriosclerosis; Aspirin; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Dipyridamole; Humans; Hyperlipidemias; Hypolipidemic Agents; Intracranial Arteriosclerosis; Nicotinic Acids; Sitosterols; Sulfinpyrazone | 1980 |
Platelet survival and the development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history and medical therapy.
Topics: Adult; Aspirin; Blood Platelets; Cell Survival; Coronary Disease; Dipyridamole; Female; Humans; Male; Middle Aged; Smoking | 1981 |
[Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
Topics: Aspirin; Blood Platelet Disorders; Brain Ischemia; Clofibrate; Coronary Disease; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1980 |
[Platelet hyperaggregation premonitory of myocardial infarct? A clinical case report].
Topics: Anticoagulants; Aspirin; Dipyridamole; Heart Block; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Platelet Function Tests | 1981 |
Effect of anticoagulation and inhibition of platelet aggregation on arterial versus venous microvascular thrombosis.
Topics: Animals; Aspirin; Blood Coagulation; Dipyridamole; Femoral Artery; Femoral Vein; Fibrinolytic Agents; Heparin; Male; Microcirculation; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Thrombophlebitis; Thrombosis; Vascular Patency | 1995 |
Pharmacological prophylaxis against postoperative graft occlusion after peripheral vascular surgery: a world-wide survey.
Topics: Anticoagulants; Aspirin; Data Collection; Dipyridamole; Drug Utilization; Graft Occlusion, Vascular; Humans; Peripheral Vascular Diseases; Practice Patterns, Physicians'; Societies, Medical; Ticlopidine; Time Factors; Vascular Surgical Procedures | 1995 |
Low dose anticoagulation after St. Jude Medical prosthesis implantation in patients under 18 years of age.
Topics: Adolescent; Anticoagulants; Aortic Valve; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Postoperative Period; Retrospective Studies; Warfarin | 1995 |
[A case of pregnancy with essential thrombocythemia].
Topics: Adult; Aspirin; Dipyridamole; Female; Heparin; Humans; Pregnancy; Pregnancy Complications, Hematologic; Thrombocythemia, Essential | 1995 |
[5 patients with Takayasu's disease in The Netherlands].
Topics: Adolescent; Adult; Aortography; Arterial Occlusive Diseases; Aspirin; Child; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Prednisone; Takayasu Arteritis | 1995 |
CarboMedics valve in congenital heart disease. Midterm follow-up study of 14 patients.
Topics: Aortic Valve; Aspirin; Child; Dipyridamole; Female; Follow-Up Studies; Heart Defects, Congenital; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Postoperative Complications; Prosthesis Design; Thrombosis; Time Factors; Tricuspid Valve; Warfarin | 1994 |
In vitro model to test the thrombogenicity of coronary stents.
Topics: Adult; Aspirin; Biocompatible Materials; Coronary Thrombosis; Coronary Vessels; Dipyridamole; Heparin; Humans; Male; Partial Thromboplastin Time; Phenprocoumon; Platelet Aggregation; Prothrombin Time; Stainless Steel; Stents; Tantalum | 1994 |
Low-molecular-weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting.
Topics: Anastomosis, Surgical; Aspirin; Dipyridamole; Drug Combinations; Femoral Artery; Graft Occlusion, Vascular; Heparin, Low-Molecular-Weight; Humans; Popliteal Artery; Postoperative Complications; Vascular Patency | 1994 |
High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
Topics: Adult; Age Factors; Aged; Aortic Valve; Aspirin; Bioprosthesis; Dipyridamole; Female; Follow-Up Studies; Heart Valve Prosthesis; Hemorrhage; Humans; Incidence; Male; Middle Aged; Mitral Valve; Postoperative Complications; Proportional Hazards Models; Risk Factors; Survival Analysis; Thromboembolism; Time Factors; Warfarin | 1995 |
Adenosine-mediated inhibition of platelet aggregation by acadesine. A novel antithrombotic mechanism in vitro and in vivo.
Topics: Adenosine; Adenosine Deaminase; Adenosine Kinase; Aminoimidazole Carboxamide; Animals; Aspirin; Blood Physiological Phenomena; Coronary Thrombosis; Coronary Vessels; Dipyridamole; Disease Models, Animal; Dogs; Erythrocytes; Humans; Male; Plasma; Platelet Aggregation; Purinergic P1 Receptor Antagonists; Regional Blood Flow; Ribonucleosides; Theophylline; Tubercidin | 1994 |
Prevention of graft occlusion by aspirin, dipyridamole, and oral anticoagulants.
Topics: Administration, Oral; Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combination; Graft Occlusion, Vascular; Humans; Research Design | 1993 |
Prevention of graft occlusion by aspirin, dipyridamole, and oral anticoagulants.
Topics: Administration, Oral; Anticoagulants; Aspirin; Coronary Artery Bypass; Data Interpretation, Statistical; Dipyridamole; Drug Therapy, Combination; Graft Occlusion, Vascular; Humans | 1993 |
Prevention of thrombus formation on biomaterials exposed to blood using different antiplatelet drugs: experimental study in dogs.
Topics: Animals; Aspirin; Biocompatible Materials; Blood; Dipyridamole; Dogs; Indium Radioisotopes; Male; Platelet Aggregation Inhibitors; Platelet Count; Prostheses and Implants; Thrombosis | 1994 |
[No advantage in the addition of dipyridamole to, or of oral anticoagulants in comparison to, a low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant stenosis following coronary bypass surgery].
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans | 1994 |
The effect of platelet inhibitory therapy on graft thromboresistance.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Dogs; Drug Therapy, Combination; Female; Femoral Artery; Graft Occlusion, Vascular; Pyridines; Radiography; Random Allocation; Thromboxane-A Synthase | 1993 |
Atrophie blanche with onset in childhood.
Topics: Aspirin; Child; Dipyridamole; Drug Therapy, Combination; Humans; Male; Skin Diseases, Vascular; Vasculitis | 1993 |
[Potentiation of the antiplatelet effect of dipyridamole and aspirin by erythrocytes. Study under flow conditions].
Topics: Adenosine; Animals; Aorta, Abdominal; Aspirin; Dipyridamole; Drug Synergism; Erythrocytes; Humans; Muscle, Smooth, Vascular; Perfusion; Platelet Aggregation; Rabbits | 1993 |
[Is it justifiable to use antiplatelet drugs as a universal protection in patients with chronic glomerular damage?].
Topics: Adolescent; Adult; Aged; Aspirin; Chronic Disease; Clinical Protocols; Dipyridamole; Female; Glomerulonephritis; Humans; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation Inhibitors | 1993 |
[No benefit in the addition of dipyridamole to, nor of anticoagulants in comparison to, a low dose of acetylsalicylic acid (50 mg) in the prevention of venous transplant stenosis following coronary bypass surgery].
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Humans; Postoperative Complications; Thrombosis | 1993 |
The role of anticoagulation in the development of pericardial effusion and late tamponade after cardiac surgery.
Topics: Adult; Anticoagulants; Aspirin; Cardiac Surgical Procedures; Cardiac Tamponade; Coronary Artery Bypass; Dipyridamole; Echocardiography; Female; Heart Defects, Congenital; Heart Valves; Heparin; Humans; Male; Pericardial Effusion; Postoperative Complications; Warfarin | 1993 |
Effects of antithrombotic drugs in a rat model of aspirin-insensitive arterial thrombosis.
Topics: Amino Acid Chloromethyl Ketones; Animals; Aspirin; Azepines; Bridged Bicyclo Compounds, Heterocyclic; Carotid Artery Thrombosis; Dipyridamole; Fibrinolytic Agents; Heparin; Male; Oxazoles; Propionates; Rats; Rats, Sprague-Dawley; Thrombolytic Therapy; Ticlopidine; Triazoles; Warfarin | 1993 |
Patency and morphology of fibrous polyurethane vascular prostheses implanted in the femoral artery of dogs after seeding with subcultivated endothelial cells.
Topics: Anastomosis, Surgical; Animals; Aspirin; Blood Vessel Prosthesis; Cells, Cultured; Dipyridamole; Dogs; Drug Administration Schedule; Endothelium, Vascular; Femoral Artery; Fibronectins; Graft Occlusion, Vascular; Microscopy, Electron, Scanning; Polyurethanes; Prosthesis Design; Surface Properties | 1993 |
Low-dose anticoagulant management of patients with St. Jude Medical mechanical valve prostheses.
Topics: Adolescent; Adult; Aged; Anticoagulants; Aortic Valve; Aspirin; Child; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Valve Prosthesis; Hospital Mortality; Humans; Male; Middle Aged; Mitral Valve; Postoperative Care; Postoperative Complications; Prosthesis Design; Turkey; Warfarin | 1993 |
Successful pregnancy outcome with combination therapy in women with the antiphospholipid antibody syndrome.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Heparin; Humans; Prednisone; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Warfarin | 1993 |
The risk of emergency intestinal bleeding among users of acenocoumarin: a population-based cohort study.
Topics: Acenocoumarol; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Cohort Studies; Dipyridamole; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Intestinal Diseases; Male; Middle Aged; Prothrombin Time; Risk Factors | 1993 |
The effect of platelet inhibitory therapy on prosthetic graft maturation.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Dogs; Drug Therapy, Combination; Female; Femoral Artery; Graft Occlusion, Vascular; Graft Survival; Platelet Aggregation Inhibitors; Pyridines; Thromboxane-A Synthase | 1993 |
Antiplatelet therapy in children with left-sided mechanical prostheses.
Topics: Adolescent; Aortic Valve; Aspirin; Child; Child, Preschool; Dipyridamole; Female; Follow-Up Studies; Heart Valve Prosthesis; Hemorrhage; Humans; Infant; Male; Mitral Valve; Patient Compliance; Postoperative Complications; Retrospective Studies; Thromboembolism; Time Factors; Warfarin | 1993 |
Influence of fibrin clot inhibitors on the efficacy of intravesical Bacillus Calmette-Guérin in the treatment of superficial bladder cancer. The Dutch Southeast Cooperative Urological Group.
Topics: Administration, Intravesical; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; BCG Vaccine; Carcinoma in Situ; Carcinoma, Transitional Cell; Coumarins; Dipyridamole; Fibrin; Humans; Male; Random Allocation; Urinary Bladder Neoplasms; Warfarin | 1993 |
Ball valve (Smeloff-Cutter) aortic valve replacement without anticoagulation.
Topics: Actuarial Analysis; Adolescent; Adult; Anticoagulants; Aortic Valve Insufficiency; Aspirin; Child; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Valve Prosthesis; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Survival Analysis | 1995 |
Reduced red cell deformability associated with blood flow and platelet activation: improved by dipyridamole alone or combined with aspirin.
Topics: Adenosine Triphosphate; Aspirin; Blood Circulation; Blood Viscosity; Dipyridamole; Drug Synergism; Erythrocyte Deformability; Erythrocytes; Humans; Perfusion; Platelet Activation; Platelet Aggregation Inhibitors | 1995 |
Reduction of haemorrhagic complications during mechanically assisted circulation with the use of a multi-system anticoagulation protocol.
Topics: Adolescent; Adult; Antifibrinolytic Agents; Antithrombin III; Aprotinin; Aspirin; Assisted Circulation; Cardiac Surgical Procedures; Child; Child, Preschool; Dipyridamole; Drug Therapy, Combination; Extracorporeal Membrane Oxygenation; Female; Heart-Assist Devices; Hemorrhage; Hemostatics; Heparin; Humans; Infant; Longitudinal Studies; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Serine Proteinase Inhibitors | 1995 |
In vivo evaluation of antiplatelet agents in gerbil model of carotid artery thrombosis.
Topics: Animals; Aspirin; Carotid Artery Diseases; Carotid Artery Injuries; Carotid Artery, Common; Cerebrovascular Disorders; Dipyridamole; Disease Models, Animal; Drug Evaluation, Preclinical; Endothelium, Vascular; Feasibility Studies; Gerbillinae; Injections, Intravenous; Male; Microscopy, Electron; Platelet Aggregation Inhibitors; Pyridines; Reproducibility of Results; Thrombosis; Ticlopidine | 1996 |
[Prescription of platelet antiaggregants in secondary prevention of ischemic heart disease].
Topics: Age Factors; Aged; Aged, 80 and over; Aspirin; Dipyridamole; Drug Prescriptions; Family Practice; Female; Humans; Male; Medical Audit; Medicine; Myocardial Ischemia; Platelet Aggregation Inhibitors; Prevalence; Primary Health Care; Salicylates; Spain; Specialization; Ticlopidine; Urban Population | 1996 |
Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy.
Topics: Adrenal Cortex Hormones; Anemia, Hemolytic; Aspirin; Dipyridamole; Heart Transplantation; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Plasma; Plasma Exchange; Tacrolimus | 1996 |
[Stroke in young people].
Topics: Adolescent; Adult; Aspirin; Brain Ischemia; Child; Dipyridamole; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Retrospective Studies; Risk Factors; Sex Factors; Ticlopidine | 1996 |
Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease.
Topics: Adult; Anticoagulants; Aspirin; Dipyridamole; Female; Heparin; Humans; Kidney Diseases; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Retrospective Studies; Treatment Outcome | 1995 |
[The successful therapy of an exacerbation of mesangioproliferative nephritis during pregnancy].
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diagnosis, Differential; Dipyridamole; Drug Therapy, Combination; Female; Glomerulonephritis, Membranoproliferative; Humans; Nephrotic Syndrome; Parity; Prednisolone; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Second | 1995 |
Effect of aspirin-dipyridamole and heparin and their combination on venous thrombosis in hypercoagulable or thrombotic animals.
Topics: Animals; Aspirin; Blood Coagulation; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Ellagic Acid; Female; Heparin; Infusions, Intravenous; Male; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Thrombosis; Vena Cava, Inferior | 1996 |
Gastrointestinal endoscopy in patients taking antiplatelet agents and anticoagulants: survey of ASGE members. American Society for Gastrointestinal Endoscopy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Colonoscopy; Dipyridamole; Endoscopy, Digestive System; Endoscopy, Gastrointestinal; Heparin; Humans; Platelet Aggregation Inhibitors; Societies, Medical; Sphincterotomy, Endoscopic; Surveys and Questionnaires; United States; Warfarin | 1996 |
Red blood cell aggregability is increased by aspirin and flow stress, whereas dipyridamole induces cell shape alterations: measurements by digital image analysis.
Topics: Aspirin; Cell Size; Cyclooxygenase Inhibitors; Dipyridamole; Drug Interactions; Erythrocyte Aggregation; Erythrocytes; Humans; Image Processing, Computer-Assisted; Platelet Aggregation Inhibitors | 1996 |
Fraud and ethics charges hit stroke drug trial.
Topics: Aspirin; Brain Diseases; Cerebrovascular Disorders; Controlled Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Ethics Committees, Research; Ethics, Medical; Europe; Humans; Multicenter Studies as Topic; Placebos; Platelet Aggregation Inhibitors; Recurrence; Scientific Misconduct | 1996 |
Effect of aspirin plus dipyridamole on the retinal vascular pattern in experimental diabetes mellitus.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Diabetes Mellitus, Experimental; Dipyridamole; Epoprostenol; Male; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Retina; Streptozocin | 1997 |
CAPRIE trial.
Topics: Aspirin; Cerebrovascular Disorders; Clopidogrel; Cost-Benefit Analysis; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine; Treatment Outcome | 1997 |
After peripheral angioplasty should we prescribe both aspirin and Persantin (dipyridamole), or one of them, and how much?
Topics: Angioplasty, Balloon; Aspirin; Dipyridamole; Humans; Platelet Aggregation Inhibitors | 1997 |
Aspirin and stroke.
Topics: Aspirin; Cerebrovascular Disorders; Controlled Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Ethics, Medical; Humans; Placebos; Scientific Misconduct | 1997 |
[Progression of livedo vasculitis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Dipyridamole; Disease Progression; Female; Humans; Male; Middle Aged; Sneddon Syndrome | 1996 |
Comparison of arterial and venous patency in a rat model of subendothelium-stimulated thrombosis.
Topics: Animals; Anticoagulants; Arteries; Aspirin; Dipyridamole; Endothelium, Vascular; Femoral Vein; Heparin; Male; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Lew; Thrombosis; Vascular Patency; Veins | 1996 |
Inappropriate practices in prescribing: who decides and how.
Topics: Aged; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Prescriptions; Drug Therapy, Combination; Humans; Ontario; Randomized Controlled Trials as Topic | 1997 |
Anticoagulation in children with mechanical valve prostheses.
Topics: Adolescent; Anticoagulants; Aspirin; Child; Child, Preschool; Dipyridamole; Female; Heart Valve Prosthesis; Humans; Infant; Male; Platelet Aggregation Inhibitors; Prospective Studies; Thromboembolism; Warfarin | 1997 |
Spectrofluorometric estimation of aspirin and dipyridamole in pure admixtures and in dosage forms.
Topics: Aspirin; Dipyridamole; Drug Combinations; Spectrometry, Fluorescence; Vasodilator Agents | 1997 |
Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
Topics: Aspirin; Brain Ischemia; Cerebrovascular Disorders; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Vasodilator Agents | 1997 |
Glutaraldehyde treated bovine pericardium: changes in calcification due to vitamins and platelet inhibitors.
Topics: Animals; Ascorbic Acid; Aspirin; Biological Transport; Bioprosthesis; Calcinosis; Calcium; Calcium Phosphates; Cattle; Dipyridamole; Drug Combinations; Fixatives; Glutaral; Microscopy, Electron, Scanning; Pericardium; Platelet Aggregation Inhibitors; Pyridoxine; Vitamin E; Vitamins | 1997 |
[Comparative efficiency of 1 direct and 2 indirect methods for the detection of differences in erythrocyte aggregation, in normal blood and in blood with echinocytosis].
Topics: Aspirin; Blood Sedimentation; Blood Viscosity; Centrifugation; Dipyridamole; Erythrocyte Aggregation; Erythrocytes, Abnormal; Hematology; Humans; Image Processing, Computer-Assisted; Microscopy | 1997 |
[Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses].
Topics: Acenocoumarol; Adult; Aged; Anticoagulants; Aspirin; Coronary Disease; Dipyridamole; Drug Evaluation; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Stents; Thrombosis; Ticlopidine | 1997 |
[Atypical and incomplete Kawasaki disease].
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Humans; Immunoglobulins, Intravenous; Infant; Male; Mucocutaneous Lymph Node Syndrome; Platelet Aggregation Inhibitors | 1997 |
[Primary antiphospholipid syndrome in obstetrics. Apropos of 4 cases with fetal survival].
Topics: Adult; Anti-Inflammatory Agents; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Heparin; Humans; Prednisone; Pregnancy; Pregnancy Complications | 1996 |
Secondary prevention of stroke--new trials.
Topics: Aged; Aspirin; Cerebrovascular Disorders; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Ticlopidine | 1998 |
Carotid-subclavian bypass for subclavian artery revascularization: long-term follow-up and effect of antiplatelet therapy.
Topics: Adult; Aged; Angiography; Anticoagulants; Arm; Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Carotid Arteries; Dipyridamole; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Ischemia; Longitudinal Studies; Male; Middle Aged; Platelet Aggregation Inhibitors; Polyethylene Terephthalates; Polytetrafluoroethylene; Prosthesis Design; Retrospective Studies; Saphenous Vein; Subclavian Artery; Ultrasonography; Vascular Patency; Vertebrobasilar Insufficiency | 1998 |
[Atrial fibrillation and thromboembolism: a multicenter cooperative study. Research Group for Antiarrhythmic Drug Therapy].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Dipyridamole; Female; Heart Diseases; Humans; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Prevalence; Prognosis; Retrospective Studies; Risk Factors; Thromboembolism; Ticlopidine; Warfarin | 1998 |
Indobufen compared with aspirin and dipyridamole on graft patency after coronary artery bypass surgery: results of a combined analysis.
Topics: Aspirin; Coronary Artery Bypass; Cyclooxygenase Inhibitors; Dipyridamole; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Isoindoles; Male; Middle Aged; Phenylbutyrates; Platelet Aggregation Inhibitors; Radiography; Randomized Controlled Trials as Topic | 1998 |
[Predictive factors for development of hemolytic uremic syndrome (HUS) and early intensive treatments for prevention of HUS enterohemorrhagic Escherichia coli infection].
Topics: Abdominal Pain; Adolescent; Age Factors; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Diarrhea; Dipyridamole; Escherichia coli Infections; Female; Fever; Fosfomycin; gamma-Globulins; Glycoproteins; Hemolytic-Uremic Syndrome; Humans; Kidney Diseases; Leukocyte Count; Liver Diseases; Male; Melena; Platelet Aggregation Inhibitors; Risk Factors; Sex Factors; Time Factors | 1997 |
[An acetylsalicylic acid-dypiridamole combination (Asasantine) in the prevention of the recurrence of cerebrovascular accidents (a cost-effectiveness analysis)].
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Belgium; Cerebrovascular Disorders; Cost-Benefit Analysis; Costs and Cost Analysis; Delayed-Action Preparations; Dipyridamole; Disease-Free Survival; Drug Combinations; Drug Costs; Economics, Pharmaceutical; Follow-Up Studies; Humans; Markov Chains; Placebos; Platelet Aggregation Inhibitors; Recurrence; Sensitivity and Specificity; Social Security | 1998 |
Changes in pericardial calcification due to antiplatelet agents: in vitro studies.
Topics: Anesthetics, Intravenous; Animals; Anti-Bacterial Agents; Aspirin; Bioprosthesis; Calcinosis; Cattle; Dipyridamole; Gentamicins; Glutaral; In Vitro Techniques; Pericardium; Platelet Aggregation Inhibitors; Thiopental; Tissue Fixation; Vitamins | 1998 |
[Thrombosis prophylaxis after cerebrovascular attack].
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Intracranial Embolism and Thrombosis; Platelet Aggregation Inhibitors; Thrombolytic Therapy | 1998 |
Physical activity, dyspnea, and chest pain before and after coronary artery bypass grafting in relation to a history of diabetes.
Topics: Activities of Daily Living; Aspirin; Chest Pain; Coronary Artery Bypass; Diabetic Angiopathies; Dipyridamole; Dyspnea; Female; Humans; Internal Mammary-Coronary Artery Anastomosis; Male; Middle Aged; Physical Exertion; Postoperative Period; Surveys and Questionnaires; Sweden | 1998 |
Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts.
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Internal Mammary-Coronary Artery Anastomosis; Saphenous Vein; Sulfinpyrazone; Ticlopidine | 1998 |
Effect of platelet inhibitors on thromboembolism after implantation of a Novacor N100--preliminary results.
Topics: Anticoagulants; Aspirin; Case-Control Studies; Dipyridamole; Female; Heart-Assist Devices; Heparin; Humans; Male; Middle Aged; Phenprocoumon; Platelet Aggregation Inhibitors; Thromboembolism | 1998 |
[Method of quantitative measurement of human platelet aggregation in clinical practice].
Topics: Adenosine Diphosphate; Adult; Aged; Aspirin; Dipyridamole; Epinephrine; Female; Humans; Male; Methods; Middle Aged; Myocardial Ischemia; Platelet Aggregation; Platelet Aggregation Inhibitors; Trapidil | 1998 |
Aspirin and dipyridamole for the secondary prevention of stroke.
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Combinations; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Reproducibility of Results; Treatment Outcome | 1999 |
[Substantiation of complex surgical treatment of inguinal hernia in children based on pathogenetic criteria].
Topics: Age Factors; Antioxidants; Ascorbic Acid; Aspirin; Blood-Testis Barrier; Child; Dipyridamole; Hernia, Inguinal; Humans; Hyperbaric Oxygenation; Infant; Infant, Newborn; Inosine Diphosphate; Ischemia; Male; Microcirculation; Platelet Aggregation Inhibitors; Postoperative Care; Testis; Vasodilator Agents | 1998 |
Application of the findings of the European Stroke Prevention Study 2 (ESPS-2) to a New Zealand ischaemic stroke cost analysis.
Topics: Aspirin; Brain Ischemia; Costs and Cost Analysis; Dipyridamole; Health Care Costs; Humans | 1997 |
Drug utilization review: dipyridamole plus aspirin antiplatelet therapy.
Topics: Aspirin; Blood Platelets; California; Dipyridamole; Drug Utilization; Humans | 1985 |
Secondary stroke prevention with drugs: single or combined therapy?
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Ticlopidine | 1999 |
Platelet aggregating activity of plasma in patients with thrombotic thrombocytopenic purpura evaluated by a particle counting method using light scattering.
Topics: Adolescent; Adult; Aspirin; Dipyridamole; Female; Humans; Light; Male; Middle Aged; Particle Size; Platelet Aggregation; Platelet Aggregation Inhibitors; Purpura, Thrombocytopenic | 1999 |
[Dipyridamole plus acetylsalicylic acid--who is to be trusted?].
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Vasodilator Agents | 1999 |
Corticosteroids in the treatment of the acute phase of Kawasaki disease.
Topics: Acute Disease; Aspirin; Child, Preschool; Coronary Aneurysm; Dipyridamole; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Male; Mucocutaneous Lymph Node Syndrome; Prednisolone; Propranolol; Retrospective Studies | 1999 |
Changes in prostacyclin, thromboxane A2 and F2-isoprostanes, and influence of eicosapentaenoic acid and antiplatelet agents in patients with hypertension and hyperlipidemia.
Topics: Aspirin; Dinoprost; Dipyridamole; Eicosapentaenoic Acid; Epoprostenol; Humans; Hyperlipidemias; Hypertension; Platelet Aggregation Inhibitors; Thromboxane A2; Ticlopidine | 1999 |
Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aortic Valve; Aspirin; Child; Dipyridamole; Drug Therapy, Combination; Female; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Mitral Valve; Platelet Aggregation Inhibitors; Postoperative Care; Prosthesis Design; Retrospective Studies; Survival Rate; Thromboembolism; Warfarin | 1999 |
From the Food and Drug Administration.
Topics: Aspirin; Dipyridamole; Drug Combinations; Equipment Reuse; Humans; Platelet Aggregation Inhibitors; Quality Control; Reagent Kits, Diagnostic; Stroke; United States; United States Food and Drug Administration | 2000 |
FDA approves new drug to reduce risk of stroke.
Topics: Aspirin; Dipyridamole; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Stroke; United States; United States Food and Drug Administration | 2000 |
Aspirin and dipyridamole for stroke prevention.
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke | 2000 |
[Bone marrow transplantation-associated thrombotic microangiopathy manifested by visual disturbance].
Topics: Adult; Aspirin; Bone Marrow Transplantation; Dipyridamole; Female; Humans; Leukemia, Myeloid, Acute; Microcirculation; Plasma; Prednisolone; Recurrence; Retinal Vessels; Thrombosis; Treatment Outcome; Vision Disorders | 2000 |
Aggrenox: a combination of antiplatelet drugs for stroke prevention.
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Clinical Trials as Topic; Dipyridamole; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Fees, Pharmaceutical; Humans; Platelet Aggregation Inhibitors; Stroke | 2000 |
An in-vitro model to study device-induced thrombosis and embolism: evaluation of the efficacy of tirofiban, aspirin, and dipyridamole.
Topics: Animals; Anticoagulants; Aspirin; Blood Flow Velocity; Cattle; Dipyridamole; Dose-Response Relationship, Drug; Edetic Acid; Embolism; Equipment and Supplies; Equipment Design; Evaluation Studies as Topic; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Scattering, Radiation; Stents; Thrombosis; Tirofiban; Tyrosine | 2000 |
Changes in platelet activation associated with left ventricular assist system placement.
Topics: Annexin A5; Anticoagulants; Antigens, CD; Aspirin; Blood Platelets; Dipyridamole; Heart Transplantation; Heart-Assist Devices; Heparin; Humans; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Tetraspanin 30; Thrombin | 2000 |
Supplement to the AHA guidelines for the management of transient ischemic attacks.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors | 2000 |
Effect of dipyridamole and aspirin on the platelet-neutrophil interaction via the nitric oxide pathway.
Topics: Adult; Aspirin; Blood Platelets; Cyclic GMP; Dipyridamole; Dose-Response Relationship, Drug; Humans; Male; Neutrophils; Nitric Oxide; Platelet Aggregation; Platelet Aggregation Inhibitors | 2000 |
Outcome in patients with symptomatic occlusion of the internal carotid artery.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Carotid Artery, Internal; Carotid Stenosis; Cohort Studies; Dipyridamole; Drug Therapy, Combination; Endarterectomy, Carotid; Female; Heparin; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Survival Rate; Treatment Outcome | 2000 |
Dipyridamole plus aspirin in cerebrovascular disease.
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Research Design; Risk Assessment; Scientific Misconduct; Stroke; Treatment Outcome | 2000 |
Aspirin plus extended-release dipyridamole or clopidogrel compared with aspirin monotherapy for the prevention of recurrent ischemic stroke: a cost-effectiveness analysis.
Topics: Aspirin; Clopidogrel; Cost-Benefit Analysis; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Recurrence; Stroke; Ticlopidine | 2000 |
Antiplatelet drugs in cardiovascular prevention: take adverse effects and costs into account.
Topics: Aspirin; Cardiovascular Diseases; Cost-Benefit Analysis; Dipyridamole; Drug Costs; Flurbiprofen; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 2000 |
Antiplatelet drugs in cardiovascular prevention: stroke: acute phase and secondary prevention.
Topics: Anticoagulants; Arrhythmia, Sinus; Aspirin; Atrial Fibrillation; Cost-Benefit Analysis; Dipyridamole; Drug Therapy, Combination; Heparin; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2000 |
Cost-effectiveness of new antiplatelet regimens used as secondary prevention of stroke or transient ischemic attack.
Topics: Aged; Aspirin; Clopidogrel; Cost-Benefit Analysis; Decision Trees; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Markov Chains; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Recurrence; Stroke; Ticlopidine | 2000 |
Alert to physicians: possible interaction of aggrenox and adenosine.
Topics: Adenosine; Aspirin; Aspirin, Dipyridamole Drug Combination; Brain Ischemia; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Drug Interactions; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Vasodilator Agents | 2000 |
[New antiplatelet agents].
Topics: Abciximab; Acetates; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clopidogrel; Cyclooxygenase Inhibitors; Dipyridamole; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Ticlopidine; Tirofiban; Tyrosine | 2000 |
[Calculation of costs of stroke, cost effectiveness of stroke units and secondary prevention in patients after a stroke, as recommended by revised CBO practice guideline 'Stroke'].
Topics: Age Factors; Aspirin; Clopidogrel; Cost-Benefit Analysis; Dipyridamole; Drug Costs; Health Care Costs; Humans; Intensive Care Units; Length of Stay; Models, Economic; Netherlands; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Secondary Prevention; Sex Factors; Stroke; Ticlopidine | 2000 |
[Old and new platelet aggregation inhibitors: which to choose for prevention of stroke?].
Topics: Aspirin; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Ticlopidine | 2000 |
[Prevention of thromboembolic disease in patients with heart disease].
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cross-Sectional Studies; Dipyridamole; Female; Heart Diseases; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Salicylates; Sex Factors; Thromboembolism; Ticlopidine | 2000 |
Transient ischemic attacks after dipyridamole-aspirin therapy.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Recurrence; Stroke; Vasodilator Agents | 2000 |
Aggrenox and stress testing.
Topics: Adenosine; Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Humans; Ischemia; Platelet Aggregation Inhibitors; Stroke; Vasodilator Agents | 2001 |
Newer antiplatelet therapies in stroke prevention.
Topics: Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2001 |
Antiplatelet agents in tissue factor-induced blood coagulation.
Topics: Abciximab; Adult; Alprostadil; Animals; Antibodies, Monoclonal; Antithrombin III; Aspirin; Blood Coagulation; Dipyridamole; Eptifibatide; Fibrinopeptide A; Humans; Immunoglobulin Fab Fragments; Mice; Osteonectin; Partial Thromboplastin Time; Peptide Hydrolases; Peptides; Plant Proteins; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Proteins; Prothrombin Time; Receptors, Thrombin; Thromboplastin | 2001 |
Sensory perineuritis presented as a mononeuritis multiplex associated with livedo vasculitis.
Topics: Anabolic Agents; Aspirin; Biopsy; Danazol; Diagnosis, Differential; Dipyridamole; Drug Therapy, Combination; Humans; Male; Middle Aged; Mononeuropathies; Platelet Aggregation Inhibitors; Skin Diseases, Vascular; Sural Nerve; Treatment Outcome | 2001 |
Second stroke.
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Chemoprevention; Dipyridamole; Drug Approval; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Recurrence; Stroke; United States; United States Food and Drug Administration | 2000 |
Is treatment with aspirin combined with dipyridamole really more cost-effective than aspirin alone?
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Cost-Benefit Analysis; Dipyridamole; Drug Therapy, Combination; Fees, Pharmaceutical; Humans; Meta-Analysis as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors | 2001 |
Clinical correlates and drug treatment of residents with stroke in long-term care.
Topics: Aged; Aged, 80 and over; Aspirin; Cognition Disorders; Comorbidity; Cross-Sectional Studies; Databases, Factual; Dipyridamole; Drug Therapy, Combination; Female; Humans; Inpatients; Logistic Models; Long-Term Care; Male; Nursing Homes; Odds Ratio; Prevalence; Risk Assessment; Risk Factors; Severity of Illness Index; Stroke; Ticlopidine; United States; Warfarin | 2001 |
[Cardiac involvement in Kawasaki disease. Our experience].
Topics: Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Coronary Aneurysm; Dipyridamole; Echocardiography; Female; Follow-Up Studies; Humans; Immunoglobulins, Intravenous; Infant; Male; Mucocutaneous Lymph Node Syndrome; Platelet Aggregation Inhibitors; Risk Factors; Time Factors | 2001 |
Moyamoya syndrome with spherocytosis: effect of splenectomy on strokes.
Topics: Aspirin; Brain; Child, Preschool; Dipyridamole; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Moyamoya Disease; Platelet Aggregation Inhibitors; Spherocytosis, Hereditary; Splenectomy; Stroke; Treatment Outcome | 2001 |
Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method.
Topics: Adenosine Diphosphate; Amino Acid Chloromethyl Ketones; Aspirin; Blood Coagulation; Blood Platelets; Cilostazol; Collagen; Dipyridamole; Filtration; Heparin; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Pressure; Tetrazoles; Time Factors; Tirofiban; Tyrosine | 2001 |
Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Aspirin; Blood Platelets; Cell Communication; Dipyridamole; Drug Synergism; Flow Cytometry; Humans; Leukocytes; Macrophage-1 Antigen; Monocytes; Neutrophils; P-Selectin; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors | 2001 |
Antithrombotic drugs for secondary stroke prophylaxis--a comment.
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Dipyridamole; Drug Combinations; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2001 |
Antiplatelet therapy: a neurology perspective.
Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Humans; Neurology; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticlopidine; United States | 2000 |
Antiplatelet therapy: a neurology perspective.
Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Humans; Neurology; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticlopidine; United States | 2000 |
Current strategies of secondary prevention after a cerebrovascular event: the Vienna stroke registry.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Austria; Clopidogrel; Cohort Studies; Comorbidity; Contraindications; Cross-Sectional Studies; Dipyridamole; Drug Combinations; Female; Humans; Intracranial Embolism; Ischemic Attack, Transient; Logistic Models; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Registries; Secondary Prevention; Stroke; Ticlopidine | 2001 |
Is acetylsalicylic acid plus dipyridamole superior to ASA alone for secondary prevention of stroke?
Topics: Aged; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke | 2001 |
Malignant atrophic papulosis in an infant.
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Humans; Infant; Platelet Aggregation; Platelet Aggregation Inhibitors; Skin Diseases, Papulosquamous | 2002 |
Adenosine and Aggrenox: a hazardous combination.
Topics: Adenosine; Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Bradycardia; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Drug Interactions; Female; Heart; Humans; Radionuclide Imaging | 2002 |
[Secondary prevention after stroke. 2 platelet inhibitors are better than one].
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Cerebral Infarction; Clinical Trials as Topic; Dipyridamole; Drug Combinations; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Treatment Outcome | 2002 |
Aspirin should be first-line antiplatelet therapy in the secondary prevention of stroke.
Topics: Aspirin; Clopidogrel; Dipyridamole; Dose-Response Relationship, Drug; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Ticlopidine; Treatment Outcome | 2002 |
Aspirin therapy should be first-line treatment in secondary prevention of stroke--against.
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Dipyridamole; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk; Stroke; Ticlopidine; Treatment Outcome | 2002 |
Aspirin therapy should be first line: probably, but watch this space.
Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Synergism; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Treatment Outcome | 2002 |
Effect of acetylsalicylic acid and dipyridamole in primary membranoproliferative glomerulonephritis type I.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Creatinine; Dipyridamole; Drug Therapy, Combination; Female; Glomerulonephritis, Membranoproliferative; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Prospective Studies; Proteinuria; Serum Albumin; Treatment Outcome | 2001 |
Effects of dipyridamole and aspirin on shear-induced platelet aggregation in whole blood and platelet-rich plasma.
Topics: Adult; Arginine; Aspirin; Blood; Dipyridamole; Female; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Stress, Mechanical | 2002 |
Going with the flow of anticoagulant therapy.
Topics: Anticoagulants; Aspirin; Dipyridamole; Heparin; Humans; Patient Education as Topic; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Prothrombin; Pulmonary Embolism; Pyridines; Thoracic Surgery; Thrombophilia; Warfarin | 2003 |
[Anticoagulation and antiaggregation in neurological patients].
Topics: Acute Disease; Administration, Oral; Aged; Anticoagulants; Aspirin; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Meta-Analysis as Topic; Middle Aged; Placebos; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Stroke; Ticlopidine; Warfarin | 2003 |
[Anticoagulation and antiaggregation in patients with peripheral arterial occlusive diseases].
Topics: Administration, Oral; Angioplasty, Balloon; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Confidence Intervals; Dipyridamole; Drug Therapy, Combination; Embolectomy; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Iloprost; Intermittent Claudication; Leg; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Thrombectomy; Ticlopidine; Time Factors; Vitamin K | 2003 |
Benign cutaneous Degos' disease.
Topics: Adult; Aspirin; Dipyridamole; Humans; Male; Platelet Aggregation Inhibitors; Skin Diseases, Papulosquamous | 2003 |
Oral anticoagulation in patients after cerebral ischemia of arterial origin and risk of intracranial hemorrhage.
Topics: Anticoagulants; Arterial Occlusive Diseases; Asia, Southeastern; Aspirin; Brain Ischemia; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Europe; Follow-Up Studies; Humans; Incidence; International Normalized Ratio; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Assessment; Stroke | 2003 |
Antiplatelet agents. European perspective.
Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Europe; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2003 |
Antiplatelet drugs.
Topics: Aspirin; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Primary Prevention; Pulmonary Embolism; Thrombosis; Ticlopidine; Venous Thrombosis | 2003 |
The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions.
Topics: Abciximab; Adenosine Monophosphate; Antibodies, Monoclonal; Aspirin; Blood Platelets; CD11b Antigen; Dipyridamole; Humans; Immunoglobulin Fab Fragments; In Vitro Techniques; Leukocytes; Monocytes; Neutrophils; Oligopeptides; Peptides, Cyclic; Platelet Glycoprotein GPIIb-IIIa Complex; Thiazolidines; Thromboplastin | 2003 |
[Recurrence prophylaxis for stroke patients. Which platelet inhibitor combination protects best?].
Topics: Angiotensin II Type 1 Receptor Blockers; Aspirin; Aspirin, Dipyridamole Drug Combination; Benzimidazoles; Benzoates; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Humans; Middle Aged; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Telmisartan; Ticlopidine | 2003 |
Racial disparities in receipt of secondary stroke prevention agents among US nursing home residents.
Topics: Aged; Anticoagulants; Aspirin; Databases, Factual; Dipyridamole; Drug Therapy, Combination; Drug Utilization Review; Health Services Accessibility; Humans; Nursing Homes; Prejudice; Preventive Medicine; Racial Groups; Risk Reduction Behavior; Secondary Prevention; Stroke; Ticlopidine; United States; Warfarin | 2003 |
[PRoFESS study presented. Change in secondary prevention].
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Aspirin, Dipyridamole Drug Combination; Benzimidazoles; Benzoates; Clopidogrel; Controlled Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Multicenter Studies as Topic; Placebos; Platelet Aggregation Inhibitors; Recurrence; Risk; Stroke; Telmisartan; Ticlopidine; Time Factors | 2003 |
[ASS and dipyridamole combination. A decisive contribution to secondary prevention after stroke].
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Clinical Trials as Topic; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Recurrence; Stroke | 2003 |
[Secondary prevention of ischemic insult and transient cerebral ischemia. Is ASS alone enough?].
Topics: Aspirin; Controlled Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Meta-Analysis as Topic; Phosphodiesterase Inhibitors; Placebos; Platelet Aggregation Inhibitors; Recurrence; Risk; Stroke | 2003 |
[Secondary prevention after stroke. Doubled performs better].
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Controlled Clinical Trials as Topic; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Placebos; Platelet Aggregation Inhibitors; Stroke | 2003 |
[After stroke or TIA. Double protection by second platelet inhibitor].
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Clinical Trials as Topic; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Humans; Ischemic Attack, Transient; Placebos; Practice Guidelines as Topic; Risk; Stroke | 2003 |
Guidelines on the management of secondary prophylaxis of vascular events in stable patients in primary care.
Topics: Acute Disease; Aged; Aspirin; Cardiovascular Diseases; Clopidogrel; Coronary Artery Bypass; Dipyridamole; Endarterectomy, Carotid; Humans; Life Style; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Secondary Prevention; Stents; Ticlopidine; Treatment Outcome | 2004 |
Noncompliance in antiplatelet trials: the AGATE trial perspective.
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Controlled Clinical Trials as Topic; Dipyridamole; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Stroke; Treatment Refusal | 2004 |
Late incidence and determinants of stroke after aortic and mitral valve replacement.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aortic Valve; Aspirin; Atrial Fibrillation; Cerebral Hemorrhage; Comorbidity; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Valve Prosthesis Implantation; Humans; Incidence; International Normalized Ratio; Intracranial Embolism; Life Tables; Male; Middle Aged; Mitral Valve; Postoperative Complications; Proportional Hazards Models; Prospective Studies; Risk Factors; Smoking; Stroke; Ventricular Dysfunction, Left; Warfarin | 2004 |
Economic assessment of the secondary prevention of ischaemic stroke with dipyridamole plus aspirin (Aggrenox/Asasantin) in France.
Topics: Adolescent; Adult; Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Confidence Intervals; Cost-Benefit Analysis; Dipyridamole; Double-Blind Method; Drug Combinations; Female; France; Humans; Male; Middle Aged; Monte Carlo Method; Randomized Controlled Trials as Topic; Retrospective Studies; Stroke | 2004 |
[Asasantin Retard or Persantin Retard+ASA?].
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Practice Patterns, Physicians'; Stroke | 2004 |
[For which patient ASS, clopidogrel or dipyridamole? (interview by Dr. Med. Dirk Einecke)].
Topics: Aspirin; Cerebral Infarction; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Secondary Prevention; Ticlopidine; Treatment Outcome | 2004 |
[ASS plus dipyridamole instead of ASS monotherapy. Risk for second stroke cut in half].
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Cerebral Infarction; Clinical Trials as Topic; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Risk; Secondary Prevention | 2004 |
Antiplatelet therapy.
Topics: Aged; Aspirin; Clopidogrel; Dipyridamole; Drug Interactions; Humans; Myocardial Infarction; Patient Selection; Platelet Aggregation Inhibitors; Stroke; Thromboembolism; Ticlopidine | 2004 |
Dipyridamole selectively inhibits inflammatory gene expression in platelet-monocyte aggregates.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Cell Aggregation; Cell Communication; Chemokine CCL2; Dipyridamole; Gene Expression; Humans; Inflammation Mediators; Matrix Metalloproteinase 9; Monocytes; Platelet Aggregation Inhibitors; Protein Biosynthesis; RNA, Messenger | 2005 |
Oral antiplatelet therapy.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Clopidogrel; Coronary Artery Disease; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 2005 |
[Endothelium and platelets in pregnant women with chronic glomerulonephritis and therapeutic efficacy of acetylsalicylic acid and dipiridamol].
Topics: Administration, Oral; Aspirin; Biomarkers; Blood Platelets; Dipyridamole; Embryo Loss; Endothelium; Female; Glomerulonephritis; Humans; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy | 2004 |
[Summary of the practice guideline 'TIA' (first revision) from the Dutch College of General Practitioners].
Topics: Aspirin; Dipyridamole; Family Practice; Female; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Male; Netherlands; Physicians, Family; Practice Patterns, Physicians' | 2005 |
Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1.
Topics: Adolescent; Aspirin; Biomarkers; Biopsy; Calgranulin A; Calgranulin B; Child; Creatinine; Cyclophosphamide; Dipyridamole; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis, Membranoproliferative; Hematuria; Humans; Kidney Function Tests; Kidney Glomerulus; Macrophages; Male; Methylprednisolone; Platelet Aggregation Inhibitors; Prednisolone; Prognosis; Proteinuria | 2005 |
Efficacy of aspirin plus extended-release dipyridamole in preventing recurrent stroke in high-risk populations.
Topics: Adult; Aged; Aspirin; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention; Stroke | 2005 |
Counting the true cost of antiplatelet therapy for stroke prevention.
Topics: Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Cost-Benefit Analysis; Dipyridamole; Drug Combinations; Female; Gastrointestinal Diseases; Humans; Male; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine; United Kingdom | 2005 |
[Summary of the practice guideline 'TIA' (first revision) from the Dutch College of General Practitioners].
Topics: Aspirin; Dipyridamole; Evidence-Based Medicine; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Treatment Outcome | 2005 |
Use of dipyridamole in patients with recent stroke or TIA.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Myocardial Infarction; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke | 2005 |
The clinical variability of Wallenberg's syndrome. The anatomical correlate of ipsilateral axial lateropulsion.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Brain; Cerebral Infarction; Clopidogrel; Dipyridamole; Functional Laterality; Gait Disorders, Neurologic; Heparin; Humans; Lateral Medullary Syndrome; Magnetic Resonance Imaging; Male; Medulla Oblongata; Neurologic Examination; Platelet Aggregation Inhibitors; Ticlopidine | 2006 |
Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Neurology; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine | 2005 |
Effect of combined treatment with aspirin and dipyridamole on oxidative homeostasis in mouse serum.
Topics: Animals; Antioxidants; Aspirin; Blood; Dipyridamole; Dose-Response Relationship, Drug; Free Radicals; Homeostasis; Luminescent Measurements; Mice; Mice, Inbred C57BL; Oxidation-Reduction; Platelet Aggregation; Platelet Aggregation Inhibitors | 2005 |
Platelet emboli and ischemia in rabbit's brain caused by ADP or arachidonic acid and the protective effect of ASA and dipyridamole.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acid; Aspirin; Dipyridamole; Intracranial Embolism; Ischemic Attack, Transient; Male; Pia Mater; Platelet Aggregation; Rabbits | 1977 |
Antiplatelet drugs in the secondary prevention after stroke: differential efficacy in large versus small vessel disease? A subgroup analysis from ESPS-2.
Topics: Aged; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Dipyridamole; Female; Humans; Male; Middle Aged; Placebos; Platelet Aggregation Inhibitors; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk; Stroke; Time Factors; Treatment Outcome | 2006 |
Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial.
Topics: Algorithms; Arteriovenous Shunt, Surgical; Aspirin; Aspirin, Dipyridamole Drug Combination; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Graft Occlusion, Vascular; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Renal Dialysis; Research Design; Sample Size; Vascular Patency | 2005 |
Dipyridamole decreases protease-activated receptor and annexin-v binding on platelets of post stroke patients with aspirin nonresponsiveness.
Topics: Aged; Aspirin; Cell Culture Techniques; Dipyridamole; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptor, PAR-1; Receptors, Peptide; Stroke | 2006 |
[Peroral antithrombotic treatment].
Topics: Administration, Oral; Antifibrinolytic Agents; Aspirin; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke; Vitamin K | 2006 |
Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Clopidogrel; Dipyridamole; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Esophagitis; Female; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Hematemesis; Humans; Intestinal Mucosa; Male; Middle Aged; Platelet Aggregation Inhibitors; Stomach Ulcer; Ticlopidine; Warfarin | 2006 |
Antiplatelet therapy in stroke prevention: present and future.
Topics: Aspirin; Blood Platelets; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Ticlopidine | 2006 |
[Germany's girths in an international comparison].
Topics: Abdominal Fat; Adult; Anthropometry; Aspirin; Aspirin, Dipyridamole Drug Combination; Body Mass Index; Cardiovascular Diseases; Cerebral Infarction; Combined Modality Therapy; Cross-Cultural Comparison; Dipyridamole; Drug Combinations; Female; Germany; Humans; Male; Practice Guidelines as Topic; Secondary Prevention; United Kingdom | 2005 |
[New DGN-/DSG guidelines].
Topics: Adult; Aspirin; Aspirin, Dipyridamole Drug Combination; Cerebral Infarction; Clinical Trials as Topic; Cross-Cultural Comparison; Dipyridamole; Drug Combinations; Germany; Humans; Ischemic Attack, Transient; Practice Guidelines as Topic; Societies, Medical; United Kingdom | 2005 |
Moyamoya syndrome in a splenectomized patient with beta-thalassemia intermedia.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; beta-Thalassemia; Carotid Arteries; Dipyridamole; Female; Humans; Magnetic Resonance Imaging; Moyamoya Disease; Rare Diseases; Splenectomy; Stroke; Vasodilator Agents | 2006 |
Dipyridamole plus aspirin: the best regimen for stroke prevention after noncardioembolic focal cerebral ischemia.
Topics: Aspirin; Brain Ischemia; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke | 2006 |
Dipyridamole with aspirin for secondary stroke prevention.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dipyridamole; Drug Therapy, Combination; Humans; Randomized Controlled Trials as Topic; Stroke; Vasodilator Agents | 2006 |
Secondary stroke prevention and antiplatelet therapy.
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Stroke | 2006 |
Dipyridamole plus aspirin for stroke prevention.
Topics: Aspirin; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Stroke | 2006 |
Infantile Kawasaki disease and peripheral gangrene.
Topics: Abciximab; Amputation, Surgical; Anti-Bacterial Agents; Antibodies, Monoclonal; Anticoagulants; Antithrombin III; Aspirin; Dipyridamole; Foot; Gangrene; Glucocorticoids; Heparin; Humans; Immunoglobulin Fab Fragments; Immunoglobulins, Intravenous; Infant; Ischemia; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Nitroglycerin; Platelet Aggregation Inhibitors; Vasodilator Agents | 2006 |
ESPRIT trial.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dipyridamole; Humans; Patient Selection; Randomized Controlled Trials as Topic; Reproducibility of Results | 2006 |
ESPRIT trial.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; Dipyridamole; Drug Interactions; Gastrointestinal Hemorrhage; Humans | 2006 |
ESPRIT trial.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Pressure; Brain Ischemia; Dipyridamole; Dose-Response Relationship, Drug; Endpoint Determination; Humans; Secondary Prevention | 2006 |
[The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischaemic attack or cerebral infarction: the debate is closed].
Topics: Anticoagulants; Aspirin; Cerebral Infarction; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Preventive Medicine; Vasodilator Agents | 2006 |
[Prevention of vascular events after transient ischemic attack or cerebral infarct].
Topics: Angioplasty, Balloon; Anticoagulants; Aspirin; Cerebral Infarction; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Hypolipidemic Agents; Ischemic Attack, Transient; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Recurrence; Risk Factors; Stents; Stroke; Ticlopidine; Time Factors; Warfarin | 2006 |
Clinical trials and dipyridamole formulation selection.
Topics: Aspirin; Brain Ischemia; Chemistry, Pharmaceutical; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Humans; Intracranial Embolism; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Research Design; Stroke; Treatment Outcome | 2007 |
Role of antiplatelets in carotid artery stenting.
Topics: Angioplasty, Balloon; Aspirin; Carotid Stenosis; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Eptifibatide; Humans; Peptides; Platelet Aggregation Inhibitors; Stents; Stroke; Ticlopidine | 2007 |
[Combination of acetylsalicylic acid with dipyridamole is better than acetylsalicylic acid monotherapy].
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Humans; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke | 2006 |
Stroke: the dashed hopes of neuroprotection.
Topics: Acute Disease; Aspirin; Benzenesulfonates; Carotid Arteries; Clopidogrel; Dipyridamole; Europe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neuroprotective Agents; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Stroke; Ticlopidine | 2007 |
[The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischaemic attack or cerebral infarction: the debate is closed].
Topics: Aspirin; Cerebral Infarction; Dipyridamole; Headache; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Risk Factors; Vasodilator Agents | 2006 |
[The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischaemic attack or cerebral infarction: the debate is closed].
Topics: Aspirin; Cerebral Infarction; Dipyridamole; Evidence-Based Medicine; Financial Support; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Vasodilator Agents | 2006 |
Emerging therapies: ESPRIT.
Topics: Aspirin; Brain Ischemia; Cerebral Hemorrhage; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Reproducibility of Results; Stroke | 2007 |
TNF-alpha and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents.
Topics: Acute Disease; Adult; Aged; Aspirin; Brain Ischemia; Cells, Cultured; Clopidogrel; Dipyridamole; Female; Humans; In Vitro Techniques; Interleukin-8; Leukocytes; Male; Middle Aged; Piracetam; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Tumor Necrosis Factor-alpha | 2007 |
Update on the use of antiplatelet agents in secondary stroke prevention.
Topics: Arteriosclerosis; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Embolism, Cholesterol; Humans; Platelet Aggregation Inhibitors; Stroke; Thromboembolism; Ticlopidine | 2007 |
Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis.
Topics: Aged; Aspirin; Clopidogrel; Dipyridamole; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Embolism; Endocarditis, Bacterial; Female; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Prevalence; Retrospective Studies; Risk Assessment; Stroke; Ticlopidine | 2007 |
Combination treatment with dipyridamole, aspirin, and tPA in an embolic model of stroke in rats.
Topics: Animals; Aspirin; Brain; Cerebral Infarction; Cerebrovascular Circulation; Dipyridamole; Drug Therapy, Combination; Intracranial Embolism; Male; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Stroke; Tissue Plasminogen Activator | 2007 |
Cerebral ischemia probably related to isotretinoin.
Topics: Adult; Aspirin; Brain Ischemia; Dermatologic Agents; Dipyridamole; Heparin; Humans; Isotretinoin; Male; Platelet Aggregation Inhibitors | 2007 |
Combination shows no advantage over aspirin alone.
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke | 2007 |
Influence of antiplatelet therapy on cerebral micro-emboli after carotid endarterectomy using postoperative transcranial Doppler monitoring.
Topics: Aged; Anticoagulants; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Dextrans; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Endarterectomy, Carotid; Female; Hemorrhage; Humans; Intracranial Embolism; Ischemic Attack, Transient; Male; Middle Aged; Middle Cerebral Artery; Pilot Projects; Platelet Aggregation Inhibitors; Postoperative Care; Randomized Controlled Trials as Topic; Research Design; Stroke; Ticlopidine; Treatment Outcome; Ultrasonography, Doppler, Transcranial | 2007 |
Improving depiction of benefits and harms: analyses of studies of well-known therapeutics and review of high-impact medical journals.
Topics: Antipsychotic Agents; Appetite Depressants; Aspirin; Aspirin, Dipyridamole Drug Combination; Contraceptives, Oral; Decision Making; Dipyridamole; Drug Combinations; Drug Evaluation; Evidence-Based Medicine; Fibrinolytic Agents; Hormone Replacement Therapy; Humans; Information Dissemination; Pharmacoepidemiology; Phenylpropanolamine; Review Literature as Topic; Risk Assessment; Stroke; Tissue Plasminogen Activator | 2007 |
[Antithrombotic therapy in ischemic stroke and transient ischemic attack].
Topics: Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Recurrence; Stroke; Thromboembolism; Ticlopidine | 2007 |
Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Clopidogrel; Combined Modality Therapy; Dipyridamole; Early Ambulation; Enoxaparin; Female; Fibrinolytic Agents; Hematologic Agents; Humans; Intermittent Pneumatic Compression Devices; Male; Middle Aged; Platelet Aggregation Inhibitors; Pulmonary Embolism; Retrospective Studies; Risk Assessment; Thromboembolism; Ticlopidine; Venous Thrombosis; Warfarin | 2007 |
Antiplatelet agents for stroke prevention following transient ischemic attack.
Topics: Angioplasty, Balloon; Aspirin; Carotid Artery Diseases; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Endarterectomy, Carotid; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Stents; Stroke; Ticlopidine | 2008 |
Outcomes associated with combined antiplatelet and anticoagulant therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Cohort Studies; Coronary Artery Disease; Dipyridamole; Drug Therapy, Combination; Female; Hemorrhage; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Thromboembolism; Ticlopidine; Treatment Outcome; Warfarin | 2008 |
The Cataract National Dataset electronic multicentre audit of 55,567 operations: antiplatelet and anticoagulant medications.
Topics: Aged; Anesthetics, Local; Anticoagulants; Aspirin; Blood Loss, Surgical; Cataract Extraction; Choroid Hemorrhage; Clopidogrel; Dipyridamole; Eye Hemorrhage; Humans; Intraoperative Complications; Lens Capsule, Crystalline; Platelet Aggregation Inhibitors; Risk Factors; Rupture; Ticlopidine; Warfarin | 2009 |
Prevention of thrombosis in polycythemia vera and essential thrombocythemia.
Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Hydroxyurea; Janus Kinase 2; Multicenter Studies as Topic; Phlebotomy; Polycythemia Vera; Retrospective Studies; Risk Factors; Severity of Illness Index; Thrombocythemia, Essential; Thrombophilia; Thrombosis; Ticlopidine; Venous Thrombosis | 2008 |
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack.
Topics: Aspirin; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine | 2008 |
Trends in usage of alternative antiplatelet therapy after stroke and transient ischemic attack.
Topics: Aged; Aged, 80 and over; Aspirin; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Prescriptions; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Marketing of Health Services; Middle Aged; Platelet Aggregation Inhibitors; Registries; Stroke; Ticlopidine; United States | 2008 |
[Antiplatelet treatment after acute and chronic ischemic heart and brain events is insufficient according to recommendations].
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Angina Pectoris; Angina, Unstable; Aspirin; Brain Infarction; Brain Ischemia; Clopidogrel; Diabetes Mellitus; Dipyridamole; Drug Therapy, Combination; Female; Guideline Adherence; Humans; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine | 2008 |
Correction to the PRoFESS Trial paper by Diener et al. (Cerebrovasc Dis 2007;23:368-80.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Aspirin, Dipyridamole Drug Combination; Benzimidazoles; Benzoates; Clopidogrel; Data Interpretation, Statistical; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Drug Interactions; Humans; Platelet Aggregation Inhibitors; Telmisartan; Ticlopidine | 2008 |
[Thromboprophylaxis for cerebrovascular disorders: acetylsalicylic acid remains the cornerstone].
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Humans | 2008 |
Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
Topics: Adult; Aged; Anticoagulants; Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Prescriptions; Drug Therapy, Combination; Female; Fibrinolytic Agents; Health Care Surveys; Humans; Hungary; Male; Middle Aged; Neurology; Platelet Aggregation; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Stroke; Surveys and Questionnaires; Ticlopidine | 2008 |
Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Topics: Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Evidence-Based Medicine; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Injections, Intravenous; Injections, Subcutaneous; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Stroke; Thrombolytic Therapy; Ticlopidine; Tissue Plasminogen Activator | 2008 |
[ASS plus dipyridamole or clopidogrel after stroke: what is the best secondary prevention?].
Topics: Aspirin; Cerebral Infarction; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Germany; Humans; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Secondary Prevention; Ticlopidine | 2008 |
[Secondary stroke prevention according to the PRoFESS Study. What are the sequelae for practical therapy?].
Topics: Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Germany; Humans; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Recurrence; Stroke; Ticlopidine | 2008 |
Does Aggrenox (aspirin/dipyridamole) reduce the risk of recurrent stroke to a greater degree than aspirin alone?
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Recurrence; Stroke | 2008 |
The PRoFESS trial results: what went wrong?
Topics: Aspirin; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Ticlopidine | 2008 |
Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
Topics: Age Factors; Aged; Aspirin; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Risk Assessment; Stroke; Ticlopidine; Time Factors | 2006 |
Stroke prevention--insights from incoherence.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk; Secondary Prevention; Stroke; Telmisartan; Ticlopidine | 2008 |
Is the finding of the PROFESS study consistent with predictions of network meta-analysis?
Topics: Aspirin; Bayes Theorem; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Stroke | 2008 |
[Inhibition of platelet aggregation and angiotensin II-receptor blockade following TIA; the unexpected results of the Prevention Regimen For Effectively Avoiding Second Strokes (PROFESS) trial].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Aspirin; Benzimidazoles; Benzoates; Clopidogrel; Cost-Benefit Analysis; Dipyridamole; Headache; Humans; Platelet Aggregation Inhibitors; Stroke; Telmisartan; Ticlopidine | 2008 |
Antiplatelets for stroke prevention: implications of the PRoFESS trial.
Topics: Aspirin; Cerebral Hemorrhage; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Heart Diseases; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Ticlopidine | 2009 |
Aggrenox (Asasantin retard)-induced Stevens-Johnson syndrome.
Topics: Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Female; Humans; Stevens-Johnson Syndrome | 2009 |
Bleeding risks with combination of oral anticoagulation plus antiplatelet therapy: is clopidogrel any safer than aspirin when combined with warfarin?
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Coagulation; Clopidogrel; Coumarins; Dipyridamole; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Platelet Aggregation Inhibitors; Registries; Risk Assessment; Risk Factors; Ticlopidine; Warfarin | 2008 |
Effect of oral antiplatelet agents on major bleeding in users of coumarins.
Topics: Acenocoumarol; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Coagulation; Case-Control Studies; Clopidogrel; Coumarins; Dipyridamole; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Logistic Models; Male; Medical Records Systems, Computerized; Middle Aged; Netherlands; Odds Ratio; Phenprocoumon; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Vitamin K | 2008 |
[Incremental cost-effectiveness of dipyridamole + acetylsalicylic acid in secondary prevention of ischemic noncardioembolic stroke].
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cause of Death; Cerebral Infarction; Cost Savings; Cost-Benefit Analysis; Cross-Sectional Studies; Decision Support Techniques; Dipyridamole; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Female; Germany; Humans; Incidence; Long-Term Care; Male; Markov Chains; Middle Aged; National Health Programs; Platelet Aggregation Inhibitors; Secondary Prevention; Survival Rate | 2008 |
Risk indicators for development of headache during dipyridamole treatment after cerebral ischaemia of arterial origin.
Topics: Aged; Aspirin; Brain Ischemia; Cerebral Arteries; Dipyridamole; Drug Therapy, Combination; Female; Headache; Humans; Hypertension; Male; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Factors; ROC Curve; Sex Factors; Smoking; Stroke | 2009 |
Does the combination of warfarin and aspirin have a place in secondary stroke prevention? Yes.
Topics: Anticoagulants; Aspirin; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk; Stroke; Ticlopidine; Warfarin | 2009 |
The use of aspirin and dipyridamole in the treatment of acute ischaemic stroke/transient ischaemic attack: an audit-based discussion.
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Medical Audit; Platelet Aggregation Inhibitors; Stroke; Surveys and Questionnaires; United Kingdom; Vasodilator Agents | 2009 |
Antiplatelet therapy and vascular-access patency.
Topics: Aspirin; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Graft Occlusion, Vascular; Humans; Platelet Aggregation Inhibitors; Renal Dialysis; Thrombosis | 2009 |
Dipyridamole plus aspirin and hemodialysis graft patency.
Topics: Aspirin; Blood Vessel Prosthesis; Dipyridamole; Drug Therapy, Combination; Graft Occlusion, Vascular; Humans; Hyperplasia; Platelet Aggregation Inhibitors; Renal Dialysis; Rheology; Thrombosis | 2009 |
Dipyridamole plus aspirin and hemodialysis graft patency.
Topics: Aspirin; Blood Vessel Prosthesis; Dipyridamole; Drug Therapy, Combination; General Surgery; Graft Occlusion, Vascular; Humans; Platelet Aggregation Inhibitors; Renal Dialysis; Thrombosis | 2009 |
[Guidelines recommend aspirin/dipyridamole retard in high recurrence risk. Well protected from the second stroke].
Topics: Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Cerebral Infarction; Clinical Trials as Topic; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Humans; Ischemic Attack, Transient; Practice Guidelines as Topic; Secondary Prevention | 2009 |
Aspirin for prevention of stroke and cardiovascular events among patients with peripheral artery disease.
Topics: Aspirin; Cardiovascular Diseases; Dipyridamole; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Publication Bias | 2009 |
Medical treatment of patients with intracranial atherosclerotic disease.
Topics: Anticoagulants; Aspirin; Atherosclerosis; Brain Ischemia; Cilostazol; Clopidogrel; Dipyridamole; Embolism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Arteriosclerosis; Intracranial Thrombosis; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Risk Factors; Tetrazoles; Ticlopidine | 2009 |
ProFESS trial: any lessons to learn for future anti-platelet trials?
Topics: Aged; Aspirin; Brain; Cerebral Arteries; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Risk Reduction Behavior; Stroke; Ticlopidine | 2009 |
Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Contraindications; Dipyridamole; Drug Incompatibility; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Fibrinolytic Agents; Humans; Incidence; Injections, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Assessment; Stroke; Ticlopidine; Tissue Plasminogen Activator; Treatment Outcome; Young Adult | 2010 |
Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Female; Humans; Male; Middle Aged; Patient Compliance; Platelet Aggregation Inhibitors; Recurrence; Retrospective Studies; Stroke; Survivors; Ticlopidine; Treatment Outcome; Young Adult | 2010 |
Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD.
Topics: Anticoagulants; Aspirin; Dipyridamole; Female; Gastrointestinal Hemorrhage; Heart Ventricles; Heart-Assist Devices; Heparin; Humans; Incidence; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Warfarin | 2010 |
Antiplatelet drugs and risk of subarachnoid hemorrhage: a population-based case-control study.
Topics: Adolescent; Adult; Aged; Aspirin; Case-Control Studies; Clopidogrel; Denmark; Dipyridamole; Female; Humans; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Registries; Risk; Subarachnoid Hemorrhage; Ticlopidine; Time Factors; Young Adult | 2010 |
Dipyridamole with low-dose aspirin augments the infarct size-limiting effects of simvastatin.
Topics: Animals; Aspirin; CREB-Binding Protein; Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Simvastatin | 2010 |
A multi-case report of acute renal failure in patients treated with Aggrenox.
Topics: Acute Kidney Injury; Aspirin; Aspirin, Dipyridamole Drug Combination; Creatinine; Dipyridamole; Drug Combinations; Humans | 2010 |
Incomplete Kawasaki disease in a patient with chronic granulomatous disease.
Topics: Aspirin; Child, Preschool; Coronary Aneurysm; Coronary Angiography; Dipyridamole; Follow-Up Studies; Granulomatous Disease, Chronic; Humans; Immunoglobulins, Intravenous; Male; Monitoring, Physiologic; Mucocutaneous Lymph Node Syndrome; Risk Assessment; Severity of Illness Index; Time Factors | 2010 |
[Myocardial infarction after voluntary intoxication by drug interaction between dipyridamole and aspirin].
Topics: Aspirin; Dipyridamole; Drug Interactions; Humans; Male; Middle Aged; Myocardial Infarction; Suicide, Attempted | 2010 |
Invited commentary.
Topics: Acenocoumarol; Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans; Phenprocoumon; Vitamin K | 2010 |
Paradoxical embolism.
Topics: Aged; Aspirin; Clopidogrel; Dipyridamole; Dyspnea; Echocardiography, Transesophageal; Embolism, Paradoxical; Female; Heart Atria; Humans; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine; Tomography, X-Ray Computed; Treatment Outcome; Walking | 2010 |
TIAs - management in general practice.
Topics: Anticoagulants; Antihypertensive Agents; Aspirin; Atorvastatin; Clopidogrel; Dipyridamole; Dopamine Antagonists; General Practitioners; Heptanoic Acids; Humans; Hypolipidemic Agents; Ischemic Attack, Transient; Perindopril; Platelet Aggregation Inhibitors; Primary Health Care; Prochlorperazine; Pyrroles; Ticlopidine; Vasodilator Agents; Warfarin | 2010 |
Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy.
Topics: Adolescent; Adult; Aspirin; Dipyridamole; Female; Fibrinolysis; Humans; Male; Plasminogen Activator Inhibitor 1; Platelet Aggregation Inhibitors; Protein Stability; Skin Diseases; Vascular Diseases | 2011 |
Effects of extended-release dipyridamole in vitro on thrombin indices measured by calibrated automated thrombography in poststroke survivors.
Topics: Aged; Aspirin; Brain Ischemia; Delayed-Action Preparations; Dipyridamole; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation Inhibitors; Stroke; Survivors; Thrombin; Time Factors | 2012 |
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (NICE technology appraisal guidance 90).
Topics: Aspirin; Clopidogrel; Constriction, Pathologic; Delayed-Action Preparations; Dipyridamole; Drugs, Generic; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Ticlopidine; Vascular Diseases | 2011 |
What is the best antiplatelet agent for prevention of recurrent stroke in Pakistani patients? Do combinations offer significant advantages in the South Asian context?
Topics: Asian People; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Evidence-Based Medicine; Follow-Up Studies; Humans; Pakistan; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome | 2010 |
What is the best first agent to give to a patient with acute ischaemic stroke? Aspirin, heparin, clopidogrel, cilostazol or dipyridamole?
Topics: Aspirin; Brain Ischemia; Cilostazol; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Evidence-Based Medicine; Fibrinolytic Agents; Heparin; Humans; Platelet Aggregation Inhibitors; Stroke; Tetrazoles; Ticlopidine | 2010 |
Aspirin and arteriovenous graft thrombosis in hemodialysis: just what the doctor ordered?
Topics: Arteriovenous Shunt, Surgical; Aspirin; Chronic Disease; Dipyridamole; Humans; Kidney Diseases; Platelet Aggregation Inhibitors; Renal Dialysis; Thrombosis; Treatment Outcome | 2011 |
Use of the oral platelet inhibitors dipyridamole and acetylsalicylic acid is associated with increased risk of fracture.
Topics: Acute Coronary Syndrome; Adult; Aged; Aspirin; Case-Control Studies; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Fractures, Bone; Humans; Male; Middle Aged; Osteoporosis; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Risk; Ticlopidine | 2012 |
Meta-analysis and sensitivity analysis for multi-arm trials with selection bias.
Topics: Aspirin; Blood Platelet Disorders; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Meta-Analysis as Topic; Models, Statistical; Selection Bias | 2011 |
Calculation of numbers-needed-to-treat in parallel group trials assessing ordinal outcomes: case examples from acute stroke and stroke prevention.
Topics: Aged; Algorithms; Aspirin; Aspirin, Dipyridamole Drug Combination; Clinical Trials as Topic; Confidence Intervals; Dipyridamole; Drug Combinations; Female; Fibrinolytic Agents; Humans; Male; Platelet Aggregation Inhibitors; Research Design; Sample Size; Stroke; Tissue Plasminogen Activator; Treatment Outcome | 2011 |
Central and hemicentral retinal vein occlusion: role of anti-platelet aggregation agents and anticoagulants.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cohort Studies; Dipyridamole; Female; Humans; Macular Edema; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Retinal Hemorrhage; Retinal Vein Occlusion; Treatment Outcome; Visual Acuity; Visual Field Tests; Visual Fields; Warfarin; Young Adult | 2011 |
Experience with distal finger replantation: a 20-year retrospective study from a major trauma center.
Topics: Adult; Amputation, Traumatic; Anastomosis, Surgical; Animals; Anticoagulants; Aspirin; Dipyridamole; Female; Fingers; Heparin, Low-Molecular-Weight; Humans; Leeching; Length of Stay; Male; Microscopy; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Complications; Replantation; Retrospective Studies; Trauma Centers | 2011 |
Level of systolic blood pressure within the normal range and risk of recurrent stroke.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Blood Pressure; Brain Ischemia; Clopidogrel; Diastole; Dipyridamole; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Reference Values; Risk; Stroke; Systole; Telmisartan; Ticlopidine; Vascular Diseases | 2011 |
A method for anticoagulation of children on mechanical circulatory support.
Topics: Adolescent; Anticoagulants; Aspirin; Child; Child, Preschool; Dipyridamole; Female; Heart-Assist Devices; Heparin; Humans; Infant; Infant, Newborn; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Retrospective Studies; Thrombelastography | 2011 |
Persistence, adherence and outcomes with antiplatelet regimens following cerebral infarction in the Tayside Stroke Cohort.
Topics: Aged; Aspirin; Cerebral Infarction; Clopidogrel; Cohort Studies; Dipyridamole; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization; Female; Humans; Male; Medical Record Linkage; Medical Records Systems, Computerized; Medication Adherence; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Proportional Hazards Models; Radiography; Risk Assessment; Risk Factors; Scotland; Survival Analysis; Ticlopidine; Time Factors; Treatment Outcome | 2012 |
Antiplatelet therapy for transient ischemic attack.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; Clopidogrel; Cognition Disorders; Diffusion Magnetic Resonance Imaging; Dipyridamole; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Primary Prevention; Prognosis; Secondary Prevention; Stroke; Ticlopidine | 2012 |
Budd-Chiari syndrome in children and outcome after liver transplant.
Topics: Anticoagulants; Aspirin; Budd-Chiari Syndrome; Child, Preschool; Dipyridamole; Factor V; Female; Gastroenteritis; Hepatic Veins; Heterozygote; Homozygote; Humans; IgA Deficiency; Liver Diseases; Liver Transplantation; Male; Mutation; Treatment Outcome; Venous Thrombosis | 2012 |
Comparison of the protective effect of dipyridamole and acetylsalicylic acid on long-term histologic damage in a rat model of testicular ischemia-reperfusion injury.
Topics: Animals; Apoptosis; Aspirin; Dipyridamole; Disease Models, Animal; Drug Administration Schedule; In Situ Nick-End Labeling; Injections, Intraperitoneal; Male; Platelet Aggregation Inhibitors; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Spermatic Cord Torsion; Spermatozoa; Testis; Treatment Outcome | 2012 |
Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Platelets; Brain Ischemia; Clopidogrel; Cross-Sectional Studies; Dipyridamole; Drug Combinations; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Stroke; Ticlopidine | 2013 |
Secondary stroke prevention: misguided by guidelines?
Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Retrospective Studies; Secondary Prevention; Stroke; Ticlopidine | 2012 |
Use of antithrombotic agents in patients with intracerebral cavernous malformations.
Topics: Aged; Aspirin; Cerebral Hemorrhage; Dipyridamole; Female; Fibrinolytic Agents; Follow-Up Studies; Hemangioma, Cavernous, Central Nervous System; Humans; Male; Middle Aged; Risk Factors; Warfarin | 2013 |
Longitudinal assessment of thrombin generation potential in response to alteration of antiplatelet therapy after TIA or ischaemic stroke.
Topics: Adult; Aged; Aspirin; Clopidogrel; Dipyridamole; Female; Humans; Ischemic Attack, Transient; Longitudinal Studies; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Statistics, Nonparametric; Stroke; Thrombin; Ticlopidine | 2013 |
Long-term effects of secondary prevention on cognitive function in stroke patients.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Aspirin; Cognition Disorders; Dipyridamole; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Longitudinal Studies; Male; Middle Aged; Platelet Aggregation Inhibitors; Prevalence; Registries; Risk Factors; Stroke | 2013 |
Spray drying as a fast and simple technique for the preparation of extended release dipyridamole (DYP) microparticles in a fixed dose combination (FDC) product with aspirin.
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Microscopy, Electron, Scanning; Particle Size; Solubility; Technology, Pharmaceutical; X-Ray Diffraction | 2014 |
Implications of aspirin biochemistry in the pathobiology of ischemic cerebrovascular disease.
Topics: Aspirin; Dipyridamole; Female; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Male; Randomized Controlled Trials as Topic; Stroke | 2014 |
Enteric-coated aspirin versus other antiplatelet drugs in acute non-cardioembolic ischemic stroke: post-marketing study in Japan.
Topics: Aged; Aged, 80 and over; Aspirin; Cerebral Hemorrhage; Cerebral Infarction; Cilostazol; Dipyridamole; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Japan; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Secondary Prevention; Stroke; Succinates; Tablets, Enteric-Coated; Tetrazoles; Ticlopidine | 2014 |
Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke.
Topics: Adult; Aged; Aspirin; Clopidogrel; Dipyridamole; Enzyme-Linked Immunosorbent Assay; Female; Humans; Ischemic Attack, Transient; Longitudinal Studies; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Protein Precursors; Statistics, Nonparametric; Stroke; Ticlopidine; Time Factors; von Willebrand Factor | 2014 |
Syncope during a pharmacologic nuclear stress test.
Topics: Adenosine; Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Drug Interactions; Exercise Test; Female; Heart Arrest; Humans; Middle Aged; Platelet Aggregation Inhibitors; Radiopharmaceuticals; Syncope | 2014 |
A serious complication of a common stress test (May 2014).
Topics: Adenosine; Aspirin; Dipyridamole; Female; Heart Arrest; Humans; Platelet Aggregation Inhibitors; Radiopharmaceuticals; Syncope | 2014 |
In reply.
Topics: Adenosine; Aspirin; Dipyridamole; Female; Heart Arrest; Humans; Platelet Aggregation Inhibitors; Radiopharmaceuticals; Syncope | 2014 |
Dipyridamole-induced headache and lower recurrence risk in secondary prevention of ischaemic stroke: a post hoc analysis.
Topics: Aged; Aspirin; Brain Ischemia; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Female; Headache; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Risk; Secondary Prevention; Stroke; Treatment Outcome | 2014 |
Regular dipyridamole therapy produces sustained protection against cardiac ischemia-reperfusion injury: is it time to revisit PARIS?
Topics: Animals; Aspirin; Cardiotonic Agents; Dipyridamole; Drug Therapy, Combination; Guinea Pigs; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Time Factors | 2014 |
A selection model for accounting for publication bias in a full network meta-analysis.
Topics: Aspirin; Bayes Theorem; Dipyridamole; Drug Combinations; Humans; Markov Chains; Meta-Analysis as Topic; Placebos; Platelet Aggregation Inhibitors; Publication Bias; Randomized Controlled Trials as Topic; Research Design; Sample Size | 2014 |
Antiplatelets Versus Anticoagulation for Cervical Arterial Dissection.
Topics: Anticoagulants; Aortic Dissection; Aspirin; Carotid Artery, Internal, Dissection; Cervical Vertebrae; Clopidogrel; Dipyridamole; Drug Administration Schedule; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Ticlopidine; Treatment Outcome; Vertebral Artery Dissection | 2015 |
Underutilisation of Guideline-based Therapy Primary Prevention among Patients Presenting with AF-related Ischaemic Stroke.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Clopidogrel; Dabigatran; Dipyridamole; Female; Guideline Adherence; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Primary Prevention; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Ticlopidine; Warfarin | 2015 |
Comparison of antiplatelet regimens in secondary stroke prevention: a nationwide cohort study.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Cohort Studies; Denmark; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Recurrence; Registries; Secondary Prevention; Stroke; Ticlopidine | 2015 |
Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support.
Topics: Adult; Aged; Anticoagulants; Aspirin; Chi-Square Distribution; Dipyridamole; Disease-Free Survival; Drug Therapy, Combination; Female; Heart Failure; Heart-Assist Devices; Hemorrhage; Humans; International Normalized Ratio; Kaplan-Meier Estimate; Linear Models; Male; Middle Aged; Multivariate Analysis; New York City; Platelet Aggregation Inhibitors; Prevalence; Proportional Hazards Models; Prosthesis Design; Retrospective Studies; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Treatment Outcome; Ventricular Function, Left; Warfarin | 2016 |
Continuation and adherence rates on initially-prescribed intensive secondary prevention therapy after Rapid Access Stroke Prevention (RASP) service assessment.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Humans; Incidence; Male; Medication Adherence; Middle Aged; Recurrence; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome; Warfarin; Young Adult | 2016 |
Simultaneous Determination of Aspirin, Dipyridamole and Two of Their Related Impurities in Capsules by Validated TLC-Densitometric and HPLC Methods.
Topics: Acetates; Aspirin; Capsules; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Densitometry; Dipyridamole; Hydrogen-Ion Concentration; Methanol; Reproducibility of Results; Salicylic Acid; Solvents; Tartrates; Toluene | 2016 |
The difference in association between aspirin use and other thrombocyte aggregation inhibitors and survival in patients with colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Colorectal Neoplasms; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Netherlands; Platelet Aggregation Inhibitors; Survival Analysis; Ticlopidine | 2017 |
Capillary leak syndrome and aseptic meningitis in a patient with Kawasaki disease: A case report.
Topics: Aspirin; Capillary Leak Syndrome; Dipyridamole; Diuretics; Furosemide; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Infant; Male; Mannitol; Meningitis, Aseptic; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Platelet Aggregation Inhibitors; Serum Albumin, Human | 2018 |
Prescribing patterns of oral antiplatelets in Wales: evolving trends from 2005 to 2016.
Topics: Administration, Oral; Aspirin; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Prasugrel Hydrochloride; Retrospective Studies; Ticagrelor; Wales | 2018 |
Acute myocarditis as a revealing clue of complete Kawasaki disease.
Topics: Acute Disease; Aspirin; Child, Preschool; Dipyridamole; Drug Substitution; Female; Humans; Immunoglobulins, Intravenous; Mucocutaneous Lymph Node Syndrome; Myocarditis; Shock, Cardiogenic | 2018 |
Effect of Antiplatelet Therapy (Aspirin + Dipyridamole Versus Clopidogrel) on Mortality Outcome in Ischemic Stroke.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Secondary Prevention; Stroke; Treatment Outcome | 2018 |
The Safety of Continuing Antiplatelet Medication Among Elderly Patients Undergoing Urgent Hip Fracture Surgery.
Topics: Aged; Aged, 80 and over; Aspirin; Blood Loss, Surgical; Blood Transfusion; Dipyridamole; Drug Therapy, Combination; Emergencies; Female; Hip Fractures; Humans; Male; Mortality; Platelet Aggregation Inhibitors; Retrospective Studies | 2019 |
Intensive antiplatelet therapy with three agents does not reduce risk of another stroke.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Stroke | 2020 |
Stomach pH before vs. after different bariatric surgery procedures: Clinical implications for drug delivery.
Topics: Administration, Oral; Adult; Aspirin; Bariatric Surgery; Dipyridamole; Drug Liberation; Female; Gastric Mucosa; Gastrointestinal Contents; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Postoperative Period; Preoperative Period; Tablets | 2021 |
Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke.
Topics: Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Risk Assessment; Stroke; Ticlopidine; Treatment Outcome | 2021 |
Use of dipyridamole is associated with lower risk of lymphoid neoplasms: a propensity score-matched cohort study.
Topics: Aged; Aged, 80 and over; Aspirin; Chemoprevention; Comorbidity; Dipyridamole; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Lymphoid; Lymphoma; Male; Middle Aged; Platelet Aggregation Inhibitors; Population Surveillance; Propensity Score; Proportional Hazards Models; Registries; Risk Assessment; Risk Factors; Sweden | 2022 |
Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic stroke.
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Brain Ischemia; Dipyridamole; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Stroke | 2022 |
Antiplatelet agents aspirin and dipyridamole, and the risk of different carcinoma in patients with type 2 diabetes mellitus: A Taiwan retrospective cohort study.
Topics: Aspirin; Carcinoma; Diabetes Mellitus, Type 2; Dipyridamole; Humans; Liver Neoplasms; Platelet Aggregation Inhibitors; Retrospective Studies; Taiwan | 2022 |
Antiplatelet drugs and breast cancer risk in a large nationwide Danish case-control study.
Topics: Aspirin; Breast Neoplasms; Case-Control Studies; Clopidogrel; Denmark; Dipyridamole; Female; Humans; Logistic Models; Middle Aged; Platelet Aggregation Inhibitors | 2023 |
Dipyridamole enhances the anti-cancer ability of aspirin against colorectal cancer by inducing apoptosis in an unfolded protein response-dependent manner.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Aspirin; Colorectal Neoplasms; Dipyridamole; Humans; Mice; Unfolded Protein Response | 2023 |